{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "SVNS.L",
  "generated_at": "2026-02-11T23:07:24.303648Z",
  "top_card": {
    "ticker": "SVNS.L",
    "company_name": "Solvonis Therapeutics plc",
    "sector": "Industrials",
    "market_cap_gbp": 17696648,
    "days_active": 338,
    "apex_score_100": 61,
    "confidence_score_100": 45,
    "ai_final_score_25": 15,
    "ai_strength": "STRONG",
    "timing_regime": "EARLY_BUILD",
    "action": "WATCH",
    "thesis_one_liner": "WATCH - EARLY_BUILD timing with 61/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Solvonis Therapeutics plc",
      "sector": "Industrials",
      "industry": "Specialty Industrial Machinery",
      "exchange": "LSE",
      "market": "MAIN",
      "currency": "GBP",
      "risk_tier": "Low Risk",
      "current_market_cap": 17696648,
      "current_close_price": 0.26
    },
    "basics": {
      "ticker": "SVNS.L",
      "current_price": 0.26,
      "ath": 22.463,
      "atl": 0.1,
      "ath_date": "2022-01-06",
      "atl_date": "2024-03-15",
      "week_52_high": 0.4,
      "week_52_low": 0.11,
      "week_52_high_date": "2025-10-07",
      "week_52_low_date": "2025-04-17",
      "drawdown_from_ath_pct": 98.84,
      "data_start": "2022-01-06",
      "data_end": "2026-02-11",
      "total_bars": 868
    },
    "latest_signal": {
      "date": "2025-03-10",
      "scan_date": "2026-01-26",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "price": 0.155,
      "drawdown_pct": 88.98,
      "ai_score": 12.0,
      "rsi": 20.0,
      "cycle_position": 0.0505,
      "holding_period_days": 338,
      "current_pnl_pct": 67.74,
      "rally_state": "pulling_back",
      "distance_from_high_pct": -29.74,
      "Rally_Count": 3,
      "days_since_last_high": 19,
      "last_high_date": "2026-01-07",
      "lock_in_reached": true,
      "lock_in_date": "2025-10-07",
      "best_rally_pct": 151.61
    },
    "best_historical_signal": {
      "signal_date": "2024-04-08",
      "signal_type": "EXTREME CRASH BOTTOM",
      "signal_color": "ORANGE",
      "entry_price": 0.135,
      "peak_price": 1.407,
      "peak_date": "2024-05-31",
      "rally_pct": 942.22,
      "days_to_peak": 53,
      "ai_score": 13.0
    },
    "all_historical_signals": [
      {
        "signal_id": "SVNS.L_2023-09-27",
        "signal_date": "2023-09-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.7,
        "current_price": 0.274,
        "current_return_pct": -83.88,
        "best_rally_pct": 8.82,
        "best_rally_date": "2023-10-09",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -85.19,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 852,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-09-28",
        "signal_date": "2023-09-28",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.65,
        "current_price": 0.274,
        "current_return_pct": -83.39,
        "best_rally_pct": 12.12,
        "best_rally_date": "2023-10-09",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -85.19,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 851,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-11-16",
        "signal_date": "2023-11-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.4,
        "current_price": 0.274,
        "current_return_pct": -80.43,
        "best_rally_pct": -0.0,
        "best_rally_date": "2023-11-17",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 802,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-11-23",
        "signal_date": "2023-11-23",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.3,
        "current_price": 0.274,
        "current_return_pct": -78.92,
        "best_rally_pct": -3.85,
        "best_rally_date": "2023-11-24",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 795,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-11-24",
        "signal_date": "2023-11-24",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.25,
        "current_price": 0.274,
        "current_return_pct": -78.08,
        "best_rally_pct": 0.0,
        "best_rally_date": "2023-11-27",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 794,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-11-29",
        "signal_date": "2023-11-29",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.05,
        "current_price": 0.274,
        "current_return_pct": -73.9,
        "best_rally_pct": -0.0,
        "best_rally_date": "2023-11-30",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 789,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-11-30",
        "signal_date": "2023-11-30",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.05,
        "current_price": 0.274,
        "current_return_pct": -73.9,
        "best_rally_pct": -0.0,
        "best_rally_date": "2023-12-01",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 788,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-12-12",
        "signal_date": "2023-12-12",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.0,
        "current_price": 0.274,
        "current_return_pct": -72.6,
        "best_rally_pct": 1.0,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 776,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-12-19",
        "signal_date": "2023-12-19",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.0,
        "current_price": 0.274,
        "current_return_pct": -72.6,
        "best_rally_pct": 1.0,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 769,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-12-22",
        "signal_date": "2023-12-22",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.725,
        "current_price": 0.274,
        "current_return_pct": -62.21,
        "best_rally_pct": 39.31,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 766,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-12-28",
        "signal_date": "2023-12-28",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.66,
        "current_price": 0.274,
        "current_return_pct": -58.48,
        "best_rally_pct": 53.03,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 760,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2023-12-29",
        "signal_date": "2023-12-29",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.575,
        "current_price": 0.274,
        "current_return_pct": -52.35,
        "best_rally_pct": 75.65,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 759,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-01-02",
        "signal_date": "2024-01-02",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.575,
        "current_price": 0.274,
        "current_return_pct": -52.35,
        "best_rally_pct": 75.65,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 755,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-01-03",
        "signal_date": "2024-01-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.65,
        "current_price": 0.274,
        "current_return_pct": -57.85,
        "best_rally_pct": 55.38,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 754,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-03-04",
        "signal_date": "2024-03-04",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.65,
        "current_price": 0.274,
        "current_return_pct": -57.85,
        "best_rally_pct": 55.38,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 693,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-03-05",
        "signal_date": "2024-03-05",
        "signal_type": "ENHANCED DEEP CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 0.65,
        "current_price": 0.274,
        "current_return_pct": -57.85,
        "best_rally_pct": 55.38,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 692,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-03-06",
        "signal_date": "2024-03-06",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.525,
        "current_price": 0.274,
        "current_return_pct": -47.81,
        "best_rally_pct": 92.38,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 691,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-03-08",
        "signal_date": "2024-03-08",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.525,
        "current_price": 0.274,
        "current_return_pct": -47.81,
        "best_rally_pct": 92.38,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 689,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-03-15",
        "signal_date": "2024-03-15",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.25,
        "current_price": 0.274,
        "current_return_pct": 9.6,
        "best_rally_pct": 304.0,
        "best_rally_date": "2024-05-31",
        "rally_state": "pulling_back",
        "Rally_Count": 7,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 682,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-03-18",
        "signal_date": "2024-03-18",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.275,
        "current_price": 0.274,
        "current_return_pct": -0.36,
        "best_rally_pct": 267.27,
        "best_rally_date": "2024-05-31",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 679,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-04-08",
        "signal_date": "2024-04-08",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.135,
        "current_price": 0.274,
        "current_return_pct": 102.96,
        "best_rally_pct": 648.15,
        "best_rally_date": "2024-05-31",
        "rally_state": "pulling_back",
        "Rally_Count": 7,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 658,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-04-09",
        "signal_date": "2024-04-09",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.135,
        "current_price": 0.274,
        "current_return_pct": 102.96,
        "best_rally_pct": 648.15,
        "best_rally_date": "2024-05-31",
        "rally_state": "pulling_back",
        "Rally_Count": 7,
        "distance_from_high_pct": -72.87,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 657,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-07-03",
        "signal_date": "2024-07-03",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.135,
        "current_price": 0.274,
        "current_return_pct": 102.96,
        "best_rally_pct": 188.89,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 572,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-07-04",
        "signal_date": "2024-07-04",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.135,
        "current_price": 0.274,
        "current_return_pct": 102.96,
        "best_rally_pct": 188.89,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 571,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-07-05",
        "signal_date": "2024-07-05",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.115,
        "current_price": 0.274,
        "current_return_pct": 138.26,
        "best_rally_pct": 239.13,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 1,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 570,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-07-09",
        "signal_date": "2024-07-09",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 0.123,
        "current_price": 0.274,
        "current_return_pct": 122.76,
        "best_rally_pct": 217.07,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 566,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-07-10",
        "signal_date": "2024-07-10",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.143,
        "current_price": 0.274,
        "current_return_pct": 91.61,
        "best_rally_pct": 172.73,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 565,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-07-11",
        "signal_date": "2024-07-11",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.205,
        "current_price": 0.274,
        "current_return_pct": 33.66,
        "best_rally_pct": 90.24,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 564,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-07-18",
        "signal_date": "2024-07-18",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.19,
        "current_price": 0.274,
        "current_return_pct": 44.21,
        "best_rally_pct": 105.26,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 6,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 557,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2024-09-05",
        "signal_date": "2024-09-05",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.153,
        "current_price": 0.274,
        "current_return_pct": 79.08,
        "best_rally_pct": 154.9,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 508,
        "status": "historical"
      },
      {
        "signal_id": "SVNS.L_2025-03-10",
        "signal_date": "2025-03-10",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.155,
        "current_price": 0.274,
        "current_return_pct": 76.77,
        "best_rally_pct": 151.61,
        "best_rally_date": "2025-10-07",
        "rally_state": "pulling_back",
        "Rally_Count": 3,
        "distance_from_high_pct": -29.74,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 322,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 31,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 185.22,
      "median_rally_pct": 116.46,
      "best_rally_pct": 942.22,
      "worst_rally_pct": 8.23
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-02-11 20:06:44 UTC",
    "volatility": {
      "atr_normalized": 8.0,
      "stddev_20d": 0.5493
    },
    "trends": {
      "intelligence_signal": "DOWNTREND"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 61/100 indicates strong opportunity quality",
      "Timing regime: EARLY_BUILD",
      "Historical profile: 3 rallies, 152% best run"
    ],
    "main_risk": "Confidence 45/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "SVNS.L",
      "latest": [
        {
          "title": "Expansion of SVN-015 into depression",
          "announcement_date": "28th Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "28 Jan 2026 07:00\nRNS Number : 5931Q\nSolvonis Therapeutics PLC\n28 January 2026\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n28 January 2026\nSolvonis Therapeutics plc(\"Solvonis\" or the \"Company\")\nExpansion of SVN-015 into depression following positive preclinical data\nDemonstrates antidepressant-like activity benchmarked against fluoxetine (Prozac\u00ae), supporting potential in patients with inadequate SSRI response\nSolvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, announces the expansion of its investigational compound SVN-015 into the treatment of\ndepression\n, supported by preclinical data demonstrating antidepressant-like activity benchmarked against fluoxetine.\nKey highlights:\n\u00b7\nSVN-015 expanded into depression following positive preclinical data in validated rodent behavioural models\n\u00b7\nAntidepressant-like activity benchmarked against fluoxetine after 14-day, once-daily dosing\n\u00b7\nSVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor (\"SDRI\") designed to engage pathways central to mood, motivation and reward processing\n\u00b7\nSupports potential in patients with inadequate response to SSRIs in depression, including symptoms such as anhedonia and reduced motivation\n\u00b7\nSVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles\nIn a direct preclinical evaluation, SVN-015 demonstrated antidepressant-like activity comparable to fluoxetine following 14-day, once-daily dosing in validated rodent behavioural models widely used to assess antidepressant activity. Fluoxetine, a selective serotonin reuptake inhibitor (\"SSRI\"), is one of the most established benchmark compounds in antidepressant drug development.\nSVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor (\"SDRI\"), with patent applications filed, designed to engage pathways central to mood regulation, motivation, and reward processing. Despite widespread SSRI use, many patients fail to achieve adequate symptom control, particularly for symptoms such as anhedonia (feeling emotionally flat), reduced motivation, and impaired reward function. According to the U.S. National Institute of Mental Health (NIMH), Major Depressive Disorder (\"MDD\") affects more than 20 million adults in the United States annually, and tens of millions more across major international markets, including Europe and Japan.\nSVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, intended to support continuous symptom management within standard antidepressant treatment cycles. Its delivery model and reimbursement pathway are intended to align with established SSRI therapies, with potential advantages in scalability, patient access and long-term adherence.\nAs previously announced, SVN-015 has also been independently selected for evaluation within the U.S. National Institute on Drug Abuse (\"NIDA\") Addiction Treatment Discovery Program for stimulant use disorders, providing external, non-dilutive validation of the compound's pharmacological profile in a separate CNS indication. This programme is separate from Solvonis' research on depression.\nAnthony Tennyson, Chief Executive Officer, commented:\n\"\nDemonstrating antidepressant-like activity versus a gold-standard SSRI following repeat dosing is a notable preclinical signal, supporting SVN-015's expansion into research and development of small molecule therapies for depression.\"\nProfessor David Nutt, Chief Scientific Officer, added:\n\"These data are highly encouraging and reflect a mechanistically grounded approach engaging both serotonergic and dopaminergic systems. Demonstrating antidepressant-like effects under repeat-dose conditions supports further development of SVN-015 and the broader SDRI class as a potential new class of antidepressant medicines.\"\nEnquiries:\nSolvonis Therapeutics plc\nVia Walbrook\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets\n(Broker)\n+44 (0) 20 7496 3000\nPhil Davies\nWalbrook PR (PR/IR advisers)\nTel: +44 (0)20 7933 8780 or\nsolvonistherapeutics@walbrookpr.com\nAnna Dunphy\nMob: +44 (0)7876 741 001\nLianne Applegarth\nMob:\n+44 (0)7584 391 303\nRachel Broad\nMob:\u00a0+44 (0)7747 515 393\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction and psychiatry.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with additional development and discovery work supporting expansion into further addiction and psychiatric indications, including stimulant use disorder and depressive disorders.\nIts lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK, while SVN-002 is preparing for a Phase 2b trial in the US targeting moderate-to-severe AUD. The preclinical PTSD programme (SVN-SDN-14) leverages novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn parallel, Solvonis is advancing proprietary CNS discovery programmes supported by a dedicated compound library to identify new small-molecule modulators of key neurotransmitter systems. This platform enables efficient early-stage innovation and supports the Company's integrated approach to developing therapies across its three strategic pillars.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to deliver sustained value through innovation in CNS therapeutics.\nsolvonis.com\n|\nLinkedIn\n|\nX (Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCBSGDBGBDDGLR",
          "rns_number": "RNS Number : 5931Q"
        },
        {
          "title": "US Patent allowance for PTSD discovery programme",
          "announcement_date": "7th Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "7 Jan 2026 07:00\nRNS Number : 8747N\nSolvonis Therapeutics PLC\n07 January 2026\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nU.S. Patent allowance received for PTSD discovery programme\nDemonstrating scientific and commercial significance\nSolvonis Therapeutics plc (LSE: SVNS\n), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, announces that it has received a Notice of Allowance (the \"Allowance\") from the United States Patent and Trademark Office (\"USPTO\") for a series of compounds within its proprietary SVN-SDN-14 Post-Traumatic Stress Disorder (\"PTSD\") discovery programme. One compound from this series is currently being evaluated alongside other candidates, with a lead compound expected to be selected in Q1 2026 in line with prior guidance.\nThe Allowance strengthens the intellectual property foundations of SVN-SDN-14 at an important stage as the programme advances toward lead-candidate selection. In addition to this IP milestone, the Company is highlighting the scientific significance of the newly protected compounds in addressing long-standing challenges in the development of next-generation PTSD therapeutics.\nScientific significance\nSVN-SDN-14 is focused on developing serotonin (\"SERT\"), dopamine (\"DAT\") and noradrenaline (\"NET\") modulators designed to support pro-social engagement and improve the effectiveness of psychological therapy in PTSD.\nWhile balanced modulation of these pathways is increasingly recognised as therapeutically valuable, translating this biology into a practical medicine has historically been difficult. Key challenges have included controlling duration of action,\nmanaging variability between patients, and ensuring compatibility with scalable, real-world clinical use.\nThe newly allowed patent covers a novel chemical series designed to retain the core SERT, DAT and NET activity underpinning the programme, while introducing greater pharmacological control through predictable metabolic deactivation. This approach is intended to maintain therapeutic effects while improving dosing flexibility, safety margins and overall suitability for clinical use.\nIn allowing the claims, the USPTO examiner concluded that no existing patents or publications disclosed or suggested the claimed compounds, confirming the novelty of the approach.\nProfessor David Nutt, Chief Scientific Officer of Solvonis, commented:\n\"These compounds are scientifically exciting because they address a long-standing challenge in this field. They are designed to preserve the monoaminergic profile that supports positive social engagement in therapy, while introducing a level of pharmacokinetic control that has historically been difficult to achieve. This increases our confidence that the core biology of SVN-SDN-14 can be translated into a medicine that is practical to develop, regulate and ultimately deploy.\"\nAnthony Tennyson, Chief Executive Officer of Solvonis, added:\n\"This patent allowance strengthens both the scientific and commercial foundations of our PTSD programme. It reflects our strategy of combining rigorous neuroscience with disciplined medicinal chemistry to build differentiated, scalable CNS therapeutics.\"\nEnquiries:\nSolvonis Therapeutics plc\nVia Walbrook\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets\n(Broker)\n+44 (0) 20 7496 3000\nPhil Davies\nWalbrook PR (PR/IR advisers)\nTel: +44 (0)20 7933 8780 or\nsolvonistherapeutics@walbrookpr.com\nAnna Dunphy\nMob: +44 (0)7876 741 001\nLianne Applegarth\nMob:\n+44 (0)7584 391 303\nRachel Broad\nMob:\u00a0+44 (0)7747 515 393\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction, psychiatry, and neurology.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with additional discovery work supporting expansion into broader CNS indications. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK, while SVN-002 is preparing for a Phase 2b trial in the US targeting moderate-to-severe AUD. The preclinical PTSD programme (SVN-SDN-14) leverages novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn parallel, Solvonis is advancing proprietary CNS discovery programmes built on a dedicated compound library to identify new small-molecule modulators of key neurotransmitter systems. This platform enables efficient early-stage innovation and supports the Company's integrated approach to developing therapies across its three strategic pillars.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to deliver sustained value through innovation in CNS therapeutics.\nsolvonis.com\n|\nLinkedIn\n|\nX (Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCEASFKELSKEFA",
          "rns_number": "RNS Number : 8747N"
        },
        {
          "title": "Research and Development Update - Q4 2025",
          "announcement_date": "22nd Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "22 Dec 2025 07:00\nRNS Number : 3621M\nSolvonis Therapeutics PLC\n22 December 2025\n22 December 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nResearch and Development Update - Q4 2025\nPipeline advancing across addiction and psychiatry with multiple 2026 catalysts\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders,\nprovides an update on progress across its development pipeline and discovery programmes as the Company concludes 2025 and enters a catalyst-rich period in 2026.\nPipeline development advancing across addiction and psychiatry\nSVN-001 | Severe Alcohol Use Disorder (AUD) - UK & EU\nThe Company's lead programme, SVN-001, continues to advance through a potentially pivotal Phase 3 clinical trial for severe AUD in the United Kingdom, addressing a large and underserved patient population across the UK and EU. In parallel, the Company continues to progress licensing and commercial-partnership discussions.\nRecruitment remains ongoing in this\nNHS\n-based study, conducted in collaboration with the University of Exeter (\"\nUoE\n\") and co-funded by the National Institute for Health and Care Research (\"\nNIHR\n\"), the Medical Research Council (\"\nMRC\n\"), and Solvonis. Top-line results are anticipated in late 2027 / early 2028. In parallel, with potential partners in UK and internationally.\nSVN-002 | Moderate-to-Severe AUD - Global (ex-UK & EU) | Initial focus: United States\nSVN-002, Solvonis' proprietary esketamine oral thin-film programme, is being advanced under a planned U.S. FDA 505(b)(2) regulatory pathway referencing Johnson & Johnson's blockbuster esketamine product, Spravato\u00ae.\nDuring Q4 2025, preparatory work continued with WuXi AppTec on a pharmacokinetic bridging programme to support regulatory alignment. Initial data are expected in Q1 2026, with further progress through Q2 2026.\nIf the scientific bridge to Spravato\u00ae is successfully established the Company plans to promptly seek approval from the US Food and Drug Administration (\"\nFDA\n\") for a Phase 2b trial, thereby potentially avoiding the significant costs associated with pre-clinical programmes and Phase1 and Phase 2a trials.\nThe programme targets approximately 15 million adults in the United States living with moderate-to-severe AUD and represents a differentiated, clinic-based therapeutic approach within a large and underserved market.\nSVN-015 | Stimulant (Methamphetamine and Cocaine) Use Disorder\nIn December 2025, Solvonis announced that SVN-015, a novel compound emerging from its AI-enabled discovery programme, was accepted into the U.S. National Institute on Drug Abuse's (\"\nNIDA\n\") Addiction Treatment Discovery Program (\"\nATDP\n\").\nUnder the programme, NIDA - part of the U.S. National Institutes of Health (\"\nNIH\n\") - will fund and conduct a standard package of preclinical safety and pharmacology studies, including cardiovascular risk assessment. Initial results are expected in Q1 2026. Subject to supportive outcomes, SVN-015 may progress into further NIDA-funded efficacy testing in validated models of methamphetamine and cocaine addiction.\nAcceptance into ATDP represents an important external validation of Solvonis' proprietary discovery platform and expands the Company's pipeline beyond alcohol use disorder into stimulant addictions, which remain among the most severe psychiatric conditions with no approved pharmacological treatments.\nSuccessful completion of the ATDP programme would position Solvonis to compete for subsequent NIH development funding, including potential UG3/UH3 awards, providing a non-dilutive pathway from preclinical validation toward clinical development.\nSVN-SDN-14 | Post-Traumatic Stress Disorder (PTSD)\nFollowing the announcement of positive preclinical data in August 2025, Solvonis' proprietary serotonin-dopamine-noradrenalin modulator programme continues to progress through final in-vivo studies designed to support lead-candidate selection.\nFour compounds are currently being evaluated in rat brain microdialysis studies to confirm central pharmacokinetics and target engagement across relevant monoaminergic pathways. Lead-candidate selection is expected in Q1 2026, after which the Company intends to advance the selected compound into IND-enabling studies.\nAI-enabled CNS discovery platform\nBeyond SVN-015 and SVN-SDN-14, Solvonis continues to advance its AI-enabled discovery programme, generating novel small-molecule candidates targeting key neurotransmitter systems relevant to addiction and psychiatry. Exploratory work is also underway to assess potential applications in neurology.\nFurther updates on discovery-stage progress are expected during H1 2026 as compound evaluation and prioritisation continue.\nAnthony Tennyson, Chief Executive Officer of Solvonis Therapeutics plc, commented:\n\"\n2025 has been a transformative year for Solvonis. The completion of the acquisition of Awakn Life Sciences in May materially reshaped the Company, establishing a differentiated CNS platform spanning late-stage clinical development, earlier-stage discovery, and multiple regulatory pathways.\n\"Over the course of the year, we have advanced our clinical programmes with discipline, strengthened our balance sheet, and progressed our proprietary discovery capability, including securing external validation through the acceptance of SVN-015 into the U.S. National Institute on Drug Abuse's Addiction Treatment Discovery Program.\n\"As we look ahead to 2026, the Company is entering a period with multiple clearly defined catalysts across regulatory, preclinical, and discovery activities. Our strategy remains centred on capital efficiency, clear regulatory pathways, and partnering optionality, which we believe provides near, medium, and long-term shareholder value creation opportunities.\"\nOutlook\nSolvonis enters 2026 with a diversified CNS pipeline spanning late-stage clinical development, near-term regulatory catalysts, and early-stage discovery programmes supported by external validation and non-dilutive funding pathways.\nThe Company remains focused on disciplined execution across its addiction and psychiatry programmes while continuing to selectively expand its proprietary discovery platform.\nEnquiries:\nSolvonis Therapeutics plc\nVia Walbrook\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets\n(Broker)\n+44 (0) 20 7496 3000\nPhil Davies\nWalbrook PR (PR/IR advisers)\nTel: +44 (0)20 7933 8780 or\nsolvonistherapeutics@walbrookpr.com\nAnna Dunphy\nMob: +44 (0)7876 741 001\nLianne Applegarth\nMob:\n+44 (0)7584 391 303\nRachel Broad\nMob:\u00a0+44 (0)7747 515 393\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction, psychiatry, and neurology.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with additional discovery work supporting expansion into broader CNS indications. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK, while SVN-002 is preparing for a Phase 2b trial in the US targeting moderate-to-severe AUD. The preclinical PTSD programme (SVN-SDN-14) leverages novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn parallel, Solvonis is advancing proprietary CNS discovery programmes built on a dedicated compound library to identify new small-molecule modulators of key neurotransmitter systems. This platform enables efficient early-stage innovation and supports the Company's integrated approach to developing therapies across its three strategic pillars.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to deliver sustained value through innovation in CNS therapeutics.\nsolvonis.com\n|\nLinkedIn\n|\nX (Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nUPDPKCBBOBDDFBD",
          "rns_number": "RNS Number : 3621M"
        },
        {
          "title": "SVN-015 accepted into US NIDA funded programme",
          "announcement_date": "3rd Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "3 Dec 2025 07:00\nRNS Number : 9389J\nSolvonis Therapeutics PLC\n03 December 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nSolvonis' Novel Compound SVN-015 Accepted into US NIDA-Funded Addiction Treatment Discovery Program for Methamphetamine and Cocaine Addiction\nSolvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (CNS) disorders, announces that its novel AI-discovered compound, SVN-015, targeting methamphetamine and cocaine use disorders, has been accepted into the US National Institute on Drug Abuse's (\"NIDA\") Addiction Treatment Discovery Program (\"ATDP\"). Under the programme, NIDA, part of the US National Institutes of Health (\"NIH\"), will fund and conduct early preclinical evaluation of SVN-015.\nProgramme Overview\nIn the first stage of the programme, NIDA will fund and carry out\nin vitro\npredictive safety studies on SVN-015 to assess potential cardiovascular risks. These tests are the normal first step in the development of any new medicine. If the results are supportive, SVN-015 could advance into ATDP efficacy studies in validated preclinical models of methamphetamine and cocaine addiction.\nIf the efficacy studies are successful, Solvonis would be well positioned to compete for a non-dilutive NIH research grant, which can provide up to US$3 million per year for as long as five years. These grants are competitive, but completion of early preclinical studies would provide the type of safety and efficacy data needed to support Solvonis' grant application. This creates a potential pathway from funded NIDA preclinical work through to potential NIH-funded clinical trials in humans.\nStrategic Significance\nAcceptance of SVN-015 into the ATDP marks an important milestone for Solvonis as it expands the Company's research in addiction beyond alcohol use disorder (\"AUD\") into stimulant addictions - specifically methamphetamine and cocaine - which remain among the most severe psychiatric conditions with no approved drug treatments.\nProfessor David Nutt, Solvonis Chief Scientific Officer, commented\n\"Being accepted into NIDA's ATDP for SVN-015 is a major step forward for Solvonis. ATDP provides a pathway for evaluating the therapeutic potential of SVN-015, starting with early preclinical testing and, if successful, creating the opportunity to progress towards NIH clinical development funding through the UG3/UH3 programme. For methamphetamine and cocaine addiction - where no approved drug treatments exist - this represents an important advance.\"\nEnquiries:\nSolvonis Therapeutics plc\nVia Walbrook\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets\n(Broker)\n+44 (0) 20 7496 3000\nPhil Davies\nWalbrook PR (PR/IR advisers)\nTel: +44 (0)20 7933 8780 or\nsolvonistherapeutics@walbrookpr.com\nAnna Dunphy\nMob: +44 (0)7876 741 001\nLianne Applegarth\nMob:\n+44 (0)7584 391 303\nMarcus Ulker\nMob:\u00a0+44 (0)7867 984 082\nAbout SVN-015\nSVN-015 is the second compound emerging from Solvonis' AI-enabled drug discovery programme to progress into external validation, following the advancement of SVN-SDN-14 for Post-Traumatic Stress Disorder. It is a novel candidate designed to address stimulant addictions - including methamphetamine and cocaine dependence - areas with significant unmet need and no currently approved pharmacological treatments.\nAbout NIDA\nThe US National Institute on Drug Abuse (\"NIDA\") is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science.\nAbout Methamphetamine and Cocaine Addiction\nMethamphetamine and cocaine addiction remain major public health challenges. There are no approved pharmacological treatments; patients are managed only with psychosocial interventions, which deliver limited and inconsistent outcomes. Both NIDA and the European Monitoring Centre for Drugs and Drug Addiction (\"EMCDDA\") identify stimulant use disorders as areas of critical unmet need, associated with high morbidity, mortality, and significant societal costs.\nEpidemiological data highlights the scale of the problem. In the United States, the National Survey on Drug Use and Health (\"SAMHSA 2022\") estimates approximately 2.6 million people meet diagnostic criteria for cocaine or methamphetamine use disorders. In the EU5, EMCDDA data indicate 0.35-0.5 million patients, predominantly with cocaine dependence. In Japan, national data suggest around 0.1 million patients, largely with methamphetamine dependence. Taken together, this represents a combined total of around 3.0-3.2 million individuals across the seven major markets - a large population with no existing drug treatment options.\nThe content of this press release is solely the responsibility of Solvonis and does not necessarily represent the official views of the National Institutes of Health.\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction, psychiatry, and neurology.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with additional discovery work supporting expansion into broader CNS indications. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK, while SVN-002 is preparing for a Phase 2b trial in the US targeting moderate-to-severe AUD. The preclinical PTSD programme (SVN-SDN-14) leverages novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn parallel, Solvonis is advancing proprietary CNS discovery programmes built on a dedicated compound library to identify new small-molecule modulators of key neurotransmitter systems. This platform enables efficient early-stage innovation and supports the Company's integrated approach to developing therapies across its three strategic pillars.\nsolvonis.com\n|\nLinkedIn\n|\nX (Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCBUBDDXBGDGUD",
          "rns_number": "RNS Number : 9389J"
        },
        {
          "title": "Total Voting Rights",
          "announcement_date": "31st Oct 2025",
          "release_time": "3:59 pm",
          "source": "RNS",
          "content": "31 Oct 2025 15:59\nRNS Number : 7597F\nSolvonis Therapeutics PLC\n31 October 2025\n31 October 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nTotal Voting Rights\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, confirms that the Company's issued share capital as at the date of this announcement comprises 6,806,403,493 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 6,806,403,493.\nThis includes an amendment to the issue of shares announced on 31 October 2025 where the correct figure to be issued and admitted is 23,636,362. The original figure announced was 26,636,362.\nThe above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.\nEnquiries:\nSolvonis Therapeutics plc\nanthony@solvonis.com\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets (Corporate Broker)\nPhil Davies +44 (0) 20 7496 3000\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTVREASEFDSPSFFA",
          "rns_number": "RNS Number : 7597F"
        }
      ],
      "themes": [
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 1613,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "DOWNTREND"
    },
    "volatility": {
      "atr_normalized": 8.0,
      "stddev_20d": 0.5493
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "all_events": [
      {
        "event_id": "RNS-7th Jan 2026-uspatent",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.628961Z",
        "source": "LSE_RNS",
        "data": {
          "title": "US Patent allowance for PTSD discovery programme",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/us-patent-allowance-for-ptsd-discovery-programme-avzhfgwc0dqc4bc.html",
          "rns_number": "RNS Number : 8747N",
          "full_content": "7 Jan 2026 07:00\nRNS Number : 8747N\nSolvonis Therapeutics PLC\n07 January 2026\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nU.S. Patent allowance received for PTSD discovery programme\nDemonstrating scientific and commercial significance\nSolvonis Therapeutics plc (LSE: SVNS\n), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, announces that it has received a Notice of Allowance (the \"Allowance\") from the United States Patent and Trademark Office (\"USPTO\") for a series of compounds within its proprietary SVN-SDN-14 Post-Traumatic Stress Disorder (\"PTSD\") discovery programme. One compound from this series is currently being evaluated alongside other candidates, with a lead compound expected to be selected in Q1 2026 in line with prior guidance.\nThe Allowance strengthens the intellectual property foundations of SVN-SDN-14 at an important stage as the programme advances toward lead-candidate selection. In addition to this IP milestone, the Company is highlighting the scientific significance of the newly protected compounds in addressing long-standing challenges in the development of next-generation PTSD therapeutics.\nScientific significance\nSVN-SDN-14 is focused on developing serotonin (\"SERT\"), dopamine (\"DAT\") and noradrenaline (\"NET\") modulators designed to support pro-social engagement and improve the effectiveness of psychological therapy in PTSD.\nWhile balanced modulation of these pathways is increasingly recognised as therapeutically valuable, translating this biology into a practical medicine has historically been difficult. Key challenges have included controlling duration of action,\nmanaging variability between patients, and ensuring compatibility with scalable, real-world clinical use.\nThe newly allowed patent covers a novel chemical series designed to retain the core SERT, DAT and NET activity underpinning the programme, while introducing greater pharmacological control through predictable metabolic deactivation. This approach is intended to maintain therapeutic effects while improving dosing flexibility, safety margins and overall suitability for clinical use.\nIn allowing the claims, the USPTO examiner concluded that no existing patents or publications disclosed or suggested the claimed compounds, confirming the novelty of the approach.\nProfessor David Nutt, Chief Scientific Officer of Solvonis, commented:\n\"These compounds are scientifically exciting because they address a long-standing challenge in this field. They are designed to preserve the monoaminergic profile that supports positive social engagement in therapy, while introducing a level of pharmacokinetic control that has historically been difficult to achieve. This increases our confidence that the core biology of SVN-SDN-14 can be translated into a medicine that is practical to develop, regulate and ultimately deploy.\"\nAnthony Tennyson, Chief Executive Officer of Solvonis, added:\n\"This patent allowance strengthens both the scientific and commercial foundations of our PTSD programme. It reflects our strategy of combining rigorous neuroscience with disciplined medicinal chemistry to build differentiated, scalable CNS therapeutics.\"\nEnquiries:\nSolvonis Therapeutics plc\nVia Walbrook\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets\n(Broker)\n+44 (0) 20 7496 3000\nPhil Davies\nWalbrook PR (PR/IR advisers)\nTel: +44 (0)20 7933 8780 or\nsolvonistherapeutics@walbrookpr.com\nAnna Dunphy\nMob: +44 (0)7876 741 001\nLianne Applegarth\nMob:\n+44 (0)7584 391 303\nRachel Broad\nMob:\u00a0+44 (0)7747 515 393\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction, psychiatry, and neurology.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with additional discovery work supporting expansion into broader CNS indications. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK, while SVN-002 is preparing for a Phase 2b trial in the US targeting moderate-to-severe AUD. The preclinical PTSD programme (SVN-SDN-14) leverages novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn parallel, Solvonis is advancing proprietary CNS discovery programmes built on a dedicated compound library to identify new small-molecule modulators of key neurotransmitter systems. This platform enables efficient early-stage innovation and supports the Company's integrated approach to developing therapies across its three strategic pillars.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is p",
          "content_length": 5894
        },
        "ingested_at": "2026-01-21T01:46:42.628995Z"
      },
      {
        "event_id": "RNS-22nd Dec 2025-research",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629014Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Research and Development Update - Q4 2025",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/research-and-development-update-q4-2025-oytx3w29svygo3v.html",
          "rns_number": "RNS Number : 3621M",
          "full_content": "22 Dec 2025 07:00\nRNS Number : 3621M\nSolvonis Therapeutics PLC\n22 December 2025\n22 December 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nResearch and Development Update - Q4 2025\nPipeline advancing across addiction and psychiatry with multiple 2026 catalysts\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders,\nprovides an update on progress across its development pipeline and discovery programmes as the Company concludes 2025 and enters a catalyst-rich period in 2026.\nPipeline development advancing across addiction and psychiatry\nSVN-001 | Severe Alcohol Use Disorder (AUD) - UK & EU\nThe Company's lead programme, SVN-001, continues to advance through a potentially pivotal Phase 3 clinical trial for severe AUD in the United Kingdom, addressing a large and underserved patient population across the UK and EU. In parallel, the Company continues to progress licensing and commercial-partnership discussions.\nRecruitment remains ongoing in this\nNHS\n-based study, conducted in collaboration with the University of Exeter (\"\nUoE\n\") and co-funded by the National Institute for Health and Care Research (\"\nNIHR\n\"), the Medical Research Council (\"\nMRC\n\"), and Solvonis. Top-line results are anticipated in late 2027 / early 2028. In parallel, with potential partners in UK and internationally.\nSVN-002 | Moderate-to-Severe AUD - Global (ex-UK & EU) | Initial focus: United States\nSVN-002, Solvonis' proprietary esketamine oral thin-film programme, is being advanced under a planned U.S. FDA 505(b)(2) regulatory pathway referencing Johnson & Johnson's blockbuster esketamine product, Spravato\u00ae.\nDuring Q4 2025, preparatory work continued with WuXi AppTec on a pharmacokinetic bridging programme to support regulatory alignment. Initial data are expected in Q1 2026, with further progress through Q2 2026.\nIf the scientific bridge to Spravato\u00ae is successfully established the Company plans to promptly seek approval from the US Food and Drug Administration (\"\nFDA\n\") for a Phase 2b trial, thereby potentially avoiding the significant costs associated with pre-clinical programmes and Phase1 and Phase 2a trials.\nThe programme targets approximately 15 million adults in the United States living with moderate-to-severe AUD and represents a differentiated, clinic-based therapeutic approach within a large and underserved market.\nSVN-015 | Stimulant (Methamphetamine and Cocaine) Use Disorder\nIn December 2025, Solvonis announced that SVN-015, a novel compound emerging from its AI-enabled discovery programme, was accepted into the U.S. National Institute on Drug Abuse's (\"\nNIDA\n\") Addiction Treatment Discovery Program (\"\nATDP\n\").\nUnder the programme, NIDA - part of the U.S. National Institutes of Health (\"\nNIH\n\") - will fund and conduct a standard package of preclinical safety and pharmacology studies, including cardiovascular risk assessment. Initial results are expected in Q1 2026. Subject to supportive outcomes, SVN-015 may progress into further NIDA-funded efficacy testing in validated models of methamphetamine and cocaine addiction.\nAcceptance into ATDP represents an important external validation of Solvonis' proprietary discovery platform and expands the Company's pipeline beyond alcohol use disorder into stimulant addictions, which remain among the most severe psychiatric conditions with no approved pharmacological treatments.\nSuccessful completion of the ATDP programme would position Solvonis to compete for subsequent NIH development funding, including potential UG3/UH3 awards, providing a non-dilutive pathway from preclinical validation toward clinical development.\nSVN-SDN-14 | Post-Traumatic Stress Disorder (PTSD)\nFollowing the announcement of positive preclinical data in August 2025, Solvonis' proprietary serotonin-dopamine-noradrenalin modulator programme continues to progress through final in-vivo studies designed to support lead-candidate selection.\nFour compounds are currently being evaluated in rat brain microdialysis studies to confirm central pharmacokinetics and target engagement across relevant monoaminergic pathways. Lead-candidate selection is expected in Q1 2026, after which the Company intends to advance the selected compound into IND-enabling studies.\nAI-enabled CNS discovery platform\nBeyond SVN-015 and SVN-SDN-14, Solvonis continues to advance its AI-enabled discovery programme, generating novel small-molecule candidates targeting key neurotransmitter systems relevant to addiction and psychiatry. Exploratory work is also underway to assess potential applications in neurology.\nFurther updates on discovery-stage progress are expected during H1 2026 as compound evaluation and prioritisation continue.\nAnthony Tennyson, Chief Executive Officer of Solvonis Therapeutics plc, commented:\n\"\n2025 has been a transformative year for Solvonis. The completion of the acquisition of Awakn Life Sciences in May materially r",
          "content_length": 8933
        },
        "ingested_at": "2026-01-21T01:46:42.629030Z"
      },
      {
        "event_id": "RNS-22nd Dec 2025-research",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629047Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Research and Development Update \u2013 Q4 2025",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/research-and-development-update-8211-q4-2025-ohdcqesaowuegeh.html",
          "rns_number": "RNS Number : 3621M",
          "full_content": "22 Dec 2025 07:00\nRNS Number : 3621M\nSolvonis Therapeutics PLC\n22 December 2025\n22 December 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nResearch and Development Update - Q4 2025\nPipeline advancing across addiction and psychiatry with multiple 2026 catalysts\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders,\nprovides an update on progress across its development pipeline and discovery programmes as the Company concludes 2025 and enters a catalyst-rich period in 2026.\nPipeline development advancing across addiction and psychiatry\nSVN-001 | Severe Alcohol Use Disorder (AUD) - UK & EU\nThe Company's lead programme, SVN-001, continues to advance through a potentially pivotal Phase 3 clinical trial for severe AUD in the United Kingdom, addressing a large and underserved patient population across the UK and EU. In parallel, the Company continues to progress licensing and commercial-partnership discussions.\nRecruitment remains ongoing in this\nNHS\n-based study, conducted in collaboration with the University of Exeter (\"\nUoE\n\") and co-funded by the National Institute for Health and Care Research (\"\nNIHR\n\"), the Medical Research Council (\"\nMRC\n\"), and Solvonis. Top-line results are anticipated in late 2027 / early 2028. In parallel, with potential partners in UK and internationally.\nSVN-002 | Moderate-to-Severe AUD - Global (ex-UK & EU) | Initial focus: United States\nSVN-002, Solvonis' proprietary esketamine oral thin-film programme, is being advanced under a planned U.S. FDA 505(b)(2) regulatory pathway referencing Johnson & Johnson's blockbuster esketamine product, Spravato\u00ae.\nDuring Q4 2025, preparatory work continued with WuXi AppTec on a pharmacokinetic bridging programme to support regulatory alignment. Initial data are expected in Q1 2026, with further progress through Q2 2026.\nIf the scientific bridge to Spravato\u00ae is successfully established the Company plans to promptly seek approval from the US Food and Drug Administration (\"\nFDA\n\") for a Phase 2b trial, thereby potentially avoiding the significant costs associated with pre-clinical programmes and Phase1 and Phase 2a trials.\nThe programme targets approximately 15 million adults in the United States living with moderate-to-severe AUD and represents a differentiated, clinic-based therapeutic approach within a large and underserved market.\nSVN-015 | Stimulant (Methamphetamine and Cocaine) Use Disorder\nIn December 2025, Solvonis announced that SVN-015, a novel compound emerging from its AI-enabled discovery programme, was accepted into the U.S. National Institute on Drug Abuse's (\"\nNIDA\n\") Addiction Treatment Discovery Program (\"\nATDP\n\").\nUnder the programme, NIDA - part of the U.S. National Institutes of Health (\"\nNIH\n\") - will fund and conduct a standard package of preclinical safety and pharmacology studies, including cardiovascular risk assessment. Initial results are expected in Q1 2026. Subject to supportive outcomes, SVN-015 may progress into further NIDA-funded efficacy testing in validated models of methamphetamine and cocaine addiction.\nAcceptance into ATDP represents an important external validation of Solvonis' proprietary discovery platform and expands the Company's pipeline beyond alcohol use disorder into stimulant addictions, which remain among the most severe psychiatric conditions with no approved pharmacological treatments.\nSuccessful completion of the ATDP programme would position Solvonis to compete for subsequent NIH development funding, including potential UG3/UH3 awards, providing a non-dilutive pathway from preclinical validation toward clinical development.\nSVN-SDN-14 | Post-Traumatic Stress Disorder (PTSD)\nFollowing the announcement of positive preclinical data in August 2025, Solvonis' proprietary serotonin-dopamine-noradrenalin modulator programme continues to progress through final in-vivo studies designed to support lead-candidate selection.\nFour compounds are currently being evaluated in rat brain microdialysis studies to confirm central pharmacokinetics and target engagement across relevant monoaminergic pathways. Lead-candidate selection is expected in Q1 2026, after which the Company intends to advance the selected compound into IND-enabling studies.\nAI-enabled CNS discovery platform\nBeyond SVN-015 and SVN-SDN-14, Solvonis continues to advance its AI-enabled discovery programme, generating novel small-molecule candidates targeting key neurotransmitter systems relevant to addiction and psychiatry. Exploratory work is also underway to assess potential applications in neurology.\nFurther updates on discovery-stage progress are expected during H1 2026 as compound evaluation and prioritisation continue.\nAnthony Tennyson, Chief Executive Officer of Solvonis Therapeutics plc, commented:\n\"\n2025 has been a transformative year for Solvonis. The completion of the acquisition of Awakn Life Sciences in May materially r",
          "content_length": 8933
        },
        "ingested_at": "2026-01-21T01:46:42.629063Z"
      },
      {
        "event_id": "RNS-3rd Dec 2025-svn-015a",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629077Z",
        "source": "LSE_RNS",
        "data": {
          "title": "SVN-015 accepted into US NIDA funded programme",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/svn-015-accepted-into-us-nida-funded-programme-bvr3swcz1giiad6.html",
          "rns_number": "RNS Number : 9389J",
          "full_content": "3 Dec 2025 07:00\nRNS Number : 9389J\nSolvonis Therapeutics PLC\n03 December 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nSolvonis' Novel Compound SVN-015 Accepted into US NIDA-Funded Addiction Treatment Discovery Program for Methamphetamine and Cocaine Addiction\nSolvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (CNS) disorders, announces that its novel AI-discovered compound, SVN-015, targeting methamphetamine and cocaine use disorders, has been accepted into the US National Institute on Drug Abuse's (\"NIDA\") Addiction Treatment Discovery Program (\"ATDP\"). Under the programme, NIDA, part of the US National Institutes of Health (\"NIH\"), will fund and conduct early preclinical evaluation of SVN-015.\nProgramme Overview\nIn the first stage of the programme, NIDA will fund and carry out\nin vitro\npredictive safety studies on SVN-015 to assess potential cardiovascular risks. These tests are the normal first step in the development of any new medicine. If the results are supportive, SVN-015 could advance into ATDP efficacy studies in validated preclinical models of methamphetamine and cocaine addiction.\nIf the efficacy studies are successful, Solvonis would be well positioned to compete for a non-dilutive NIH research grant, which can provide up to US$3 million per year for as long as five years. These grants are competitive, but completion of early preclinical studies would provide the type of safety and efficacy data needed to support Solvonis' grant application. This creates a potential pathway from funded NIDA preclinical work through to potential NIH-funded clinical trials in humans.\nStrategic Significance\nAcceptance of SVN-015 into the ATDP marks an important milestone for Solvonis as it expands the Company's research in addiction beyond alcohol use disorder (\"AUD\") into stimulant addictions - specifically methamphetamine and cocaine - which remain among the most severe psychiatric conditions with no approved drug treatments.\nProfessor David Nutt, Solvonis Chief Scientific Officer, commented\n\"Being accepted into NIDA's ATDP for SVN-015 is a major step forward for Solvonis. ATDP provides a pathway for evaluating the therapeutic potential of SVN-015, starting with early preclinical testing and, if successful, creating the opportunity to progress towards NIH clinical development funding through the UG3/UH3 programme. For methamphetamine and cocaine addiction - where no approved drug treatments exist - this represents an important advance.\"\nEnquiries:\nSolvonis Therapeutics plc\nVia Walbrook\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets\n(Broker)\n+44 (0) 20 7496 3000\nPhil Davies\nWalbrook PR (PR/IR advisers)\nTel: +44 (0)20 7933 8780 or\nsolvonistherapeutics@walbrookpr.com\nAnna Dunphy\nMob: +44 (0)7876 741 001\nLianne Applegarth\nMob:\n+44 (0)7584 391 303\nMarcus Ulker\nMob:\u00a0+44 (0)7867 984 082\nAbout SVN-015\nSVN-015 is the second compound emerging from Solvonis' AI-enabled drug discovery programme to progress into external validation, following the advancement of SVN-SDN-14 for Post-Traumatic Stress Disorder. It is a novel candidate designed to address stimulant addictions - including methamphetamine and cocaine dependence - areas with significant unmet need and no currently approved pharmacological treatments.\nAbout NIDA\nThe US National Institute on Drug Abuse (\"NIDA\") is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science.\nAbout Methamphetamine and Cocaine Addiction\nMethamphetamine and cocaine addiction remain major public health challenges. There are no approved pharmacological treatments; patients are managed only with psychosocial interventions, which deliver limited and inconsistent outcomes. Both NIDA and the European Monitoring Centre for Drugs and Drug Addiction (\"EMCDDA\") identify stimulant use disorders as areas of critical unmet need, associated with high morbidity, mortality, and significant societal costs.\nEpidemiological data highlights the scale of the problem. In the United States, the National Survey on Drug Use and Health (\"SAMHSA 2022\") estimates approximately 2.6 million people meet diagnostic criteria for cocaine or methamphetamine use disorders. In the EU5, EMCDDA data indicate 0.35-0.5 million patients, predominantly with cocaine dependence. In Japan, national data suggest around 0.1 million patients, largely with methamphetamine dependence. Taken together, this represents a combined total of around 3.0-3.2 million individuals across the seven major markets - a large population with no existing drug treatment options.\nThe content of this press release is solely the responsibility of Solvonis and does not necessarily represent ",
          "content_length": 7156
        },
        "ingested_at": "2026-01-21T01:46:42.629091Z"
      },
      {
        "event_id": "RNS-31st Oct 2025-totalvot",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629119Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Total Voting Rights",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/total-voting-rights-p3qve1gzjdyfn7b.html",
          "rns_number": "RNS Number : 7597F",
          "full_content": "31 Oct 2025 15:59\nRNS Number : 7597F\nSolvonis Therapeutics PLC\n31 October 2025\n31 October 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nTotal Voting Rights\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, confirms that the Company's issued share capital as at the date of this announcement comprises 6,806,403,493 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 6,806,403,493.\nThis includes an amendment to the issue of shares announced on 31 October 2025 where the correct figure to be issued and admitted is 23,636,362. The original figure announced was 26,636,362.\nThe above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.\nEnquiries:\nSolvonis Therapeutics plc\nanthony@solvonis.com\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets (Corporate Broker)\nPhil Davies +44 (0) 20 7496 3000\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTVREASEFDSPSFFA",
          "content_length": 2036
        },
        "ingested_at": "2026-01-21T01:46:42.629133Z"
      },
      {
        "event_id": "RNS-31st Oct 2025-corporat",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629147Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Corporate Structure Update and Issue of Options",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/corporate-structure-update-and-issue-of-options-cpps1a8dhr0djnv.html",
          "rns_number": "RNS Number : 5874F",
          "full_content": "31 Oct 2025 07:00\nRNS Number : 5874F\nSolvonis Therapeutics PLC\n31 October 2025\n31 October 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nCorporate Structure Update, Disposal of Non-Core Subsidiary, and Issue of Options\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders\n,\nannounces the completion of a series of corporate restructuring actions designed to simplify the Group's structure and align with its research and development (\"R&D\")-first strategy. The Company also confirms the issue of options to the Chief Executive Officer and certain Non-Executive Directors, together with the settlement of historical liabilities through the issue of equity.\nCorporate Structure Update\n\u00b7\nIrish subsidiary reorganisation.\no\nAwakn LS Europe Holdings Ltd has been renamed Solvonis Therapeutics Ireland Holdings Limited which now serves as the Group's intellectual property holding company; and\no\nAwakn Research and Development Ltd has been renamed Solvonis Therapeutics Ireland R&D Limited, one of three dedicated R&D subsidiaries.\n\u00b7\nNew R&D subsidiaries:\nThe Company has also incorporated Solvonis Therapeutics UK R&D Ltd (\nUnited Kingdom\n) and Solvonis Therapeutics US R&D Inc (Delaware, United States). Together with Solvonis Therapeutics Ireland R&D Limited,\nthese entities form a harmonised R&D framework spanning the United Kingdom, the European Union, and the United States.\n\u00b7\nLegacy entity rationalisation:\nThe Company has commenced the wind-down of Awakn LS Partnerships Ltd (Ireland) and\n1233705 B.C. Ltd. (British Columbia, Canada)\nwith strike-offs to follow as part of the ongoing simplification programme.\n\u00b7\nLegacy entity disposal:\nThe Company has sold Graft Polymer IP Limited (United Kingdom) to Meta Medix d.o.o (Slovenia) for nominal cash consideration of \u00a31.\nPrior to completion, all material intellectual property relating to the Company's core activity - including the two US provisional patent applications announced on 11 July 2024,\n\"Compositions and Methods for Treating Substance Use Disorders Using Depot Drug Delivery Systems\"\nand\n\"Compositions and Methods for Treating Mental Health Disorders Using Depot Drug Delivery Systems\"\n- was transferred from Graft Polymer IP Limited to Solvonis Therapeutics Ireland Holdings Limited, where it is now held.Graft Polymer IP Limited retained only residual assets of no ongoing strategic or commercial value to the Company, and its disposal has no material financial or operational impact on Solvonis.\nThese actions complete the post-acquisition integration of the Group and establish a clear operating structure with consolidated IP ownership and streamlined R&D execution across the UK, Ireland, and the United States.\nIssue of Equity in Lieu of Fees\nThe Company has also agreed with certain creditors to settle outstanding liabilities relating to services historically delivered to the Company amounting to \u00a378,000 through the issue of 26,636,362 new ordinary shares of \u00a30.0001 each at an issue price of \u00a30.0033 per share. The issue includes 13,939,393 shares being allotted to Professor David Nutt, CSO, as consideration for previous services rendered. Application will be made for the new ordinary shares to be admitted to trading on the Main Market of the London Stock Exchange, with Admission expected to occur on or around Friday 7th November 2025. The new shares will rank pari passu in all respects with the existing ordinary shares. Following Admission, the Company's issued share capital will comprise 6,809,403,493 ordinary shares, each carrying one voting right.\nIssue of Options to CEO\nAt the time of his appointment in May 2024, it was agreed that Chief Executive Officer Anthony Tennyson would become eligible for the award of options subject to the successful completion of certain milestones contributing to the strategic transformation of Solvonis. All such milestones have since been achieved; however, due to successive closed periods since his appointment, the formal issuance of these options has only now been completed. Accordingly, 180,000,000 share options have been granted to Mr Tennyson, exercisable over ordinary shares of \u00a30.001 each at an exercise price of \u00a30.001 per share.\nIssue of Options to PDMR's\nNon-executive directors Nicholas Nelson and Dr Renata Crome have each been granted 21 million share options under the Company's existing long term incentive plan (\"LTIP\"), exercisable over ordinary shares of \u00a30.001 each in Solvonis Therapeutics Plc at an exercise price of \u00a30.0034 & \u00a30.00163 respectively per share. The options have a three-year life and vest in three equal tranches: one-third on grant date, one-third on the first anniversary of grant date, and one-third on the second anniversary of grant.\nAdmission and Total Voting Rights\nApplication will be made for the New Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange and to list",
          "content_length": 10766
        },
        "ingested_at": "2026-01-21T01:46:42.629162Z"
      },
      {
        "event_id": "RNS-27th Oct 2025-appoints",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629175Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Appoints global biopharma leader Paul Carter",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/appoints-global-biopharma-leader-paul-carter-xs3m57kecofenix.html",
          "rns_number": "RNS Number : 8400E",
          "full_content": "27 Oct 2025 07:00\nRNS Number : 8400E\nSolvonis Therapeutics PLC\n27 October 2025\n27 October 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nAppoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, is delighted to announce the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025.\nPaul Carter is a highly accomplished global biopharmaceutical leader with nearly three decades of senior executive experience spanning commercial, operational, and strategic leadership roles. He has built and scaled businesses across Europe, North America, and Asia, combining deep operational expertise with a proven record of driving transformational growth and delivering long-term shareholder value.\nPaul currently serves as Non-Executive Chair of Clinigen Group plc, a leading global pharmaceutical services and supply company supporting access to medicines in over 120 countries. He is also Chair of Memo Therapeutics AG, a Swiss-based private clinical-stage biotech developing novel antibody therapeutics, and Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company. In addition, Paul serves as Non-Executive Director at Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company, pioneering TCR-based immunotherapies for cancer.\nHe previously held senior global roles including Executive Vice President and Chief Commercial Officer at Gilead Sciences, Inc. (NASDAQ: GILD), where he oversaw international operations across 38 markets and delivered annual revenues exceeding US$30 billion.\nHis appointment strengthens the Solvonis Board as the Company continues to advance its differentiated CNS pipeline and execute its capital-efficient, licensing-first growth strategy across addiction, psychiatry, and neurology.\nAnthony Tennyson, Chief Executive Officer of Solvonis, commented:\n\"\nWe are delighted to welcome Paul to the Solvonis Board. He brings an exceptional depth of global leadership experience and strategic insight from some of the world's most successful pharmaceutical organisations. His expertise in scaling innovative science into global commercial success will be invaluable as Solvonis advances its CNS pipeline and builds towards the next phase of sustainable growth\n.\"\nPaul Carter added:\n\"\nSolvonis is building an exciting and differentiated CNS biopharmaceutical platform with significant potential to deliver impact for patients and value for shareholders. I look forward to working with Anthony and the Board to help shape strategy, strengthen partnerships, and support the Company's continued evolution and growth\n.\"\nOption Grant\nMr Carter has been granted 21 million share options under the Company's existing long term incentive plan (\"LTIP\"), exercisable over ordinary shares of \u00a30.001 each in Solvonis Therapeutics Plc at an exercise price of \u00a30.0034 per share. The options have a three-year life and vest in three equal tranches: one-third on grant date, one-third on the first anniversary of grant date, and one-third on the second anniversary of grant.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nSinger Capital Markets\n(Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction, psychiatry, and neurology.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with additional discovery work supporting expansion into broader CNS indications. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK, while SVN-002 is preparing for a Phase 2b trial in the US targeting moderate-to-severe AUD. The preclinical PTSD programme (SVN-SDN-14) leverages novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn parallel, Solvonis is advancing proprietary CNS discovery programmes built on a dedicated compound library to identify new small-molecule modulators of key neurotransmitter systems. This platform enables efficient early-stage innovation and supports the Company's integrated approach to developing therapies across its three strategic pillars.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to deliver sustained value through innovation in CNS therapeutics.\nsolvonis.com\n|\nLinkedIn\n|\nX",
          "content_length": 7082
        },
        "ingested_at": "2026-01-21T01:46:42.629189Z"
      },
      {
        "event_id": "RNS-16th Oct 2025-raises\u00a31",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629205Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Raises \u00a31.25 Million to Accelerate Programmes",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/raises-163125-million-to-accelerate-programmes-gll0a880vzmicko.html",
          "rns_number": "RNS Number : 5667D",
          "full_content": "16 Oct 2025 07:00\nRNS Number : 5667D\nSolvonis Therapeutics PLC\n16 October 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n16 October 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nRaises \u00a31.25 Million to Accelerate Programmes in High-Burden CNS Disorders\nSolvonis Therapeutics plc (LSE: SVNS),\nan emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, is pleased to announce that it has successfully raised \u00a31.25 million (gross) through a direct subscription with certain institutional and existing strategic investors (the \"Subscription\").\nThe Subscription was priced at \u00a30.0033 per new ordinary share, representing approximately an 13% discount to the closing mid-market price on 15 October 2025, and will result in the issue of 378,787,876 new ordinary shares of \u00a30.001 each (\"New Ordinary Shares\"). The New Ordinary Shares will rank pari passu in all respects with the Company's existing ordinary shares. Application will be made for the New Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange (\"Admission\"), which is expected to occur on or around 22 October 2025.\nUse of Proceeds\nTogether with the Company's existing resources, the proceeds will enable Solvonis to broaden its research and development activities, deepening its work within addiction and psychiatry while extending early discovery into neurology, establishing a unified focus on high-burden CNS diseases across three strategic pillars: addiction, psychiatry, and neurology.\nThrough this investment, Solvonis will:\n\u00b7\nContinue advancing its clinical and pre-clinical programmes across these CNS pillars;\n\u00b7\nExpand the reach of its CNS drug-discovery programme, which integrates computational chemistry, predictive modelling, and laboratory validation to identify and optimise novel small-molecule modulators relevant across its three pillars; and\n\u00b7\nStrengthen internal R&D and translational capabilities to enable deeper evaluation of new targets and mechanisms addressing the unmet needs driving the world's most high-burden CNS disorders.\nThis fundraise marks the first step in implementing Solvonis' expanded three-pillar CNS strategy and provides a foundation for continued scientific, clinical, and partnering progress across the Company's diversified pipeline.\nAnthony Tennyson, Chief Executive Officer, commented\n\"This financing marks an important time for Solvonis as we evolve into a broader CNS biopharmaceutical company. Our focus now spans addiction, psychiatry, and neurology - three interlinked areas of enormous unmet need. The continued support of our core investors enables us to accelerate our discovery work and deepen our development programmes across these pillars, advancing our mission to deliver innovative therapies for high-burden CNS disorders\n.\"\nAdmission and Total Voting Rights\nApplication will be made for the New Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange and to listing in the FCA's Official List Equity Shares (transition) category (\"Admission\"). It is expected that Admission will become effective at 8.00 a.m. on or around 22 October 2025.\nFollowing Admission, the Company's issued ordinary share capital will comprise 6,782,767,131 ordinary shares of \u00a30.001 each. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nSinger Capital Markets\n(Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction, psychiatry, and neurology.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with additional discovery work supporting expansion into broader CNS indications. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK, while SVN-002 is preparing for a Phase 2b trial in the US targeting moderate-to-severe AUD. The preclinical PTSD programme (SVN-SDN-14) leverages novel serotonin-dopamine modulators designed to ",
          "content_length": 6406
        },
        "ingested_at": "2026-01-21T01:46:42.629220Z"
      },
      {
        "event_id": "RNS-30th Sep 2025-half-yea",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629233Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Half-year Report",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/half-year-report-cjn1m9okszamkjn.html",
          "rns_number": "RNS Number : 3055B",
          "full_content": "30 Sep 2025 07:00\nRNS Number : 3055B\nSolvonis Therapeutics PLC\n30 September 2025\n30 September 2025\nSolvonis Therapeutics PLC\nUnaudited interim results for the six months to 30 June 2025\nSolvonis Therapeutics Plc (the \"Company\" or \"Solvonis\"), an innovative biotechnology company focused on co-developing therapeutics for mental health disorders, announces its unaudited interim results for the six months to 30 June 2025.\nChairman's Statement\nThe first half of 2025 has been a period of significant progress for Solvonis. Most notably, we completed the acquisition of Awakn Life Sciences, a transformational step that broadened our pipeline, strengthened our team, and accelerated our strategy to become a leading CNS-focused biopharmaceutical platform.\nAlongside this, we advanced our R&D programmes across addiction, neuropsychiatry, and neurology. Highlights included the continued progression of SVN-001 in Alcohol Use Disorder, preparations for the next clinical stage of SVN-002 in the US, and the advancement of our AI-discovered preclinical candidate, SVN-SDN-014, which is targeted for PTSD. Together, these programmes represent a balanced portfolio spanning late-, mid- and early-stage development.\nOur focus remains firmly on executing this strategy: delivering clinical and regulatory milestones across our lead programmes, strengthening our discovery engine, and positioning Solvonis as a credible partner of choice for large pharma in CNS disorders. With the Awakn integration well underway and our discovery platform gaining momentum, the Board believes the Company is well placed to deliver material value for patients and shareholders alike.\nKey Financial Indicators\n\u00b7\nCash and cash equivalents at period end were \u00a31,719,000 (H1 2024: \u00a327,000)\n\u00b7\nLoss before taxation for the period was \u00a31,621,000 (H1 2024: \u00a3469,000)\n\u00b7\nThe Group held net assets at period-end of \u00a36,935,000 (31 December 2024: \u00a33,084,000)\n\u00b7\nThe Group held total assets at period-end of \u00a39,545,000 (31 December 2024: \u00a33,203,000)\nRisk factors\nThe principal risks facing the Group remain broadly consistent with those set out in our 2024 Annual Report. While certain risk factors have evolved following the acquisition of Awakn Life Sciences, there have been no material changes. Shareholders are directed to the risk disclosures contained in the prospectus published in May 2025, which provides an updated overview of the Group's risk profile.\nOn behalf of the Board,\nDennis Purcell\nChairman\nSolvonis Therapeutics\u00a0plc\nEnquiries:\nSolvonis Therapeutics plcAnthony Tennyson, CEO & Executive Directoranthony@solvonis.comSinger Capital Markets\u00a0(Corporate Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nsolvonis.com\n|\nLinkedIn\n|\nX (Twitter)\nSOLVONIS THERAPEUTICS PLC - CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS\nCONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME\nFOR THE 6 MONTH PERIOD ENDING 30 JUNE 2025\nNote\nUnaudited\nSix months to\n30 Jun 2025\n\u00a3'000\nUnaudited\nSix months to 30 Jun 2024\u00a3'000\nContinuing operations\nOperational costs\n-\n(18)\nAdministrative expenses\n(1,617)\n(526)\nGain on deconsolidation\n-\n139\nOperating loss\n(1,617)\n(405)\nFinance costs\n(4)\n(64)\nLoss before taxation\n(1,621)\n(469)\nIncome tax\n-\n-\nLoss for the period from continuing operations\n(1,621)\n(469)\nLoss from discontinuing operations\n-\n(157)\nTotal loss for the period attributable to equity holders of the parent\n(1,621)\n(626)\nOther comprehensive income\nForeign currency translation\n(115)\n76\nDerecognition of foreign exchange reserve\n-\n(123)\nOther comprehensive income (net of tax) for ",
          "content_length": 26040
        },
        "ingested_at": "2026-01-21T01:46:42.629247Z"
      },
      {
        "event_id": "RNS-28th Aug 2025-solvonis",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629261Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Solvonis secures exclusive CNS collaboration",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/solvonis-secures-exclusive-cns-collaboration-hxu1qw5lserrv9u.html",
          "rns_number": "RNS Number : 9220W",
          "full_content": "28 Aug 2025 07:00\nRNS Number : 9220W\nSolvonis Therapeutics PLC\n28 August 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n28 August 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nSolvonis secures exclusive CNS collaboration with CSO Professor David Nutt, establishes Scientific Advisory Committee and Issue of Equity\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, is delighted to announce amendments to its consultancy agreement with Professor David Nutt, the Company's Chief Scientific Officer. Under the revised terms, Professor Nutt will increase his commitment to Solvonis, serve as Interim Chair of the newly established Scientific Advisory Committee (\"SAC\"), and work exclusively with the Company in the field of commercial drug discovery and development for CNS disorders.\nProfessor Nutt is one of the world's foremost authorities in neuropsychopharmacology, with more than 600 peer-reviewed publications and a career spanning over four decades. He holds the Edmond J. Safra Chair in Neuropsychopharmacology at Imperial College London, has chaired the UK Advisory Council on the Misuse of Drugs, and has served as President of the European College of Neuropsychopharmacology, the British Neuroscience Association, and the British Association of Psychopharmacology. His pioneering research has advanced both the scientific understanding and clinical treatment of a wide range of brain disorders.\nThe amendments to the agreement mark three important developments for Solvonis:\n\u00b7\nExpanded commitment\n- Professor Nutt's role increases to two days per week (40% FTE).\n\u00b7\nExclusive collaboration\n- his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes.\n\u00b7\nStrengthened governance\n- as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.\nAnthony Tennyson, CEO of Solvonis, commented:\n\"Professor David Nutt's leadership has already been central to shaping Solvonis' pipeline. By securing his exclusive collaboration in CNS drug discovery and development, and establishing our Scientific Advisory Committee under his chairmanship, we are embedding world-class expertise into both our science and our governance. This strengthens Solvonis' position as a company uniquely focused on translating cutting-edge neuroscience into innovative therapies for CNS disorders.\"\nProfessor David Nutt, CSO of Solvonis, added:\n\"I am delighted to deepen my commitment to Solvonis at such an exciting stage in its growth. By focusing my commercial CNS drug development work exclusively with Solvonis and chairing the new Scientific Advisory Committee, I look forward to helping shape the Company's scientific strategy and ensuring our programmes are guided by the highest standards of innovation and rigour. Solvonis has the potential to make a real impact across the CNS field, and I am proud to be part of that mission.\"\nIssue of Equity in Lieu of Fees\nThe Company has also agreed with certain creditors to settle outstanding liabilities relating to services historically delivered to the Company amounting to \u00a3286,681 through the issue of 141,875,231 new ordinary shares of \u00a30.0001 each.\nThis comprises: (i) 81,732,308 shares at an issue price of \u00a30.0013 and 60,142,923 shares at an issue price of \u00a30.003\n. Application will be made for the new ordinary shares to be admitted to trading on the Main Market of the London Stock Exchange, with Admission expected to occur on or around 3rd September. The new shares will rank pari passu in all respects with the existing ordinary shares. Following Admission, the Company's issued share capital will comprise 6,403,979,255 ordinary shares, each carrying one voting right.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001,",
          "content_length": 6652
        },
        "ingested_at": "2026-01-21T01:46:42.629275Z"
      },
      {
        "event_id": "RNS-13th Aug 2025-mediacov",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629288Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Media Coverage: Small Cap Idea profile",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/SVNS/media-coverage-small-cap-idea-profile-ov4sctfk7m77hlu.html",
          "rns_number": "RNS Number : 2234V",
          "full_content": "13 Aug 2025 15:03\nRNS Number : 2234V\nSolvonis Therapeutics PLC\n13 August 2025\n13 August 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nMedia Coverage: Small Cap Idea profile in ThisIsMoney.co.uk / Daily Mail.\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, notes the publication of an article on\nThisIsMoney.co.uk\n(Daily Mail online) titled\n\"SMALL CAP IDEA: Ketamine drip therapy firm is taking on alcoholism\"\n.\nThe article, written by Ian Lyall of Proactive Investors, highlights:\n\u00b7\nSolvonis' recent acquisition of Awakn Life Sciences and the integration of its development pipeline.\n\u00b7\nThe Company's lead programme, SVN-001, in Phase III clinical trials for severe AUD for the UK and EU AUD markets, combining ketamine infusion with Cognitive Behavioural Therapy (CBT).\n\u00b7\nThe Company's second programme, SVN-002, targeting the US AUD market via the FDA's 505(b)(2) regulatory pathway, referencing Johnson & Johnson's approved esketamine product Spravato\u00ae.\n\u00b7\nSector valuation comparisons with US-listed peers and recent M&A activity highlighting strategic interest in novel mental health therapeutics.\n\u00b7\nThe full article can be accessed here:\nhttps://www.thisismoney.co.uk/money/markets/article-14996499/SMALL-CAP-IDEA-Ketamine-drip-therapy-firm-taking-alcoholism.html\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD)-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nsolvonis.com\n|\nLinkedIn\n|\nX (Twitter)\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAGPUUURUPAGCW",
          "content_length": 3962
        },
        "ingested_at": "2026-01-21T01:46:42.629301Z"
      },
      {
        "event_id": "RNS-12th Aug 2025-svn-sdn-",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629314Z",
        "source": "LSE_RNS",
        "data": {
          "title": "SVN-SDN-14 PTSD - Positive pre-clinical results",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/svn-sdn-14-ptsd-positive-pre-clinical-results-cht8malyuwm12nw.html",
          "rns_number": "RNS Number : 8744U",
          "full_content": "12 Aug 2025 07:00\nRNS Number : 8744U\nSolvonis Therapeutics PLC\n12 August 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n12 August 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nSVN-SDN-14 PTSD Programme - Positive pre-clinical results with three high-performing candidates advancing to in vivo studies\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, today announces positive results from pre-clinical screening in its SVN-SDN-14 programme, identifying three high-performing candidates to advance into in vivo studies.\nThe SVN-SDN-14 series is a novel class of serotonin (\"SERT\"), dopamine (\"DAT\") and noradrenaline (\"NET\") modulators designed to enhance pro-social behaviour and improve therapeutic outcomes for people living with Post-Traumatic Stress Disorder (\"PTSD\"), which the Company estimates affects over 20 million people across UK, US, and main EU markets. By modulating neurochemical pathways associated with trust, empathy, and social bonding, these compounds aim to help patients rebuild interpersonal relationships, reduce social isolation, and engage more effectively in therapy.\nIn-vitro screening for SERT, DAT, and NET modulation activity identified three of six synthesised candidates with robust, balanced modulation profiles across all three neurotransmitter systems. These are precisely the mechanistic attributes the programme is targeting to deliver a new class of medicine for trauma-related mental health conditions such as PTSD.\nWhile the Company had previously anticipated selecting a single lead candidate at this stage, the positive performance of three candidates has delivered an optimal outcome - a strong, competitive shortlist with multiple best-in-class contenders. This outcome increases optionality, strengthens the dataset and enhances the probability of selecting a best-in-class candidate with strong commercial potential.\nThe three shortlisted candidates will now advance to the final stage of the current work package - in vivo preclinical studies.\nProfessor David Nutt, Chief Scientific Officer of Solvonis, commented\n: \"\nIt is encouraging to see three candidates with equally strong, balanced SERT, DAT, and NET modulation profiles. This gives us a solid basis from which to make an informed choice. The in vivo data will enable us to select the candidate with the best potential to advance as a new treatment option for PTSD.\n\"\nAnthony Tennyson, Chief Executive Officer of Solvonis, added\n: \"\nThese results represent an important step forward for the programme. Having three high-performing candidates at this stage, rather than a single clear lead, provides us with greater flexibility and a stronger position from which to select the most promising option for PTSD.\n\"\nEnquiries:\nSolvonis Therapeutics plc (LEI: 2138005PH7OJRCRPUD88)\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (\"AUD\") and Post-Traumatic Stress Disorder (\"PTSD\")-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsyc",
          "content_length": 5825
        },
        "ingested_at": "2026-01-21T01:46:42.629328Z"
      },
      {
        "event_id": "RNS-31st Jul 2025-totalvot",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629342Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Total Voting Rights",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/total-voting-rights-erl8fc01v4l9pqj.html",
          "rns_number": "RNS Number : 2497T",
          "full_content": "31 Jul 2025 16:30\nRNS Number : 2497T\nSolvonis Therapeutics PLC\n31 July 2025\n31 July 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nTotal Voting Rights\nSolvonis Therapeutics plc (LSE: SVNS), a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, confirms that the Company's issued share capital as at the date of this announcement comprises 6,262,104,024 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 6,262,104,024.\nThe above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.\nEnquiries:\nSolvonis Therapeutics plc\nanthony@solvonis.com\nAnthony Tennyson, CEO & Executive Director\nAllenby Capital Limited (Financial Adviser and Joint Broker)\n+44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)\nGuy McDougall (Sales & Corporate Broking)\nSinger Capital Markets (Joint Broker)\n+44(0) 20 7496 3000\nPhil Davies\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTVREALXEDDFSEFA",
          "content_length": 2010
        },
        "ingested_at": "2026-01-21T01:46:42.629354Z"
      },
      {
        "event_id": "RNS-22nd Jul 2025-translat",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629367Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Translational Bridging Studies",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/translational-bridging-studies-64t330lz1r3inal.html",
          "rns_number": "RNS Number : 9498R",
          "full_content": "22 Jul 2025 07:00\nRNS Number : 9498R\nSolvonis Therapeutics PLC\n22 July 2025\n22 July 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nSVN\u2011002: Translational bridging studies initiated to support 505(b)(2) pathway and advance towards Phase 2b trial\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, is pleased to announce the initiation of key translational studies to support the advancement of SVN\u2011002 towards a planned Phase 2b clinical trial in the United States.\nSVN\u2011002 is the Company's differentiated sublingual esketamine oral thin film (\"OTF\") candidate, being developed as an innovative treatment for moderate-to-severe Alcohol Use Disorder (\"AUD\") in combination with psychosocial support. The compound is intended to reference Janssen's Spravato\u00ae under the US Food and Drug Administration's (the \"FDA\") 505(b)(2) regulatory pathway, enabling a potentially accelerated and capital-efficient route to registration.\nThe Company's regulatory strategy for SVN\u2011002 is informed by a successful pre-Investigational New Drug (\"IND\") meeting with the FDA which was held in December 2024 by Awakn Life Sciences prior to its acquisition by Solvonis.\nAs part of this plan, Solvonis has now appointed WuXi AppTec (Hong Kong:\u202f2359.HK; Shanghai:\u202f603259.SH), a leading global research and development and manufacturing services provider, to undertake a targeted pharmacokinetic (\"PK\") programme designed to generate the scientific bridging data requested by the FDA to establish a clear link to the reference product.\nThis activity represents a key step in preparing SVN\u2011002 for the IND submission and Phase 2b trial readiness, in alignment with Solvonis' clinical and regulatory development timelines. The programme is focused on the US AUD market, which remains significantly underserved and affects approximately 29 million individuals.\nProfessor David Nutt, Chief Scientific Officer of Solvonis, commented:\n\"\nThis translational programme is a critical milestone in delivering on the FDA's feedback which was received during our pre IND meeting. By generating the bridging data required to connect SVN\u2011002 to the reference product, we are laying the scientific foundation for a streamlined 505(b)(2) development pathway and a clear route into Phase 2b trials in the US. AUD remains a devastating and under-treated condition, and we believe SVN\u2011002 has the potential to make a meaningful difference for millions of patients.\n\"\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (\"AUD\") and Post-Traumatic Stress Disorder (\"PTSD\"), conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary central nervous system compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nAbout WuXi AppTec\nAs a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare",
          "content_length": 6111
        },
        "ingested_at": "2026-01-21T01:46:42.629382Z"
      },
      {
        "event_id": "RNS-18th Jul 2025-exercise",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629396Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Exercise of warrants",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/exercise-of-warrants-eylqfvgtz1kkkdy.html",
          "rns_number": "RNS Number : 6918R",
          "full_content": "18 Jul 2025 11:03\nRNS Number : 6918R\nSolvonis Therapeutics PLC\n18 July 2025\n18 July 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nExercise of warrants\nSolvonis Therapeutics plc (LSE: SVNS), a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, announces that the\u00a0Company has received a notice to exercise warrants over 20,000,000 new ordinary shares of\u00a0\u00a30.001 each in the Company (the \"Warrant Shares\") at an exercise price of \u00a30.001 per Warrant Share, raising\u00a0\u00a320,000 of new funds for the Company.\nAdmission and Total Voting Rights\nApplication will be made for the Warrant Shares to be admitted to trading on the Main Market of the London Stock Exchange and to listing in the FCA's Official List Equity Shares (transition) category (\"Admission\"). It is expected that Admission will become effective at 8.00 a.m. on or around 24 July 2025.\nFollowing Admission, the Company's issued ordinary share capital will comprise 6,262,104,024 ordinary shares\nof \u00a30.001 each. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (\"AUD\") and Post-Traumatic Stress Disorder (\"PTSD\"), conditions which the Company estimates affect over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in the UK and EU. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery programme built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nIOERPMMTMTMBBBA",
          "content_length": 3967
        },
        "ingested_at": "2026-01-21T01:46:42.629408Z"
      },
      {
        "event_id": "RNS-14th Jul 2025-solvonis",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629422Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Solvonis Chair to speak at Lucid Capital Markets",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/SVNS/solvonis-chair-to-speak-at-lucid-capital-markets-8dvmmiuf1wkc5r4.html",
          "rns_number": "RNS Number : 8962Q",
          "full_content": "14 Jul 2025 07:00\nRNS Number : 8962Q\nSolvonis Therapeutics PLC\n14 July 2025\n14 July 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nSolvonis Chair Dennis Purcell to speak at Lucid Capital Markets biotech leadership event\n.\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders is pleased to announce that its Chairman, Dennis Purcell, will participate in an exclusive investor event hosted by Lucid Capital Markets on Thursday, 17 July 2025 at 2:00pm ET.\nThe event, moderated by Elem\u00e9r Piros, PhD, Managing Director and Senior Biotech Analyst at Lucid Capital Markets, features a panel discussion with three of the most influential figures in global biopharma: Dennis Purcell (Chair, Solvonis; Founder, Aisling Capital), Stelios Papadopoulos (Chair, Exelixis), and Jeremy Levin (Chair and CEO, Ovid Therapeutics).\nThe session will explore leadership, innovation, and strategic capital deployment across the biotechnology sector.\nDennis Purcell brings more than 30 years of experience in life sciences investment, having deployed over $15 billion in more than 200 companies through Aisling Capital. His participation in this panel underscores the strength of strategic leadership at Solvonis as the Company advances its AI-enabled CNS drug discovery platform.\nEvent details:\nDate:\nThursday, 17 July 2025\nTime:\n2:00pm ET / 7:00pm BST\nRegistration link:\nhttps://lnkd.in/eq5pWiFn\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD)-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAGPUWCMUPAGBW",
          "content_length": 4023
        },
        "ingested_at": "2026-01-21T01:46:42.629434Z"
      },
      {
        "event_id": "RNS-11th Jul 2025-\u00a31msubsc",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629448Z",
        "source": "LSE_RNS",
        "data": {
          "title": "\u00a31m subscription to accelerate AI drug discovery",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/1631m-subscription-to-accelerate-ai-drug-discovery-2ui3rq9di7xqu21.html",
          "rns_number": "RNS Number : 6425Q",
          "full_content": "11 Jul 2025 07:00\nRNS Number : 6425Q\nSolvonis Therapeutics PLC\n11 July 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n11 July 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\n\u00a31.0 million subscription by major shareholders to accelerate AI drug discovery programme\nSolvonis Therapeutics plc (LSE: SVNS), a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, announces that it has raised gross proceeds of \u00a31.0 million through a direct subscription (the \"Subscription\") for 333,333,334 new ordinary shares of \u00a30.001 each in the capital of the Company (the \"Subscription Shares\") at a price of 0.3 pence per Subscription Share (the \"Issue Price\"). The Issue Price is approximately a 3.5% premium to the closing price of 0.29 pence per share on 10 July 2025.\nThe Subscription is being undertaken by three of the Company's largest shareholders, reflecting their continued strong support for Solvonis' strategy and execution.\nUse of proceeds\nThe net proceeds of the Subscription will be deployed to accelerate Solvonis' AI supported central nervous system drug discovery programme, which is initially focused on major depressive disorder and stimulant use disorder, being two therapeutic areas with significant unmet needs and limited innovation. The global antidepressant drug market was valued by Global Market Insights, the global market research and management consulting company catering to corporations, non-profits, universities, and government agencies, at approximately \u00a315\u202fbillion in 2024. Global Market Insights projects this to grow at a compound annual growth rate of 7.5% through to 2034. Meanwhile, stimulant use disorders, such as those related to cocaine and amphetamine dependence, remain underserved by the pharmaceutical industry, with no FDA-approved medications currently available, despite the substantial public health burden they represent\n(source: U.S. Veterans Affairs Health Services R&D\n).\nSolvonis is uniquely positioned to address both of these high-burden conditions through its AI enabled, central nervous system focused R&D platform. This R&D platform integrates proprietary compound libraries, predictive modelling and rapid translational tools to drive discovery in areas traditionally marked by low investment and slow innovation.\nThe proceeds from the Subscription will enable the Company to accelerate lead identification and early-stage candidate validation across these two core therapeutic indications.\nAdmission and Total Voting Rights\nApplication will be made for the Subscription Shares to be admitted to trading on the Main Market of the London Stock Exchange and to listing in the FCA's Official List Equity Shares (transition) category (\"Admission\").\nIt is expected that Admission will become effective and that dealings in the Subscription Shares will commence at 8.00 a.m. on or around 17 July 2025.\nFollowing Admission, the Company's enlarged issued ordinary share capital will comprise 6,242,104,024 ordinary shares\nof \u00a30.001 each. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.\nAnthony Tennyson, Chief Executive Officer of Solvonis, commented:\n\"We are pleased to receive this investment from our largest and longest-standing shareholders. Their continued conviction supports our strategy to lead innovation in addiction and mental health therapeutics, including the acceleration of our proprietary AI-supported discovery platform. This funding enables acceleration of building a differentiated pipeline in stimulant use and depressive disorders.\"\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (",
          "content_length": 6784
        },
        "ingested_at": "2026-01-21T01:46:42.629464Z"
      },
      {
        "event_id": "RNS-8th Jul 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629477Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-2rucw0nyid1eczf.html",
          "rns_number": "RNS Number : 0752Q",
          "full_content": "8 Jul 2025 07:00\nRNS Number : 0752Q\nSolvonis Therapeutics PLC\n08 July 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BMD1Z199\nIssuer Name\nSOLVONIS THERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights\n3. Details of person subject to the notification obligation\nName\nOberon Investments Limited\nCity of registered office (if applicable)\nBasildon\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n03-Jul-2025\n6. Date on which Issuer notified\n03-Jul-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n2.176000\n0.000000\n2.176000\n128,567,604\nPosition of previous notification (if applicable)\n3.209000\n0.000000\n3.209000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BMD1Z199\n128,567,604\n2.176000\nSub Total 8.A\n128,567,604\n2.176000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n07-Jul-2025\n13. Place Of Completion\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUBSARVBUBRUR",
          "content_length": 3839
        },
        "ingested_at": "2026-01-21T01:46:42.629490Z"
      },
      {
        "event_id": "RNS-27th Jun 2025-agmstate",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629503Z",
        "source": "LSE_RNS",
        "data": {
          "title": "AGM Statement",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/agm-statement-eh0d0tzrynh06gx.html",
          "rns_number": "RNS Number : 8187O",
          "full_content": "27 Jun 2025 14:38\nRNS Number : 8187O\nSolvonis Therapeutics PLC\n27 June 2025\n27 June 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nAGM statement and strategic update\nSolvonis Therapeutics plc (LSE: SVNS)\n, a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders\n, announces that all resolutions proposed at its Annual General Meeting (\"AGM\") held earlier today were duly passed. A summary of the resolutions is provided at the end of this announcement.\nThis year's AGM marks a significant milestone in the Company's growth trajectory. Following the successful completion of the acquisition of Awakn Life Sciences on 28 May 2025, Solvonis has rapidly established itself as a leading European innovator in the development of precision neuropsychiatric therapeutics.\nThe combined company now benefits from a high-quality pipeline of preclinical and clinical-stage assets targeting alcohol use disorder, post-traumatic stress disorder, and other complex neuropsychiatric conditions. These programmes, including lead candidate SVN-001, are underpinned by translational science, real-world evidence, and a regulatory strategy aligned with expedited pathways in key jurisdictions.\nIntegration activities are progressing in line with plan, with a focus on operational efficiency, disciplined capital deployment, and preparing lead programmes for Phase 3 readiness and partnering opportunities. Solvonis continues to advance a virtual biotech model, supported by a lean team and an expanding network of expert collaborators and CROs.\nAnthony Tennyson, CEO of Solvonis Therapeutics, commented:\n\"Today's AGM reflects strong shareholder support for our vision and execution. With the acquisition of Awakn now complete, we are strategically positioned to lead in transforming the treatment landscape for substance use and treatment-resistant mental health disorders across Europe and beyond. We are focused on delivering value through rigorous development, targeted commercial strategy, and partnerships that extend our reach and impact.\"\nThe Board remains committed to building a capital-efficient, data-driven, and licensing-led business capable of delivering meaningful therapeutic advances and long-term value creation.\nFurther updates on programme progress and strategic initiatives will be provided in due course.\nAs noted, all resolutions proposed at the meeting were passed. The results of voting on each resolution are summarised below:\nResolution\nVotes for\nFor %\nVotes against\nAgainst %\nVotes total\nVotes withheld\nResolution 1\n600,321,074\n99.90%\n572,816\n0.10%\n600,893,890\n2,000\nResolution 2\n565,318,574\n99.90%\n572,816\n0.10%\n565,891,390\n35,004,500\nResolution 3\n599,379,529\n99.75%\n1,514,361\n0.25%\n600,893,890\n2,000\nResolution 4\n564,851,874\n99.82%\n1,039,516\n0.18%\n565,891,390\n35,004,500\nResolution 5\n564,851,874\n99.82%\n1,039,516\n0.18%\n565,891,390\n35,004,500\nResolution 6\n599,846,229\n99.83%\n1,047,661\n0.17%\n600,893,890\n2,000\nResolution 7\n564,377,029\n93.92%\n36,516,861\n6.08%\n600,893,890\n2,000\nResolution 8\n600,321,074\n99.90%\n572,816\n0.10%\n600,893,890\n2,000\nNotes:\n1)\nResolutions 1 to 6 were passed as ordinary resolutions. Resolution 7 and 8 were passed as special resolutions.\n2)\nA vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes \"For\" or \"Against\" any of the resolutions.\n3)\nAs at the date of the GM, the Company's issued share capital consisted of 5,908,770,690 ordinary shares of \u00a30.001 each.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD)-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative exp",
          "content_length": 6111
        },
        "ingested_at": "2026-01-21T01:46:42.629517Z"
      },
      {
        "event_id": "RNS-27th Jun 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629530Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-hwcxrqznplxjgum.html",
          "rns_number": "RNS Number : 7389O",
          "full_content": "27 Jun 2025 08:54\nRNS Number : 7389O\nSolvonis Therapeutics PLC\n27 June 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BMD1Z199\nIssuer Name\nSOLVONIS THERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights; An event changing the breakdown of voting rights\n3. Details of person subject to the notification obligation\nName\nStuart Sharpless\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n28-May-2025\n6. Date on which Issuer notified\n26-June-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n3.32\n0.00\n3.32\n196351963\nPosition of previous notification (if applicable)\n6.31\n0.00\n6.31\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BMD1Z199\n196351963\n3.32\nSub Total 8.A\n196351963\n3.32%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n26-June-2025\n13. Place Of Completion\nUK\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUBVBRVAUNURR",
          "content_length": 3816
        },
        "ingested_at": "2026-01-21T01:46:42.629542Z"
      },
      {
        "event_id": "RNS-26th Jun 2025-initiati",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629555Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Initiation of Research Coverage",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/SVNS/initiation-of-research-coverage-wwuh7717v0mirbi.html",
          "rns_number": "RNS Number : 5618O",
          "full_content": "26 Jun 2025 10:21\nRNS Number : 5618O\nSolvonis Therapeutics PLC\n26 June 2025\nREACH - non-regulatory announcement\n26 June 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nInitiation of research coverage by Singer Capital Markets\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, is pleased to announce that Singer Capital Markets (\"Singers\") has today initiated equity research coverage (the \"Initiation Note\") on the Company.\nThe Initiation Note, titled\n\"Psyching up for success\"\n, has been authored by Dr. Karl Keegan, Head of Life Sciences Research at Singers.\nThe research note is currently available to eligible institutional investors and will be made publicly available via Singers next week.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD)-conditions which the Company estimates affect over 60 million people across the UK, US, and EU4. Its lead asset, SVN\u2011001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN\u2011002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme, SVN\u2011SDN\u2011014, leveraging novel serotonin, dopamine, and noradrenalin modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders.\nWith a capital-efficient model, focused pipeline strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nAbout Reach announcements\nThis is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAUNAKRVWUNURR",
          "content_length": 3622
        },
        "ingested_at": "2026-01-21T01:46:42.629567Z"
      },
      {
        "event_id": "RNS-23rd Jun 2025-allowanc",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629580Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Allowance of U.S. patent covering AI-supported CNS",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/allowance-of-us-patent-covering-ai-supported-cns-frksiws5ob9ei9b.html",
          "rns_number": "RNS Number : 8613N",
          "full_content": "23 Jun 2025 07:00\nRNS Number : 8613N\nSolvonis Therapeutics PLC\n23 June 2025\n23 June 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nAllowance of U.S. patent covering AI-supported CNS discovery programme compounds\nSolvonis Therapeutics plc (LSE: SVNS)\n, a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders\n, is pleased to announce that the U.S. Patent and Trademark Office (the \"USPTO\") has allowed a key patent application protecting compounds within the Company's AI-enabled CNS discovery programme.\nThe application-U.S. No. 18/838,986, titled\n\"Bridged Ring Compounds and Their Therapeutic Use as CNS Agents\"\n-received a first-action allowance with no objections or rejections. The claims cover composition of matter and methods of use for a family of novel morpholine-class compounds, originally developed by Awakn Life Sciences Corp. and now central to Solvonis' Central Nervous System (\"CNS\") library.\nAn \"allowance\" confirms that a patent will be granted, subject only to final administrative steps.\nThe CNS library, which includes multiple chemically distinct, preclinically validated series, underpins Solvonis' AI-supported drug discovery platform. The patent adds meaningful protection across novel CNS chemical space, especially in depression, stimulant use disorder and other neuropsychiatric conditions.\nThe patent, expected to be granted in the coming months, will confer U.S. exclusivity through to at least 2043, reinforcing the long-term value of Solvonis' early-stage pipeline.\nProfessor David Nutt, Chief Scientific Officer of Solvonis, commented:\n\"This patent strengthens the foundation of our discovery platform and provides long-term protection for a chemically distinct series of CNS-active compounds already integrated into our AI-supported programme. The favourable examination outcome reflects the novelty and robustness of the underlying chemistry, which has now been further validated through translational screening and computational analyses.\"\nAnthony Tennyson, Chief Executive Officer of Solvonis, added:\n\"We are delighted by this outcome, which validates the early-stage innovation acquired through Awakn and enhances the strategic value of our AI-enabled platform. This grant provides additional confidence as we advance our discovery pipeline targeting major unmet needs in neuropsychiatry.\"\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programmes address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD)-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD programme leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI-supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nUPDFBMLTMTMTMJA",
          "content_length": 4998
        },
        "ingested_at": "2026-01-21T01:46:42.629593Z"
      },
      {
        "event_id": "RNS-11th Jun 2025-initiati",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629606Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Initiation of AI supported CNS drug discovery",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/initiation-of-ai-supported-cns-drug-discovery-vtbnp27ajy2k6dr.html",
          "rns_number": "RNS Number : 3646M",
          "full_content": "11 Jun 2025 07:30\nRNS Number : 3646M\nSolvonis Therapeutics PLC\n11 June 2025\n11 June 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nInitiation of artificial intelligence supported CNS drug discovery programme\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, is pleased to announce the initiation of an artificial intelligence (\"AI\") supported drug discovery programme focused on its proprietary central nervous system (\"CNS\") compound library.\nThe library, acquired through the Company's recent acquisition of Awakn Life Sciences Corp. (\"Awakn\"), includes multiple patent-pending chemical series developed through a completed hit-to-lead programme. This body of work incorporated\nin silico\ndesign,\nin vitro\nscreening and\nin vivo\ncharacterisation. The resulting dataset forms a structurally differentiated early-stage portfolio with therapeutic potential across a range of neuropsychiatric indications.\nThe new programme will apply AI and computational modelling techniques to enable data-driven asset prioritisation, structure-activity relationship (\"SAR\") analysis and translational hypothesis generation. The objective is to accelerate the identification and optimisation of high-value development candidates within the library.\nUnder the scientific leadership of Professor David Nutt, Solvonis' Chief Scientific Officer, the AI enabled programme will initially prioritise indications in depression and stimulant use disorders.\nThis initiative is distinct from Solvonis' existing preclinical programme, SVN-SDN-014, which targets post-traumatic stress disorder (\"PTSD\"). Together, these efforts comprise a strategically diversified R&D pipeline spanning late-stage clinical assets in Alcohol Use Disorder, a novel preclinical PTSD programme and a discovery platform focused on comorbid, high-burden neuropsychiatric conditions.\nProfessor David Nutt, Chief Scientific Officer of Solvonis, commented\n:\n\"The integration of AI supported analytics into our discovery workflow enhances our ability to identify high-potential compounds for further development. The underlying chemistry is robust and scientifically validated, and we believe this approach will bring forward differentiated candidates in areas of persistent clinical need.\"\nAnthony Tennyson, Chief Executive Officer of Solvonis, added\n:\n\"Following the acquisition of Awakn, we now possess a CNS compound library with strong early validation. This initiative reflects our strategy to combine capital-efficient innovation with rigorous translational science as we develop next-generation therapeutics for depression, addiction, and other high-burden mental health conditions.\"\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange (transition category), Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programs address Alcohol Use Disorder (\"AUD\") and Post-Traumatic Stress Disorder (PTSD)-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD program leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nIn addition, Solvonis is advancing an AI supported discovery platform built on a proprietary CNS compound library, with initial focus on depression and stimulant use disorders. This initiative expands the Company's R&D pipeline into earlier-stage innovation while maintaining strategic focus on comorbid and underserved neuropsychiatric conditions.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compli",
          "content_length": 5371
        },
        "ingested_at": "2026-01-21T01:46:42.629620Z"
      },
      {
        "event_id": "RNS-5th Jun 2025-synthesi",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629634Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Synthesis of development candidate for SVN-SDN-014",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/synthesis-of-development-candidate-for-svn-sdn-014-i6w3ymb0zeof2h0.html",
          "rns_number": "RNS Number : 5149L",
          "full_content": "5 Jun 2025 07:00\nRNS Number : 5149L\nSolvonis Therapeutics PLC\n05 June 2025\n5 June 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nSynthesis of development candidates for SVN-SDN-014 programme\nFurther to the Company's announcement on 18 March 2025, Solvonis Therapeutics plc (LSE: SVNS), a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, provides a progress update on its preclinical programme, SVN-SDN-014 (the \"\nProgramme\n\"), a novel series of serotonin (\"\nSERT\n\"), dopamine (\"\nDAT\n\"), and noradrenaline (\"\nNET\n\") modulators in development for trauma-related mental health conditions, including Post-Traumatic Stress Disorder (\"\nPTSD\n\"). Prior to the Company's acquisition of Awakn Life Sciences Corp., which completed on 27 May 2025, the Programme was previously referred to as AWKN-SDN-014.\nThe Programme aims to develop a new class of medicines for PTSD which affects an estimated 13 million adults in the United States alone, with the Company estimating a total affected population of approximately 20 million across the United States, United Kingdom and key other European markets.\nThe SVN-SDN-014 series is designed to enhance pro-social behaviour and is being developed with the aim of delivering an improved safety profile compared to existing investigational treatments for PTSD. By modulating neurochemical pathways associated with trust, empathy, and social bonding, the compounds aim to support patients in rebuilding interpersonal relationships, reducing isolation, and engaging more effectively in therapy.\nThe Company has now completed the synthesis of development candidates, marking the third of seven stages in the SVN-SDN-014 translational development plan. This latest phase involved the synthesis of a focused set of compounds for subsequent preclinical characterisation, including pharmacological and toxicological profiling.\nThe remaining stages for the programme are as follows:\n1. In-vitro screening for SERT, DAT and NET re-absorption inhibition\n2. In-vitro screening for SERT, DAT and NET release - expected to complete by the end of July 2025\n3. Pre-clinical animal testing\n4. Lead candidate selection - expected by the end of Q3 2025\nFurther details of the remaining stages can be found in the Company's announcement on 18 March 2025.\nAnthony Tennyson, Chief Executive Officer of Solvonis, commented:\n\"SVN-SDN-014 represents a novel, mechanism-driven approach to treating PTSD, an area of significant and persistent clinical need. With candidate synthesis now complete, we are progressing the programme toward formal lead selection and IND-enabling studies.\"\nFurther updates will be provided as the Programme advances toward regulatory submission.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds that target high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's lead programs address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD)-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 trials for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD program leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nUPDFI",
          "content_length": 5010
        },
        "ingested_at": "2026-01-21T01:46:42.629647Z"
      },
      {
        "event_id": "RNS-3rd Jun 2025-noticeof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629661Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Notice of Annual General Meeting",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/notice-of-annual-general-meeting-p91xrkre78ywtuo.html",
          "rns_number": "RNS Number : 2395L",
          "full_content": "3 Jun 2025 16:30\nRNS Number : 2395L\nSolvonis Therapeutics PLC\n03 June 2025\n3 June 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nNotice of Annual General Meeting (the \"AGM\")\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders, is pleased to announce t\nhat the notice of the Company's 2025 AGM and proxy form have today been posted to shareholders and can be found on the Company's website at\nhttps://solvonis.com/investor-relations/shareholder-circulars\n.\nThe Annual General Meeting will take place at 12.00 noon on 27 June 2025 at the Company's registered office being,\u00a025 Eccleston Place, London SW1W 9NF.\nIn compliance with Listing Rule 9.6.1R, the notice of AGM and proxy form have today been submitted to the National Storage Mechanism and will shortly be available at\nhttps://data.fca.org.uk/#/nsm/nationalstoragemechanism\n.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds that target high-burden neuropsychiatric conditions with significant unmet need.\nThe company's lead programs address Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD)-conditions affecting over 80 million people across the UK, US, and EU4. Its lead asset, SVN-001, is currently in Phase 3 trials for severe AUD in Europe and the UK. SVN-002 is preparing for a Phase 2b trial in the US targeting moderate to severe AUD. Solvonis also has a preclinical PTSD program leveraging novel serotonin-dopamine modulators designed to enhance pro-social behaviour and long-term outcomes.\nWith a capital-efficient model, dual development strategy, and near-term partnering opportunities, Solvonis is positioned to generate value through innovation in neuropsychiatry.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNOAPKNBNKBKDOAK",
          "content_length": 3284
        },
        "ingested_at": "2026-01-21T01:46:42.629674Z"
      },
      {
        "event_id": "RNS-3rd Jun 2025-appointm",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629687Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Appointment of Prof. David Nutt as CSO",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/appointment-of-prof-david-nutt-as-cso-frf3mgqhywo2g2h.html",
          "rns_number": "RNS Number : 1028L",
          "full_content": "3 Jun 2025 07:00\nRNS Number : 1028L\nSolvonis Therapeutics PLC\n03 June 2025\n3 June 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nAppointment of Professor David Nutt as Chief Scientific Officer\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders, is pleased to announce that Professor David Nutt, who has served as Senior Scientific Advisor to the Company since July 2024, has been appointed to the Company's management team as Chief Scientific Officer (\"\nCSO\n\") with immediate effect.\nProfessor Nutt is one of the world's foremost authorities in brain science and psychiatric medicine, with a distinguished career spanning more than four decades. He holds the Edmond J. Safra Chair in Neuropsychopharmacology at Imperial College London, where he leads the Neuropsychopharmacology Unit within the Division of Brain Sciences. His research has significantly advanced the understanding and treatment of central nervous system (\"\nCNS\n\") disorders, particularly in addiction, depression, anxiety, and other high-burden mental health conditions.\nProfessor Nutt has authored over 600 peer-reviewed publications and several landmark texts on psychiatric illness, brain chemistry and CNS drug development. His work has played a pivotal role in translating neuroscience into effective clinical interventions. Professor Nutt is a Fellow of the Royal College of Physicians, the Royal College of Psychiatrists and the Academy of Medical Sciences and has held senior advisory roles with leading UK and European medical research institutions.\nProfessor David Nutt, CSO of Solvonis, commented:\n\"It's a privilege to take on this expanded role at Solvonis at such a pivotal stage in the Company's growth. Solvonis is distinguished by its unwavering commitment to rigorous neuroscience, translational innovation, and clinically grounded development - all of which align closely with my own scientific philosophy. The pipeline reflects both ambition and focus, with the potential to deliver transformative treatments for brain disorders that continue to impose an immense personal and societal burden. I look forward to helping accelerate the development of therapies that are not only scientifically robust, but capable of making a real difference in patients' lives at scale.\"\"\nAs CSO, Professor Nutt will lead the scientific strategy and clinical development of Solvonis' expanding pipeline, including:\n\u00b7\nSVN-001\n- a Phase 3-stage, proprietary combination of intravenous ketamine and relapse-prevention cognitive behavioural therapy (\"\nCBT\n\") for severe Alcohol Use Disorder (\"\nAUD\n\"), currently being evaluated across eight NHS Trusts in the UK. The trial is co-funded by the Medical Research Council (\"\nMRC\n\"), the National Institute for Health and Care Research (\"\nNIHR\n\") and Solvonis.\n\u00b7\nSVN-002\n- a patent-pending sublingual/buccal esketamine formulation, paired with therapy, targeting moderate to severe AUD for the US market. The programme is in Phase 2b planning under the FDA 505(b)(2) regulatory pathway.\n\u00b7\nSVN-SDN-14\n- a preclinical-stage programme focused on multi-receptor modulation (serotonin, dopamine, noradrenaline) to promote pro-social behaviour and improve safety relative to existing investigational therapies for trauma related mental health disorders, such as Post-Traumatic Stress Disorder (\"\nPTSD\n\").\n\u00b7\nSolvonis' proprietary CNS compound library\n, comprising multiple patented chemical series that have completed hit-to-lead progression. Professor Nutt will oversee scientific direction, asset prioritisation, and translational development across the early-stage pipeline.\nProfessor Nutt's scientific leadership will be instrumental in shaping translational strategy, regulatory engagement, and clinical execution across the Company's portfolio.\nThis non-board appointment reinforces Solvonis' commitment to world-class neuroscience and to delivering innovation in areas of urgent, unmet clinical need.\nAnthony Tennyson, CEO of Solvonis, commented\n:\n\"David is one of the most accomplished neuroscientists of his generation. His contributions to our understanding of brain chemistry and psychiatric illness are unmatched, and his leadership will be central to advancing Solvonis' pipeline of novel therapeutics for addiction and mental health disorders. We are delighted that David has agreed to become Solvonis' CSO.\"\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing novel medicines for addiction and mental health disorders. Headquartered in Londo",
          "content_length": 6696
        },
        "ingested_at": "2026-01-21T01:46:42.629701Z"
      },
      {
        "event_id": "RNS-2nd Jun 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629714Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-g4ch4qvi2hrij41.html",
          "rns_number": "RNS Number : 0425L",
          "full_content": "2 Jun 2025 11:58\nRNS Number : 0425L\nSolvonis Therapeutics PLC\n02 June 2025\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nSOLVONIS THERAPEUTICS PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nx\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nx\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nWilliam Potts\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n27/05/2025\n6.\nDate on which issuer notified (DD/MM/YYYY):\n02/06/2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n10.33\nNil\n10.33\n610,461,538\nPosition of previous notification (if\napplicable)\n23.17\nNil\n23.17\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\n610,461,538\nNil\n10.33\nSUBTOTAL 8. A\n610,461,538\n10.33\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nN/A\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nx\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nSurrey, UK\nDate of completion\n02/06/2025\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUUVRRVNUNRAR",
          "content_length": 4263
        },
        "ingested_at": "2026-01-21T01:46:42.629727Z"
      },
      {
        "event_id": "RNS-30th May 2025-totalvot",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629739Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Total Voting Rights",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/total-voting-rights-sbiyhn3ctp750mp.html",
          "rns_number": "RNS Number : 8050K",
          "full_content": "30 May 2025 17:00\nRNS Number : 8050K\nSolvonis Therapeutics PLC\n30 May 2025\n30 May 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nTotal Voting Rights\nSolvonis Therapeutics plc (LSE: SVNS), a clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders, confirms that the Company's issued share capital as at the date of this announcement comprises 5,908,770,690 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 5,908,770,690.\nThe above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.\nEnquiries:\nSolvonis Therapeutics plc\nanthony@solvonis.com\nAnthony Tennyson, CEO & Executive Director\nAllenby Capital Limited (Financial Adviser and Joint Broker)\n+44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)\nGuy McDougall (Sales & Corporate Broking)\nSinger Capital Markets (Joint Broker)\n+44(0) 20 7496 3000\nPhil Davies\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTVREANSEDDXSEEA",
          "content_length": 2041
        },
        "ingested_at": "2026-01-21T01:46:42.629752Z"
      },
      {
        "event_id": "RNS-29th May 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629764Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-gjo5qelu3p4h691.html",
          "rns_number": "RNS Number : 6643K",
          "full_content": "29 May 2025 15:11\nRNS Number : 6643K\nSolvonis Therapeutics PLC\n29 May 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BMD1Z199\nIssuer Name\nSOLVONIS THERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights; An acquisition or disposal of financial instruments\n3. Details of person subject to the notification obligation\nName\nSpreadex LTD\nCity of registered office (if applicable)\nSt. Albans\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n28-May-2025\n6. Date on which Issuer notified\n29-May-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n3.485700\n0.372300\n3.858000\n227961538\nPosition of previous notification (if applicable)\n3.654900\n0.456900\n4.111800\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BMD1Z199\n205961538\n3.485700\nSub Total 8.A\n205961538\n3.485700%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nCFD/Spreadbet\n22000000\n0.372300\nSub Total 8.B1\n22000000\n0.372300%\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\nLorenzo Dal Col01727 895144Spreadex is an FCA regulated provider of spread betting and CFD trading. Founded in 1999, Spreadex gives both retail and professional traders the opportunity to trade over 10,000 global markets, including UK small caps. For more information see\nwww.spreadex.com/financials\n.\n12. Date of Completion\n29-May-2025\n13. Place Of Completion\nUK\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUKASRVRUVUAR",
          "content_length": 4223
        },
        "ingested_at": "2026-01-21T01:46:42.629777Z"
      },
      {
        "event_id": "RNS-29th May 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629789Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-9leb4q37m7lcikc.html",
          "rns_number": "RNS Number : 6345K",
          "full_content": "29 May 2025 12:02\nRNS Number : 6345K\nSolvonis Therapeutics PLC\n29 May 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BMD1Z199\nIssuer Name\nSOLVONIS THERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn event changing the breakdown of voting rights\n3. Details of person subject to the notification obligation\nName\nOberon Investments Limited\nCity of registered office (if applicable)\nBasildon\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n27-May-2025\n6. Date on which Issuer notified\n29-May-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n3.209000\n0.000000\n3.209000\n189613635\nPosition of previous notification (if applicable)\n8.188000\n0.000000\n8.188000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BMD1Z199\n189613635\n3.209000\nSub Total 8.A\n189613635\n3.209000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\nChanged percentage is following an issue of new shares by the issuer.\n12. Date of Completion\n13. Place Of Completion\nLondon\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUKRARVAUVUAR",
          "content_length": 3896
        },
        "ingested_at": "2026-01-21T01:46:42.629802Z"
      },
      {
        "event_id": "RNS-29th May 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629814Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-t2r3gioxrz5sezs.html",
          "rns_number": "RNS Number : 6008K",
          "full_content": "29 May 2025 10:30\nRNS Number : 6008K\nSolvonis Therapeutics PLC\n29 May 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BMD1Z199\nIssuer Name\nSOLVONIS THERAPEUTICS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights; An event changing the breakdown of voting rights\n3. Details of person subject to the notification obligation\nName\nSpreadex LTD\nCity of registered office (if applicable)\nSt. Albans\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n27-May-2025\n6. Date on which Issuer notified\n28-May-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n3.654900\n0.456900\n4.111800\n242961538\nPosition of previous notification (if applicable)\n5.988900\n1.132400\n7.121300\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BMD1Z199\n215961538\n3.654900\nSub Total 8.A\n215961538\n3.654900%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nCFD/Spread Bet\n27000000\n0.456900\nSub Total 8.B1\n27000000\n0.456900%\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\nSam Meisel01727 895138Spreadex is an FCA regulated provider of spread betting and CFD trading. Founded in 1999, Spreadex gives both retail and professional traders the opportunity to trade over 10,000 global markets, including UK small caps. For more information see\nwww.spreadex.com/financials\n.\n12. Date of Completion\n28-May-2025\n13. Place Of Completion\nUK\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUKOWRVNUVURR",
          "content_length": 4216
        },
        "ingested_at": "2026-01-21T01:46:42.629827Z"
      },
      {
        "event_id": "RNS-29th May 2025-presenta",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629840Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Presentation at Mello2025",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/SVNS/presentation-at-mello2025-quvo4ehc78z8qh2.html",
          "rns_number": "RNS Number : 4732K",
          "full_content": "29 May 2025 07:00\nRNS Number : 4732K\nSolvonis Therapeutics PLC\n29 May 2025\nREACH- non-regulatory announcement\n29 May 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nPresentation at Mello2025\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders, is pleased to announce that\nthe Company will be presenting at the\u00a0Mello2025 investor event on\u00a0Tuesday 3rd June 2025, to be held at The Clayton Hotel & Conference Centre, Chiswick High Road, London, W4 5RY. Anthony Tennyson, CEO, will be presenting and will take questions during the event.\nFor further information and tickets (use code ShareM2550 for 50% off ticket price) for the\u00a0Mello2025 conference, please visit the event\u00a0website at\nwww.melloevents.com/mello2025\n.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders. Headquartered in London and listed on the Main Market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's current focus is on Alcohol Use Disorder (AUD), which affects more than 40 million people across the US, UK, and EU4, and Post-Traumatic Stress Disorder (PTSD), impacting over 13million adults in the US and approximately 20 million across the same regions.Solvonis has three core R&D programmes and a proprietary library of preclinical drug candidates:\n1.\nSVNS-001:\nA novel investigational combination therapy for the treatment of severe AUD, currently in Phase 3 clinical development. In a prior Phase 2 study, participants in the active treatment arm achieved 86% abstinence from alcohol in the six months post-treatment, compared to just 2% pre-trial.\nA market analysis commissioned by Solvonis and conducted by PharmaVentures indicates that comparable late-stage UK/EU-focused assets in the substance use disorder space typically achieve total deal values of ~\u00a360 million in upfront and milestone payments, in addition to royalties on net sales if successfully out licensed.\n2.\nSVNS-002:\nA proprietary, investigational, patent-pending sublingual/buccal esketamine formulation for use in combination with manualised therapy in treating moderate to severe AUD. This programme is in Phase 2b planning in the US and is expected to follow the FDA's 505(b)(2) regulatory pathway.\nPharmaVentures estimates that, following successful Phase 2b completion, comparable mid-stage assets typically achieve total deal values of ~\u00a3150 million, plus future royalties if out licensed.\n3.\nSVNS-SDN-14:\nA novel series of serotonin, dopamine, and noradrenaline receptor modulators, currently at preclinical stage, being developed to promote pro-social behavior and improve upon the safety profile of existing investigational PTSD treatments.\nIn addition to these lead programmes, Solvonis owns a proprietary library of preclinical compounds, each having completed hit-to-lead progression, with composition-of-matter patents filed across multiple chemical series.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nAbout Reach announcements\nThis is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAEVLFLEELBBBV",
          "content_length": 4794
        },
        "ingested_at": "2026-01-21T01:46:42.629852Z"
      },
      {
        "event_id": "RNS-28th May 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629865Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-7wn42ejot7zi0tf.html",
          "rns_number": "RNS Number : 2794K",
          "full_content": "28 May 2025 07:30\nRNS Number : 2794K\nSolvonis Therapeutics PLC\n28 May 2025\nTR-1: S\ntandard form for notification of major holdings\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nSolvonis Therapeutics Plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nx\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nx\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nNicholas Christian Paul Nelson\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n27/05/2025\n6.\nDate on which issuer notified (DD/MM/YYYY):\n27/05/2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n205,961,538\n3.49\n205,961,538\nPosition of previous notification (if\napplicable)\n167,500,000\n7.30\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BMD1Z199\n205,961,538\n3.49\nSUBTOTAL 8. A\n205,961,538\n3.49\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nN/A\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nx\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nChanged percentage is following an issue of new shares by the issuer plus the issue of some of those new shares to the person (above) subject to the notification\nPlace of completion\nLondon, UK\nDate of completion\n27/05/2025\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUBUSRVKUVUAR",
          "content_length": 4420
        },
        "ingested_at": "2026-01-21T01:46:42.629877Z"
      },
      {
        "event_id": "RNS-28th May 2025-completi",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629891Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Completion of the acquisition of Awakn",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/completion-of-the-acquisition-of-awakn-o053y6gv722v0ra.html",
          "rns_number": "RNS Number : 3084K",
          "full_content": "28 May 2025 07:00\nRNS Number : 3084K\nSolvonis Therapeutics PLC\n28 May 2025\n28 May 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nCompletion of the acquisition of Awakn Life Sciences Corp.\nSolvonis Therapeutics plc (LSE: SVNS),\na clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders, is pleased to announce that on May 27, 2025, it acquired all of the common shares of Awakn (\"\nAwakn Shares\n\"), restricted share units of Awakn (\"\nAwakn RSUs\n\") and deferred share units of Awakn (\"\nAwakn DSUs\n\") pursuant to a plan of arrangement under section 288 of the\nBusiness Corporations Act (\nBritish Columbia) (the \"\nArrangement\n\").\nThis acquisition significantly expands Solvonis' research and development (\"\nR&D\n\") pipeline. Of specific near-term interest is AWKN-001, now named SVNS-001, an investigational, novel combination therapy comprising an N-methyl-D-aspartate (\"\nNMDA\n\") receptor-modulating drug (ketamine), delivered intravenously in combination with a proprietary, manualised relapse prevention cognitive behavioural therapy (\"\nCBT\n\"), for the treatment of severe Alcohol Use Disorder (\"\nAUD\n\") in the UK and the EU.\nSVNS-001 is currently in a Phase 3 clinical trial being conducted across eight NHS Trusts in the UK. The study is co-funded by a partnership between the UK's Medical Research Council (\"\nMRC\n\"), the National Institute for Health and Care Research (\"\nNIHR\n\"), and now Solvonis. The trial began in Q3 2024 and is expected to be completed in late 2026 or early 2027. Solvonis' contribution to the study costs is capped at \u00a3800,000. The trial is being run by the University of Exeter's Clinical Trial Unit.\nAnthony Tennyson, Chief Executive Officer of Solvonis, commented:\n\"The completion of the Awakn acquisition marks a transformative milestone for Solvonis. The acquisition of Awakn significantly enhances our position as a leading clinical-stage platform developing evidence-based, innovative treatments for patients suffering from addiction and mental health disorders.The addition of Awakn's assets expands and accelerates our R&D pipeline. In the near term, we are focused on Alcohol Use Disorder and Post-Traumatic Stress Disorder - two high-burden conditions with significant unmet medical needs and few effective treatment options. We are excited to take this next step in our journey and look forward to advancing our late-stage and pre-clinical programmes with strong scientific and commercial momentum.\"\nRegulatory information:\nPrior to the Arrangement, Solvonis did not hold any Awakn Shares, Awakn RSUs or Awakn DSUs. Following completion of the Arrangement, Solvonis now owns 42,922,623 Awakn Shares, 998,300 Awakn RSUs and 526,872 Awakn DSUs, representing 100% of the issued and outstanding Awakn Shares, Awakn RSUs and Awakn DSUs.\nPursuant to the terms of the Arrangement, each holder of Awakn Shares, Awakn RSUs and Awakn DSUs received 46.67 common shares of Solvonis per Awakn Share, Awakn RSU or Awakn DSU, as applicable. An aggregate of\n2,074,378,528\ncommon shares of Solvonis were issued pursuant to the Arrangement.\nThis disclosure is issued pursuant to Multilateral Instrument 62-104 -\nTake-Over Bids and Issuer Bids,\nwhich also requires an early warning report to be filed containing additional information with respect to the foregoing matters. A copy of the early warning report will be made available on SEDAR+ under Awakn's profile at\nwww.sedarplus.ca.\nTo obtain a copy of the early warning report, please contact Solvonis.\nSolvonis's address is Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive Directoranthony@solvonis.com\nAllenby Capital Limited\n(Financial Adviser and Joint Broker)Nick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)Guy McDougall (Sales & Corporate Broking)+44 (0) 20 3328 5656\nSinger Capital Markets\n(Joint Broker)Phil Davies+44 (0) 20 7496 3000\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company focused on developing innovative medicines for the treatment of addiction and mental health disorders. Headquartered in London and listed on the Main Market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need.\nThe Company's current focus is on Alcohol Use Disorder (AUD), which affects more than 40 million people across the US, UK, and EU4, and Post-Traumatic Stress Disorder (PTSD), impacting over 13million adults in the US and approximately 20 million across the same regions.Solvonis has three core R&D programmes and a proprietary library of preclinical drug candidates:\n1.\nSVNS-001:\nA novel investigational combination therapy for the treatment of severe AUD, currently in Phase 3 clinical development. In a prior Phase 2",
          "content_length": 7273
        },
        "ingested_at": "2026-01-21T01:46:42.629905Z"
      },
      {
        "event_id": "RNS-21st May 2025-publicat",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629918Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Publication of a Prospectus",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/publication-of-a-prospectus-s2tnijnl5rcm2yy.html",
          "rns_number": "RNS Number : 6521J",
          "full_content": "21 May 2025 15:24\nRNS Number : 6521J\nSolvonis Therapeutics PLC\n21 May 2025\n21 May 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nPublication of a Prospectus\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that, further to the announcements released by the Company on 15 May 2025 and 16 May 2025, it has today published a prospectus pursuant to the Prospectus Regulation Rules made by the Financial Conduct Authority (\"\nFCA\n\") under Part VI of FSMA (the Financial Services and Markets Act 2000, as amended) (the \"\nProspectus\n\").\nThe Prospectus, which has been approved by the FCA, will be available shortly on the Company's website at\nwww.solvonis.com\nand will also be available at the FCA's National Storage Mechanism at:\nhttps://data.fca.org.uk/#/nsm/nationalstoragemechanism\n.\nEnquiries:\nSolvonis Therapeutics plc\nanthony@solvonis.com\nAnthony Tennyson, CEO & Executive Director\nAllenby Capital Limited (Financial Adviser and Joint Broker)\n+44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance)\nGuy McDougall (Sales & Corporate Broking)\nSinger Capital Markets Limited (Joint Broker)\n+44(0) 20 7496 3000\nPhil Davies / Patrick Weaver\nAbout Solvonis Therapeutics plc\nSolvonis\nTherapeutics plc is an innovative biotechnology company focused on developing intellectual property related to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Solvonis' mission is to improve outcomes for individuals suffering from mental health disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD affected approximately 13 million adults in the U.S. in 2020, with the Company estimating a current affected population of 20 million across the U.S., UK, and key EU markets.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nPDIMZGZKDMVGKZM",
          "content_length": 2740
        },
        "ingested_at": "2026-01-21T01:46:42.629931Z"
      },
      {
        "event_id": "RNS-16th May 2025-resultof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629944Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Result of placing",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/result-of-placing-djqwu664gye4cj5.html",
          "rns_number": "RNS Number : 9923I",
          "full_content": "16 May 2025 07:31\nRNS Number : 9923I\nSolvonis Therapeutics PLC\n16 May 2025\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO OR FROM THE UNITED STATES\n(INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE \"UNITED STATES\" OR THE \"US\"))\n, AUSTRALIA, NEW ZEALAND, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA,\nTHE REPUBLIC OF IRELAND, SINGAPORE, HONG KONG OR JAPAN\nOR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.\nTHIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER, SOLICITATION OR SALE OF SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"), AND IS DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF MAR. IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION (AS\nPERMITTED BY UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n16 May 2025\nSolvonis Therapeutics plc\n(\"\nSolvonis\"\nor the \"\nCompany\n\")\nResult of Bookbuild\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that, further to the Company's announcement on 15 May 2025 (the \"\nFundraise Launch Announcement\n\"), the Company has conditionally raised gross proceeds of\napproximately\n\u00a32.0 million (the \"\nFundraise\n\") through the proposed issue of 1,538,461,529 new ordinary shares of \u00a30.001 each in the Company (the\n\"Fundraise Shares\"\n) with certain existing and new institutional and other investors at the Issue Price of 0.13 pence per Fundraise Share.\nThe Fundraise Shares, in aggregate, represent approximately 67.01 per cent of the issued share capital of the Company prior to the Fundraise.\nAllenby Capital Limited (\"\nAllenby\n\") and Singer Capital Markets Securities Limited (\"\nSinger\n\") acted as joint brokers and joint bookrunners in respect of the Fundraise.\nAdmission and Total Voting Rights\nApplication will be made for the 3,612,840,057 Fundraise Shares and Consideration Shares, as defined in the Fundraise Launch Announcement (together the \"\nNew Ordinary Shares\n\"), to be admitted to trading on the Main Market of the London Stock Exchange and to listing in the FCA's Official List Equity Shares (transition) category (\"\nAdmission\n\").\nIt is expected that Admission will become effective and that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 27 May 2025. The issue and allotment of the Fundraise Shares is conditional upon,\ninter alia\n, Admission becoming effective and the placing agreement entered into between the Company, Allenby and Singer (the\n\"Placing Agreement\"\n) not being terminated in accordance with its terms.\nFollowing Admission, the Company's enlarged issued ordinary share capital will comprise 5,908,770,690 ordinary shares. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.\nDirector Participations\nThe Company is undertaking material related party transactions with Nicholas Nelson (Non-Executive Director), Dennis Purcell (Non-Executive Chairman) (together the \"\nParticipating Directors\n\") and Ryan Neates (a PDMR) in relation to their participation in the\nFundraise\nfor the purpose of rule 7.3 of the FCA's Disclosure Guidance and Transparency Rules, as further detailed below:\na) Nicholas Nelson will acquire 38,461,538 Fundraise Shares at the Issue Price;\nb) Dennis Purcell will acquire 38,461,538\nFundraise\nShares at the Issue Price; and\nc) Ryan Neates, the non-board finance director of the Company, will acquire 3,846,153\nFundraise\nShares at the Issue Price.\nThese material related party transactions have been approved by the board of directors of the Company. The Participating Directors did not take part in the board of directors' consideration of the transactions with them and they did not vote on the relevant board decision.\nDirectors' shareholdings on Admission\nName\nRole\nNew Ordinary Shares being subscribed for\nNew Ordinary Shares to be issued pursuant to Awakn Acquisition\nShareholding on Admission\n% of enlarged issued share capital on Admission\nNicholas Nelson\nNon",
          "content_length": 8244
        },
        "ingested_at": "2026-01-21T01:46:42.629958Z"
      },
      {
        "event_id": "RNS-15th May 2025-proposed",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629971Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Proposed equity fundraising via ABB",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/proposed-equity-fundraising-via-abb-spc10j3x9goi17l.html",
          "rns_number": "RNS Number : 9011I",
          "full_content": "15 May 2025 16:53\nRNS Number : 9011I\nSolvonis Therapeutics PLC\n15 May 2025\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO OR FROM THE UNITED STATES\n(INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE \"UNITED STATES\" OR THE \"US\"))\n, AUSTRALIA, NEW ZEALAND, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA,\nTHE REPUBLIC OF IRELAND, SINGAPORE, HONG KONG OR JAPAN\nOR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.\nTHIS ANNOUNCEMENT, INCLUDING THE APPENDICES, IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER, SOLICITATION OR SALE OF SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"), AND IS DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF MAR. IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION (AS\nPERMITTED BY UK MAR) PRIOR TO THE DATE HEREOF. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\nPLEASE SEE THE IMPORTANT NOTICES IN THE APPENDICES AT THE END OF THIS ANNOUNCEMENT.\n15 May 2025\nSolvonis Therapeutics plc\n(\"\nSolvonis\"\nor the \"\nCompany\n\")\nProposed equity fundraising to raise a minimum of approximately \u00a32 million\nFurther to the Company's announcement on 24 February 2025, Solvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, announces its intention to carry out an equity fundraising to raise a minimum of approximately \u00a32 million through an issue of new Ordinary Shares (the \"\nFundraise Shares\n\") to new and existing institutional and other investors (the \"\nFundraise\n\") at a fixed\nissue\nprice of 0.13 pence per Fundraise Share (the \"\nIssue Price\n\").\nFollowing the Company's entry into an arrangement agreement (the \"\nArrangement Agreement\n\") with Awakn Life Sciences Corp. (\"\nAwakn\n\") on 22 February 2025 and having now satisfied the key conditions for the proposed acquisition of Awakn (the \"\nProposed Acquisition\n\"), t\nhe proceeds of the Fundraise, net of expenses relating to both the Fundraise and the Proposed Acquisition,\nas well as taking into account the Company's existing cash resources,\nwill provide the Company with sufficient working capital for the requirements of the enlarged group, thereby satisfying one of the remaining conditions under the Arrangement Agreement.\nThe Fundraise is being conducted via an accelerated bookbuild process (the \"\nBookbuild\n\") to be undertaken by Allenby Capital Limited (\"\nAllenby\n\") and Singer Capital Markets Securities Limited (\"\nSinger\n\"), the Company's joint brokers\n(together, the \"\nJoint\nBookrunners\n\" or \"\nJoint Brokers\n\")\n. The Bookbuild will be launched immediately following the publication of this announcement. The final number of Fundraise Shares to be issued will be determined at the close of the Bookbuild and the result will be announced as soon as practicable thereafter. The Fundraise is subject to the terms and conditions set out in Appendix I to this announcement (the \"\nAnnouncement\n\").\nThe Fundraise is conditional upon,\ninter alia\n: (i) a placing agreement dated 15 May 2025 between the Company, Allenby and Singer (the \"\nPlacing Agreement\n\") not having been terminated and becoming unconditional; (ii) the publication by the Company of a prospectus (the \"\nProspectus\n\") approved by the Financial Conduct Authority (the \"\nFCA\"\n); and (iii) admission of the Fundraise Shares and the new Ordinary Shares to be issued pursuant to the Arrangement Agreement\n(the \"\nConsideration Shares\n\")\nto trading on the Main Market of the London Stock Exchange and to the Official List Equity Shares (transition) category of the FCA (\"\nAdmission\n\").\nThe Fundraise is\nbeing undertaken on a reasonable endeavours basis but is\nnot being underwritten by Allenby, Singer or any other person.\nCertain directors of the Company and another person discharging managerial responsibilities on its behalf intend to participate in the Fundraise\nbut it is not available to the public generally\n.\nFurther details of the Bookbuild and the Proposed Acquisition are provided below and in the Appendices to this Announcement.\nProposed Acquisition terms\nSolvonis is issuing 2,074,378,528 Consideration Shares as consideration for the Proposed Acquisition. The Proposed Acquisition values Awakn at approximately \u00a34.98 million (based up",
          "content_length": 99873
        },
        "ingested_at": "2026-01-21T01:46:42.629985Z"
      },
      {
        "event_id": "RNS-28th Apr 2025-resultof",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.629998Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Result of General Meeting",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/result-of-general-meeting-f90fop2fbke5x9r.html",
          "rns_number": "RNS Number : 4509G",
          "full_content": "28 Apr 2025 11:30\nRNS Number : 4509G\nSolvonis Therapeutics PLC\n28 April 2025\n28 April 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nResult of General Meeting and update on the Proposed Acquisition\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that all the resolutions, which relate to the proposed acquisition of Awakn Life Sciences Corp. (\"Awakn\") (the \"Proposed Acquisition\"), were duly passed by way of a poll at the General Meeting (\"GM\") held earlier today.\nResolution 1 was passed as an ordinary resolution by 99.92% in favour and 0.08% against, with 818,975,059 votes for, 662,618 votes against and 564,523 votes withheld*. Resolution 2 was passed as a special resolution by 99.92% in favour and 0.08% against, with 818,975,059 votes for, 662,618 votes against, and 564,523 votes withheld\n*.\nStrategic and commercial rationale\nThe Proposed Acquisition represents a major step for Solvonis and underscores the Company's strategy to address significant unmet needs in the treatment of mental health and addiction. The Proposed Acquisition includes two clinical-stage assets, AWKN-001 and AWKN-002, targeting Alcohol Use Disorder (\"AUD\"), a condition that the Company estimates affects 40 million individuals across the U.S. and key European markets, and for which existing treatment options are deemed inadequate.\n\u00b7\nAWKN-001\nis a Phase 3 novel investigational combination therapy for severe AUD with targeted regulatory pathways in the UK and EU that may confer up to 10 years of regulatory data and market protection.\n\u00b7\nAWKN-002\nis a proprietary Phase 2b planning sublingual/buccal esketamine formulation under development for moderate to severe AUD for the US market.\nAccording to a market analysis by PharmaVentures, which was announced by the Company on 4 April 2025, comparable late and mid-stage assets to AWKN-001 and AWKN-002 have achieved aggregate deal values of more than \u00a3200 million, including upfront and commercial milestone payments, plus additional future material royalties on net sales.\nAnthoy Tennyson, the CEO of Solvonis, commented,\n\"Today's approval by our shareholders marks an exciting and important milestone in Solvonis' evolution. The proposed acquisition of Awakn Life Sciences represents an opportunity to expand our pipeline with two highly innovative, late-stage assets targeting the significant unmet needs in AUD. We believe AWKN-001 and AWKN-002 will significantly enhance our ability to deliver on our mission to improve outcomes for individuals suffering from mental health and addiction disorders. We look forward to completing the Proposed Acquisition and integrating Awakn's team and expertise as we advance these promising therapies toward regulatory approval and commercialisation.\"\nConditions and timeline\nCompletion of the Proposed Acquisition remains subject to the satisfaction (or waiver) of various conditions, including: i) the receipt by Solvonis of all necessary regulatory consents and approvals; ii) final approval of the Plan of Arrangement by the Supreme Court of British Columbia (at a hearing scheduled for 28 April 2025); iii) necessary approvals from the Canadian Securities Exchange; iv) consent of the stock option holders in Awakn to cancel their options to acquire Awakn common shares; v) completion of an equity fundraising by Solvonis to ensure that the enlarged group has sufficient working capital; vi) Financial Conduct Authority (the \"FCA\") regulatory approval of and publication of a prospectus for the issue of the shares being issued as consideration for the Proposed Acquisition and the shares to be issued pursuant to an equity fundraising to provide the enlarged group with working and development capital (together the \"New Shares\"); and viii) admission of the New Shares to trading on the Main Market of the London Stock Exchange and listing on the equity shares (transition) category of the FCA's Official List.\nAssuming all conditions are satisfied or waived, the proposed Acquisition is anticipated to complete before the end of May 2025.\n* Notes\n:\n\u00b7\nA \"vote withheld\" is not a vote in law and is therefore not counted towards the calculation of the proportion of votes \"for\" or \"against\" the resolutions.\n\u00b7\nAs at the date of the GM, the Company's issued share capital comprised 2,295,930,633 ordinary shares of \u00a30.001 each.\nEnquiries:\nSolvonis\nTherapeutics plc, Anthony Tennyson, CEO & Executive Director, Email: anthony@solvonis.com\nAllenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance) | Guy McDougall (Sales)\nAbout Solvonis Therapeutics plc\nSolvonis\nTherapeutics plc is an innovative biotechnology company focused on developing intellectual property related to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Solvonis' mission is to",
          "content_length": 6727
        },
        "ingested_at": "2026-01-21T01:46:42.630011Z"
      },
      {
        "event_id": "RNS-23rd Apr 2025-proposed",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630025Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Proposed acquisition of Awakn approved",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/proposed-acquisition-of-awakn-approved-mpatvsfpoi8css2.html",
          "rns_number": "RNS Number : 7552F",
          "full_content": "23 Apr 2025 07:00\nRNS Number : 7552F\nSolvonis Therapeutics PLC\n23 April 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n23 April 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nProposed acquisition of Awakn approved by Awakn security holders\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that, further to its announcements dated 24 February 2025, the security holders of Awakn Life Sciences Corp. (CSE: AWKN) (\"Awakn\") have, on 22 April 2025, approved the proposed acquisition of Awakn by Solvonis (the \"Proposed Acquisition\").\nThe special resolution (the \"Special Resolution\") of Awakn's security holders approving the statutory plan of arrangement (the \"Arrangement\") under the Business Corporations Act (British Columbia) was passed by: i) 99.89% of Awakn shareholders holding Common Shares; (ii) holders of Common Shares, Common Share purchase warrants, restricted share units (the \"RSUs\"), and deferred share units (the \"DSUs\"), voting as a single class, representing 99.92% of votes cast; and (iii) 99.88% of minority shareholders (excluding certain insiders).\nThe Proposed Acquisition involves Solvonis acquiring all outstanding Common Shares, RSUs, and DSUs in the capital of Awakn.\nProposed Acquisition terms\nSolvonis intends to issue approximately 2,074,378,592 new ordinary shares of \u00a30.001 each (\"Ordinary Shares\") as consideration for the Proposed Acquisition (the \"Consideration Shares\"). The Proposed Acquisition values Awakn at approximately \u00a34.98 million based upon a closing price of 0.24 pence per Ordinary Share on 13 December 2024, being the business day before the Company announced that it had entered into a binding letter of agreement with Awakn regarding the Proposed Acquisition. Solvonis will issue to Awakn shareholders 46.67 Consideration Shares for every one common share held by or due to them (the \"Exchange Ratio\"). Based on the same Exchange Ratio, the holders of DSUs and RSUs will receive 46.67 Consideration Shares for each one DSU and for each one RSU held by them.\nIt is proposed that all issued and outstanding common share purchase warrants in Awakn (the \"Awakn Warrants\") will be exchanged for approximately 703,465,432 new warrants over new Ordinary Shares in Solvonis based upon the Exchange Ratio. It is also intended that Awakn will seek the consent from holders of stock options to cancel all existing stock options issued by Awakn.\nStrategic and commercial significance\nThe Proposed Acquisition represents a major step for Solvonis and underscores the Company's strategy to address significant unmet needs in the treatment of mental health and addiction. The Proposed Acquisition includes two clinical-stage assets, AWKN-001 and AWKN-002, targeting Alcohol Use Disorder (\"AUD\"), a condition that the Company estimates affects 40 million individuals across the U.S. and key European markets, and for which existing treatment options are deemed inadequate.\nAWKN-001\nis a Phase 3 novel investigational combination therapy for severe AUD with targeted regulatory pathways in the UK and EU that may confer up to 10 years of regulatory data and market protection.\nAWKN-002\nis a proprietary Phase 2b planning sublingual/buccal esketamine formulation under development for moderate to severe AUD.\nAccording to a market analysis by PharmaVentures, which was announced by the Company on 4 April 2025, comparable late and mid-stage assets to AWKN-001 and AWKN-002 have achieved aggregate deal values of more than \u00a3200 million, including upfront and commercial milestone payments, plus additional future material royalties on net sales.\nAnthony Tennyson, CEO Solvonis, commented\n\"We are delighted by the overwhelming support from Awakn's security holders. Their endorsement reinforces the strategic and scientific rationale for this acquisition and sets the stage for an exciting future. With this transaction we are acquiring clinical-stage assets with a significant addressable market. We note that PharmaVentures' recent analysis highlights the potential value with similar at assets in the substance use disorder space typically achieving an approximate aggregate of \u00a3200 million in deal payments (upfront and milestones), plus additional future material royalties.\"\nConditions and timeline\nCompletion of the Arrangement remains subject to the satisfaction (or waiver) of various conditions, including: i) the receipt by Solvonis of all necessary regulatory consents and approvals; ii) final approval of the Plan of Arrangement by the Supreme Court of British Columbia (at a hearing scheduled for 28 April 2025); iii) ",
          "content_length": 8231
        },
        "ingested_at": "2026-01-21T01:46:42.630038Z"
      },
      {
        "event_id": "RNS-16th Apr 2025-finalres",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630052Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Final Results for the year ended 31 December 2024",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/final-results-for-the-year-ended-31-december-2024-ze5w3ru5wq31sy6.html",
          "rns_number": "RNS Number : 1813F",
          "full_content": "16 Apr 2025 07:00\nRNS Number : 1813F\nSolvonis Therapeutics PLC\n16 April 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n16 April 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nFinal Results for the year ended 31 December 2024\nI am pleased to present the annual financial report and financial statements for Solvonis Therapeutics Plc (the \"Company\" or \"Solvonis\") formerly Graft Polymer (UK) Plc, for the year ended 31 December 2024.\nThis past year has been a transformative year for our company-one defined by strategic reorientation, decisive leadership changes, and a sharpened focus on becoming a leading player in the mental health therapeutics space.\nThe most visible reflection of this transformation is our rebranding to Solvonis Therapeutics plc, which received shareholder approval in January 2025. This name change signals our evolution from a polymer-focused business into a purpose-driven biotech company targeting urgent, unmet needs in mental health and addiction treatment.\nDuring the year, we made the strategic decision to divest our non-core assets, notably the sale of our Slovenian polymer facility. This allowed us to realign resources toward high-impact therapeutic R&D and forge commercial and clinical partnerships that lay the groundwork for long-term value creation.\nOne of the most defining moments of the year was our agreement to acquire Awakn Life Sciences Corp., a clinical-stage biotechnology company specialising in therapies for addiction and mental health disorders. We believe this acquisition, expected to complete in 2025, positions Solvonis at the forefront of innovation in this critical field.\nOn governance, we welcomed Anthony Tennyson as our new CEO in May. Anthony brings deep sectoral expertise and a compelling strategic vision that has already begun to take shape in our repositioning and execution priorities.\nWe are proud of the resilience, agility, and dedication shown by our teams throughout this period of change. The Board extends its gratitude to all our employees, partners, and shareholders who have supported this journey. As we move into 2025, we are more focused than ever on building a therapeutics company capable of making a tangible difference in the lives of patients.\nDennis Purcell\nNon-Executive Chairman\nPrincipal Risks and Uncertainties\nThe Group operates in an uncertain environment and is subject to a number of risk factors. The Directors consider the following risk factors are of particular relevance to the Group's activities although it should be noted that this list is not exhaustive and that other risk factors not presently known or currently deemed immaterial may apply.\nRisks associated with the financial condition of the enlarged group\nBoth the Company and Awakn have been historically loss making, and it is anticipated that the Group will continue to incur losses for the foreseeable future\nBoth the Company and Awakn have each accumulated significant losses since their inception. The Group will focus on funding its clinical and pre-clinical stage research projects and the Group will have no immediate sources of revenue. Shareholders should therefore be aware that the ongoing activities of the Group are being supported by the equity fundraising, existing cash resources and funds received from existing debt facilities entered into by Awakn. As an early-stage biotechnology company engaged in clinical and pre-clinical trials, the capital resources of the Group will be used to develop these programmes.\nThere is no guarantee that any of the product candidates of the Group will reach a point of being successfully commercialised. There is therefore a high risk that the Group will continue to remain loss making for the foreseeable future.\nThe combined losses of the Company and Awakn and anticipated future losses of the Group could have an adverse impact on the market price of its ordinary shares, its ability to raise capital and continued operations.\nRisks associated with the business of the Group\nSome of the Group's research programmes are at a very early stage of progression and there is a greater risk of those projects not being commercialised or abandoned\nThe Group will continue with research projects that are at a pre-clinical phase, including its aminoindane new chemical entity (\"NCE\") research programme. This focuses on developing serotonin, dopamine, noradrenalin targeted small molecule therapeutics for trauma related mental health disorders, such as PTSD.\nOn 10 December 2024, the Company announced initial findings from a study undertaken by the University of Nottingham in relation to a NCE being developed in collaboration with Awakn. Initial st",
          "content_length": 104778
        },
        "ingested_at": "2026-01-21T01:46:42.630068Z"
      },
      {
        "event_id": "RNS-10th Apr 2025-postingo",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630082Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Posting of Circular and Notice of General Meeting",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/posting-of-circular-and-notice-of-general-meeting-mdhlc5ilkbncd8b.html",
          "rns_number": "RNS Number : 5529E",
          "full_content": "10 Apr 2025 14:00\nRNS Number : 5529E\nSolvonis Therapeutics PLC\n10 April 2025\n10 April 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nPosting of Circular and Notice of General Meeting\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, announces that it is today posting a Circular (containing a notice of general meeting) (the \"\nCircular\n\") and a form of proxy to the Company's shareholders setting out further details on seeking authority to issue shares for the proposed acquisition, by the Company, of the entire issued share capital of Awakn Life Sciences Corp. (\"\nAwakn\n\") pursuant to the terms of the Arrangement Agreement dated 22 February 2025 between the Company and Awakn (the \"\nProposed Acquisition\n\") and the enlarged group's working capital requirements.\nThe General Meeting is due to be held at the offices of Orana Corporate LLP at Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF at 11:00 a.m. on 28 April 2025.\nExtracts from the Circular are appended to this announcement. The Circular will shortly be available on the Company's website:\nhttps://solvonis.com/investor-relations/shareholder-circulars\n.\nCapitalised terms in this announcement have the meaning ascribed to them in the Definitions section of the Circular.\nEnquiries:\nSolvonis Therapeutics plc, Anthony Tennyson, CEO & Executive Director, Email: anthony@solvonis.com\nAllenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance) | Guy McDougall (Sales)\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc is an innovative biotechnology company focused on developing intellectual property related to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Solvonis' mission is to improve outcomes for individuals suffering from mental health disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD affected approximately 13 million adults in the U.S. in 2020, with the Company estimating a current affected population of 20 million across the U.S., UK, and key EU markets.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nAbout Awakn Life Sciences Corp.\nAwakn Life Sciences Corp. is a clinical-stage biotechnology company developing therapeutics targeting substance use and mental health disorders. Awakn has a near-term focus on AUD, a condition affecting approximately 29 million adults in the US with Awakn estimating a current affected population of 40 million in the US and US and key European markets for which the current standard of care is inadequate. Awakn's goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and its strategy is focused on commercialising its R&D pipeline across multiple channels.\nwww.awaknlifesciences.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nLETTER FROM CHAIRMAN\n1. Introduction\nOn 16 December 2024, the Company announced that it had entered into a binding Letter of Agreement with Awakn in relation to its proposed acquisition of Awakn. The Letter of Agreement was superseded by the Arrangement Agreement, which was announced by the Company on 24 February 2025.\nUnder the terms of the Arrangement Agreement, the Company is proposing to issue approximately 2,074,378,592 Consideration Shares as consideration for the acquisition of all of the issued and outstanding Awakn Common Shares, all of the Awakn DSUs and all of the Awakn RSUs. Completion of the Proposed Acquisition remains subject to and conditional upon the satisfaction of various conditions by no later than the Long Stop Date (being 15 May 2025\nor such later date as may be agreed in writing by the parties to the Arrangement Agreement\n).\nAs announced by the Company on 24 February 2025, one of the conditions of the Proposed Acquisition is the completion of an equity fundraising by the Company to raise sufficient working capital for the requirements of the Enlarged Group for a period of at least 12 months. At the date of this document the Company has not, as yet, raised the necessary funds in connection with the Proposed Acquisition however it has appointed advisers in connection with the Proposed Fundraise and the Company is seeking to procure investors for the Proposed Fundraise over the coming weeks. Solvonis and Awakn aim to satisfy all conditions of the Proposed Acquisition during the second quarter of 2025.\nThe purpose of this document is, amongst other things, to explain the background to and reasons for the Proposed Acquisition and the Proposed Fundraise and to explain why the Directors believe that the Proposed Acquisition and the Proposed Fundraise will promote the growth and success of the Company for the benefit of the Shareholders as a whole, and to seek Shareholders' approval to the passing of the Resolutions at the General Meeting.\nThe purpose of the Resolu",
          "content_length": 20432
        },
        "ingested_at": "2026-01-21T01:46:42.630104Z"
      },
      {
        "event_id": "RNS-7th Apr 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630120Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-ts8dshrprkpsmqk.html",
          "rns_number": "RNS Number : 8860D",
          "full_content": "7 Apr 2025 07:00\nRNS Number : 8860D\nSolvonis Therapeutics PLC\n07 April 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BMD1Z199\nIssuer Name\nSolvonis Therapeutics PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of financial instruments\n3. Details of person subject to the notification obligation\nName\nSpreadex LTD\nCity of registered office (if applicable)\nSt. Albans\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n02-Apr-2025\n6. Date on which Issuer notified\n03-Apr-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n5.988900\n1.132400\n7.121300\n163500000\nPosition of previous notification (if applicable)\n6.576900\n0.392000\n6.968900\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BMD1Z199\n137500000\n5.988900\nSub Total 8.A\n137500000\n5.988900%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nCFD/Spread Bet\n26000000\n1.132400\nSub Total 8.B1\n26000000\n1.132400%\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\nSam Meisel01727 895138Spreadex is an FCA regulated provider of spread betting and CFD trading. Founded in 1999, Spreadex gives both retail and professional traders the opportunity to trade over 10,000 global markets, including UK small caps. For more information see\nwww.spreadex.com/financials\n.\n12. Date of Completion\n03-Apr-2025\n13. Place Of Completion\nUK\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUNOKRVOUSRAR",
          "content_length": 4175
        },
        "ingested_at": "2026-01-21T01:46:42.630132Z"
      },
      {
        "event_id": "RNS-4th Apr 2025-engageme",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630145Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Engagement of PharmaVentures",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/engagement-of-pharmaventures-bd5rpri0mnoc3wa.html",
          "rns_number": "RNS Number : 5966D",
          "full_content": "4 Apr 2025 07:00\nRNS Number : 5966D\nSolvonis Therapeutics PLC\n04 April 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n04 April 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nEngagement of PharmaVentures to advise on the commercialisation of late-stage assets being acquired\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that it has engaged PharmaVentures Ltd (\"\nPharmaVentures\n\"), a leading global biopharma transaction advisory firm, to support the commercialisation of two clinical-stage programmes, AWKN-001 and AWKN-002. These programmes are being acquired by Solvonis through its proposed acquisition of Awakn Life Sciences Corp. (\"\nAwakn\n\"), which was first announced on 16 December 2024 and is expected to complete in the second quarter of 2025.\nAlcohol Use Disorder\nAWKN-001 and AWKN-002 both target the treatment of Alcohol Use Disorder (\"\nAUD\n\"), a significant unmet medical need that is estimated to affect approximately 10 million people across the UK and major EU markets, and 29 million in the US\n[1]\n. Currently, 90% of patients remain untreated, and the existing treatments and standard of care have relapse rates of up to 75%1.\nPharmaVentures engagement\nThe engagement of PharmaVentures, by the Company, is structured in two phases:\n\u00b7\nPhase 1 - a review of comparable transaction valuations and market sizing exercise in relation to target clinical use of AWKN-001 and AWKN-002; and\n\u00b7\nPhase 2 - transaction advisory support to guide the commercialisation strategy for AWKN-001.\nMarket opportunity for AWKN-001 and AWKN-002\nThe first phase of the engagement - the review of comparable transaction valuations and market sizing exercise in relation to target clinical use of AWKN-001 and AWKN-002 - has now been completed. The analysis by PharmaVentures shows the following:\n\u00b7\nAWKN-001\nis a novel investigational combination therapy for the treatment of severe AUD. It is targeting full mixed marketing authorisation in the UK and EU, with expected regulatory protection to include eight years of data exclusivity in the EU and ten years of concurrent market exclusivity in both regions\nBased on a market analysis by PharmaVentures, comparable transactions for late-stage UK/EU-focused assets in the substance use disorder space, typically achieve a total deal value of approximately \u00a360 million, in upfront and commercial milestone payments, plus additional future material royalties on net sales\n[2]\n.\n\u00b7\nAWKN-002\nis a proprietary, investigational, patent-pending sublingual or buccal esketamine formulation designed for use alongside manualised behavioural therapy in patients with moderate to severe AUD. It is currently in Phase 2b planning in the US and is expected to follow the FDA's 505(b)(2) regulatory pathway.\nAccording to PharmaVentures' market analysis, subject to the successful completion of the planned Phase 2b trial and based on similar transactions for mid-stage assets, comparable assets typically achieve a total deal value of approximately \u00a3150 million, in upfront and commercial milestone payments, plus additional future material royalties on net sales2.\nAdrian Dawkes, Managing Director of PharmaVentures, commented:\n\"Based on market comparables and recent transactions in the substance use disorder space, our analysis highlights the significant commercial potential of these two clinical-stage programmes with potential value based on comparable assets of more than \u00a3200 million as well as future material royalties on net sales. Combined, AWKN-001 and AWKN-002 represent a significant commercial opportunity with potential for significant licensing deals with substantial future royalty streams.\"\nAnthony Tennyson, CEO of Solvonis, added:\n\"We are pleased to be working with PharmaVentures to unlock the full value of these transformative mental health treatments. Completing the market analysis phase marks an important milestone, and we're excited to share these encouraging results. Our mission remains clear: to bring life-changing therapies to patients while creating lasting value for our shareholders.\"\nEnquiries:\nSolvonis Therapeutics plc, Anthony Tennyson, CEO & Executive Director, Email: anthony@solvonis.com\nAllenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance) | Guy McDougall (Sales)\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc is an innovative biotechnology company focused on developing intellectual property related to the treatment of mental health and substance use disorders, and co-developing ther",
          "content_length": 8166
        },
        "ingested_at": "2026-01-21T01:46:42.630159Z"
      },
      {
        "event_id": "RNS-26th Mar 2025-positive",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630172Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Positive progress on European Patent Application",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/positive-progress-on-european-patent-application-x0h55c8v2o41j8v.html",
          "rns_number": "RNS Number : 0614C",
          "full_content": "26 Mar 2025 07:00\nRNS Number : 0614C\nSolvonis Therapeutics PLC\n26 March 2025\n26 March 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nPositive progress on European Patent Application for the AWKN-SDN-14 programme\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to report a positive development in the intellectual property position of the AWKN-SDN-14 programme (the \"Programme\"), its collaboration with Awakn Life Sciences Corp. (\"Awakn\"). The collaboration is focused on developing next-generation medicine for the treatment of trauma-related mental health disorders, such as Post-Traumatic Stress Disorder (\"PTSD\"), which affects approximately 13 million adults in the U.S. and which the Company estimates affects 20 million in the US, the UK, and other key EU markets.\nFollowing the Company's announcement on 22 March 2025 regarding preclinical progress and the appointment of Evotec SE to lead in-vitro testing, the European Patent Office (the \"EPO\") has confirmed that the claims under European Patent Application No. 22730070.4, titled \"Therapeutic Aminoindane Compounds and Compositions\", are considered allowable with no objections.\nThis application is one of two patent families underpinning the Programme's intellectual property portfolio and specifically covers key compound classes being advanced through preclinical development. It represents the European leg of a broader international patent strategy for the Programme, with protection also being pursued in other key jurisdictions, including the United States.\nIn line with standard EPO procedure, the patent examiner has requested a minor amendment to the description to reflect the scope of the allowed claims. Subject to this formality, the application is expected to proceed to grant.\nThis development provides strong validation of the novelty and inventiveness of the Programme's core compounds and further strengthens its intellectual property position across Europe.\nAnthony Tennyson, CEO of Solvonis Therapeutics, commented:\n\"This positive news from the European Patent Office is a strong validation of the scientific and commercial potential of the AWKN-SDN-14 programme. Robust intellectual property is a critical pillar of our and Awakn's strategy, and this progress represents an important step forward as we continue to advance our pipeline toward clinical development across key markets.\"\nEnquiries:\nSolvonis Therapeutics plc, Anthony Tennyson, CEO & Executive Director, Email: anthony@solvonis.com\nAllenby Capital (Financial Adviser and Broker) +44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance) | Guy McDougall (Sales)\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc is an innovative biotechnology company focused on developing intellectual property related to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Solvonis' mission is to improve outcomes for individuals suffering from mental health disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD affected approximately 13 million adults in the U.S. in 2020, with the Company estimating a current affected population of 20 million across the U.S., UK, and key EU markets.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nUPDPPUCCWUPAUBA",
          "content_length": 4199
        },
        "ingested_at": "2026-01-21T01:46:42.630185Z"
      },
      {
        "event_id": "RNS-18th Mar 2025-updateon",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630198Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Update on AWKN-SDN-14 programme",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/update-on-awkn-sdn-14-programme-b6au4r48huo0eut.html",
          "rns_number": "RNS Number : 0119B",
          "full_content": "18 Mar 2025 07:00\nRNS Number : 0119B\nSolvonis Therapeutics PLC\n18 March 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n18 March 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nUpdate on AWKN-SDN-14 programme, including the appointment of Evotec SE (\"Evotec\") to progress preclinical testing\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, provides an update on its collaboration with Awakn Life Sciences Corp. (\"Awakn\"). The collaboration is focused on developing next-generation treatments for trauma-related mental health disorders, such as Post-Traumatic Stress Disorder (\"PTSD\"), which affects approximately 13 million adults in the U.S. and which the Company estimates affects 20 million in the US, the UK, and other key EU markets.\nAWKN-SDN-14 programme overview\nThe AWKN-SDN-14 programme (the \"Programme\") is dedicated to developing a novel pro-social drug candidate, with the potential for an improved safety profile compared to existing investigational PTSD treatments. By enhancing trust, empathy, and social bonding, being critical elements in PTSD therapy, AWKN-SDN-14 aims to help individuals rebuild relationships, overcome isolation and engage more effectively in treatment.\nThe drug candidate is designed to modulate neurotransmitter activity, specifically enhancing the release of Serotonin (\"SERT\"), Dopamine (\"DAT\"), and Noradrenaline (\"NET\").\nThe key initial stages of the Programme include:\n1. Preclinical drug discovery\n2. Intellectual property protection\n3. Synthesis of development candidates\n4. In-vitro screening for SERT, DAT, and NET re-absorption inhibition\n5. In-vitro screening for SERT, DAT, and NET release\n6. Preclinical animal testing\n7. Lead candidate selection\nProgress and updates\n1.\nPreclinical drug discovery\n.\nThis phase was successfully completed by Prof. David Nutt prior to the execution of the collaboration agreement between Solvonis and Awakn, details of which were announced by the Company on 18 July 2024.\n2.\nIntellectual property (\"IP\") protection\n.\nAwakn has protected relevant IP through two patents filed with the World Intellectual Property Organization (\"WIPO\") in Q2 2022 and Q3 2024.\n3.\nSynthesis of development candidates.\nThe synthesis of six development candidates was originally contracted to Charnwood Discovery (\"Charnwood\"). However, following Charnwood's administration in Q4 2024 (the \"Administration\") work was temporarily disrupted. At the time of the Administration, 50% of the synthesis had been completed, with three development candidates successfully synthesised.\nAwakn has now contracted Concept Life Sciences (\"Concept\"), the acquirer of Charnwood, to complete the remaining synthesis. Following a brief pause for knowledge transfer, work has now resumed, and completion is expected by end-May 2025.\n4.\nIn-vitro screening for re-absorption inhibition (SERT, DAT, NET)\n.\nPartial completion has been achieved by Eurofins Discovery (\"Eurofins\"), with testing performed on the three development candidates synthesised by Charnwood.\n5.\nIn-vitro screening for SERT, DAT, and NET release - Evotec appointed by Awakn to lead key preclinical testing\n.\nTo ensure the highest standard of preclinical validation, Awakn has appointed Evotec, a globally recognised leader in drug discovery and development, to conduct in-vitro screening for SERT, DAT, and NET release activity.\nEvotec brings world-class expertise in:\n\u00b7\nNeurotransmitter pharmacology\n\u00b7\nHigh-throughput screening\n\u00b7\nPrecision drug discovery\nEvotec's analysis will provide critical insights into the candidates' ability to modulate neurotransmitter release, a key mechanism underpinning AWKN-SDN-14's therapeutic potential.\nThis in-vitro testing phase, which builds on the positive animal testing results, is expected to be completed by the end of July 2025, aligning with the revised Programme timeline.\n6.\nPreclinical animal testing\n.\nAwakn has previously announced successful preclinical animal testing results for one of the three synthesised candidates. The study demonstrated promising early signs of efficacy, supporting the potential of AWKN-SDN-14 as a next-generation PTSD treatment. These results provide a strong scientific foundation for the next phase of testing.\n7.\nLead candidate selection\n.\nFollowing the completion of all preclinical screening, the Company expects to select a lead candidate by the end of Q3 2025, with a view to complete the sixth and final phase of the Programme.\nConclusion\nSolvonis and Awakn remain fully committed to advancing the Programme and are encouraged by the progress achieved to date. With Concept resuming syn",
          "content_length": 6903
        },
        "ingested_at": "2026-01-21T01:46:42.630212Z"
      },
      {
        "event_id": "RNS-11th Mar 2025-holding(",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630225Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Holding(s) in Company",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/holdings-in-company-lqmqk2m2svhsrsj.html",
          "rns_number": "RNS Number : 0885A",
          "full_content": "11 Mar 2025 09:00\nRNS Number : 0885A\nSolvonis Therapeutics PLC\n11 March 2025\nTR-1: S\ntandard form for notification of major holdings\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nSolvonis Therapeutics plc\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify)iii:\n3. Details of person subject to the notification obligation\niv\nName\nSteven Myers\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n10/03/2025\n6.\nDate on which issuer notified (DD/MM/YYYY):\n10/03/2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights of issuer\nvii\nResulting situation on the date on which threshold was crossed or reached\n5.11\nNil\n5.11\n2,295,930,633\nPosition of previous notification (if\napplicable)\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(Art 9 of Directive 2004/109/EC) (DTR5.1)\nIndirect\n(Art 10 of Directive 2004/109/EC) (DTR5.2.1)\nDirect\n(Art 9 of Directive 2004/109/EC) (DTR5.1)\nIndirect\n(Art 10 of Directive 2004/109/EC) (DTR5.2.1)\nGB00BMD1Z199\n117,500,000\n5.11\nSUBTOTAL 8. A\n117,500,000\n5.11\nB 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nsettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\nxiv\n(please add additional rows as necessary)\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nGibraltar\nDate of completion\n10/03/2025\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLURRKRVUUOAAR",
          "content_length": 4407
        },
        "ingested_at": "2026-01-21T01:46:42.630237Z"
      },
      {
        "event_id": "RNS-11th Mar 2025-appointm",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630250Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Appointment of Non-Executive Director",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/appointment-of-non-executive-director-luvuznh0219t7bt.html",
          "rns_number": "RNS Number : 0888A",
          "full_content": "11 Mar 2025 07:00\nRNS Number : 0888A\nSolvonis Therapeutics PLC\n11 March 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n11 March 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nStrengthens Board with Appointment of Pharmaceutical Industry Executive Dr. Renata Crome as Non-Executive Director\nSolvonis Therapeutics plc (LSE:SVNS),\nan innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce the appointment of pharmaceutical industry veteran, Dr. Renata Crome DSc, MBA, MFPM, as an independent Non-Executive Director, effective from 11 March 2025.\nDr. Crome brings over 40 years of experience in scientific and clinical development, regulatory approval, and commercialisation of breakthrough medicines. A recognised leader in CNS (Central Nervous System), oncology, and infectious diseases, Dr. Crome has guided more than 100 novel therapies from early-stage research to first-in-human clinical trials.\nDuring her 30-year tenure at Roche, Dr. Crome progressed through increasingly senior roles, ultimately becoming Deputy Head of Early Development & Global Head of Development Operations. In this capacity, she led a team of over 250 professionals and managed a portfolio of more than 100 early development programmes across several therapeutic areas, including CNS, a key area of focus for Solvonis.\nDr. Crome's strategic leadership has been pivotal in the commercialisation of several blockbuster drugs, including leading the prioritisation of Avastin\u00ae and Tamiflu\u00ae, resulting in rapid regulatory approvals and the realisation of US$7 billion and US$3 billion peak annual sales respectively for Roche\n.\nThese achievements reflect her ability to drive the development of impactful treatments, especially in therapeutic areas closely aligned with Solvonis's commitment to addressing mental health and addiction.\nCurrently, Dr. Crome consults for Novo Nordisk, advising on early-stage drug development strategies, and previously led the UK Government's UKRI-sponsored COVID-19 treatments programme.\nDr. Crome also served as a Non-Executive Director at Camcon Robotics and is a Trustee for the PTEN Research Foundation, Success Charity and Isabel Hospice. Her involvement in academia includes lecturing at the University of Hertfordshire and chairing the Infectious Diseases Expert Group within the Faculty of Pharmaceutical Medicine's Policy & Communications Group.\nDennis Purcell, Chair of Solvonis Therapeutics plc, commented:\n\"We are thrilled to welcome Dr. Renata Crome to the Board. Her extensive experience in drug development, regulatory affairs, and commercial strategy, combined with her governance expertise, will be invaluable as Solvonis continues to advance its innovative therapies in the mental health and addiction spaces.\"\nDr. Crome added\n: \"I am excited to join Solvonis at such a transformative time. The Company's dedication to addressing unmet needs in addiction and mental health through pioneering science is inspiring. I look forward to collaborating with the Board and leadership team to help drive the development of groundbreaking therapies.\"\nPursuant to Listing Rule 9.6.13, there are no other details to disclose regarding this appointment.\nEnquiries:\nSolvonis Therapeutics plc, Anthony Tennyson, CEO & Executive Director, Email: anthony@solvonis.com\nAllenby Capital (Financial Adviser and Broker) +44 (0) 20 3328 5656\nNick Naylor / Nick Athanas / Ashur Joseph (Corporate Finance) | Guy McDougall (Sales)\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc is an innovative biotechnology company focused on developing intellectual property related to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Solvonis' mission is to improve outcomes for individuals suffering from mental health disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD affected approximately 13 million adults in the U.S. in 2020, with the Company estimating a current affected population of 20 million across the U.S., UK, and key EU markets.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained",
          "content_length": 5279
        },
        "ingested_at": "2026-01-21T01:46:42.630263Z"
      },
      {
        "event_id": "RNS-25th Feb 2025-presenta",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630276Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Presentation at PharmaSynergyRx Event",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/SVNS/presentation-at-pharmasynergyrx-event-3sqkxncybg188ld.html",
          "rns_number": "RNS Number : 2530Y",
          "full_content": "25 Feb 2025 07:00\nRNS Number : 2530Y\nSolvonis Therapeutics PLC\n25 February 2025\nRNS Reach - non-regulatory announcement\n25 February 2025\nSolvonis Therapeutics plc(\"Solvonis Therapeutics\" or the \"Company\")\nSolvonis Therapeutics - Advancing Treatments for Mental Health and Addiction\nSolvonis Therapeutics (LSE:\nSVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders,\u00a0announces that Anthony Tennyson, Chief Executive Officer of the Company, will be presenting Solvonis Therapeutics plc in the\nStrategy and Growth track\nat the PharmaSynergyRx 2025 event in London on 27 February 2025.\nPharmaSynergyRx brings together over 200 Business Development and C-suite executives, creating a platform for companies pursuing co-developments, partnerships, licensing and commercial deals within the bio-technology industry.\nFor more information, please visit:\nhttps://pharma-synergy-conference.com/pharmasynergy-2025/\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive DirectorEmail: anthony@solvonis.com\nAllenby Capital (Financial Adviser and Broker)\n+44 (0) 20 3328 5656\nNick\nNaylor / Liz Kirchner (Corporate Finance) | Guy McDougall (Sales)\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc is an innovative biotechnology company focused on developing intellectual\nproperty related to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Solvonis' mission is to improve outcomes for individuals suffering from mental health disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD affected approximately 13 million adults in the U.S. in 2020, with the Company estimating a current affected population of 20 million across the U.S., UK, and key EU markets.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nAbout Reach announcements\nThis is an RNS Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRADZGZZKDKGKZM",
          "content_length": 3033
        },
        "ingested_at": "2026-01-21T01:46:42.630289Z"
      },
      {
        "event_id": "RNS-24th Feb 2025-entryint",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630302Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Entry into an Arrangement Agreement with Awakn",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/entry-into-an-arrangement-agreement-with-awakn-1oxnekcr3hyab2c.html",
          "rns_number": "RNS Number : 1757Y",
          "full_content": "24 Feb 2025 07:00\nRNS Number : 1757Y\nSolvonis Therapeutics PLC\n24 February 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n24 February 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nEntry into an Arrangement Agreement with Awakn Life Sciences Corp.\nUnaudited results for nine months ended 30 September 2024\nSolvonis Therapeutics plc (LSE: SVNS), (\"Solvonis\" or the \"Company\") an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that, further to its announcement on 16 December 2024 regarding its proposed acquisition of Awakn Life Sciences Corp. (\"Awakn\"), the Company has entered into an arrangement agreement (the \"Arrangement Agreement\") with Awakn setting out the basis on which the parties will cooperate to execute a transaction whereby Solvonis will acquire all issued and outstanding common shares in the capital of Awakn (the \"Common Shares\"), all outstanding restricted share units in the capital of Awakn (the \"RSUs\") and all outstanding deferred share units in the capital of Awakn (the \"DSUs\") by way of a Court approved plan of arrangement under the British Columbia Business Corporations Act (together the \"Arrangement\" or the \"Proposed Acquisition\").\nIn addition, Solvonis is today announcing its unaudited results for the 9 months ended 30 September 2024. These unaudited results are required to be included in the circular being sent by Awakn to its shareholders in the coming days.\nSolvonis intends to issue approximately 2,074,378,592\u00a0new ordinary shares of \u00a30.001 each (\"Ordinary Shares\") as consideration for the Proposed Acquisition (the \"Consideration Shares\"). The Proposed Acquisition values Awakn at approximately \u00a34.98 million (CAN$8.89 million) based upon the closing price of the Ordinary Shares on 13 December 2024, being 0.24 pence per Ordinary Share (the \"Issue Price\").\u00a0Solvonis will issue to Awakn shareholders 46.67 Consideration Shares for every one Common Share held by or due to them (the \"Exchange Ratio\"). Based on the same Exchange Ratio, the holders of DSUs and RSUs will receive 46.67 Consideration Shares for each one DSU and for each one RSU held by them.\nIt is proposed that all issued and outstanding common share purchase warrants in Awakn (the \"Warrants\") shall be exchanged for approximately 703,465,432 new warrants over new Ordinary Shares in Solvonis based upon the Exchange Ratio. Finally it is also intended that Awakn will seek the consent from holders of stock options to cancel all existing stock options issued by Awakn.\nFurther details on the Arrangement\nThe Arrangement will, inter alia, require the approval of the Supreme Court of British Columbia and the approval of the Awakn security holders at an annual general and special meeting of Awakn security holders to consider the Arrangement (the \"Awakn Meeting\"), in particular: (i) 66 2/3 per cent. of the votes cast on the security holder resolution to approve the Arrangement at the Awakn Meeting; and (ii) any other shareholder approvals required by the Canadian Securities Exchange. The Proposed Acquisition is conditional on the satisfaction (or waiver) of a number of conditions including:\n\u00b7\nthe receipt, by Solvonis, of all necessary regulatory consents and approvals required for the Proposed Acquisition;\n\u00b7\nthe approval of the Plan of Arrangement by the Supreme Court of British Columbia;\n\u00b7\nthe approval of Awakn's shareholders (as detailed above);\n\u00b7\nthe receipt of any necessary approvals of the Canadian Securities Exchange;\n\u00b7\nthe consent of holders of stock options in Awakn to the cancellation of such stock options;\n\u00b7\nobtaining the necessary regulatory approvals of the Financial Conduct Authority (the \"FCA\") in relation to a prospectus (the \"Prospectus\") which Solvonis is required to publish pursuant to the Prospectus Regulation rules in order for Solvonis to issue the Consideration Shares;\n\u00b7\nthe approval of the Company's shareholders, at a general meeting of the Company (to be convened), of resolutions to provide authority to the Directors to issue and allot the Consideration Shares, otherwise than on a pre-emptive basis;\n\u00b7\nthe procurement of equity fundraising by the Company to raise sufficient working capital for the requirements of the enlarged group for a period of at least 12 months;\n\u00b7\nthe admission of Consideration Shares to trading on the Main Market of the London Stock Exchange and to listing on the equity shares (transition) category of the FCA's Official List (together \"Admission\").\nAs such, there is no certainty that the Proposed Acquisition will proceed nor any certainty regarding the final terms or the final timings on which it will proceed.",
          "content_length": 30945
        },
        "ingested_at": "2026-01-21T01:46:42.630316Z"
      },
      {
        "event_id": "RNS-30th Jan 2025-proactiv",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630329Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Proactive Investors interview with Chairman",
          "category": "RNS-R",
          "url": "https://www.lse.co.uk/rns/SVNS/proactive-investors-interview-with-chairman-upqgdk64chdu6qu.html",
          "rns_number": "RNS Number : 3198V",
          "full_content": "30 Jan 2025 12:00\nRNS Number : 3198V\nSolvonis Therapeutics PLC\n30 January 2025\nRNS Reach - non-regulatory announcement\n30 January 2025\nSolvonis Therapeutics plc(\"Solvonis Therapeutics\" or the \"Company\")\nProactive Investors interview with Chairman\nSolvonis Therapeutics (LON:\nSVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders,\u00a0announces that Dennis Purcell, Chairman of the Company, has recently given an interview to Proactive Investors about the increasing mergers and acquisitions activity in the neuroscience sector. The interview can be viewed at\nhttps://www.proactiveinvestors.co.uk/companies/news/1065372/solvonis-therapeutics-chairman-on-the-future-of-biotech-neuroscience-ma.html\n.\nEnquiries:\nSolvonis Therapeutics plc\nAnthony Tennyson, CEO & Executive DirectorEmail: anthony@solvonis.com\nAllenby Capital (Financial Adviser and Broker)\n+44 (0) 20 3328 5656\nNick\nNaylor / Liz Kirchner (Corporate Finance) | Guy McDougall (Sales)\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc is an innovative biotechnology company focused on developing intellectual\nproperty related to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Solvonis' mission is to improve outcomes for individuals suffering from mental health disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD affected approximately 13 million adults in the U.S. in 2020, with the Company estimating a current affected population of 20 million across the U.S., UK, and key EU markets.\nwww.solvonis.com\n|\nLinkedIn\n|\nX (formerly Twitter)\nAbout Reach announcements\nThis is an RNS Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRASDDFFSEISEIF",
          "content_length": 2825
        },
        "ingested_at": "2026-01-21T01:46:42.630341Z"
      },
      {
        "event_id": "RNS-27th Jan 2025-updateon",
        "event_type": "rns_announcement",
        "date": "2026-01-21T01:46:42.630356Z",
        "source": "LSE_RNS",
        "data": {
          "title": "Update on Awakn Life Sciences\u2019 R&D Progress",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/update-on-awakn-life-sciences8217-rd-progress-n4ymhy6l31cdypu.html",
          "rns_number": "RNS Number : 6694U",
          "full_content": "27 Jan 2025 07:00\nRNS Number : 6694U\nSolvonis Therapeutics PLC\n27 January 2025\n27 January 2025\nSolvonis Therapeutics plc\n(\"Solvonis\" or the \"Company\")\nUpdate on Awakn Life Sciences' Research and Development Progress\nSolvonis Therapeutics plc (LSE: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, provides the following overview and update on the research and development (\"R&D\") progress of Awakn Life Sciences Corp. (\"Awakn\"), the company that Solvonis plans to acquire. Details of the Company's proposed acquisition of Awakn were set out in its announcement on 16 December 2024.\nAwakn currently has three principal R&D programmes, as outlined below:\n1. AWKN\n-001: Combination therapy for severe alcohol use disorder (\"AUD\")\nAWKN-001 is an investigational, novel combination therapy consisting of an N-methyl-D-aspartate (\"NMDA\") receptor-modulating drug (ketamine) delivered intravenously (\"IV\") in combination with copywritten relapse prevention cognitive behavioural therapy (\"CBT\") for the treatment of severe AUD in the UK and potentially the EU.\nPhase 2 results demonstrated a 50% reduction in heavy drinking days in the 6 months post treatment versus the placebo. The phase 2 results also demonstrated an on average 86% abstinence rate in the 6 months post treatment versus 2% abstinence pre-trial.\nCurrent status:\nAWKN-001 is in a Phase 3 clinical trial in the UK across 9 NHS Trusts. The Phase 3 trial is co-funded by a partnership between the UK's Medical Research Council (the \"MRC\"), the National Institute for Health and Care Research (the \"NIHR\"), and Awakn. Awakn's costs are capped at \u00a3800,000. The trial is managed the University of Exeter Clinical Trials Unit.\nRegulatory path and exclusivity:\nAwakn is targeting a Regulation 52b hybrid application in the UK for AWKN-001. If successful, this could provide 8 years of market exclusivity, with an additional 2 years of supplementary protection, preventing competitors from marketing a similar product for the same indication. Awakn is planning to commence market access discussions with the UK Department of Health this year.\n2. AWKN-002: Esketamine oral thin film (\"OTF\") for AUD\nAWKN-002 is a proprietary oral thin film (\"OTF\") formulation of esketamine, developed for sublingual and buccal administration in combination with structured alcohol education for moderate to severe AUD in the US.\nCurrent status:\nAwakn has in-licensed a Phase 1 programme from LTS Lohmann Therapie-Systeme AG and has completed two mechanistic studies in AUD with AWKN-002. The data from these studies was used to file method-of-use patents. Awakn also held a pre-Investigational New Drug (\"IND\") meeting with the US Food and Drug Administration (the \"FDA\") in December 2024, where the FDA confirmed that AWKN-002 can be reviewed under the 505(b)(2) New Drug Application (\"NDA\") pathway. Furthermore, the FDA confirmed that no additional clinical data is required to proceed with a Phase 2b trial in patients with moderate to severe AUD.\nPatents have been filed for esketamine OTF formulation and esketamine OTF AUD method of use.\nRegulatory path and exclusivity:\nAwakn plans to submit an IND Application for AWKN-002 in H2 2025, followed by a Clinical Trial Application (\"CTA\") for a Phase 2b trial in H1 2026. In due course, Awakn will submit a NDA under the 505(b)(2) pathway. The reference product for Awakn's NDA will be J&J's Spravato\u00ae, which is forecast to achieve US$1bn in sales in 2024. Subject to successful clinical trial outcomes and FDA approval, AWKN-002 could be granted up to 5 years of market exclusivity in the US for the treatment of AUD, provided its patents are granted and recognised in the US Orange Book. Awakn anticipates that the Phase 2b clinical trial application will be made in 2026.\n3. AWKN-SND-14: Pre-clinical investigation for Post-Traumatic Stress Disorder (\"PTSD\")\nAWKN-SND-14 is a series of serotonin, dopamine, and noradrenaline modulators under pre-clinical investigation for trauma-related mental health disorders, including PTSD. Previously, this programme was referred to as Awakn's aminoindane new chemical entity programme.\nProgramme focus:\nAWKN-SND-14 is designed to promote pro-social behaviour with a potentially improved safety profile compared to existing investigational treatments for PTSD. By enhancing trust, empathy, and social bonding, critical elements in addressing PTSD, AWKN-SND-14 aims to help individuals rebuild relationships, overcome isolation, and engage more effectively in therapy.\nAwakn anticipates identifying a lead candidate and initiating lead optimisation in 2025, with pre-clinical development work commencing in 2026 and IND enabling studies taking place in 2028 ahead of IND submission in 2029.\nAwakn's approach to treating addiction\nAwakn's therapeutics for addiction target the brain circuits that drive addiction. These circuits control the behavioural drivers of addiction, as set out in the image below. This disruption",
          "content_length": 10075
        },
        "ingested_at": "2026-01-21T01:46:42.630369Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260937-bonesgt-47406790",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.433446",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Looking good Tricky. News anytime . Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.295",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-22T21:26:24.444882+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261000-dvharris--6637802",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.433027",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "My favourite colour! \ud83d\ude0d",
          "sentiment": 0.5,
          "engagement": "21,003",
          "price_at_post": "0.30",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-22T21:26:24.444864+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261000-TrickyEF--7258314",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.432611",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "That tune from Rocky pops to mind. 'Gonna fly now'",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.30",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-22T21:26:24.444846+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261001-TrickyEF-45162427",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.432187",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "To do what Solvonis has been doing since it's launch. Let get that licensing news.",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.30",
          "thread_title": "The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-22T21:26:24.444829+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261003-dvharris--3574090",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.431755",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pivotal Quarter for Solvonis....",
          "sentiment": 0.5,
          "engagement": "21,003",
          "price_at_post": "0.30",
          "thread_title": "RE: The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-22T21:26:24.444811+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261017-LlamaFar-52511851",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.431336",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "JP Morgan week this week 12 - 15th ... Movers and Shakers back at desks next week ....",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.30",
          "thread_title": "RE: The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-22T21:26:24.444794+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261023-RhHh--5815742",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.430918",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Buys outstripping sells at the moment. Always good to see. Massive year for svns. I think this is the last of the bargain basement prices so if you want in then don't delay.",
          "sentiment": 0.5,
          "engagement": "318",
          "price_at_post": "0.30",
          "thread_title": "Buys v sells",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=269EC9EC-8229-4DB2-B529-CF1F39723135"
        },
        "ingested_at": "2026-01-22T21:26:24.444776+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260855-dvharris--1924089",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.430506",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A few decent buys and folks looking forward to the next piece of the jigsaw being put in place.....",
          "sentiment": 0.5,
          "engagement": "21,003",
          "price_at_post": "0.305",
          "thread_title": "Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444758+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260859-bonesgt-70044794",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.430086",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Looking  good Dv ,heading up to the next news ,which as we all know could be transformational. Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.30",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444741+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260909-RhHh-77559752",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.429675",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Lot of small trades but at least they are buys!",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.305",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444723+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260925-MrsRobin--8771337",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.429265",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "5m available when .32 tick up - now down to 1m",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.31",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444706+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-MrsRobin-83020029",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.428847",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Not a lot of stock around - it seems 5m available when .33 tick up - now down to 2m",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.31",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444688+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260933-dvharris--1640569",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.428435",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "We had a Seller who helped push the SP down from 0 4p to 0.23p. Hopefully those shares are in sticky hands as we push back up up to 0.4p, helped by the regular (positive) updates from the BoD...",
          "sentiment": 0.5,
          "engagement": "21,003",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444670+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260936-TrickyEF-44979287",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.428008",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Morning all. Well yesterdays buy to sells which was decent is being smashed today.",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444652+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260951-DrMicho-53869683",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.427590",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I agree, we should have never been anywhere near .23. Nevertheless, seller gone and we should be sitting at .4 on news and push up further from there depending on what gets released. How this is here is unbelievable\u2026",
          "sentiment": 0.5,
          "engagement": "8,146",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444634+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261031-Andys288-34038161",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.427175",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Horses ready? \ud83d\udc0e\ud83d\udc34",
          "sentiment": 0.0,
          "engagement": "513",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-22T21:26:24.444617+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261045-MadEngli-47131833",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.426756",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "I'm not complaining,  I'm happy we're on the move again finally but I find myself a tad philosophical this morning  \ud83d\ude01 Why is it ( in life as well as stocks)  positive action never elicits an equal response to a negative one ? Can you imagine the market response to all that blue today being red ?  \ud83e\udd23 We'd be in the basement. ATB LTHs @ all ME",
          "sentiment": 0.0,
          "engagement": "714",
          "price_at_post": "0.32",
          "thread_title": "Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-22T21:26:24.444599+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261120-MrsRobin-64703825",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.426326",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "9m or so sells taken it back to around 12m available at  .32/.33",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.32",
          "thread_title": "RE: Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-22T21:26:24.444581+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261724-TrickyEF--1710880",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.425899",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Well sellers clearly won today. Till tomorrow and beyond",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.31",
          "thread_title": "RE: Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-22T21:26:24.444562+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261739-Barnsley-83951070",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.425477",
        "source": "LSE_CHAT",
        "data": {
          "author": "BarnsleyBitter",
          "content": "Solvonis Therapeutics Bounce above a falling 50-day line combined with an RSI 50-plus rebound suggests a bull flag. Target: up to 0.46p by end of next month while above the 50-day (0.27p).",
          "sentiment": 0.0,
          "engagement": "553",
          "price_at_post": "0.31",
          "thread_title": "Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-22T21:26:24.444544+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261213-bonesgt-15029316",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.425042",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "What no chat come on guys ,you must have something to say . Come on svns, gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.305",
          "thread_title": "RE: Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-22T21:26:24.444526+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261259-LlamaFar-15541962",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.424630",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Dry January...",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.305",
          "thread_title": "RE: Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-22T21:26:24.444509+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261430-Opportun-74602954",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.424216",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "I asked Google AI for it's thoughts on the pending licensing deal for SVN-001 and received the below response: Based on Solvonis Therapeutics' current activities as of early 2026, the company is actively in discussions with four major pharmaceutical firms to out-license its lead program, SVN-001. Given the reported Phase 3 progress and strong Phase 2b data\u2014which showed an 86% abstinence rate at six months versus 2% pre-trial\u2014the likely deal structure and valuation are as follows: Likely Deal Structure: Global or Territorial Licensing With four major players in contention, Solvonis is positioned for a competitive licensing or commercial partnership deal. Commercialization Partnership: Solvonis has engaged specialist firm Pharma Ventures to shop SVN-001, typically signaling a search for a partner with a deep commercial footprint to handle the heavy lifting of a global launch while Solvonis retains some upside. Licensing Type: A global exclusive license is most common for a Phase 3 Central Nervous System (CNS) asset, where the partner manages late-stage regulatory filings and commercialization in exchange for upfront cash and future milestones. Alternative Structure: \"Ex-China\" or \"Regional\" deals (e.g., UK/EU vs. US rights) are possible to split risk, though the CEO's mention of four major firms suggests a broader global interest. Estimated Dollar Amounts Valuations for de-risked CNS assets in Phase 3 are currently commanding significant premiums due to high unmet needs in addiction and mental health. Total Deal Value: Solvonis leadership has explicitly pointed to peer company Gilgamesh, which out-licensed a lead program for a total price of $1.2 billion. Upfront Payment: For a Phase 3 asset with positive \"pivotal\" data, upfront payments typically range from $150 million to $700 million. For comparison, the Solvonis chair recently oversaw a deal for another company (IGI) that secured $700 million upfront within a $1.9 billion total package. Milestones and Royalties: Expect the remaining balance ($500M to $1B+) to be tied to regulatory approvals (FDA/EMA) and commercial sales targets, along with double-digit royalties on net sales. Key Drivers of Value Strong Clinical Data: Phase 2b results (50% reduction in heavy drinking days and 86% abstinence) are considered \"striking\" and \"smashing endpoints\" for the Alcohol Use Disorder (AUD) market. Market Opportunity: SVN-001 targets a population of ~40 million patients across the US, UK, and EU, where standard therapies currently see a 75% relapse rate. Regulatory Exclusivity: Solvonis is pursuing a hybrid application in the UK that could provide up to 10 years of market protection.",
          "sentiment": 0.5,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "AI's thoughts on SVN-001 licensing deal",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=E0E550A8-65DB-4217-8052-6C70F7E92DBC"
        },
        "ingested_at": "2026-01-22T21:26:24.444491+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261435-Opportun--6026334",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.423722",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "I then followed up by asking AI:  Given your above answer regarding the licensing deal for SVN-001, if the bridging data allows Solvonis to move SVN-002 into Phase 2B and Solvonis moves forward with a Nasdaq listing, where do you think the market cap of Solvonis is likely to be after that point?  Please also take into consideration the SVN-015 U.S. funding and the U.S. patent allowance for SVN-014. The response is below: If Solvonis Therapeutics successfully executes its 2026 milestones\u2014licensing SVN-001, advancing SVN-002 to Phase 2b, and achieving a Nasdaq listing\u2014the company\u2019s market capitalization would likely undergo a significant upward rerating from its current level of approximately \u00a319M\u2013\u00a320M ($24M\u2013$26M). Based on peer comparisons and the current status of its multi-asset pipeline, here is the projected market cap outlook: 1. Projected Market Cap Range: $300 Million \u2013 $700 Million+ Following a successful Nasdaq uplisting and a major licensing deal for SVN-001, Solvonis would likely shift from a \"micro-cap\" LSE listing to a mid-range clinical-stage biotech valuation. Asset-Specific Value: The SVN-001 deal alone, if aligned with the CEO\u2019s comparison to Gilgamesh\u2019s $1.2B deal, would provide a massive cash infusion and validation, often driving market caps to 0.5x\u20131x the total deal value depending on upfront cash. Nasdaq Premium: U.S.-listed CNS biotechs with Phase 2b/3 assets typically command significantly higher valuations than their LSE counterparts due to deeper liquidity and a larger pool of specialist institutional investors. 2. Strategic Value of SVN-002 and Bridging Data The successful establishment of a \"scientific bridge\" to Janssen\u2019s Spravato\u00ae in Q1/Q2 2026 is critical. Accelerated Pathway: By using the 505(b)(2) pathway, Solvonis can bypass Phase 1 and 2a trials, potentially saving tens of millions in development costs and years of time. Valuation Impact: Moving directly into a Phase 2b trial for a market of 15 million U.S. adults transforms SVN-002 from a theoretical asset into a near-term commercial prospect, adding substantial \"Net Present Value\" (NPV) to the company. 3. Impact of SVN-015 U.S. Funding (NIDA/NIH) Non-Dilutive Capital: SVN-015\u2019s acceptance into the NIDA Addiction Treatment Discovery Program provides free preclinical safety and efficacy testing. Future Grant Potential: Success in these initial studies allows Solvonis to compete for NIH grants of up to $3 million per year for five years ($15M total). This non-dilutive funding reduces the need for equity raises, preserving shareholder value and supporting a higher market cap. 4. SVN-014 U.S. Patent Allowance and PTSD Franchise IP Protection: The January 2026 patent allowance for the SVN-SDN-14 series provides \"composition of matter\" protection, which is the \"gold standard\" for biotech valuation.",
          "sentiment": 0.5,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-22T21:26:24.444473+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261436-Opportun--5893968",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:24.423210",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "Lead Candidate Selection: With lead selection expected in Q1 2026, the company transitions from a discovery-stage firm to a clinical-stage platform company with multiple distinct franchises (AUD, PTSD, and Stimulant Use Disorder). Summary Table: Valuation Drivers Catalyst \tImpact on Market Cap SVN-001 Licensing\tImmediate cash infusion and multi-hundred million dollar validation. SVN-002 Phase 2b\tMoves a second major asset into late-stage U.S. development via an accelerated pathway. Nasdaq Listing\tIncreases liquidity and attracts high-conviction U.S. institutional funds. SVN-014/015 Progress\tValidates the AI-discovery platform, adding \"pipeline-in-a-product\" value.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-22T21:26:24.444455+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261439-Opportun--7242446",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.855468",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "All-in-all, things look very good considering that we know that Solvonis is already in talks with 4 pharma companies to license SVN-001, we know the bridging data is likely to come back good and allow SVN-002 to move into Phase 2B in the coming months and Solvonis has already stated that a Nasdaq listing is a major priority at some point. It seems that if the things that are very likely to occur happen, a 10-20x in market cap is a real possibility.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-22T21:26:24.444435+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261544-ComesMar-48148122",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.855045",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "What I really like here is not just the potential upside, but also the clear path that the BOD has designed, and the commitment of a person with the pedigree of Paul Carter.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-22T21:26:24.444417+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261555-TrickyEF-48385412",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.854632",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi Marcelino. Obviously Dennis and Nutt have high pedigree but Paul Carter is clearly of some top top pedigree and is not as visible as the other two. Massive part of the team. He previously held senior global roles including Executive Vice President and Chief Commercial Officer at Gilead Sciences, Inc. (NASDAQ: GILD), where he oversaw international operations across 38 markets and delivered annual revenues exceeding US$30 billion.",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-22T21:26:24.444399+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261601-LlamaFar--8193946",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.854190",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Usually with these small caps the BOD are substandard and are trying to promote assets that are often subpar, nothing about Solvonis is sub par! Paul Carter is interesting with his ex head of GSK China Hat on and 002 having a worldwide licence for China / Asia etc as well as his other attributes. Also in that he was part of the original Awakn team, the last one to rejoin after they listed it in the U.K.  ;) Dr Renata Crome is interesting  - The majority of Renata\u2019s pharmaceutical career was spent in early clinical development, initially as a Clinical Pharmacologist in the Cardiovascular Disease, Infectious Diseases, and Central Nervous System therapeutic areas.  As a Project Leader, she led project teams for Roche\u2019s key projects including the influenza drug oseltamivir, and oncology drugs bevacizumab and obinutuzumab. Renata\u2019s most recent role at Roche was as the Global Head of Early Development Clinical Operations and Deputy Head of Early Development. Prof David Nutt  - Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there.Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology. Add in Chairman Dennis Purcell and CEO Anthony Tennyson... The only weak link here is whoever's started selling yesterday?",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-22T21:26:24.444382+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261607-TrickyEF-28453996",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.853663",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi Lama. They can't all be barking up the wrong tree. They all believe in the destination and so far the NIH/NHS and FDA seem to also with funding most of it.",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.30",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-22T21:26:24.444364+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261628-LlamaFar--7092401",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.853242",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page Three types of trades showing up Sint , Xoff & Xlon... Someone's dragging it backwards ... Either they have a good idea of timing?? or are desperate to sell?",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.30",
          "thread_title": "Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-22T21:26:24.444345+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261634-LlamaFar-18448565",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.852816",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Look at all those tiny SINT trades messing around in and out, I wonder what they've been set up to achieve? XLON This is the official Market Identifier Code (MIC) for the London Stock Exchange main Regulated Market (the lit on-exchange order book). When you see XLON as the venue, the trade was executed on-exchange through the LSE's electronic order book in the normal, transparent, public way (continuous auction, opening/closing auctions etc.). XOFF This is a special \"generic\" MIC code meaning Off-Exchange (or OTC \u2014 Over-The-Counter) for instruments that are admitted to trading on a venue (usually a lit exchange like LSE). \u2192 Trade was not done on the actual exchange order book \u2192 Most commonly used for:  Negotiated trades / block trades reported to the LSE but executed bilaterally Trades with systematic internalisers (SIs) Pure OTC trades between two parties (market maker  client, institution  institution, etc.) Any off-book trade in a listed instrument SINT This is the special MIC code that means the trade was executed against a Systematic Internaliser (SI). \u2192 It is a subset of off-exchange trading \u2192 The counterparty was specifically operating as an SI (a firm that systematically executes client orders outside a trading venue using its own capital \u2014 think big banks/market makers like Citadel Securities, Jane Street, Flow Traders, Optiver, etc. when acting in SI mode) \u2192 Very often seen on UK/European retail flow and some institutional flow",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.30",
          "thread_title": "RE: Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-22T21:26:24.444328+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261635-LlamaFar-79961954",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.852346",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "It must be lovely to trade if you are handed over direct market access and can set the prices on each of your trades?",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.295",
          "thread_title": "RE: Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-22T21:26:24.444310+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261140-DrMicho-30672204",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.851924",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Dropped a grand in just 2 days.. be back up soon enough, pub money and gamblers that want instant returns.., 15-Jan-26\t09:56:33\t0.2848\t3,137,628\tSell* 8,936 13-Jan-26\t09:22:45\t0.317\t3,137,628\tBuy* 9,946",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.295",
          "thread_title": "Just No Patience",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18B00745-62B4-497B-91B1-F4D2AA27ADF6"
        },
        "ingested_at": "2026-01-22T21:26:24.444292+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261159-Andys288--3369055",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.851511",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Just need the weather to clear up and we are back at the races. \ud83d\udc0e\ud83d\udc34",
          "sentiment": 0.0,
          "engagement": "513",
          "price_at_post": "0.295",
          "thread_title": "RE: Just No Patience",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18B00745-62B4-497B-91B1-F4D2AA27ADF6"
        },
        "ingested_at": "2026-01-22T21:26:24.444274+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261217-LlamaFar-88152207",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.851096",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nothing likely to happen this week as decision makers will be busy. That said, Exeter, More Kare, Dr Celia Morgan has announced they have increased from 9 to 14 assistant psychologists to run the trial - that is a 56% increase in staffing levels.",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.295",
          "thread_title": "JP Morgan Week 12 - 15th Jan",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=88E510C6-7E44-4179-BBFB-F264FDF46534"
        },
        "ingested_at": "2026-01-22T21:26:24.444256+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261118-Andys288--6876951",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.850686",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Don\u2019t be shy, the big boys are back next week, so but cheap while you still can.",
          "sentiment": 0.0,
          "engagement": "513",
          "price_at_post": "0.285",
          "thread_title": "FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-22T21:26:24.444238+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261121-Andys288-84078323",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.850277",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Buy not but obvs",
          "sentiment": 0.0,
          "engagement": "513",
          "price_at_post": "0.285",
          "thread_title": "RE: FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-22T21:26:24.444220+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261133-bonesgt--8178119",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.849862",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Defo, I wouldn't leave this much longer ,news imminent, exciting to see where first leg takes us .gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.285",
          "thread_title": "RE: FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-22T21:26:24.444202+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261329-LlamaFar--2223458",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.849455",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Q1 Expected Newsflow on day 16/93. 1.Update on how many Pharmas in talks to outlicense SVN001. 2.Update on bridging data for SVN002 from Wuxi App Tec to enter Phase 2b. 3. Update on lead candidate for SVN014 PTSD 4.Update on USA Govt funded pre clinical in vitro trial for SVN015 Meth & Coke treatment. 5.Update on new findings from AI Engine running through the CNS Library - specifically have they investigated further the 2 x patents held by Awakn on MDMA? 6. Update on new Neurology Pipeline? 7.Recent Board visit / presentations in the U.S.A. future Nasdaq listing mooted - potential update? Lots of irons in the fire at Solvonis - interesting that the share price has dipped on sellers being  active but conversely that the S.P. hasn't cratered as they are all getting quietly bought up!",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.285",
          "thread_title": "Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444184+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261332-LlamaFar-63918445",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.849007",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "16/90\ud83e\udd26",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444165+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20260953-Andys288--1094568",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.848602",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Happy Monday, looking forward to a great week here. Horses are fed and watered and ready for the races \ud83d\udc0e\ud83d\udc0e\ud83d\udc0e\ud83d\udc0e",
          "sentiment": 0.0,
          "engagement": "513",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444147+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20260959-RhHh-88742304",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.848186",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Encouraging that after the early chunky sell we're not down. Looking forward to the company updates.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444128+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20261948-covgaz-63074876",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.847773",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I'm looking for some inspiration here , in at 32+ only 8 days ago. Is this going to 23?",
          "sentiment": 0.0,
          "engagement": "3,498",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444090+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262100-ComesMar--5900516",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.847357",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I would be surprised if it drops that much. We are waiting for news, but some have no patience.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444072+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262102-covgaz--2659442",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.846937",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I was expecting 60p by today ...",
          "sentiment": 0.0,
          "engagement": "3,498",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444054+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262151-LlamaFar--3830208",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.846532",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 19 of 90 in Quarter 1, not even 25% of the way through... Covgas you posted on the 9th you bought on the previous Monday i.e., 5/01/26? Then posted that you bought in at 0.32p 8 days ago? And were expecting 60p today \ud83e\udd23\ud83e\udd23\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444036+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262228-covgaz-77587518",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.846108",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I was avin a larf Llama , lighten up fella!",
          "sentiment": 0.0,
          "engagement": "3,498",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444018+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260516-ComesMar--5887935",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.845686",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I asked AI to analyse yesterday trading dynamics in the same way llamafarmer did few days ago. Below is the response: SVNS: Technical Analysis of 19-Jan Trading Session & Venue Dynamics Following the recent consolidation to 0.275p, a forensic look at the tape from yesterday (Monday, Jan 19) provides a clearer picture of the price action. While the mid-price appeared to weaken, the volume distribution across different venues suggests a \"mechanical\" rather than \"organic\" drop. 1. Venue Volume Breakdown Total volume for the session was approximately 19.6M shares, split across three primary execution venues: SINT (Systematic Internaliser): ~11.1M shares. This represented over 56% of the day's activity. As a reminder, SINT trades occur when a Market Maker (MM) executes against their own inventory (\"book\"). XLON (Standard LSE Order Book): ~6.5M shares. This is the \"lit\" market where transparent buy/sell orders meet. XOFF (Off-Exchange): ~2.0M shares. Private block trades reported to the exchange post-execution. 2. Identifying the \"Mechanical\" Fade The move from 0.29p down to 0.275p was characterized by a high frequency of \"micro-trades\" on the SINT code. We observed numerous sell prints of negligible size (often under \u00a35.00 in value). Technical Interpretation: These tiny SINT prints are typically used by automated market-making algorithms to \"walk back\" the mid-price during periods of low retail demand. Because the MM is trading against their own book, they can print these lower prices to manage their inventory risk without requiring a large volume of actual sellers. 3. The Bullish Divergence in XLON/XOFF Interestingly, while the SINT volume was skewed toward \"Sells,\" the XLON (Open Market) and XOFF (Off-Book) data showed a different trend: Organic Support: On the actual LSE order book (XLON), the \"Buy\" volume actually outpaced the \"Sell\" volume by a notable margin. Accumulation Signature: The 2M shares traded XOFF suggest that institutional or \"high-conviction\" hands were picking up blocks quietly while the SINT bots were painting the tape red. 4. Summary & Q1 Outlook The \"drop\" yesterday appears to be a Liquidity Trap. By suppressing the mid-price via SINT trades, the market has successfully triggered stop-losses and shaken out short-term momentum players. However, the fundamentals remain unchanged as we move further into Quarter 1. With the WuXi bridging data for SVN-002 and lead candidate selection for the PTSD program still pending, the current price action looks like a classic \"pre-catalyst shakeout.\" Conclusion: Look past the mid-price. The real story is in the XOFF accumulation and the lack of high-volume selling on the XLON exchange.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.444000+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260738-LlamaFar-80665687",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:19.845184",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ComesMarcellino - that's really interesting - thanks for that.",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.443983+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260828-LlamaFar-55658934",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.128862",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "You can pretty much see which way we are being pulled by running through the trades on the official LSE trade page. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page Looking around at other stocks where large holders are building positions there does seem to be a familiar pattern, would assume that changes on either news or completion of position? I'm taking it as a positive as if you didn't want to side sweep the stock - why would you bother?",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-22T21:26:24.443964+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-LlamaFar-90837140",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.128441",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Q1 Expected Newsflow. 1.Update on how many Pharmas in talks to outlicense SVN001. 2.Update on bridging data for SVN002 from Wuxi App Tec to enter Phase 2b. 3. Update on lead candidate for SVN014 PTSD 4.Update on USA Govt funded pre clinical in vitro trial for SVN015 Meth & Coke treatment. 5.Update on new findings from AI Engine running through the CNS Library - specifically have they investigated further the 2 x patents held by Awakn on MDMA? 6. Update on new Neurology Pipeline? 7.Recent Board visit / presentations in the U.S.A. future Nasdaq listing mooted - potential update? Lots of irons in the fire at Solvonis - interesting that the share price has dipped on sellers being active but conversely that the S.P. hasn't cratered as they are all getting quietly bought up!",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.27",
          "thread_title": "Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-22T21:26:24.443946+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261205-ComesMar-29127280",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.127995",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I asked AI once again about today price action, specifically requesting to cross check with the morning narrative. Below is the response. SVNS: Technical Analysis of the 3-Day Compression & Volume Exhaustion \u200bAnalysis: The current price action in SVNS appears to be following a defined Three-Day Exhaustion Cycle on the XLON venue, likely signifying the final stages of a strategic supply overhang. \u200b1. Volume Profile vs. Price Drift: Over the last 72 hours, we have seen a consistent downward tick. However, today\u2019s intraday tape shows a notable divergence: Increasing unit volume on decreasing trade frequency. The appearance of concentrated 1m and 2m blocks on XLON hitting the bid is indicative of a \"Principal Trade\" or a managed \"Leak-Out.\" In these scenarios, a larger institutional holder is fulfilling a quota at a fixed price floor, rather than multiple retail actors selling out of panic. \u200b2. Support Level Validation: The 0.26p \u2013 0.27p range aligns with the historical consolidation base observed in late 2025. The fact that the bid is absorbing multi-million share blocks at this level without a breakdown suggests a significant counter-party buy-side interest is currently neutralizing the seller's pressure. \u200b3. Technical Indicators: \u200bOscillators: Intraday RSI is approaching \"Oversold\" territory, which often serves as a precursor to a \"snap-back\" rally toward the 50-day moving average (currently approx. 0.273p). \u200bTape Reading: Today\u2019s \"Red\" prints are likely part of a \"Deck Clearing\" exercise. In a low-float environment, the removal of a dominant seller typically creates a liquidity vacuum, allowing the price to re-rate rapidly once the overhead supply is exhausted. \u200bConclusion: The current activity represents a high-volume Transfer of Ownership at a technical floor. We are watching for stabilization in the closing auction as a confirmation that the selling cycle has completed ahead of anticipated Q1 operational updates.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.27",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-22T21:26:24.443929+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261212-LlamaFar--1557714",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.127537",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ComesMarcellino - add in to that you could sell just over 35m earlier, then the MM's were bouncing to 5,8,18m as they ran it up and down looking for parcels at 0.26p zone and it all ties in nicely. News can't be long?",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.27",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-22T21:26:24.443910+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261539-dvharris--8164130",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.127126",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Defo need news for as interesting as the AI analysis is the more sells than buys will push the SP down as we've seen. I also think markets generally are in for a bumpy ride for the foreseeable future with Trump's antics and worldwide uncertainty..\ud83e\udd14 I'm now down to just the 2 small cap shares after a broader review of my investments.",
          "sentiment": 0.5,
          "engagement": "21,003",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-22T21:26:24.443892+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar-45069129",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.126699",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-22T21:26:24.443874+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF--5420858",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.126279",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-22T21:26:24.443856+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--2424989",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.125865",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-22T21:26:24.443838+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar--1253495",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.125458",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-22T21:26:24.443819+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb-13741763",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.125003",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-22T21:26:24.443801+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar--6065728",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.124597",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-22T21:26:24.443784+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz-39112760",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.124189",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,498",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-22T21:26:24.443766+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar-19492467",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.123766",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-22T21:26:24.443748+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh-32682665",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.123358",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-22T21:26:24.443730+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar--2775862",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.122936",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-22T21:26:24.443712+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris--5168906",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.122531",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,003",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-22T21:26:24.443694+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb--4590203",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.122118",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-22T21:26:24.443676+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF-49654119",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.121656",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,032",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-22T21:26:24.443658+00:00"
      },
      {
        "event_id": "SOCIAL-Today0732-EpicViru-40277841",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.121240",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "35",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-22T21:26:24.443639+00:00"
      },
      {
        "event_id": "SOCIAL-Today0826-dvharris-21938777",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.120816",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,003",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-22T21:26:24.443622+00:00"
      },
      {
        "event_id": "SOCIAL-Today0924-EpicViru--2659425",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.120401",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "35",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-22T21:26:24.443604+00:00"
      },
      {
        "event_id": "SOCIAL-Today1122-dvharris-62106407",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.119980",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,003",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-22T21:26:24.443585+00:00"
      },
      {
        "event_id": "SOCIAL-Today1219-LlamaFar-64073716",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.119563",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "852",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-22T21:26:24.443566+00:00"
      },
      {
        "event_id": "SOCIAL-Today1521-Andys288--8127249",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.119139",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "513",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-22T21:26:24.443542+00:00"
      },
      {
        "event_id": "SOCIAL-Today1836-MadEngli--6783936",
        "event_type": "social_post",
        "date": "2026-01-22T21:26:16.118700",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "714",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-01-22T21:26:24.443518+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261520-bonesgt--5229233",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.120106",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Mms Just waiting for the weak ,then bang another buyer satisfied. Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.31",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134990+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261701-LlamaFar-73321237",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.119697",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Someones Empire building here. Mms filling orders, news flow is known, price increased by 20% from (double top at 0.40 and) double bottom at 0.246p. Walk it down, close rhe spread, chase out the credit card bill holders who are nervous. Watch that pattern sliding those lumps of stock sideways...",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.31",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134972+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261703-Stay.cal--1195633",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.119283",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stay.calm",
          "content": "I didn't call it right today :-( If it stays around this price for Thursday-Friday I'll be over the moon ;-)",
          "sentiment": 0.0,
          "engagement": "288",
          "price_at_post": "0.31",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134954+00:00"
      },
      {
        "event_id": "SOCIAL-5Jan20261729-MadEngli-76962991",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.118863",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Good Luck S/C . ATB ME",
          "sentiment": 0.0,
          "engagement": "713",
          "price_at_post": "0.31",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134936+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261143-MadEngli-58549683",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.118449",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Thought I'd got a bargain yesterday,  turns out I should have waited 24 hours  ( as usual \ud83d\ude05) ME",
          "sentiment": 0.0,
          "engagement": "713",
          "price_at_post": "0.30",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134918+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261153-dvharris-20074686",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.118020",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Not sure you'll even notice a fraction of a penny when the SP takes off!",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.30",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134900+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261206-DrMicho-59681407",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.117608",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Unfortunately, this happens quite often where we get a good run then it falls away..... Until we get some solid news (on a number of fronts) we will drift back down. Nevertheless, as DV says you wont even notice it... Just sit back and wait, GLA..",
          "sentiment": 0.5,
          "engagement": "8,146",
          "price_at_post": "0.30",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134883+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261213-TrickyEF-73706929",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.117201",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "12:10:23\t0.3068\t3,850,000\tBuy*\t11.81k Should not take much more to change the direction back northbound",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.30",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134865+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261215-TrickyEF-58520501",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.116775",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Well that got us back level \ud83d\ude00",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.31",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134847+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261216-dvharris--1191179",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.116365",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'm happy to see shares transfer from weak hands/traders to more (long term) sticky fingers....",
          "sentiment": 0.0,
          "engagement": "20,994",
          "price_at_post": "0.31",
          "thread_title": "RE: Trades.....",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3E63298A-3B09-440F-B7CE-2591EF908346"
        },
        "ingested_at": "2026-01-21T21:42:33.134830+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261246-TrickyEF-67315167",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.115941",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "\ud83d\ude09",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.31",
          "thread_title": "Could be blue by two",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=80B0A3E1-0E7A-4E42-96FF-4EBBFE51A1FA"
        },
        "ingested_at": "2026-01-21T21:42:33.134812+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261257-dvharris--3927677",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.115530",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Probably need another chunky buy to take the next step up..",
          "sentiment": 0.0,
          "engagement": "20,994",
          "price_at_post": "0.31",
          "thread_title": "RE: Could be blue by two",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=80B0A3E1-0E7A-4E42-96FF-4EBBFE51A1FA"
        },
        "ingested_at": "2026-01-21T21:42:33.134794+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261302-TrickyEF--4591536",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.115117",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "That last buy was higher than yesterday's close. Fingers crossed it may shift a bit",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.31",
          "thread_title": "RE: Could be blue by two",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=80B0A3E1-0E7A-4E42-96FF-4EBBFE51A1FA"
        },
        "ingested_at": "2026-01-21T21:42:33.134777+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261304-LlamaFar--6777452",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.114692",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "I'll say it again... Masterclass Who ever's been buying these must be very, very happy with themselves. Perfectly weighted and timed.",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.31",
          "thread_title": "RE: Could be blue by two",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=80B0A3E1-0E7A-4E42-96FF-4EBBFE51A1FA"
        },
        "ingested_at": "2026-01-21T21:42:33.134759+00:00"
      },
      {
        "event_id": "SOCIAL-6Jan20261628-dvharris--2448354",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.114277",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like a blue finish....",
          "sentiment": 0.0,
          "engagement": "20,994",
          "price_at_post": "0.315",
          "thread_title": "RE: Could be blue by two",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=80B0A3E1-0E7A-4E42-96FF-4EBBFE51A1FA"
        },
        "ingested_at": "2026-01-21T21:42:33.134742+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260705-dafad-19915210",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.113855",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Https://www.londonstockexchange.com/news-article/SVNS/us-patent-allowance-for-ptsd-discovery-programme/17401871",
          "sentiment": 0.0,
          "engagement": "2,390",
          "price_at_post": "0.31",
          "thread_title": "Rns out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B1C887D1-7354-4D4B-96E2-EE4D3DFB8EE0"
        },
        "ingested_at": "2026-01-21T21:42:33.134724+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260706-dafad--1791081",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.113449",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Solvonis Therapeutics plc (\"Solvonis\" or the \"Company\") U.S. Patent allowance received for PTSD discovery programme Demonstrating scientific and commercial significance Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, announces that it has received a Notice of Allowance (the \"Allowance\") from the United States Patent and Trademark Office (\"USPTO\") for a series of compounds within its proprietary SVN-SDN-14 Post-Traumatic Stress Disorder (\"PTSD\") discovery programme. One compound from this series is currently being evaluated alongside other candidates, with a lead compound expected to be selected in Q1 2026 in line with prior guidance. The Allowance strengthens the intellectual property foundations of SVN-SDN-14 at an important stage as the programme advances toward lead-candidate selection. In addition to this IP milestone, the Company is highlighting the scientific significance of the newly protected compounds in addressing long-standing challenges in the development of next-generation PTSD therapeutics.",
          "sentiment": 0.0,
          "engagement": "2,390",
          "price_at_post": "0.31",
          "thread_title": "RE: Rns out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B1C887D1-7354-4D4B-96E2-EE4D3DFB8EE0"
        },
        "ingested_at": "2026-01-21T21:42:33.134706+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260716-Andys288--3908396",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.113002",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Get your horses ready, it\u2019s race day\u2026. \ud83d\udc34\ud83d\udc0e\ud83d\udc34\ud83d\udc0e\ud83c\udf7e\ud83c\udf7e\ud83c\udf7e\ud83d\udc34\ud83d\udc0e\ud83d\udc34\ud83d\udc0e",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.31",
          "thread_title": "RE: Rns out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B1C887D1-7354-4D4B-96E2-EE4D3DFB8EE0"
        },
        "ingested_at": "2026-01-21T21:42:33.134688+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260716-hitthebi--1824201",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.112593",
        "source": "LSE_CHAT",
        "data": {
          "author": "hitthebigtime",
          "content": "Excellent news. Things definitely heading in the right direction. A great start to 2026.",
          "sentiment": 0.5,
          "engagement": "133",
          "price_at_post": "0.31",
          "thread_title": "RE: Rns out",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B1C887D1-7354-4D4B-96E2-EE4D3DFB8EE0"
        },
        "ingested_at": "2026-01-21T21:42:33.134670+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260730-dafad--5612489",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.112182",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Anthony Tennyson, Chief Executive Officer of Solvonis, added: \"This patent allowance strengthens both the scientific and commercial foundations of our PTSD programme. It reflects our strategy of combining rigorous neuroscience with disciplined medicinal chemistry to build differentiated, scalable CNS therapeutics.\"",
          "sentiment": 0.0,
          "engagement": "2,390",
          "price_at_post": "0.31",
          "thread_title": "Could be HUGE",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2B043526-A76B-41AF-95A1-B603695D6F6C"
        },
        "ingested_at": "2026-01-21T21:42:33.134653+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260732-Scoutt-16248835",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.111764",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "Ownership of compound is everything, pretty much demonstrated it works on what is becoming the worlds hangover, excuse the pun, this could knock the fat busting drugs into the long grass as drink drugs and PDSD impact the GDP of developed country, the Governmental Medical Experts will want to fast track this to deployment as quickly as possible.  A truly blue sky share.",
          "sentiment": 0.0,
          "engagement": "962",
          "price_at_post": "0.31",
          "thread_title": "Massive moment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=64AAE886-64A8-4841-A68A-7E1C0DB7617D"
        },
        "ingested_at": "2026-01-21T21:42:33.134635+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260747-TrickyEF-91718940",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.111360",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "If you build it they will come",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.31",
          "thread_title": "Kevin costner",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C1417DAA-7F8F-407A-AB64-E32A3F915A1D"
        },
        "ingested_at": "2026-01-21T21:42:33.134617+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260811-Sujood--7709251",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.110928",
        "source": "LSE_CHAT",
        "data": {
          "author": "Sujood",
          "content": "A great RNS Speeding ticket day, I wonder ?",
          "sentiment": 0.5,
          "engagement": "1,259",
          "price_at_post": "0.31",
          "thread_title": "Today RNS",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=EBFC74E7-D9F1-44B2-A52C-4AA2A67ADA58"
        },
        "ingested_at": "2026-01-21T21:42:33.134598+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260815-DrMicho-75100470",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.110507",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I believe this is the start to more news, and we can see where they want this to go. Absolute steal at this price... Speeding ticket, give your head a wobble\ud83d\ude02\ud83e\udd23\ud83d\ude02\ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "8,146",
          "price_at_post": "0.33",
          "thread_title": "RE: Massive moment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=64AAE886-64A8-4841-A68A-7E1C0DB7617D"
        },
        "ingested_at": "2026-01-21T21:42:33.134581+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260826-LlamaFar-49372138",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:33.110064",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The Co had advised of 6 pieces of news to fall into Q4 2025 and due to varying factors, ranging from the conference season - Chinese import/export licenses on Ketamin most of these were pushed back into Q1 2026. However in Q4 they did release the unexpected news of 015 a new compound that they had arranged U.S. Govt funding for. There are more pieces of the jigsaw to fall into place in Q1.",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.325",
          "thread_title": "RE: Massive moment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=64AAE886-64A8-4841-A68A-7E1C0DB7617D"
        },
        "ingested_at": "2026-01-21T21:42:33.134564+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260851-RhHh-73408198",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.951255",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Miserable UK market, probably end up red today!",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.315",
          "thread_title": "RE: Massive moment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=64AAE886-64A8-4841-A68A-7E1C0DB7617D"
        },
        "ingested_at": "2026-01-21T21:42:33.134546+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260855-dvharris-21350888",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.950840",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Sooner we move to the USA the better....",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.315",
          "thread_title": "RE: Massive moment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=64AAE886-64A8-4841-A68A-7E1C0DB7617D"
        },
        "ingested_at": "2026-01-21T21:42:33.134528+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260858-Stretcht--1915183",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.950422",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Hi all, I\u2019ve been buying in here and probably some more still to acquire. I like a the story and potential, high risk but could be explosive. I\u2019m here for a multi-bagger.",
          "sentiment": 0.5,
          "engagement": "190",
          "price_at_post": "0.315",
          "thread_title": "New",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=378889F7-A80C-4664-99FE-BEB3474B3AC0"
        },
        "ingested_at": "2026-01-21T21:42:33.134510+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260858-TrickyEF-54354548",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.949998",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Pay attention folk. It's all there The newly allowed patent covers a novel chemical series designed to retain the core SERT, DAT and NET activity underpinning the programme, while introducing greater pharmacological control through predictable metabolic deactivation. This approach is intended to maintain therapeutic effects while improving dosing flexibility, safety margins and overall suitability for clinical use. In allowing the claims, the USPTO examiner concluded that no existing patents or publications disclosed or suggested the claimed compounds, confirming the novelty of the approach.",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.315",
          "thread_title": "Golden AI",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=878442F0-61B9-4E38-A9C4-4B4337676A77"
        },
        "ingested_at": "2026-01-21T21:42:33.134492+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260903-Scoutt--9084255",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.949577",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "If we were listed in NY this would be 25p, have to wonder why any reputable company bothers with London, the market is so incomprehensible, look at Mobility1 snakes without mirrors and they\u2019ve risen 400%, alright they\u2019ll be back below where they started from but still.  Anyway the market gets it right in the end, just have to be patient.",
          "sentiment": 0.0,
          "engagement": "962",
          "price_at_post": "0.315",
          "thread_title": "If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134474+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260906-TrickyEF-55438252",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.949167",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Scoutt. Re mobility one and several others seem to be spiked with pump n dumpers. One positive with svns is it seems to have proper substance to it and the market won't allow it to act like a basket case. How this has not sailed pat 0.5p is insane.",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.315",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134456+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260910-LlamaFar--3053532",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.948738",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Close the spaces up. h t t p s : / / t. me/+nD8wL-lHmcA3ZTM8",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.315",
          "thread_title": "Telegram research group",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=28969536-3F54-49E2-96BD-7F0C226C80BC"
        },
        "ingested_at": "2026-01-21T21:42:33.134438+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260925-dvharris-73845851",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.948332",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD needs to carry on with their transformative work until the market eventually wakes up to the potential of this little gem \ud83d\udc8e",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.315",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134420+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260932-SCC06--2754018",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.947907",
        "source": "LSE_CHAT",
        "data": {
          "author": "SCC06",
          "content": "The news is great here today and sure the US will agree. There\u2019s been a lot of legacy shares at 0.3p  being churned recently but they won\u2019t last forever.",
          "sentiment": 0.0,
          "engagement": "8,500",
          "price_at_post": "0.315",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134403+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260942-dvharris--6388482",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.947501",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Interesting to see that bunch of sells (\u00a340k) over a 4 minute spell from 9.20am. Individual offloading? Anyway, they have been bought by others and we move onwards and upwards....",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134385+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260959-wookieem--2993191",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.947073",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "Enjoying quietly holding and watching things unfold here. Feel all things considered it\u2019s kept in a healthy range. It\u2019s still absolutely reliant on the obvious but there\u2019s a positive undertone and continue to feel this could do well. A classic risk / reward scenario for sure..  but feel optimistic. Just waiting and watching. Here\u2019s to some good luck and a good 2026.",
          "sentiment": 0.0,
          "engagement": "4,350",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134367+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261034-MadEngli--1267309",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.946656",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Wookie, Could do well ? \ud83d\ude02 Appreciate you obviously have a very cautious approach but Come On, with  multiple irons in the fire and several programs progressing in areas with none or little medical therapy I think you win the award for most understated review of the week \ud83d\ude01. ATB ME",
          "sentiment": 0.0,
          "engagement": "713",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134348+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261454-TrickyEF--1064885",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.946241",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Https://www.cnbc.com/2026/01/07/big-pharma-race-to-snap-up-biotech-assets-as-170-billion-patent-cliff-looms.html",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.32",
          "thread_title": "Good timing from SVNS",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=E3F96D91-4BC5-4C37-ACDF-ED876A113A88"
        },
        "ingested_at": "2026-01-21T21:42:33.134331+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261506-wookieem--4180606",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.945813",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "Haha that maybe so MadEnglish,  but over the last few decades I\u2019ve heard that kind of optimism more times than I care to remember :) very few ever get there. Think if it was so certain this would be well over 1 or 2p by now. Either way I\u2019ve been making the most of cheaper prices and can only hope this comes as good as you think it will. As cautious as I might seem, believe that If this does do well, it\u2019ll do very very well.",
          "sentiment": 0.0,
          "engagement": "4,350",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T21:42:33.134312+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261521-Troajan-76414500",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.945397",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1085276/solvonis-ceo-on-us-patent-win-and-ptsd-drug-progress-1085276.html",
          "sentiment": 0.0,
          "engagement": "125,391",
          "price_at_post": "0.32",
          "thread_title": "Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134294+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20261524-DrMicho--4492271",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.944974",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Nice, very nice indeed.... Looking ahead to Q1 2026, Tennyson highlighted the milestones investors should monitor, including completion of in-vivo work, confirmation of brain activity, narrowing the candidate set, and final lead selection. He described this as \u201ca key inflection point as the program transitions from discovery to IND enabling work.\u201d Beyond PTSD, Tennyson discussed broader pipeline progress across addiction and psychiatric indications. He said 2026 could be a catalyst-rich year, with advancement of clinical programs, potential partnering discussions, and continued progress within the company\u2019s discovery engine.",
          "sentiment": 0.5,
          "engagement": "8,146",
          "price_at_post": "0.32",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134275+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20262018-VikR--5260719",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.944549",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Everything this company is doing is amazing and the way they are diversifying and not standing still waiting for the lead addiction workflows to conclude is testament to the proactivity of the entire BOD. Every single newsflow going forward will be a catalyst but the absolute biggest catalyst will be the phase 2b permission by FDA following WuXis bridging work completion. As spravato  is already licensed, flying through the rest of the clinical trials will be a breeze for repurposed esketamine. \u2018During Q4 2025, preparatory work continued with WuXi AppTec on a pharmacokinetic bridging programme to support regulatory alignment. Initial data are expected in Q1 2026, with further progress through Q2 2026\u2019 When WuXI complete there work and SVNS RNS it, thats going to be a good day for the SP. With Professor Nutts stamp of approval and a well compiled case FDA approval will be a given. Load and hold these valuable shares for 2026/27/28. One of the best long term holds in the market",
          "sentiment": 0.5,
          "engagement": "934",
          "price_at_post": "0.32",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134129+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20262257-MadEngli-22356180",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.944124",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Great  post VikR, good to see you on GSCU also ! Should be a great year for both ATB ME",
          "sentiment": 0.0,
          "engagement": "713",
          "price_at_post": "0.32",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134087+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20260904-dvharris--5854522",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.943692",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Plenty of sells this morning, almost like we didn't have good news yesterday!\ud83d\ude10",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.305",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134069+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261000-Canary3-26673242",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.943275",
        "source": "LSE_CHAT",
        "data": {
          "author": "Canary3",
          "content": "18 million traded almost 7 Billion in existence... I can't do the percentage traded but it is quite tiny. It doesn't mean much IMO",
          "sentiment": 0.0,
          "engagement": "1,420",
          "price_at_post": "0.305",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134052+00:00"
      },
      {
        "event_id": "SOCIAL-8Jan20261006-LlamaFar--8138604",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.942839",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Re: Volume - yes, being moved about in a very tight range and scooped out sideways into someones account. IMO sit tight, wait for news and for their orders to be filled and then it goes.",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.305",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134034+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20260849-bonesgt--7646502",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.942427",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Someone still hoovering these up ,can sell 5mil No problem, news again next week, news rich time ,let's have it solvonis. Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.30",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.134017+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20261241-ParetoPr-44932334",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.941995",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "\u201c18 million traded almost 7 Billion in existence...\u201c About 0.25%",
          "sentiment": 0.0,
          "engagement": "2,315",
          "price_at_post": "0.295",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.133999+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20261748-covgaz-77219855",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.941572",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I have to apologise for the constant drip in the share price , that'll be down to me buying some last Monday.",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.29",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.133981+00:00"
      },
      {
        "event_id": "SOCIAL-9Jan20261804-MadEngli--3108070",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:28.941137",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Did you get your shares ? Great price today, hopefully you loaded up... Will we hear news next week ? \ud83e\udd1e ATB ME",
          "sentiment": 0.0,
          "engagement": "713",
          "price_at_post": "0.29",
          "thread_title": "StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T21:42:33.133963+00:00"
      },
      {
        "event_id": "SOCIAL-10Jan20261232-turnthec--5516422",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.954814",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "I\u2019m starting to get tetchy to top up further on Monday if SVNS remains the same price. I\u2019m more than happy with my current holding but considering what could happen anytime now a further bite of the cherry would not go a miss.",
          "sentiment": 0.0,
          "engagement": "308",
          "price_at_post": "0.29",
          "thread_title": "RE: StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T21:42:33.133946+00:00"
      },
      {
        "event_id": "SOCIAL-10Jan20261453-Stay.cal-32318758",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.954405",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stay.calm",
          "content": "Hi MadEnglish, I have a small top every week in Solvonis as a rule. However on Monday and Wednesday this week I bought into another company that was recommended to me by a friend. I still hold all my Solvonis shares, but I put my top up money into MobilityOne Ltd (MBO) this week. My friend has a very large holding in MBO. He recommended it, and was still topping up himself this week. MBO rose 1200% in 4 days a week or so ago and has retraced a bit the last few days. My friend reckons it will go on a run again and could multi bag again from current price??? I'm not cross ramping, I'm not even sure if I've done the right thing, I may regret my decision next week. Next week I maybe thinking that it should have gone into SVNS as normal. I've not put too much into MBO, so if it goes pear shaped I've not lost much. My mate is adamant about it having another run after this consolidation. I hope no one has a go at me for my post. I'm not cross ramping, I was asked a question and gave an honest answer. I am 100% not recommending that people should invest into MBO....that's for them to decide. If I make money from MBO it will be going straight into here. I'm totally happy and excited with my SVNS investment....I'll be topping up as normal again from next week. I'm looking forward to news.",
          "sentiment": 0.0,
          "engagement": "288",
          "price_at_post": "0.29",
          "thread_title": "RE: StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T21:42:33.133928+00:00"
      },
      {
        "event_id": "SOCIAL-10Jan20261552-MadEngli-74424628",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.953976",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Hi S/C, your money, your choice, always D.Y.O.R ATB ME",
          "sentiment": 0.0,
          "engagement": "713",
          "price_at_post": "0.29",
          "thread_title": "RE: StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T21:42:33.133910+00:00"
      },
      {
        "event_id": "SOCIAL-11Jan20261408-MG01--6395238",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.953563",
        "source": "LSE_CHAT",
        "data": {
          "author": "MG01",
          "content": "From Sky news today.  Distressing what the lad & family have gone thru'.  Will Svns drug pipeline help such victims? I think it will & supports my investment here which I'll increase when funds available. \"It wasn't until last year, four years after he unwillingly saw the disturbing video, that Frazer was diagnosed with complex Post\u2011Traumatic Stress Disorder, directly linked to what he saw at school.\"",
          "sentiment": 0.5,
          "engagement": "143",
          "price_at_post": "0.29",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T21:42:33.133892+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260858-TrickyEF-21914567",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.953148",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "On R&D, the professional services firm has urged drugmakers to redirect their pipelines toward urgent and undertreated diseases, bidding companies to \u201cmove beyond incremental improvements in crowded categories.\u201d PwC singled out reversing organ decline, curing genetic conditions and extending health lifespans as particularly enticing targets. To get there, the pharma industry should pool internal expertise with biotech \u201ctrailblazers,\u201d AI discovery platforms, venture incubators and academic institutions, PwC advised.",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.295",
          "thread_title": "Solvonis is so sexy right now",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B5B6FC43-C566-4F7C-9C34-5E72795F9CF1"
        },
        "ingested_at": "2026-01-21T21:42:33.133874+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260859-TrickyEF-12196500",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.952714",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Full article. Bring it on https://www.fiercebiotech.com/biotech/build-future-pharmas-must-embrace-ai-patient-experience-and-new-rd-frontiers-pwc",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.295",
          "thread_title": "RE: Solvonis is so sexy right now",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B5B6FC43-C566-4F7C-9C34-5E72795F9CF1"
        },
        "ingested_at": "2026-01-21T21:42:33.133857+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260921-TrickyEF-53177660",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.952297",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Back at it",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.295",
          "thread_title": "Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T21:42:33.133839+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20260937-bonesgt-55559384",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.951873",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Looking good Tricky. News anytime . Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.295",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T21:42:33.133821+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261000-dvharris--2719593",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.951468",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "My favourite colour! \ud83d\ude0d",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.30",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T21:42:33.133803+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261000-TrickyEF--3376833",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.951047",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "That tune from Rocky pops to mind. 'Gonna fly now'",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.30",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T21:42:33.133786+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261001-TrickyEF-36290429",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.950630",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "To do what Solvonis has been doing since it's launch. Let get that licensing news.",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.30",
          "thread_title": "The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-21T21:42:33.133768+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261003-dvharris-64440343",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.950216",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pivotal Quarter for Solvonis....",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.30",
          "thread_title": "RE: The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-21T21:42:33.133748+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261017-LlamaFar--2192361",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.949787",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "JP Morgan week this week 12 - 15th ... Movers and Shakers back at desks next week ....",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.30",
          "thread_title": "RE: The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-21T21:42:33.133731+00:00"
      },
      {
        "event_id": "SOCIAL-12Jan20261023-RhHh--7662990",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.949378",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Buys outstripping sells at the moment. Always good to see. Massive year for svns. I think this is the last of the bargain basement prices so if you want in then don't delay.",
          "sentiment": 0.5,
          "engagement": "318",
          "price_at_post": "0.30",
          "thread_title": "Buys v sells",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=269EC9EC-8229-4DB2-B529-CF1F39723135"
        },
        "ingested_at": "2026-01-21T21:42:33.133713+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260855-dvharris-70842296",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.948958",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A few decent buys and folks looking forward to the next piece of the jigsaw being put in place.....",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.305",
          "thread_title": "Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133695+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260859-bonesgt--7847869",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.948538",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Looking  good Dv ,heading up to the next news ,which as we all know could be transformational. Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.30",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133677+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260909-RhHh-53636267",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.948127",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Lot of small trades but at least they are buys!",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.305",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133660+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260925-MrsRobin--7914538",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.947708",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "5m available when .32 tick up - now down to 1m",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.31",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133642+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-MrsRobin--6187254",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.947298",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Not a lot of stock around - it seems 5m available when .33 tick up - now down to 2m",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.31",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133624+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260933-dvharris-40767862",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.946868",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "We had a Seller who helped push the SP down from 0 4p to 0.23p. Hopefully those shares are in sticky hands as we push back up up to 0.4p, helped by the regular (positive) updates from the BoD...",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133606+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260936-TrickyEF--6584504",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.946449",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Morning all. Well yesterdays buy to sells which was decent is being smashed today.",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133588+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20260951-DrMicho--5271433",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.946016",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I agree, we should have never been anywhere near .23. Nevertheless, seller gone and we should be sitting at .4 on news and push up further from there depending on what gets released. How this is here is unbelievable\u2026",
          "sentiment": 0.5,
          "engagement": "8,146",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133571+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261031-Andys288-29028575",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.945595",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Horses ready? \ud83d\udc0e\ud83d\udc34",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T21:42:33.133553+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261045-MadEngli-36278879",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.945170",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "I'm not complaining,  I'm happy we're on the move again finally but I find myself a tad philosophical this morning  \ud83d\ude01 Why is it ( in life as well as stocks)  positive action never elicits an equal response to a negative one ? Can you imagine the market response to all that blue today being red ?  \ud83e\udd23 We'd be in the basement. ATB LTHs @ all ME",
          "sentiment": 0.0,
          "engagement": "713",
          "price_at_post": "0.32",
          "thread_title": "Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-21T21:42:33.133535+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261120-MrsRobin--3316806",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:23.944651",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "9m or so sells taken it back to around 12m available at  .32/.33",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.32",
          "thread_title": "RE: Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-21T21:42:33.133517+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261724-TrickyEF-52501967",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.525469",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Well sellers clearly won today. Till tomorrow and beyond",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.31",
          "thread_title": "RE: Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-21T21:42:33.133499+00:00"
      },
      {
        "event_id": "SOCIAL-13Jan20261739-Barnsley-37340564",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.525044",
        "source": "LSE_CHAT",
        "data": {
          "author": "BarnsleyBitter",
          "content": "Solvonis Therapeutics Bounce above a falling 50-day line combined with an RSI 50-plus rebound suggests a bull flag. Target: up to 0.46p by end of next month while above the 50-day (0.27p).",
          "sentiment": 0.0,
          "engagement": "551",
          "price_at_post": "0.31",
          "thread_title": "Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-21T21:42:33.133481+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261213-bonesgt-50572194",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.524630",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "What no chat come on guys ,you must have something to say . Come on svns, gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.305",
          "thread_title": "RE: Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-21T21:42:33.133463+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261259-LlamaFar--2582798",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.524226",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Dry January...",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.305",
          "thread_title": "RE: Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-21T21:42:33.133446+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261430-Opportun-26027156",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.523808",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "I asked Google AI for it's thoughts on the pending licensing deal for SVN-001 and received the below response: Based on Solvonis Therapeutics' current activities as of early 2026, the company is actively in discussions with four major pharmaceutical firms to out-license its lead program, SVN-001. Given the reported Phase 3 progress and strong Phase 2b data\u2014which showed an 86% abstinence rate at six months versus 2% pre-trial\u2014the likely deal structure and valuation are as follows: Likely Deal Structure: Global or Territorial Licensing With four major players in contention, Solvonis is positioned for a competitive licensing or commercial partnership deal. Commercialization Partnership: Solvonis has engaged specialist firm Pharma Ventures to shop SVN-001, typically signaling a search for a partner with a deep commercial footprint to handle the heavy lifting of a global launch while Solvonis retains some upside. Licensing Type: A global exclusive license is most common for a Phase 3 Central Nervous System (CNS) asset, where the partner manages late-stage regulatory filings and commercialization in exchange for upfront cash and future milestones. Alternative Structure: \"Ex-China\" or \"Regional\" deals (e.g., UK/EU vs. US rights) are possible to split risk, though the CEO's mention of four major firms suggests a broader global interest. Estimated Dollar Amounts Valuations for de-risked CNS assets in Phase 3 are currently commanding significant premiums due to high unmet needs in addiction and mental health. Total Deal Value: Solvonis leadership has explicitly pointed to peer company Gilgamesh, which out-licensed a lead program for a total price of $1.2 billion. Upfront Payment: For a Phase 3 asset with positive \"pivotal\" data, upfront payments typically range from $150 million to $700 million. For comparison, the Solvonis chair recently oversaw a deal for another company (IGI) that secured $700 million upfront within a $1.9 billion total package. Milestones and Royalties: Expect the remaining balance ($500M to $1B+) to be tied to regulatory approvals (FDA/EMA) and commercial sales targets, along with double-digit royalties on net sales. Key Drivers of Value Strong Clinical Data: Phase 2b results (50% reduction in heavy drinking days and 86% abstinence) are considered \"striking\" and \"smashing endpoints\" for the Alcohol Use Disorder (AUD) market. Market Opportunity: SVN-001 targets a population of ~40 million patients across the US, UK, and EU, where standard therapies currently see a 75% relapse rate. Regulatory Exclusivity: Solvonis is pursuing a hybrid application in the UK that could provide up to 10 years of market protection.",
          "sentiment": 0.5,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "AI's thoughts on SVN-001 licensing deal",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=E0E550A8-65DB-4217-8052-6C70F7E92DBC"
        },
        "ingested_at": "2026-01-21T21:42:33.133428+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261435-Opportun--5458612",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.523337",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "I then followed up by asking AI:  Given your above answer regarding the licensing deal for SVN-001, if the bridging data allows Solvonis to move SVN-002 into Phase 2B and Solvonis moves forward with a Nasdaq listing, where do you think the market cap of Solvonis is likely to be after that point?  Please also take into consideration the SVN-015 U.S. funding and the U.S. patent allowance for SVN-014. The response is below: If Solvonis Therapeutics successfully executes its 2026 milestones\u2014licensing SVN-001, advancing SVN-002 to Phase 2b, and achieving a Nasdaq listing\u2014the company\u2019s market capitalization would likely undergo a significant upward rerating from its current level of approximately \u00a319M\u2013\u00a320M ($24M\u2013$26M). Based on peer comparisons and the current status of its multi-asset pipeline, here is the projected market cap outlook: 1. Projected Market Cap Range: $300 Million \u2013 $700 Million+ Following a successful Nasdaq uplisting and a major licensing deal for SVN-001, Solvonis would likely shift from a \"micro-cap\" LSE listing to a mid-range clinical-stage biotech valuation. Asset-Specific Value: The SVN-001 deal alone, if aligned with the CEO\u2019s comparison to Gilgamesh\u2019s $1.2B deal, would provide a massive cash infusion and validation, often driving market caps to 0.5x\u20131x the total deal value depending on upfront cash. Nasdaq Premium: U.S.-listed CNS biotechs with Phase 2b/3 assets typically command significantly higher valuations than their LSE counterparts due to deeper liquidity and a larger pool of specialist institutional investors. 2. Strategic Value of SVN-002 and Bridging Data The successful establishment of a \"scientific bridge\" to Janssen\u2019s Spravato\u00ae in Q1/Q2 2026 is critical. Accelerated Pathway: By using the 505(b)(2) pathway, Solvonis can bypass Phase 1 and 2a trials, potentially saving tens of millions in development costs and years of time. Valuation Impact: Moving directly into a Phase 2b trial for a market of 15 million U.S. adults transforms SVN-002 from a theoretical asset into a near-term commercial prospect, adding substantial \"Net Present Value\" (NPV) to the company. 3. Impact of SVN-015 U.S. Funding (NIDA/NIH) Non-Dilutive Capital: SVN-015\u2019s acceptance into the NIDA Addiction Treatment Discovery Program provides free preclinical safety and efficacy testing. Future Grant Potential: Success in these initial studies allows Solvonis to compete for NIH grants of up to $3 million per year for five years ($15M total). This non-dilutive funding reduces the need for equity raises, preserving shareholder value and supporting a higher market cap. 4. SVN-014 U.S. Patent Allowance and PTSD Franchise IP Protection: The January 2026 patent allowance for the SVN-SDN-14 series provides \"composition of matter\" protection, which is the \"gold standard\" for biotech valuation.",
          "sentiment": 0.5,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T21:42:33.133411+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261436-Opportun--1468378",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.522847",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "Lead Candidate Selection: With lead selection expected in Q1 2026, the company transitions from a discovery-stage firm to a clinical-stage platform company with multiple distinct franchises (AUD, PTSD, and Stimulant Use Disorder). Summary Table: Valuation Drivers Catalyst \tImpact on Market Cap SVN-001 Licensing\tImmediate cash infusion and multi-hundred million dollar validation. SVN-002 Phase 2b\tMoves a second major asset into late-stage U.S. development via an accelerated pathway. Nasdaq Listing\tIncreases liquidity and attracts high-conviction U.S. institutional funds. SVN-014/015 Progress\tValidates the AI-discovery platform, adding \"pipeline-in-a-product\" value.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T21:42:33.133393+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261439-Opportun--5060777",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.522420",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "All-in-all, things look very good considering that we know that Solvonis is already in talks with 4 pharma companies to license SVN-001, we know the bridging data is likely to come back good and allow SVN-002 to move into Phase 2B in the coming months and Solvonis has already stated that a Nasdaq listing is a major priority at some point. It seems that if the things that are very likely to occur happen, a 10-20x in market cap is a real possibility.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T21:42:33.133375+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261544-ComesMar--3747694",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.521996",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "What I really like here is not just the potential upside, but also the clear path that the BOD has designed, and the commitment of a person with the pedigree of Paul Carter.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T21:42:33.133356+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261555-TrickyEF--5378909",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.521590",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi Marcelino. Obviously Dennis and Nutt have high pedigree but Paul Carter is clearly of some top top pedigree and is not as visible as the other two. Massive part of the team. He previously held senior global roles including Executive Vice President and Chief Commercial Officer at Gilead Sciences, Inc. (NASDAQ: GILD), where he oversaw international operations across 38 markets and delivered annual revenues exceeding US$30 billion.",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T21:42:33.133338+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261601-LlamaFar-13829906",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.521165",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Usually with these small caps the BOD are substandard and are trying to promote assets that are often subpar, nothing about Solvonis is sub par! Paul Carter is interesting with his ex head of GSK China Hat on and 002 having a worldwide licence for China / Asia etc as well as his other attributes. Also in that he was part of the original Awakn team, the last one to rejoin after they listed it in the U.K.  ;) Dr Renata Crome is interesting  - The majority of Renata\u2019s pharmaceutical career was spent in early clinical development, initially as a Clinical Pharmacologist in the Cardiovascular Disease, Infectious Diseases, and Central Nervous System therapeutic areas.  As a Project Leader, she led project teams for Roche\u2019s key projects including the influenza drug oseltamivir, and oncology drugs bevacizumab and obinutuzumab. Renata\u2019s most recent role at Roche was as the Global Head of Early Development Clinical Operations and Deputy Head of Early Development. Prof David Nutt  - Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there.Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology. Add in Chairman Dennis Purcell and CEO Anthony Tennyson... The only weak link here is whoever's started selling yesterday?",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T21:42:33.133320+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261607-TrickyEF--3753016",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.520720",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi Lama. They can't all be barking up the wrong tree. They all believe in the destination and so far the NIH/NHS and FDA seem to also with funding most of it.",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.30",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T21:42:33.133302+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261628-LlamaFar-72922806",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.520299",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page Three types of trades showing up Sint , Xoff & Xlon... Someone's dragging it backwards ... Either they have a good idea of timing?? or are desperate to sell?",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.30",
          "thread_title": "Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-21T21:42:33.133283+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261634-LlamaFar--5776823",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.519869",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Look at all those tiny SINT trades messing around in and out, I wonder what they've been set up to achieve? XLON This is the official Market Identifier Code (MIC) for the London Stock Exchange main Regulated Market (the lit on-exchange order book). When you see XLON as the venue, the trade was executed on-exchange through the LSE's electronic order book in the normal, transparent, public way (continuous auction, opening/closing auctions etc.). XOFF This is a special \"generic\" MIC code meaning Off-Exchange (or OTC \u2014 Over-The-Counter) for instruments that are admitted to trading on a venue (usually a lit exchange like LSE). \u2192 Trade was not done on the actual exchange order book \u2192 Most commonly used for:  Negotiated trades / block trades reported to the LSE but executed bilaterally Trades with systematic internalisers (SIs) Pure OTC trades between two parties (market maker  client, institution  institution, etc.) Any off-book trade in a listed instrument SINT This is the special MIC code that means the trade was executed against a Systematic Internaliser (SI). \u2192 It is a subset of off-exchange trading \u2192 The counterparty was specifically operating as an SI (a firm that systematically executes client orders outside a trading venue using its own capital \u2014 think big banks/market makers like Citadel Securities, Jane Street, Flow Traders, Optiver, etc. when acting in SI mode) \u2192 Very often seen on UK/European retail flow and some institutional flow",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.30",
          "thread_title": "RE: Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-21T21:42:33.133265+00:00"
      },
      {
        "event_id": "SOCIAL-14Jan20261635-LlamaFar--5952271",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.519397",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "It must be lovely to trade if you are handed over direct market access and can set the prices on each of your trades?",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.295",
          "thread_title": "RE: Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-21T21:42:33.133247+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261140-DrMicho--1806460",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.518979",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Dropped a grand in just 2 days.. be back up soon enough, pub money and gamblers that want instant returns.., 15-Jan-26\t09:56:33\t0.2848\t3,137,628\tSell* 8,936 13-Jan-26\t09:22:45\t0.317\t3,137,628\tBuy* 9,946",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.295",
          "thread_title": "Just No Patience",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18B00745-62B4-497B-91B1-F4D2AA27ADF6"
        },
        "ingested_at": "2026-01-21T21:42:33.133229+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261159-Andys288-38800260",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.518564",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Just need the weather to clear up and we are back at the races. \ud83d\udc0e\ud83d\udc34",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.295",
          "thread_title": "RE: Just No Patience",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18B00745-62B4-497B-91B1-F4D2AA27ADF6"
        },
        "ingested_at": "2026-01-21T21:42:33.133211+00:00"
      },
      {
        "event_id": "SOCIAL-15Jan20261217-LlamaFar--2268322",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.518151",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nothing likely to happen this week as decision makers will be busy. That said, Exeter, More Kare, Dr Celia Morgan has announced they have increased from 9 to 14 assistant psychologists to run the trial - that is a 56% increase in staffing levels.",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.295",
          "thread_title": "JP Morgan Week 12 - 15th Jan",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=88E510C6-7E44-4179-BBFB-F264FDF46534"
        },
        "ingested_at": "2026-01-21T21:42:33.133193+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261118-Andys288--7293993",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.517726",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Don\u2019t be shy, the big boys are back next week, so but cheap while you still can.",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.285",
          "thread_title": "FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-21T21:42:33.133174+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261121-Andys288--2662795",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.517317",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Buy not but obvs",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.285",
          "thread_title": "RE: FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-21T21:42:33.133156+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261133-bonesgt--8264726",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.516891",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Defo, I wouldn't leave this much longer ,news imminent, exciting to see where first leg takes us .gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.285",
          "thread_title": "RE: FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-21T21:42:33.133130+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261329-LlamaFar-74011311",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.516474",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Q1 Expected Newsflow on day 16/93. 1.Update on how many Pharmas in talks to outlicense SVN001. 2.Update on bridging data for SVN002 from Wuxi App Tec to enter Phase 2b. 3. Update on lead candidate for SVN014 PTSD 4.Update on USA Govt funded pre clinical in vitro trial for SVN015 Meth & Coke treatment. 5.Update on new findings from AI Engine running through the CNS Library - specifically have they investigated further the 2 x patents held by Awakn on MDMA? 6. Update on new Neurology Pipeline? 7.Recent Board visit / presentations in the U.S.A. future Nasdaq listing mooted - potential update? Lots of irons in the fire at Solvonis - interesting that the share price has dipped on sellers being  active but conversely that the S.P. hasn't cratered as they are all getting quietly bought up!",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.285",
          "thread_title": "Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.133088+00:00"
      },
      {
        "event_id": "SOCIAL-16Jan20261332-LlamaFar-10449184",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.516013",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "16/90\ud83e\udd26",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.133070+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20260953-Andys288--1481174",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.515591",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Happy Monday, looking forward to a great week here. Horses are fed and watered and ready for the races \ud83d\udc0e\ud83d\udc0e\ud83d\udc0e\ud83d\udc0e",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.133052+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20260959-RhHh--7724912",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:20.515148",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Encouraging that after the early chunky sell we're not down. Looking forward to the company updates.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.133034+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20261948-covgaz--1127729",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.303163",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I'm looking for some inspiration here , in at 32+ only 8 days ago. Is this going to 23?",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.133016+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262100-ComesMar-56943822",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.302741",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I would be surprised if it drops that much. We are waiting for news, but some have no patience.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.132995+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262102-covgaz--1522849",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.302333",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I was expecting 60p by today ...",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.132977+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262151-LlamaFar-75486266",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.301920",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 19 of 90 in Quarter 1, not even 25% of the way through... Covgas you posted on the 9th you bought on the previous Monday i.e., 5/01/26? Then posted that you bought in at 0.32p 8 days ago? And were expecting 60p today \ud83e\udd23\ud83e\udd23\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.132959+00:00"
      },
      {
        "event_id": "SOCIAL-19Jan20262228-covgaz-46647123",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.301497",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I was avin a larf Llama , lighten up fella!",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.132942+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260516-ComesMar-67089202",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.301084",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I asked AI to analyse yesterday trading dynamics in the same way llamafarmer did few days ago. Below is the response: SVNS: Technical Analysis of 19-Jan Trading Session & Venue Dynamics Following the recent consolidation to 0.275p, a forensic look at the tape from yesterday (Monday, Jan 19) provides a clearer picture of the price action. While the mid-price appeared to weaken, the volume distribution across different venues suggests a \"mechanical\" rather than \"organic\" drop. 1. Venue Volume Breakdown Total volume for the session was approximately 19.6M shares, split across three primary execution venues: SINT (Systematic Internaliser): ~11.1M shares. This represented over 56% of the day's activity. As a reminder, SINT trades occur when a Market Maker (MM) executes against their own inventory (\"book\"). XLON (Standard LSE Order Book): ~6.5M shares. This is the \"lit\" market where transparent buy/sell orders meet. XOFF (Off-Exchange): ~2.0M shares. Private block trades reported to the exchange post-execution. 2. Identifying the \"Mechanical\" Fade The move from 0.29p down to 0.275p was characterized by a high frequency of \"micro-trades\" on the SINT code. We observed numerous sell prints of negligible size (often under \u00a35.00 in value). Technical Interpretation: These tiny SINT prints are typically used by automated market-making algorithms to \"walk back\" the mid-price during periods of low retail demand. Because the MM is trading against their own book, they can print these lower prices to manage their inventory risk without requiring a large volume of actual sellers. 3. The Bullish Divergence in XLON/XOFF Interestingly, while the SINT volume was skewed toward \"Sells,\" the XLON (Open Market) and XOFF (Off-Book) data showed a different trend: Organic Support: On the actual LSE order book (XLON), the \"Buy\" volume actually outpaced the \"Sell\" volume by a notable margin. Accumulation Signature: The 2M shares traded XOFF suggest that institutional or \"high-conviction\" hands were picking up blocks quietly while the SINT bots were painting the tape red. 4. Summary & Q1 Outlook The \"drop\" yesterday appears to be a Liquidity Trap. By suppressing the mid-price via SINT trades, the market has successfully triggered stop-losses and shaken out short-term momentum players. However, the fundamentals remain unchanged as we move further into Quarter 1. With the WuXi bridging data for SVN-002 and lead candidate selection for the PTSD program still pending, the current price action looks like a classic \"pre-catalyst shakeout.\" Conclusion: Look past the mid-price. The real story is in the XOFF accumulation and the lack of high-volume selling on the XLON exchange.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.132924+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260738-LlamaFar--7167270",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.300605",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ComesMarcellino - that's really interesting - thanks for that.",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.132905+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20260828-LlamaFar-23444460",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.300200",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "You can pretty much see which way we are being pulled by running through the trades on the official LSE trade page. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page Looking around at other stocks where large holders are building positions there does seem to be a familiar pattern, would assume that changes on either news or completion of position? I'm taking it as a positive as if you didn't want to side sweep the stock - why would you bother?",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T21:42:33.132887+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-LlamaFar--3199224",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.299762",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Q1 Expected Newsflow. 1.Update on how many Pharmas in talks to outlicense SVN001. 2.Update on bridging data for SVN002 from Wuxi App Tec to enter Phase 2b. 3. Update on lead candidate for SVN014 PTSD 4.Update on USA Govt funded pre clinical in vitro trial for SVN015 Meth & Coke treatment. 5.Update on new findings from AI Engine running through the CNS Library - specifically have they investigated further the 2 x patents held by Awakn on MDMA? 6. Update on new Neurology Pipeline? 7.Recent Board visit / presentations in the U.S.A. future Nasdaq listing mooted - potential update? Lots of irons in the fire at Solvonis - interesting that the share price has dipped on sellers being active but conversely that the S.P. hasn't cratered as they are all getting quietly bought up!",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.27",
          "thread_title": "Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T21:42:33.132869+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261205-ComesMar-90149385",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.299321",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I asked AI once again about today price action, specifically requesting to cross check with the morning narrative. Below is the response. SVNS: Technical Analysis of the 3-Day Compression & Volume Exhaustion \u200bAnalysis: The current price action in SVNS appears to be following a defined Three-Day Exhaustion Cycle on the XLON venue, likely signifying the final stages of a strategic supply overhang. \u200b1. Volume Profile vs. Price Drift: Over the last 72 hours, we have seen a consistent downward tick. However, today\u2019s intraday tape shows a notable divergence: Increasing unit volume on decreasing trade frequency. The appearance of concentrated 1m and 2m blocks on XLON hitting the bid is indicative of a \"Principal Trade\" or a managed \"Leak-Out.\" In these scenarios, a larger institutional holder is fulfilling a quota at a fixed price floor, rather than multiple retail actors selling out of panic. \u200b2. Support Level Validation: The 0.26p \u2013 0.27p range aligns with the historical consolidation base observed in late 2025. The fact that the bid is absorbing multi-million share blocks at this level without a breakdown suggests a significant counter-party buy-side interest is currently neutralizing the seller's pressure. \u200b3. Technical Indicators: \u200bOscillators: Intraday RSI is approaching \"Oversold\" territory, which often serves as a precursor to a \"snap-back\" rally toward the 50-day moving average (currently approx. 0.273p). \u200bTape Reading: Today\u2019s \"Red\" prints are likely part of a \"Deck Clearing\" exercise. In a low-float environment, the removal of a dominant seller typically creates a liquidity vacuum, allowing the price to re-rate rapidly once the overhead supply is exhausted. \u200bConclusion: The current activity represents a high-volume Transfer of Ownership at a technical floor. We are watching for stabilization in the closing auction as a confirmation that the selling cycle has completed ahead of anticipated Q1 operational updates.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.27",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T21:42:33.132851+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261212-LlamaFar-87992906",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.298852",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ComesMarcellino - add in to that you could sell just over 35m earlier, then the MM's were bouncing to 5,8,18m as they ran it up and down looking for parcels at 0.26p zone and it all ties in nicely. News can't be long?",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.27",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T21:42:33.132834+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261539-dvharris--5023033",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.298442",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Defo need news for as interesting as the AI analysis is the more sells than buys will push the SP down as we've seen. I also think markets generally are in for a bumpy ride for the foreseeable future with Trump's antics and worldwide uncertainty..\ud83e\udd14 I'm now down to just the 2 small cap shares after a broader review of my investments.",
          "sentiment": 0.5,
          "engagement": "20,994",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T21:42:33.132817+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar-81292073",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.298014",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T21:42:33.132800+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF--5955383",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.297593",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T21:42:33.132782+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho-13853797",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.297183",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T21:42:33.132765+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar--2698453",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.296765",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T21:42:33.132747+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb-68090574",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.296319",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T21:42:33.132729+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar-67479132",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.295897",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T21:42:33.132712+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz--8307364",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.295489",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T21:42:33.132694+00:00"
      },
      {
        "event_id": "SOCIAL-Today0832-LlamaFar--5203597",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.295068",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-21T21:42:33.132675+00:00"
      },
      {
        "event_id": "SOCIAL-Today1021-RhHh--9050390",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.294656",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-21T21:42:33.132657+00:00"
      },
      {
        "event_id": "SOCIAL-Today1056-LlamaFar-38895685",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.294252",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "851",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-21T21:42:33.132639+00:00"
      },
      {
        "event_id": "SOCIAL-Today1101-dvharris--3770798",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.293831",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "20,994",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-21T21:42:33.132621+00:00"
      },
      {
        "event_id": "SOCIAL-Today1102-BuckFuzb--6150712",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.293410",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-21T21:42:33.132602+00:00"
      },
      {
        "event_id": "SOCIAL-Today1117-TrickyEF-88840740",
        "event_type": "social_post",
        "date": "2026-01-21T21:42:17.292918",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,031",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-21T21:42:33.132580+00:00"
      },
      {
        "event_id": "SOCIAL-7Jan20260851-RhHh--5166272",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.779484",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Miserable UK market, probably end up red today!",
          "sentiment": 0.0,
          "engagement": "317",
          "price_at_post": "0.315",
          "thread_title": "RE: Massive moment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=64AAE886-64A8-4841-A68A-7E1C0DB7617D"
        },
        "ingested_at": "2026-01-21T01:47:03.591210Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260855-dvharris-40635658",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.779069",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Sooner we move to the USA the better....",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.315",
          "thread_title": "RE: Massive moment",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=64AAE886-64A8-4841-A68A-7E1C0DB7617D"
        },
        "ingested_at": "2026-01-21T01:47:03.591184Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260858-Stretcht-92061088",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.778649",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Hi all, I\u2019ve been buying in here and probably some more still to acquire. I like a the story and potential, high risk but could be explosive. I\u2019m here for a multi-bagger.",
          "sentiment": 0.5,
          "engagement": "181",
          "price_at_post": "0.315",
          "thread_title": "New",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=378889F7-A80C-4664-99FE-BEB3474B3AC0"
        },
        "ingested_at": "2026-01-21T01:47:03.591157Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260858-TrickyEF--4036960",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.778236",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Pay attention folk. It's all there The newly allowed patent covers a novel chemical series designed to retain the core SERT, DAT and NET activity underpinning the programme, while introducing greater pharmacological control through predictable metabolic deactivation. This approach is intended to maintain therapeutic effects while improving dosing flexibility, safety margins and overall suitability for clinical use. In allowing the claims, the USPTO examiner concluded that no existing patents or publications disclosed or suggested the claimed compounds, confirming the novelty of the approach.",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.315",
          "thread_title": "Golden AI",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=878442F0-61B9-4E38-A9C4-4B4337676A77"
        },
        "ingested_at": "2026-01-21T01:47:03.591130Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260903-Scoutt--8107207",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.777800",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "If we were listed in NY this would be 25p, have to wonder why any reputable company bothers with London, the market is so incomprehensible, look at Mobility1 snakes without mirrors and they\u2019ve risen 400%, alright they\u2019ll be back below where they started from but still.  Anyway the market gets it right in the end, just have to be patient.",
          "sentiment": 0.0,
          "engagement": "959",
          "price_at_post": "0.315",
          "thread_title": "If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.591085Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260906-TrickyEF--7568686",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.777389",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Scoutt. Re mobility one and several others seem to be spiked with pump n dumpers. One positive with svns is it seems to have proper substance to it and the market won't allow it to act like a basket case. How this has not sailed pat 0.5p is insane.",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.315",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.591059Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260910-LlamaFar-67116213",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.776955",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Close the spaces up. h t t p s : / / t. me/+nD8wL-lHmcA3ZTM8",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.315",
          "thread_title": "Telegram research group",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=28969536-3F54-49E2-96BD-7F0C226C80BC"
        },
        "ingested_at": "2026-01-21T01:47:03.591032Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260925-dvharris--6167483",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.776544",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD needs to carry on with their transformative work until the market eventually wakes up to the potential of this little gem \ud83d\udc8e",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.315",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.591006Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260932-SCC06-56855348",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.776124",
        "source": "LSE_CHAT",
        "data": {
          "author": "SCC06",
          "content": "The news is great here today and sure the US will agree. There\u2019s been a lot of legacy shares at 0.3p  being churned recently but they won\u2019t last forever.",
          "sentiment": 0.0,
          "engagement": "8,499",
          "price_at_post": "0.315",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.590980Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260942-dvharris-48582691",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.775704",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Interesting to see that bunch of sells (\u00a340k) over a 4 minute spell from 9.20am. Individual offloading? Anyway, they have been bought by others and we move onwards and upwards....",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.590953Z"
      },
      {
        "event_id": "SOCIAL-7Jan20260959-wookieem-76987834",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.775283",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "Enjoying quietly holding and watching things unfold here. Feel all things considered it\u2019s kept in a healthy range. It\u2019s still absolutely reliant on the obvious but there\u2019s a positive undertone and continue to feel this could do well. A classic risk / reward scenario for sure..  but feel optimistic. Just waiting and watching. Here\u2019s to some good luck and a good 2026.",
          "sentiment": 0.0,
          "engagement": "4,350",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.590927Z"
      },
      {
        "event_id": "SOCIAL-7Jan20261034-MadEngli-51999342",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.774853",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Wookie, Could do well ? \ud83d\ude02 Appreciate you obviously have a very cautious approach but Come On, with  multiple irons in the fire and several programs progressing in areas with none or little medical therapy I think you win the award for most understated review of the week \ud83d\ude01. ATB ME",
          "sentiment": 0.0,
          "engagement": "712",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.590901Z"
      },
      {
        "event_id": "SOCIAL-7Jan20261454-TrickyEF-78280110",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.774428",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Https://www.cnbc.com/2026/01/07/big-pharma-race-to-snap-up-biotech-assets-as-170-billion-patent-cliff-looms.html",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.32",
          "thread_title": "Good timing from SVNS",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=E3F96D91-4BC5-4C37-ACDF-ED876A113A88"
        },
        "ingested_at": "2026-01-21T01:47:03.590874Z"
      },
      {
        "event_id": "SOCIAL-7Jan20261506-wookieem--1262915",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.773995",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "Haha that maybe so MadEnglish,  but over the last few decades I\u2019ve heard that kind of optimism more times than I care to remember :) very few ever get there. Think if it was so certain this would be well over 1 or 2p by now. Either way I\u2019ve been making the most of cheaper prices and can only hope this comes as good as you think it will. As cautious as I might seem, believe that If this does do well, it\u2019ll do very very well.",
          "sentiment": 0.0,
          "engagement": "4,350",
          "price_at_post": "0.32",
          "thread_title": "RE: If only",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=58CEFFF4-E0B3-43F6-9B96-ECB1C43B54B6"
        },
        "ingested_at": "2026-01-21T01:47:03.590848Z"
      },
      {
        "event_id": "SOCIAL-7Jan20261521-Troajan--3880096",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.773575",
        "source": "LSE_CHAT",
        "data": {
          "author": "Troajan",
          "content": "Https://www.proactiveinvestors.co.uk/companies/news/1085276/solvonis-ceo-on-us-patent-win-and-ptsd-drug-progress-1085276.html",
          "sentiment": 0.0,
          "engagement": "125,338",
          "price_at_post": "0.32",
          "thread_title": "Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590821Z"
      },
      {
        "event_id": "SOCIAL-7Jan20261524-DrMicho--3816508",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.773083",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Nice, very nice indeed.... Looking ahead to Q1 2026, Tennyson highlighted the milestones investors should monitor, including completion of in-vivo work, confirmation of brain activity, narrowing the candidate set, and final lead selection. He described this as \u201ca key inflection point as the program transitions from discovery to IND enabling work.\u201d Beyond PTSD, Tennyson discussed broader pipeline progress across addiction and psychiatric indications. He said 2026 could be a catalyst-rich year, with advancement of clinical programs, potential partnering discussions, and continued progress within the company\u2019s discovery engine.",
          "sentiment": 0.5,
          "engagement": "8,146",
          "price_at_post": "0.32",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590795Z"
      },
      {
        "event_id": "SOCIAL-7Jan20262018-VikR-86331645",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.772655",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Everything this company is doing is amazing and the way they are diversifying and not standing still waiting for the lead addiction workflows to conclude is testament to the proactivity of the entire BOD. Every single newsflow going forward will be a catalyst but the absolute biggest catalyst will be the phase 2b permission by FDA following WuXis bridging work completion. As spravato  is already licensed, flying through the rest of the clinical trials will be a breeze for repurposed esketamine. \u2018During Q4 2025, preparatory work continued with WuXi AppTec on a pharmacokinetic bridging programme to support regulatory alignment. Initial data are expected in Q1 2026, with further progress through Q2 2026\u2019 When WuXI complete there work and SVNS RNS it, thats going to be a good day for the SP. With Professor Nutts stamp of approval and a well compiled case FDA approval will be a given. Load and hold these valuable shares for 2026/27/28. One of the best long term holds in the market",
          "sentiment": 0.5,
          "engagement": "930",
          "price_at_post": "0.32",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590767Z"
      },
      {
        "event_id": "SOCIAL-7Jan20262257-MadEngli--5921958",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.772221",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Great  post VikR, good to see you on GSCU also ! Should be a great year for both ATB ME",
          "sentiment": 0.0,
          "engagement": "712",
          "price_at_post": "0.32",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590741Z"
      },
      {
        "event_id": "SOCIAL-8Jan20260904-dvharris--4698855",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:58.771764",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Plenty of sells this morning, almost like we didn't have good news yesterday!\ud83d\ude10",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.305",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590715Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261000-Canary3-34503786",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.009856",
        "source": "LSE_CHAT",
        "data": {
          "author": "Canary3",
          "content": "18 million traded almost 7 Billion in existence... I can't do the percentage traded but it is quite tiny. It doesn't mean much IMO",
          "sentiment": 0.0,
          "engagement": "1,420",
          "price_at_post": "0.305",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590689Z"
      },
      {
        "event_id": "SOCIAL-8Jan20261006-LlamaFar-54713593",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.009440",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Re: Volume - yes, being moved about in a very tight range and scooped out sideways into someones account. IMO sit tight, wait for news and for their orders to be filled and then it goes.",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.305",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590663Z"
      },
      {
        "event_id": "SOCIAL-9Jan20260849-bonesgt--2888251",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.009018",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Someone still hoovering these up ,can sell 5mil No problem, news again next week, news rich time ,let's have it solvonis. Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.30",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590637Z"
      },
      {
        "event_id": "SOCIAL-9Jan20261241-ParetoPr--5878495",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.008605",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "\u201c18 million traded almost 7 Billion in existence...\u201c About 0.25%",
          "sentiment": 0.0,
          "engagement": "2,315",
          "price_at_post": "0.295",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590611Z"
      },
      {
        "event_id": "SOCIAL-9Jan20261748-covgaz-68427139",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.008192",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I have to apologise for the constant drip in the share price , that'll be down to me buying some last Monday.",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.29",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590584Z"
      },
      {
        "event_id": "SOCIAL-9Jan20261804-MadEngli-46226514",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.007777",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Did you get your shares ? Great price today, hopefully you loaded up... Will we hear news next week ? \ud83e\udd1e ATB ME",
          "sentiment": 0.0,
          "engagement": "712",
          "price_at_post": "0.29",
          "thread_title": "StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T01:47:03.590558Z"
      },
      {
        "event_id": "SOCIAL-10Jan20261232-turnthec-13705133",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.007357",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "I\u2019m starting to get tetchy to top up further on Monday if SVNS remains the same price. I\u2019m more than happy with my current holding but considering what could happen anytime now a further bite of the cherry would not go a miss.",
          "sentiment": 0.0,
          "engagement": "308",
          "price_at_post": "0.29",
          "thread_title": "RE: StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T01:47:03.590531Z"
      },
      {
        "event_id": "SOCIAL-10Jan20261453-Stay.cal--5431279",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.006933",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stay.calm",
          "content": "Hi MadEnglish, I have a small top every week in Solvonis as a rule. However on Monday and Wednesday this week I bought into another company that was recommended to me by a friend. I still hold all my Solvonis shares, but I put my top up money into MobilityOne Ltd (MBO) this week. My friend has a very large holding in MBO. He recommended it, and was still topping up himself this week. MBO rose 1200% in 4 days a week or so ago and has retraced a bit the last few days. My friend reckons it will go on a run again and could multi bag again from current price??? I'm not cross ramping, I'm not even sure if I've done the right thing, I may regret my decision next week. Next week I maybe thinking that it should have gone into SVNS as normal. I've not put too much into MBO, so if it goes pear shaped I've not lost much. My mate is adamant about it having another run after this consolidation. I hope no one has a go at me for my post. I'm not cross ramping, I was asked a question and gave an honest answer. I am 100% not recommending that people should invest into MBO....that's for them to decide. If I make money from MBO it will be going straight into here. I'm totally happy and excited with my SVNS investment....I'll be topping up as normal again from next week. I'm looking forward to news.",
          "sentiment": 0.0,
          "engagement": "278",
          "price_at_post": "0.29",
          "thread_title": "RE: StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T01:47:03.590504Z"
      },
      {
        "event_id": "SOCIAL-10Jan20261552-MadEngli-81639320",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.006520",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Hi S/C, your money, your choice, always D.Y.O.R ATB ME",
          "sentiment": 0.0,
          "engagement": "712",
          "price_at_post": "0.29",
          "thread_title": "RE: StayCalm",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=BAA65BD8-0389-4DF1-AA95-61E0018DE6F4"
        },
        "ingested_at": "2026-01-21T01:47:03.590476Z"
      },
      {
        "event_id": "SOCIAL-11Jan20261408-MG01-31744300",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.006092",
        "source": "LSE_CHAT",
        "data": {
          "author": "MG01",
          "content": "From Sky news today.  Distressing what the lad & family have gone thru'.  Will Svns drug pipeline help such victims? I think it will & supports my investment here which I'll increase when funds available. \"It wasn't until last year, four years after he unwillingly saw the disturbing video, that Frazer was diagnosed with complex Post\u2011Traumatic Stress Disorder, directly linked to what he saw at school.\"",
          "sentiment": 0.5,
          "engagement": "143",
          "price_at_post": "0.29",
          "thread_title": "RE: Solvonis interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=0040DF5D-FFCF-421F-AEE3-56ACD0D7FE7C"
        },
        "ingested_at": "2026-01-21T01:47:03.590432Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260858-TrickyEF--1191075",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.005679",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "On R&D, the professional services firm has urged drugmakers to redirect their pipelines toward urgent and undertreated diseases, bidding companies to \u201cmove beyond incremental improvements in crowded categories.\u201d PwC singled out reversing organ decline, curing genetic conditions and extending health lifespans as particularly enticing targets. To get there, the pharma industry should pool internal expertise with biotech \u201ctrailblazers,\u201d AI discovery platforms, venture incubators and academic institutions, PwC advised.",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.295",
          "thread_title": "Solvonis is so sexy right now",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B5B6FC43-C566-4F7C-9C34-5E72795F9CF1"
        },
        "ingested_at": "2026-01-21T01:47:03.590382Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260859-TrickyEF-25263771",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.005255",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Full article. Bring it on https://www.fiercebiotech.com/biotech/build-future-pharmas-must-embrace-ai-patient-experience-and-new-rd-frontiers-pwc",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.295",
          "thread_title": "RE: Solvonis is so sexy right now",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B5B6FC43-C566-4F7C-9C34-5E72795F9CF1"
        },
        "ingested_at": "2026-01-21T01:47:03.590335Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260921-TrickyEF-75372151",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.004822",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Back at it",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.295",
          "thread_title": "Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T01:47:03.590309Z"
      },
      {
        "event_id": "SOCIAL-12Jan20260937-bonesgt-29755471",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.004412",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Looking good Tricky. News anytime . Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.295",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T01:47:03.590283Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261000-dvharris-26223233",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.003988",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "My favourite colour! \ud83d\ude0d",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.30",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T01:47:03.590256Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261000-TrickyEF--5046150",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.003574",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "That tune from Rocky pops to mind. 'Gonna fly now'",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.30",
          "thread_title": "RE: Buys",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5338C5F9-F7EE-4E5C-921E-51623DE159D6"
        },
        "ingested_at": "2026-01-21T01:47:03.590230Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261001-TrickyEF--8116768",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.003154",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "To do what Solvonis has been doing since it's launch. Let get that licensing news.",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.30",
          "thread_title": "The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-21T01:47:03.590204Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261003-dvharris--8726595",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.002725",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pivotal Quarter for Solvonis....",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.30",
          "thread_title": "RE: The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-21T01:47:03.590176Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261017-LlamaFar-13523745",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.002310",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "JP Morgan week this week 12 - 15th ... Movers and Shakers back at desks next week ....",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.30",
          "thread_title": "RE: The industry is being urged",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=111C67AD-9A02-4488-9B7B-EA41939ED0D0"
        },
        "ingested_at": "2026-01-21T01:47:03.590150Z"
      },
      {
        "event_id": "SOCIAL-12Jan20261023-RhHh--3824880",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.001888",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Buys outstripping sells at the moment. Always good to see. Massive year for svns. I think this is the last of the bargain basement prices so if you want in then don't delay.",
          "sentiment": 0.5,
          "engagement": "317",
          "price_at_post": "0.30",
          "thread_title": "Buys v sells",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=269EC9EC-8229-4DB2-B529-CF1F39723135"
        },
        "ingested_at": "2026-01-21T01:47:03.590120Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260855-dvharris--3617431",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.001479",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A few decent buys and folks looking forward to the next piece of the jigsaw being put in place.....",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.305",
          "thread_title": "Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.590077Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260859-bonesgt--5029532",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.001049",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Looking  good Dv ,heading up to the next news ,which as we all know could be transformational. Gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.30",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.590050Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260909-RhHh--2910584",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.000633",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Lot of small trades but at least they are buys!",
          "sentiment": 0.0,
          "engagement": "317",
          "price_at_post": "0.305",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.590023Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260925-MrsRobin--4637650",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:55.000212",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "5m available when .32 tick up - now down to 1m",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.31",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.589997Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260929-MrsRobin--4597211",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:54.999765",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Not a lot of stock around - it seems 5m available when .33 tick up - now down to 2m",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.31",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.589970Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260933-dvharris-85032244",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.628556",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "We had a Seller who helped push the SP down from 0 4p to 0.23p. Hopefully those shares are in sticky hands as we push back up up to 0.4p, helped by the regular (positive) updates from the BoD...",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.589943Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260936-TrickyEF--5535948",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.628133",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Morning all. Well yesterdays buy to sells which was decent is being smashed today.",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.589917Z"
      },
      {
        "event_id": "SOCIAL-13Jan20260951-DrMicho--6109837",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.627700",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I agree, we should have never been anywhere near .23. Nevertheless, seller gone and we should be sitting at .4 on news and push up further from there depending on what gets released. How this is here is unbelievable\u2026",
          "sentiment": 0.5,
          "engagement": "8,146",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.589890Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261031-Andys288-48623357",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.627283",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Horses ready? \ud83d\udc0e\ud83d\udc34",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.32",
          "thread_title": "RE: Blue!",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F37D71D4-FFE9-4289-9B3F-2FFA336C9249"
        },
        "ingested_at": "2026-01-21T01:47:03.589863Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261045-MadEngli-32765712",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.626852",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "I'm not complaining,  I'm happy we're on the move again finally but I find myself a tad philosophical this morning  \ud83d\ude01 Why is it ( in life as well as stocks)  positive action never elicits an equal response to a negative one ? Can you imagine the market response to all that blue today being red ?  \ud83e\udd23 We'd be in the basement. ATB LTHs @ all ME",
          "sentiment": 0.0,
          "engagement": "712",
          "price_at_post": "0.32",
          "thread_title": "Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-21T01:47:03.589837Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261120-MrsRobin-36693771",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.626417",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "9m or so sells taken it back to around 12m available at  .32/.33",
          "sentiment": 0.0,
          "engagement": "185",
          "price_at_post": "0.32",
          "thread_title": "RE: Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-21T01:47:03.589809Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261724-TrickyEF--5993354",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.625973",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Well sellers clearly won today. Till tomorrow and beyond",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.31",
          "thread_title": "RE: Positive",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=41C3BBBE-62E0-45D4-8EC3-A0BB4D4886EC"
        },
        "ingested_at": "2026-01-21T01:47:03.589783Z"
      },
      {
        "event_id": "SOCIAL-13Jan20261739-Barnsley--7205093",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.625548",
        "source": "LSE_CHAT",
        "data": {
          "author": "BarnsleyBitter",
          "content": "Solvonis Therapeutics Bounce above a falling 50-day line combined with an RSI 50-plus rebound suggests a bull flag. Target: up to 0.46p by end of next month while above the 50-day (0.27p).",
          "sentiment": 0.0,
          "engagement": "551",
          "price_at_post": "0.31",
          "thread_title": "Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-21T01:47:03.589756Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261213-bonesgt--3378400",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.625109",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "What no chat come on guys ,you must have something to say . Come on svns, gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.305",
          "thread_title": "RE: Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-21T01:47:03.589729Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261259-LlamaFar--7025840",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.624683",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Dry January...",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.305",
          "thread_title": "RE: Zak Mir's view for what it's worth",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B63861B1-3581-4A8A-88DA-02246A95ED2C"
        },
        "ingested_at": "2026-01-21T01:47:03.589702Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261430-Opportun-90771971",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.624263",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "I asked Google AI for it's thoughts on the pending licensing deal for SVN-001 and received the below response: Based on Solvonis Therapeutics' current activities as of early 2026, the company is actively in discussions with four major pharmaceutical firms to out-license its lead program, SVN-001. Given the reported Phase 3 progress and strong Phase 2b data\u2014which showed an 86% abstinence rate at six months versus 2% pre-trial\u2014the likely deal structure and valuation are as follows: Likely Deal Structure: Global or Territorial Licensing With four major players in contention, Solvonis is positioned for a competitive licensing or commercial partnership deal. Commercialization Partnership: Solvonis has engaged specialist firm Pharma Ventures to shop SVN-001, typically signaling a search for a partner with a deep commercial footprint to handle the heavy lifting of a global launch while Solvonis retains some upside. Licensing Type: A global exclusive license is most common for a Phase 3 Central Nervous System (CNS) asset, where the partner manages late-stage regulatory filings and commercialization in exchange for upfront cash and future milestones. Alternative Structure: \"Ex-China\" or \"Regional\" deals (e.g., UK/EU vs. US rights) are possible to split risk, though the CEO's mention of four major firms suggests a broader global interest. Estimated Dollar Amounts Valuations for de-risked CNS assets in Phase 3 are currently commanding significant premiums due to high unmet needs in addiction and mental health. Total Deal Value: Solvonis leadership has explicitly pointed to peer company Gilgamesh, which out-licensed a lead program for a total price of $1.2 billion. Upfront Payment: For a Phase 3 asset with positive \"pivotal\" data, upfront payments typically range from $150 million to $700 million. For comparison, the Solvonis chair recently oversaw a deal for another company (IGI) that secured $700 million upfront within a $1.9 billion total package. Milestones and Royalties: Expect the remaining balance ($500M to $1B+) to be tied to regulatory approvals (FDA/EMA) and commercial sales targets, along with double-digit royalties on net sales. Key Drivers of Value Strong Clinical Data: Phase 2b results (50% reduction in heavy drinking days and 86% abstinence) are considered \"striking\" and \"smashing endpoints\" for the Alcohol Use Disorder (AUD) market. Market Opportunity: SVN-001 targets a population of ~40 million patients across the US, UK, and EU, where standard therapies currently see a 75% relapse rate. Regulatory Exclusivity: Solvonis is pursuing a hybrid application in the UK that could provide up to 10 years of market protection.",
          "sentiment": 0.5,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "AI's thoughts on SVN-001 licensing deal",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=E0E550A8-65DB-4217-8052-6C70F7E92DBC"
        },
        "ingested_at": "2026-01-21T01:47:03.589675Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261435-Opportun-28340200",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.623758",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "I then followed up by asking AI:  Given your above answer regarding the licensing deal for SVN-001, if the bridging data allows Solvonis to move SVN-002 into Phase 2B and Solvonis moves forward with a Nasdaq listing, where do you think the market cap of Solvonis is likely to be after that point?  Please also take into consideration the SVN-015 U.S. funding and the U.S. patent allowance for SVN-014. The response is below: If Solvonis Therapeutics successfully executes its 2026 milestones\u2014licensing SVN-001, advancing SVN-002 to Phase 2b, and achieving a Nasdaq listing\u2014the company\u2019s market capitalization would likely undergo a significant upward rerating from its current level of approximately \u00a319M\u2013\u00a320M ($24M\u2013$26M). Based on peer comparisons and the current status of its multi-asset pipeline, here is the projected market cap outlook: 1. Projected Market Cap Range: $300 Million \u2013 $700 Million+ Following a successful Nasdaq uplisting and a major licensing deal for SVN-001, Solvonis would likely shift from a \"micro-cap\" LSE listing to a mid-range clinical-stage biotech valuation. Asset-Specific Value: The SVN-001 deal alone, if aligned with the CEO\u2019s comparison to Gilgamesh\u2019s $1.2B deal, would provide a massive cash infusion and validation, often driving market caps to 0.5x\u20131x the total deal value depending on upfront cash. Nasdaq Premium: U.S.-listed CNS biotechs with Phase 2b/3 assets typically command significantly higher valuations than their LSE counterparts due to deeper liquidity and a larger pool of specialist institutional investors. 2. Strategic Value of SVN-002 and Bridging Data The successful establishment of a \"scientific bridge\" to Janssen\u2019s Spravato\u00ae in Q1/Q2 2026 is critical. Accelerated Pathway: By using the 505(b)(2) pathway, Solvonis can bypass Phase 1 and 2a trials, potentially saving tens of millions in development costs and years of time. Valuation Impact: Moving directly into a Phase 2b trial for a market of 15 million U.S. adults transforms SVN-002 from a theoretical asset into a near-term commercial prospect, adding substantial \"Net Present Value\" (NPV) to the company. 3. Impact of SVN-015 U.S. Funding (NIDA/NIH) Non-Dilutive Capital: SVN-015\u2019s acceptance into the NIDA Addiction Treatment Discovery Program provides free preclinical safety and efficacy testing. Future Grant Potential: Success in these initial studies allows Solvonis to compete for NIH grants of up to $3 million per year for five years ($15M total). This non-dilutive funding reduces the need for equity raises, preserving shareholder value and supporting a higher market cap. 4. SVN-014 U.S. Patent Allowance and PTSD Franchise IP Protection: The January 2026 patent allowance for the SVN-SDN-14 series provides \"composition of matter\" protection, which is the \"gold standard\" for biotech valuation.",
          "sentiment": 0.5,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T01:47:03.589649Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261436-Opportun-20681681",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.623265",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "Lead Candidate Selection: With lead selection expected in Q1 2026, the company transitions from a discovery-stage firm to a clinical-stage platform company with multiple distinct franchises (AUD, PTSD, and Stimulant Use Disorder). Summary Table: Valuation Drivers Catalyst \tImpact on Market Cap SVN-001 Licensing\tImmediate cash infusion and multi-hundred million dollar validation. SVN-002 Phase 2b\tMoves a second major asset into late-stage U.S. development via an accelerated pathway. Nasdaq Listing\tIncreases liquidity and attracts high-conviction U.S. institutional funds. SVN-014/015 Progress\tValidates the AI-discovery platform, adding \"pipeline-in-a-product\" value.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T01:47:03.589623Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261439-Opportun--5264468",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.622797",
        "source": "LSE_CHAT",
        "data": {
          "author": "Opportunities",
          "content": "All-in-all, things look very good considering that we know that Solvonis is already in talks with 4 pharma companies to license SVN-001, we know the bridging data is likely to come back good and allow SVN-002 to move into Phase 2B in the coming months and Solvonis has already stated that a Nasdaq listing is a major priority at some point. It seems that if the things that are very likely to occur happen, a 10-20x in market cap is a real possibility.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T01:47:03.589596Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261544-ComesMar--3529543",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.622380",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "What I really like here is not just the potential upside, but also the clear path that the BOD has designed, and the commitment of a person with the pedigree of Paul Carter.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T01:47:03.589569Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261555-TrickyEF-65514215",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.621939",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi Marcelino. Obviously Dennis and Nutt have high pedigree but Paul Carter is clearly of some top top pedigree and is not as visible as the other two. Massive part of the team. He previously held senior global roles including Executive Vice President and Chief Commercial Officer at Gilead Sciences, Inc. (NASDAQ: GILD), where he oversaw international operations across 38 markets and delivered annual revenues exceeding US$30 billion.",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T01:47:03.589542Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261601-LlamaFar-69072912",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.621502",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Usually with these small caps the BOD are substandard and are trying to promote assets that are often subpar, nothing about Solvonis is sub par! Paul Carter is interesting with his ex head of GSK China Hat on and 002 having a worldwide licence for China / Asia etc as well as his other attributes. Also in that he was part of the original Awakn team, the last one to rejoin after they listed it in the U.K.  ;) Dr Renata Crome is interesting  - The majority of Renata\u2019s pharmaceutical career was spent in early clinical development, initially as a Clinical Pharmacologist in the Cardiovascular Disease, Infectious Diseases, and Central Nervous System therapeutic areas.  As a Project Leader, she led project teams for Roche\u2019s key projects including the influenza drug oseltamivir, and oncology drugs bevacizumab and obinutuzumab. Renata\u2019s most recent role at Roche was as the Global Head of Early Development Clinical Operations and Deputy Head of Early Development. Prof David Nutt  - Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there.Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology. Add in Chairman Dennis Purcell and CEO Anthony Tennyson... The only weak link here is whoever's started selling yesterday?",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.305",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T01:47:03.589515Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261607-TrickyEF--3508581",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.621036",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi Lama. They can't all be barking up the wrong tree. They all believe in the destination and so far the NIH/NHS and FDA seem to also with funding most of it.",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.30",
          "thread_title": "RE: Potential Market Cap",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=3B01D30B-2064-478E-B179-3CC684233DF8"
        },
        "ingested_at": "2026-01-21T01:47:03.589489Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261628-LlamaFar-24277144",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.620600",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page Three types of trades showing up Sint , Xoff & Xlon... Someone's dragging it backwards ... Either they have a good idea of timing?? or are desperate to sell?",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.30",
          "thread_title": "Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-21T01:47:03.589462Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261634-LlamaFar-22676811",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.620169",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Look at all those tiny SINT trades messing around in and out, I wonder what they've been set up to achieve? XLON This is the official Market Identifier Code (MIC) for the London Stock Exchange main Regulated Market (the lit on-exchange order book). When you see XLON as the venue, the trade was executed on-exchange through the LSE's electronic order book in the normal, transparent, public way (continuous auction, opening/closing auctions etc.). XOFF This is a special \"generic\" MIC code meaning Off-Exchange (or OTC \u2014 Over-The-Counter) for instruments that are admitted to trading on a venue (usually a lit exchange like LSE). \u2192 Trade was not done on the actual exchange order book \u2192 Most commonly used for:  Negotiated trades / block trades reported to the LSE but executed bilaterally Trades with systematic internalisers (SIs) Pure OTC trades between two parties (market maker  client, institution  institution, etc.) Any off-book trade in a listed instrument SINT This is the special MIC code that means the trade was executed against a Systematic Internaliser (SI). \u2192 It is a subset of off-exchange trading \u2192 The counterparty was specifically operating as an SI (a firm that systematically executes client orders outside a trading venue using its own capital \u2014 think big banks/market makers like Citadel Securities, Jane Street, Flow Traders, Optiver, etc. when acting in SI mode) \u2192 Very often seen on UK/European retail flow and some institutional flow",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.30",
          "thread_title": "RE: Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-21T01:47:03.589435Z"
      },
      {
        "event_id": "SOCIAL-14Jan20261635-LlamaFar--3192614",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.619654",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "It must be lovely to trade if you are handed over direct market access and can set the prices on each of your trades?",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.295",
          "thread_title": "RE: Sint Trades Walking this back?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=66E6EEFB-B1D4-44FF-A964-AAB7A2E16EAC"
        },
        "ingested_at": "2026-01-21T01:47:03.589408Z"
      },
      {
        "event_id": "SOCIAL-15Jan20261140-DrMicho--4566328",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.619229",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Dropped a grand in just 2 days.. be back up soon enough, pub money and gamblers that want instant returns.., 15-Jan-26\t09:56:33\t0.2848\t3,137,628\tSell* 8,936 13-Jan-26\t09:22:45\t0.317\t3,137,628\tBuy* 9,946",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.295",
          "thread_title": "Just No Patience",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18B00745-62B4-497B-91B1-F4D2AA27ADF6"
        },
        "ingested_at": "2026-01-21T01:47:03.589381Z"
      },
      {
        "event_id": "SOCIAL-15Jan20261159-Andys288--4293071",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.618641",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Just need the weather to clear up and we are back at the races. \ud83d\udc0e\ud83d\udc34",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.295",
          "thread_title": "RE: Just No Patience",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18B00745-62B4-497B-91B1-F4D2AA27ADF6"
        },
        "ingested_at": "2026-01-21T01:47:03.589355Z"
      },
      {
        "event_id": "SOCIAL-15Jan20261217-LlamaFar-51188898",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.618207",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nothing likely to happen this week as decision makers will be busy. That said, Exeter, More Kare, Dr Celia Morgan has announced they have increased from 9 to 14 assistant psychologists to run the trial - that is a 56% increase in staffing levels.",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.295",
          "thread_title": "JP Morgan Week 12 - 15th Jan",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=88E510C6-7E44-4179-BBFB-F264FDF46534"
        },
        "ingested_at": "2026-01-21T01:47:03.589328Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261118-Andys288-62158601",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:52.617735",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Don\u2019t be shy, the big boys are back next week, so but cheap while you still can.",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.285",
          "thread_title": "FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-21T01:47:03.589300Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261121-Andys288-72868704",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.642058",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Buy not but obvs",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.285",
          "thread_title": "RE: FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-21T01:47:03.589273Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261133-bonesgt--2148946",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.641648",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Defo, I wouldn't leave this much longer ,news imminent, exciting to see where first leg takes us .gla",
          "sentiment": 0.5,
          "engagement": "1,564",
          "price_at_post": "0.285",
          "thread_title": "RE: FOMO",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2718DFB0-87B5-401F-8576-5128D7A04E03"
        },
        "ingested_at": "2026-01-21T01:47:03.589246Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261329-LlamaFar--2070975",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.641237",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Q1 Expected Newsflow on day 16/93. 1.Update on how many Pharmas in talks to outlicense SVN001. 2.Update on bridging data for SVN002 from Wuxi App Tec to enter Phase 2b. 3. Update on lead candidate for SVN014 PTSD 4.Update on USA Govt funded pre clinical in vitro trial for SVN015 Meth & Coke treatment. 5.Update on new findings from AI Engine running through the CNS Library - specifically have they investigated further the 2 x patents held by Awakn on MDMA? 6. Update on new Neurology Pipeline? 7.Recent Board visit / presentations in the U.S.A. future Nasdaq listing mooted - potential update? Lots of irons in the fire at Solvonis - interesting that the share price has dipped on sellers being  active but conversely that the S.P. hasn't cratered as they are all getting quietly bought up!",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.285",
          "thread_title": "Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589219Z"
      },
      {
        "event_id": "SOCIAL-16Jan20261332-LlamaFar-11926699",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.640782",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "16/90\ud83e\udd26",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589192Z"
      },
      {
        "event_id": "SOCIAL-19Jan20260953-Andys288--7755766",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.640373",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Happy Monday, looking forward to a great week here. Horses are fed and watered and ready for the races \ud83d\udc0e\ud83d\udc0e\ud83d\udc0e\ud83d\udc0e",
          "sentiment": 0.0,
          "engagement": "511",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589166Z"
      },
      {
        "event_id": "SOCIAL-19Jan20260959-RhHh-67304949",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.639953",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Encouraging that after the early chunky sell we're not down. Looking forward to the company updates.",
          "sentiment": 0.0,
          "engagement": "317",
          "price_at_post": "0.285",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589137Z"
      },
      {
        "event_id": "SOCIAL-19Jan20261948-covgaz-21638315",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.639543",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I'm looking for some inspiration here , in at 32+ only 8 days ago. Is this going to 23?",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589087Z"
      },
      {
        "event_id": "SOCIAL-19Jan20262100-ComesMar--3930857",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.639127",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I would be surprised if it drops that much. We are waiting for news, but some have no patience.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589060Z"
      },
      {
        "event_id": "SOCIAL-19Jan20262102-covgaz--6540441",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.638713",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I was expecting 60p by today ...",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589033Z"
      },
      {
        "event_id": "SOCIAL-19Jan20262151-LlamaFar--9104132",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.638304",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 19 of 90 in Quarter 1, not even 25% of the way through... Covgas you posted on the 9th you bought on the previous Monday i.e., 5/01/26? Then posted that you bought in at 0.32p 8 days ago? And were expecting 60p today \ud83e\udd23\ud83e\udd23\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.589007Z"
      },
      {
        "event_id": "SOCIAL-19Jan20262228-covgaz-58403052",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.637875",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "I was avin a larf Llama , lighten up fella!",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.588980Z"
      },
      {
        "event_id": "SOCIAL-20Jan20260516-ComesMar-83145277",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.637465",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I asked AI to analyse yesterday trading dynamics in the same way llamafarmer did few days ago. Below is the response: SVNS: Technical Analysis of 19-Jan Trading Session & Venue Dynamics Following the recent consolidation to 0.275p, a forensic look at the tape from yesterday (Monday, Jan 19) provides a clearer picture of the price action. While the mid-price appeared to weaken, the volume distribution across different venues suggests a \"mechanical\" rather than \"organic\" drop. 1. Venue Volume Breakdown Total volume for the session was approximately 19.6M shares, split across three primary execution venues: SINT (Systematic Internaliser): ~11.1M shares. This represented over 56% of the day's activity. As a reminder, SINT trades occur when a Market Maker (MM) executes against their own inventory (\"book\"). XLON (Standard LSE Order Book): ~6.5M shares. This is the \"lit\" market where transparent buy/sell orders meet. XOFF (Off-Exchange): ~2.0M shares. Private block trades reported to the exchange post-execution. 2. Identifying the \"Mechanical\" Fade The move from 0.29p down to 0.275p was characterized by a high frequency of \"micro-trades\" on the SINT code. We observed numerous sell prints of negligible size (often under \u00a35.00 in value). Technical Interpretation: These tiny SINT prints are typically used by automated market-making algorithms to \"walk back\" the mid-price during periods of low retail demand. Because the MM is trading against their own book, they can print these lower prices to manage their inventory risk without requiring a large volume of actual sellers. 3. The Bullish Divergence in XLON/XOFF Interestingly, while the SINT volume was skewed toward \"Sells,\" the XLON (Open Market) and XOFF (Off-Book) data showed a different trend: Organic Support: On the actual LSE order book (XLON), the \"Buy\" volume actually outpaced the \"Sell\" volume by a notable margin. Accumulation Signature: The 2M shares traded XOFF suggest that institutional or \"high-conviction\" hands were picking up blocks quietly while the SINT bots were painting the tape red. 4. Summary & Q1 Outlook The \"drop\" yesterday appears to be a Liquidity Trap. By suppressing the mid-price via SINT trades, the market has successfully triggered stop-losses and shaken out short-term momentum players. However, the fundamentals remain unchanged as we move further into Quarter 1. With the WuXi bridging data for SVN-002 and lead candidate selection for the PTSD program still pending, the current price action looks like a classic \"pre-catalyst shakeout.\" Conclusion: Look past the mid-price. The real story is in the XOFF accumulation and the lack of high-volume selling on the XLON exchange.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.588953Z"
      },
      {
        "event_id": "SOCIAL-20Jan20260738-LlamaFar--7418013",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.636971",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ComesMarcellino - that's really interesting - thanks for that.",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.588926Z"
      },
      {
        "event_id": "SOCIAL-20Jan20260828-LlamaFar--6351034",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.636563",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "You can pretty much see which way we are being pulled by running through the trades on the official LSE trade page. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page Looking around at other stocks where large holders are building positions there does seem to be a familiar pattern, would assume that changes on either news or completion of position? I'm taking it as a positive as if you didn't want to side sweep the stock - why would you bother?",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.275",
          "thread_title": "RE: Q1 Updates ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=11238425-1919-460F-A669-0316DB995746"
        },
        "ingested_at": "2026-01-21T01:47:03.588900Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261032-LlamaFar-38080686",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.636132",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Q1 Expected Newsflow. 1.Update on how many Pharmas in talks to outlicense SVN001. 2.Update on bridging data for SVN002 from Wuxi App Tec to enter Phase 2b. 3. Update on lead candidate for SVN014 PTSD 4.Update on USA Govt funded pre clinical in vitro trial for SVN015 Meth & Coke treatment. 5.Update on new findings from AI Engine running through the CNS Library - specifically have they investigated further the 2 x patents held by Awakn on MDMA? 6. Update on new Neurology Pipeline? 7.Recent Board visit / presentations in the U.S.A. future Nasdaq listing mooted - potential update? Lots of irons in the fire at Solvonis - interesting that the share price has dipped on sellers being active but conversely that the S.P. hasn't cratered as they are all getting quietly bought up!",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.27",
          "thread_title": "Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T01:47:03.588873Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261205-ComesMar-58474608",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.635608",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I asked AI once again about today price action, specifically requesting to cross check with the morning narrative. Below is the response. SVNS: Technical Analysis of the 3-Day Compression & Volume Exhaustion \u200bAnalysis: The current price action in SVNS appears to be following a defined Three-Day Exhaustion Cycle on the XLON venue, likely signifying the final stages of a strategic supply overhang. \u200b1. Volume Profile vs. Price Drift: Over the last 72 hours, we have seen a consistent downward tick. However, today\u2019s intraday tape shows a notable divergence: Increasing unit volume on decreasing trade frequency. The appearance of concentrated 1m and 2m blocks on XLON hitting the bid is indicative of a \"Principal Trade\" or a managed \"Leak-Out.\" In these scenarios, a larger institutional holder is fulfilling a quota at a fixed price floor, rather than multiple retail actors selling out of panic. \u200b2. Support Level Validation: The 0.26p \u2013 0.27p range aligns with the historical consolidation base observed in late 2025. The fact that the bid is absorbing multi-million share blocks at this level without a breakdown suggests a significant counter-party buy-side interest is currently neutralizing the seller's pressure. \u200b3. Technical Indicators: \u200bOscillators: Intraday RSI is approaching \"Oversold\" territory, which often serves as a precursor to a \"snap-back\" rally toward the 50-day moving average (currently approx. 0.273p). \u200bTape Reading: Today\u2019s \"Red\" prints are likely part of a \"Deck Clearing\" exercise. In a low-float environment, the removal of a dominant seller typically creates a liquidity vacuum, allowing the price to re-rate rapidly once the overhead supply is exhausted. \u200bConclusion: The current activity represents a high-volume Transfer of Ownership at a technical floor. We are watching for stabilization in the closing auction as a confirmation that the selling cycle has completed ahead of anticipated Q1 operational updates.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.27",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T01:47:03.588846Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261212-LlamaFar-41779490",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.635145",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ComesMarcellino - add in to that you could sell just over 35m earlier, then the MM's were bouncing to 5,8,18m as they ran it up and down looking for parcels at 0.26p zone and it all ties in nicely. News can't be long?",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.27",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T01:47:03.588819Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261539-dvharris-51859158",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.634715",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Defo need news for as interesting as the AI analysis is the more sells than buys will push the SP down as we've seen. I also think markets generally are in for a bumpy ride for the foreseeable future with Trump's antics and worldwide uncertainty..\ud83e\udd14 I'm now down to just the 2 small cap shares after a broader review of my investments.",
          "sentiment": 0.5,
          "engagement": "20,982",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T01:47:03.588793Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar--8149380",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.634286",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "848",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-21T01:47:03.588766Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF--6622474",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.633851",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,029",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T01:47:03.588738Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--9172883",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.633435",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T01:47:03.588711Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar--8224370",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.633006",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T01:47:03.588684Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb-36510568",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.632555",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "5",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T01:47:03.588657Z"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar-39043574",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.632134",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T01:47:03.588627Z"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz--3820806",
        "event_type": "social_post",
        "date": "2026-01-21T01:46:47.631694",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,496",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-21T01:47:03.588595Z"
      },
      {
        "event_id": "SOCIAL-30Dec20250837-dvharris-53224232",
        "event_type": "social_post",
        "date": "2026-01-10T02:51:29.186136",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Another 5M buy early doors.....",
          "sentiment": 0.5,
          "engagement": "20,946",
          "price_at_post": "0.28",
          "thread_title": "RE: Someone's got some spare Xmas cash",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=49E39ADA-EB40-41E3-B400-0B9AABEB5F1E"
        },
        "ingested_at": "2026-01-21T01:47:03.594068Z"
      },
      {
        "event_id": "SOCIAL-30Dec20250844-bonesgt-57572568",
        "event_type": "social_post",
        "date": "2026-01-10T02:51:29.185703",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Dv looking better than it has in a while , .3's looking possible.  Gla",
          "sentiment": 0.5,
          "engagement": "1,560",
          "price_at_post": "0.27",
          "thread_title": "RE: Someone's got some spare Xmas cash",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=49E39ADA-EB40-41E3-B400-0B9AABEB5F1E"
        },
        "ingested_at": "2026-01-21T01:47:03.594042Z"
      },
      {
        "event_id": "SOCIAL-30Dec20251013-TrickyEF--6540755",
        "event_type": "social_post",
        "date": "2026-01-10T02:51:29.185284",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "When it want too",
          "sentiment": 0.0,
          "engagement": "15,997",
          "price_at_post": "0.29",
          "thread_title": "Moves fast",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D71239DB-557C-463B-9656-F72BDCE73FCB"
        },
        "ingested_at": "2026-01-21T01:47:03.594015Z"
      },
      {
        "event_id": "SOCIAL-30Dec20251015-dvharris-49430125",
        "event_type": "social_post",
        "date": "2026-01-10T02:51:29.184757",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Multibag opportunity from here this year....",
          "sentiment": 0.0,
          "engagement": "20,946",
          "price_at_post": "0.29",
          "thread_title": "RE: Moves fast",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D71239DB-557C-463B-9656-F72BDCE73FCB"
        },
        "ingested_at": "2026-01-21T01:47:03.593988Z"
      },
      {
        "event_id": "SOCIAL-30Dec20251038-Andys288--6672569",
        "event_type": "social_post",
        "date": "2026-01-10T02:51:29.184325",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Back into the 3s very soon, then onto the fours and fives",
          "sentiment": 0.0,
          "engagement": "499",
          "price_at_post": "0.29",
          "thread_title": "RE: Moves fast",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D71239DB-557C-463B-9656-F72BDCE73FCB"
        },
        "ingested_at": "2026-01-21T01:47:03.593839Z"
      },
      {
        "event_id": "SOCIAL-30Dec20251049-LlamaFar--8626301",
        "event_type": "social_post",
        "date": "2026-01-10T02:51:29.183884",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "GGP has had a stellar rise, metals just come off the boil ( with some manipulation imo )  the main supporting small cap analyst has a position here and there, would imagine others follow his lead? Solvonis has had a decent amount of publicity so people will know what it has planned for 2026 etc.",
          "sentiment": 0.0,
          "engagement": "810",
          "price_at_post": "0.29",
          "thread_title": "RE: Moves fast",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D71239DB-557C-463B-9656-F72BDCE73FCB"
        },
        "ingested_at": "2026-01-21T01:47:03.593811Z"
      },
      {
        "event_id": "SOCIAL-23Jan20261725-MadEngli-56926384",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.233592",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Next week Rodney...\ud83d\ude01 ATB",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.28",
          "thread_title": "This time...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=784600CF-6EA6-48B9-8E3B-25B205222B70"
        },
        "ingested_at": "2026-01-24T02:08:53.250923+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261122-Stretcht-21745829",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234032",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Time to test those recent highs and have some positive news hitting the wires.",
          "sentiment": 0.0,
          "engagement": "195",
          "price_at_post": "0.28",
          "thread_title": "RE: 24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-01-24T02:08:53.250960+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261107-EpicViru--9184975",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234477",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Let's keep this countdown ticking. GLA \ud83d\udc0e Time to run the race",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.28",
          "thread_title": "24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-01-24T02:08:53.250998+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261047-dvharris--6295923",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234903",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Nice to see some upward movement ahead of expected newsflow this quarter......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.28",
          "thread_title": "RE: FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-01-24T02:08:53.251017+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261031-Andys288--4498478",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Strong support today, and I wouldn\u2019t want to be out over the weekend with all the expected news,",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-01-24T02:08:53.251036+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261836-MadEngli--3029909",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235739",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-01-24T02:08:53.251054+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261521-Andys288-89109735",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236157",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-24T02:08:53.251072+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261219-LlamaFar-45382099",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236578",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-24T02:08:53.251090+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261122-dvharris--7546872",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236990",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-24T02:08:53.251133+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260924-EpicViru--8803656",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237415",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-24T02:08:53.251151+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260826-dvharris--4117637",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237828",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-24T02:08:53.251169+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260732-EpicViru--5234609",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238254",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-24T02:08:53.251186+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF--2240738",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238671",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-24T02:08:53.251204+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb-22419442",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239142",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-24T02:08:53.251222+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris--6680557",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239562",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-24T02:08:53.251240+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar-37127897",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239967",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-24T02:08:53.251258+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh--8915315",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240392",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-24T02:08:53.251277+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar-59473704",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-24T02:08:53.251296+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz-36596758",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241235",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,499",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-24T02:08:53.251314+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar--6867966",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241643",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-24T02:08:53.251333+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb--4096227",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242059",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-24T02:08:53.251352+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar--4706273",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242517",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-24T02:08:53.251371+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--6892779",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242929",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-24T02:08:53.251389+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF--7238079",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243353",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-24T02:08:53.251407+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar--1946036",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243772",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-24T02:08:53.251426+00:00"
      },
      {
        "event_id": "RNS-28th Jan 2026-expansio",
        "event_type": "rns_announcement",
        "date": "2026-01-29T10:41:15.223816+00:00",
        "source": "LSE_RNS",
        "data": {
          "title": "Expansion of SVN-015 into depression",
          "category": "RNS",
          "url": "https://www.lse.co.uk/rns/SVNS/expansion-of-svn-015-into-depression-tyyilt2cisyp4w4.html",
          "rns_number": "RNS Number : 5931Q",
          "full_content": "28 Jan 2026 07:00\nRNS Number : 5931Q\nSolvonis Therapeutics PLC\n28 January 2026\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n28 January 2026\nSolvonis Therapeutics plc(\"Solvonis\" or the \"Company\")\nExpansion of SVN-015 into depression following positive preclinical data\nDemonstrates antidepressant-like activity benchmarked against fluoxetine (Prozac\u00ae), supporting potential in patients with inadequate SSRI response\nSolvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (\"CNS\") disorders, announces the expansion of its investigational compound SVN-015 into the treatment of\ndepression\n, supported by preclinical data demonstrating antidepressant-like activity benchmarked against fluoxetine.\nKey highlights:\n\u00b7\nSVN-015 expanded into depression following positive preclinical data in validated rodent behavioural models\n\u00b7\nAntidepressant-like activity benchmarked against fluoxetine after 14-day, once-daily dosing\n\u00b7\nSVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor (\"SDRI\") designed to engage pathways central to mood, motivation and reward processing\n\u00b7\nSupports potential in patients with inadequate response to SSRIs in depression, including symptoms such as anhedonia and reduced motivation\n\u00b7\nSVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles\nIn a direct preclinical evaluation, SVN-015 demonstrated antidepressant-like activity comparable to fluoxetine following 14-day, once-daily dosing in validated rodent behavioural models widely used to assess antidepressant activity. Fluoxetine, a selective serotonin reuptake inhibitor (\"SSRI\"), is one of the most established benchmark compounds in antidepressant drug development.\nSVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor (\"SDRI\"), with patent applications filed, designed to engage pathways central to mood regulation, motivation, and reward processing. Despite widespread SSRI use, many patients fail to achieve adequate symptom control, particularly for symptoms such as anhedonia (feeling emotionally flat), reduced motivation, and impaired reward function. According to the U.S. National Institute of Mental Health (NIMH), Major Depressive Disorder (\"MDD\") affects more than 20 million adults in the United States annually, and tens of millions more across major international markets, including Europe and Japan.\nSVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, intended to support continuous symptom management within standard antidepressant treatment cycles. Its delivery model and reimbursement pathway are intended to align with established SSRI therapies, with potential advantages in scalability, patient access and long-term adherence.\nAs previously announced, SVN-015 has also been independently selected for evaluation within the U.S. National Institute on Drug Abuse (\"NIDA\") Addiction Treatment Discovery Program for stimulant use disorders, providing external, non-dilutive validation of the compound's pharmacological profile in a separate CNS indication. This programme is separate from Solvonis' research on depression.\nAnthony Tennyson, Chief Executive Officer, commented:\n\"\nDemonstrating antidepressant-like activity versus a gold-standard SSRI following repeat dosing is a notable preclinical signal, supporting SVN-015's expansion into research and development of small molecule therapies for depression.\"\nProfessor David Nutt, Chief Scientific Officer, added:\n\"These data are highly encouraging and reflect a mechanistically grounded approach engaging both serotonergic and dopaminergic systems. Demonstrating antidepressant-like effects under repeat-dose conditions supports further development of SVN-015 and the broader SDRI class as a potential new class of antidepressant medicines.\"\nEnquiries:\nSolvonis Therapeutics plc\nVia Walbrook\nAnthony Tennyson, CEO & Executive Director\nSinger Capital Markets\n(Broker)\n+44 (0) 20 7496 3000\nPhil Davies\nWalbrook PR (PR/IR advisers)\nTel: +44 (0)20 7933 8780 or\nsolvonistherapeutics@walbrookpr.com\nAnna Dunphy\nMob: +44 (0)7876 741 001\nLianne Applegarth\nMob:\n+44 (0)7584 391 303\nRachel Broad\nMob:\u00a0+44 (0)7747 515 393\nAbout Solvonis Therapeutics plc\nSolvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (CNS) disorders. Headquartered in London and listed on the main market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds across addiction and psy",
          "content_length": 6975
        },
        "ingested_at": "2026-01-29T10:41:15.223862+00:00"
      },
      {
        "event_id": "SOCIAL-Today1034-dvharris-46013337",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.348543",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-29T10:41:29.585775+00:00"
      },
      {
        "event_id": "SOCIAL-Today0909-LlamaFar--3350391",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349238",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-01-29T10:41:29.585820+00:00"
      },
      {
        "event_id": "SOCIAL-Today0837-dvharris--4776008",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349995",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-29T10:41:29.585856+00:00"
      },
      {
        "event_id": "SOCIAL-Today0819-LlamaFar-39945525",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.350809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-29T10:41:29.585889+00:00"
      },
      {
        "event_id": "SOCIAL-Today0815-LlamaFar--2362682",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.351641",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-29T10:41:29.585922+00:00"
      },
      {
        "event_id": "SOCIAL-Today0010-TrickyEF-70543525",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.352511",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-01-29T10:41:29.585959+00:00"
      },
      {
        "event_id": "SOCIAL-Today0005-TrickyEF-86962106",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.353336",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-01-29T10:41:29.585994+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262015-TrickyEF--5575595",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354159",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "For use at home on a daily basis. This was an attractive investment 12 months ago now it's looking fooking beautiful. Fingers crossed it don't turn into a munter.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-01-29T10:41:29.586046+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262006-TrickyEF--8188011",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354968",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "The OTF delivery system could turn out to be a goldmine. What's next?? Solvonis said SVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles, and noted the compound has also been selected for evaluation in the US National Institute on Drug Abuse Addiction Treatment Discovery Program for stimulant use disorders. Solvonis Therapeutics plc (LON: SVNS), (\"Solvonis\" or the \"Company\") an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that Awakn Life Sciences Corp. (\"Awakn\"), the company Solvonis plans to acquire, has reached a significant regulatory milestone. Awakn announced a positive outcome from a Pre-Investigational New Drug (\"Pre-IND\") meeting with the U.S. Food and Drug Administration (\"FDA\") regarding AWKN-002, a proprietary oral thin film (\"OTF\") formulation of esketamine, designed for sublingual and buccal administration in combination with structured alcohol education. This drug candidate is being developed for the treatment of moderate to severe alcohol use disorder (\"AUD\") with a focus on U.S market",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-01-29T10:41:29.586069+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261933-MadEngli--2996074",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.355775",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "LHogbog, just keep holding, this is going to blow the bl00dy doors off one day.  When this gets picked up, JVd, bought out, it'll be by a big player and you'll be so happy you were in @ .3p. ATB ME",
          "sentiment": 0.0,
          "engagement": "721",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-01-29T10:41:29.586091+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261907-Hogbog-19130364",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.356560",
        "source": "LSE_CHAT",
        "data": {
          "author": "Hogbog",
          "content": "In various forms it is forever on social media, but what I\u2019m keen to know if when my two large holdings both in the 3s will actually make a profit.",
          "sentiment": 0.0,
          "engagement": "892",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-01-29T10:41:29.586140+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261903-VikR--7597906",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.357390",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Https://www.linkedin.com/posts/jonathanmichaelholmes_this-novel-antidepressant-targets-more-than-activity- Just noted on linkedIN a motivated investor speaking highly of the pipeline. The story here just keeps more compelling with each new discovery. SSRIs are prescribed in the million &  millions and the anxiety and depression market is multi billion. Everything SVNS targets are huge addressable markets. Once the newsflow starts here it won\u2019t stop. I understand the frustration of shareholders who are getting bored with a stagnant share price but this team is not in it for a small slice of the pie, they want to hit it big. There has to be, absolutely has to be strong interest from mainstream pharma willing to put the funds to progress the projects further. I just wait for the day the blessed RNS lands. 7422302011582484482-UjTC?utm_medium=ios_app&rcm=ACoAAErGYQIB6gTMGcSk4EsXpWwMe6tdaF1kU5E&utm_source=social_share_send&utm_campaign=copy_link",
          "sentiment": 0.5,
          "engagement": "981",
          "price_at_post": "0.265",
          "thread_title": "Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-01-29T10:41:29.586159+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261827-TrickyEF--7090837",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.358233",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I for one hope to be still holding these come  2028/2029 and have a massive \ud83d\ude01\ud83d\ude01\ud83d\ude01 on my face. 8months old and with  just \u00a32.25 million of funding the AI of Solvonis has already popped out svn15 which is in the running for $15 million of NIH funding based on early data in relation too meth and coke addiction. This NIH support was provided before they even new about the potential for depression. No wonder the AI fund raised was covered by just 3 individuals. For \u00a32.25 million down they possibly realised  \u00a310.8 million in NIH funding. Given today's news the odds would have shortened on securing that funding. FANTASTIC new science being delivered here.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-01-29T10:41:29.586194+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261810-TrickyEF--2163683",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359029",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "At around the 3min 45 second mark. Early days but WOW.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-01-29T10:41:29.586215+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261649-DrMicho-85953196",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359813",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Hopefully the smell of the seller will vanish soon enough. Waiting for buys to squeeze that little extra so must be desperate for the money. That desperation will   help move it on\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586245+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261546-LlamaFar-30346246",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.360501",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope ... cant sell, can buy",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586268+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261520-ComesMar--6406217",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.361160",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think it just appeared ,  10m",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586295+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261515-LlamaFar-25531229",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362046",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Sellers still hanging about, waiting for a large odd amount trade to show... that's the way I've seen these end before.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586324+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261504-dvharris--3757956",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362765",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Wouldn't it be nice if the latest 10M trade was the last of our sellers holding!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586350+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261400-DrMicho-28499532",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363274",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes me too DV...it would be nice to see some grants/funding to prevent any further need for funding/placings.. but the biggy is going to be a partnership or licensing deal. This would go bonkers, absolute crazy when it happens. Taking into consideration we have a fair amount of irons in the fire it surely cant be that far away.",
          "sentiment": 0.5,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586378+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261357-LlamaFar--2014430",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363733",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The further the pipelines move down the track, the bigger the numbers, i'm not rushed for answers at the moment. 015a Meth & Coke and 015b Depression are both new news, the pipelines are being widened and getting longer as they are progressed. Sit tight and add each time someone else is forced into selling, the lower the better imo.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586404+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261343-dvharris--3482099",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364170",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'm waiting for the outcome of the discussions with the big pharmas that have been ongoing for a while now....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586434+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261303-dafad-15029210",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364584",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Soon I think-usually a proactive interview would be out by now-lack of anything leads me to think nore news soon",
          "sentiment": 0.0,
          "engagement": "2,397",
          "price_at_post": "0.265",
          "thread_title": "More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-29T10:41:29.586457+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261215-LlamaFar-59529495",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365003",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - sit tight and wait for the bargains. If they have to sell cheaply the price will be dropping?",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-29T10:41:29.586487+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261205-ComesMar-46189571",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365476",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "According to Gemini, these are probably Canadian investors or institutions, with the clear mandate to quit. There is nothing to do other than wait that they are done with selling.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-29T10:41:29.586518+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261156-dvharris--8197121",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691006",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think you are right Llama, but the seller does seem to want to dispose of an awful lot of shares....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-29T10:41:29.586547+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261140-cinderco-70931296",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691680",
        "source": "LSE_CHAT",
        "data": {
          "author": "cindercone",
          "content": "Yep, some individual is selling into every rise. How much longer is anyone's guess as not a lot of liquidity here.",
          "sentiment": 0.0,
          "engagement": "2,102",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-29T10:41:29.586570+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261120-LlamaFar-47429992",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692318",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "There's obviously a large seller about - they must be in a forced sale position as you wouldn't be selling otherwise on this mornings news. Once the seller dries up, my opinion is it rockets.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-29T10:41:29.586601+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261119-dvharris--3537496",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692922",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, didn't think I'd be on the verge of meeting desmond again!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-29T10:41:29.586622+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261118-LlamaFar-24992040",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.693581",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "3.50mins - \"All depressives\" All depressives\" refers to the broad spectrum of clinical, chronic, and situational mental health conditions characterized by persistent low mood, loss of interest, and decreased energy. Psychiatrists often view depression as a range of experiences rather than one single disease, spanning from mild, temporary, to severe. Here is a breakdown of the various types of depression based on recognized diagnostic criteria (DSM-5): Primary Types of Depressive Disorders Major Depressive Disorder (MDD) / Clinical Depression: The most common form, involving severe symptoms\u2014such as intense sadness, hopelessness, or loss of interest\u2014that last for at least two weeks and interfere with daily life. Persistent Depressive Disorder (PDD) / Dysthymia: A chronic, low-grade, or moderate depression that lasts for two years or more. Bipolar Disorder (Manic Depression): While not exclusively a depressive disorder, this involves alternating episodes of depression and high-energy mania or hypomania. Premenstrual Dysphoric Disorder (PMDD): A severe form of PMS causing extreme irritability, anxiety, or depression in the week before a period. Disruptive Mood Dysregulation Disorder (DMDD): A childhood condition characterized by extreme irritability and intense anger outbursts.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-29T10:41:29.586655+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261115-DrMicho--6134823",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694200",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Absolutely amazed that we are worse off after a positive update.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-29T10:41:29.586675+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261113-LlamaFar-54970203",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694808",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.youtube.com/watch?v=ZLhyKGvWypg At 1.50m GAME ON!!!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-29T10:41:29.586710+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261059-Bill999-48141295",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.695431",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bill999",
          "content": "Good video out on Proactive today with David Nutt.",
          "sentiment": 0.0,
          "engagement": "3",
          "price_at_post": "0.265",
          "thread_title": "Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-29T10:41:29.586730+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261055-dvharris-77760371",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696024",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very funny!\ud83d\ude01",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.26",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586765+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261029-bonesgt--5662208",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696635",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Going to stick my neck out ,think we will finish up today. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586785+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261027-dvharris-30482132",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697256",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "And we're red!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586813+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261022-bonesgt-79768512",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697855",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Was that an 8m buy disguised as a sell . Is that our buyer mopping up. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586839+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260908-ComesMar-37632977",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.698463",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "There could be tons of reasons why selling despite good news and expected catalysts. This is a gift for the ones believing in the story and with available cash.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586866+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260858-DrMicho-54664375",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699053",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our 5M buyer early on has took a 1500 quid hit. The thing that is going to move this properly is a licensing deal/large funding/partnership news. All of this could happen imminently, US listing, results take time.. still hopeful of something dropping that will shift this selling trend.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586893+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260856-TheDealB-16183576",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699614",
        "source": "LSE_CHAT",
        "data": {
          "author": "TheDealBreaker",
          "content": "The bigger question is not who is selling but why?  Why sell on good news and the potential of more good news? They are clearly not moving shares into an ISA as there are no corresponding buys. Thanks",
          "sentiment": 0.0,
          "engagement": "304",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586918+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260847-RhHh--6609010",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700037",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I thought the seller was finished ages ago! Who is it?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586946+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260842-bonesgt-62989009",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700480",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "This is nuts ,what will it take. Who is the seller? Can't have many left surely.",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586968+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260838-dvharris-58770287",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700904",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pow,  5M number 3! Not another red day after yet another positive update surely?",
          "sentiment": 0.0,
          "engagement": "21,054",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.586999+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260836-RhHh-88364508",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.701462",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I hate that damn seller! Be a red finish at this rate ffs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587018+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260816-dvharris--3238959",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702149",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like the 5M seller is up early. Oh well......",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587053+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260815-RhHh--6204900",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702662",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Tq",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587073+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260811-LlamaFar-13890294",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703082",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Get a broker and buy on the pre market - hence the premium.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587119+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260805-EpicViru--8675068",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703515",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "You can place an order to be executed",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587141+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260804-RhHh-64764712",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703931",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "How can you buy before the open?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587171+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260802-dvharris--3802837",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.704377",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "With the number of darts we're throwing at the board one is going to hit the bullseye!\ud83c\udfaf",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.29",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587197+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260755-DaffyPic--8305725",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558067",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice and early. 07:54:38\t0.295\t5,000,000\t14.75k",
          "sentiment": 0.0,
          "engagement": "3,575",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587227+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260740-Scoutt--2609334",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558633",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "Diversification always good in binary developments, shaping up to be a wonder treatment, if it goes half as well as I\u2019m expecting we will be a penny share by mid year.  Substance mis-use, PTSD, Depression, if we can use it for Anxiety we can shout Bingo.",
          "sentiment": 0.0,
          "engagement": "975",
          "price_at_post": "0.27",
          "thread_title": "Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-29T10:41:29.587251+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260724-Stretcht-27515111",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559180",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Good news, let\u2019s see how that is received.",
          "sentiment": 0.0,
          "engagement": "207",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-01-29T10:41:29.587279+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260711-Andys288-63190751",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559701",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019m feeling a bit blue today, if only there was a new treatment for depression\u2026.. #hellofreddy",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-01-29T10:41:29.587305+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260706-EpicViru-58814941",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560283",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Here we go hold onto your seats. An hour before the floodgates open.",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-01-29T10:41:29.587330+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261602-bonesgt-74640025",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560797",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Flat or up a point today, be nice all in all we're still on track. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587359+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261147-TrickyEF--1991150",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561345",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice bones. May join ya and the Dr with a purchase this week.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587382+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261141-bonesgt-91420087",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561848",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Never  mind Tricky I've just bought another 1 mil and again another 170k . Nothings changed on coarse for licencing,  among other great things we are working on. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587413+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261139-RhHh-16931054",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562370",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Looks like the sells are being mopped up. Might even be a flat close. Not long to wait for news.",
          "sentiment": 0.5,
          "engagement": "324",
          "price_at_post": "0.255",
          "thread_title": "Buyers coming in",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18FDEE2C-AFBF-4A99-A347-D1CDEDF15437"
        },
        "ingested_at": "2026-01-29T10:41:29.587434+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261137-covgaz-51180936",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562870",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "If it hits 23 will I be correct?",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587466+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261134-TrickyEF-26754791",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.563524",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "If something is the same as it was there is no change. It looks the same to me as it did on the 20th. Not pretty not ugly the same. Same same.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587487+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261129-TrickyEF-86654262",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564177",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Covgaz don't think you realise that when you said it was going to 0.23p the trades where at 0.264p on the 20th. Guess what today's latest trade is for the same price. So it's identical price to the 20th when you posted. How is it getting messy if there is no change. \ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udee3\ud83e\udee3\ud83e\udee3",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587519+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261124-covgaz-53883114",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564764",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "It's getting very ugly here , I did say will this be testing 23 again. Looks like it will.",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587539+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261120-DrMicho--6034145",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565378",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I have bought another 3M over the past few days to add to my growing collection. I\u2019m not complaining just curious why some would sell so close to news. Anyway GL to all\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587573+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261113-Andys288--4689467",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565967",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019ve not sold anything and have bought a few more over the last few weeks,  I\u2019ve not seen or heard anything to dissuade me that this is a great share to hold, and as a long term holder I am still in profit.  Just waiting for the news flow to start and this should go bonkers",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587594+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261108-DrMicho-47273347",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.566597",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering it\u2019s been reported that we are expecting a news rich period (originally dec) it\u2019s looking pretty grim at the moment. I am surprised at the constant selling tbh, is someone aware of something.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587626+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20262005-LlamaFar-43384772",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567196",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nice lumpy rollover, then a bed n isa.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587648+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261601-dvharris-64560544",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567625",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like someone is taking steps to protect future profits from HMRC!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587865+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261226-LlamaFar-46035280",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568050",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 26 / 90. Looks like traders entered on Friday as the MM's ran it up 10% and were stopped out this morning after no RNS turned up to save their positions....",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587889+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261131-ComesMar-60298625",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568488",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "It is clear that until news lands, the sp will be at the mercy of traders. In the long term perspective this is just noise, provided that the science behaves the way they claim.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587920+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260956-turnthec--6354648",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569024",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Couldn\u2019t resist another top up at 0.2768 as only a matter of time will make this look like steal",
          "sentiment": 0.0,
          "engagement": "314",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587943+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260927-wookieem--6996098",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569681",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "As volitile as an alcoholic this share",
          "sentiment": 0.0,
          "engagement": "4,352",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.587974+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260925-RhHh-35293557",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570224",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "As expected after the ut on Friday. Poxy MMs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "**** drop",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DDC62C70-85CB-418D-B6A7-4EC41E27F08D"
        },
        "ingested_at": "2026-01-29T10:41:29.587993+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262144-LlamaFar-64889836",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570667",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Only slightly .. 001 and 002 - Aud - market leading results 014 - Ptsd - no other treatment 015 - Meth & coke - no other treatment.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.588026+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262003-dvharris--7410743",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.571083",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Are you suggesting we're undervalued?  \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-29T10:41:29.588046+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261725-MadEngli--9099146",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.233592",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Next week Rodney...\ud83d\ude01 ATB",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.28",
          "thread_title": "This time...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=784600CF-6EA6-48B9-8E3B-25B205222B70"
        },
        "ingested_at": "2026-01-29T10:41:29.588081+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261122-Stretcht-39420088",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234032",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Time to test those recent highs and have some positive news hitting the wires.",
          "sentiment": 0.0,
          "engagement": "195",
          "price_at_post": "0.28",
          "thread_title": "RE: 24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-01-29T10:41:29.588118+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261107-EpicViru-85220000",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234477",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Let's keep this countdown ticking. GLA \ud83d\udc0e Time to run the race",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.28",
          "thread_title": "24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-01-29T10:41:29.588152+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261047-dvharris--3210488",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234903",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Nice to see some upward movement ahead of expected newsflow this quarter......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.28",
          "thread_title": "RE: FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-01-29T10:41:29.588172+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261031-Andys288-24965164",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Strong support today, and I wouldn\u2019t want to be out over the weekend with all the expected news,",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-01-29T10:41:29.588206+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261836-MadEngli--4401065",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235739",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-01-29T10:41:29.588231+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261521-Andys288--5688688",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236157",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-29T10:41:29.588264+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261219-LlamaFar--2565549",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236578",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-29T10:41:29.588284+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261122-dvharris-75567331",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236990",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-29T10:41:29.588315+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260924-EpicViru-89236066",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237415",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-29T10:41:29.588337+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260826-dvharris--6152924",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237828",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-29T10:41:29.588366+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260732-EpicViru-61118346",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238254",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-29T10:41:29.588390+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF-52396733",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238671",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-29T10:41:29.588418+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb-46500842",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239142",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-29T10:41:29.588444+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris--3700689",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239562",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-29T10:41:29.588470+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar--5655122",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239967",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-29T10:41:29.588498+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh-41892621",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240392",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-29T10:41:29.588523+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar--5964491",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-29T10:41:29.588553+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz-86134926",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241235",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,499",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-29T10:41:29.588576+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar--5380477",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241643",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-29T10:41:29.588607+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb-41230150",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242059",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-29T10:41:29.588629+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar--5116307",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242517",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-29T10:41:29.588661+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--5065468",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242929",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-29T10:41:29.588681+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF-84467103",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243353",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-29T10:41:29.588714+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar-52445807",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243772",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-29T10:41:29.588734+00:00"
      },
      {
        "event_id": "SOCIAL-Today1626-dvharris-11951209",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.964825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, still sell many millions of shares and now full ask for anything!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461532+00:00"
      },
      {
        "event_id": "SOCIAL-Today1620-Makingmi-13555379",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965393",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well was monitoring what I could sell a reasonable amount at and it stayed same but after that sell has now increased.  Not worth overthinking it. It\u2019s a good price to keep holding.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461554+00:00"
      },
      {
        "event_id": "SOCIAL-Today1514-dvharris-42173992",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965819",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The ask is dropping which usually signifies a worked sell. Interesting though that you can sell many millions of shares atm. We'll see after close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461574+00:00"
      },
      {
        "event_id": "SOCIAL-Today1512-DrMicho--8049410",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966247",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I was thinking the same thing to be honest... with the amount of buying i expected this to have moved up.",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461609+00:00"
      },
      {
        "event_id": "SOCIAL-Today1458-DaffyPic-44768923",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966667",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "I'm surprised it hasn't ticked up yet. Perhaps there is a big sell order being worked ??",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461629+00:00"
      },
      {
        "event_id": "SOCIAL-Today1333-Cambsblu-42506507",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967076",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Must admit I was tempted to sell several times over the past couple of months, but have been convinced it is worth holding on and adding.",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461647+00:00"
      },
      {
        "event_id": "SOCIAL-Today1328-Makingmi--3313431",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967503",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Possibly a few depressed people on here, with the price at this low level. Fortunately just a small dose of patience will do the trick. Lol.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461665+00:00"
      },
      {
        "event_id": "SOCIAL-Today1327-Andys288--1411352",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967912",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Welcome back cambsblue. I thought you had sold up months ago",
          "sentiment": 0.0,
          "engagement": "517",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461683+00:00"
      },
      {
        "event_id": "SOCIAL-Today1311-DaffyPic-51032234",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968340",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "There are a lot of depressed people on planet Earth, so  this should do very well.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461701+00:00"
      },
      {
        "event_id": "SOCIAL-Today1217-dvharris--7708556",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968754",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A very decent holding!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461718+00:00"
      },
      {
        "event_id": "SOCIAL-Today1215-Cambsblu--3788371",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969178",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Yes, couldn't resist at this level. Already have 48m bought last Autumn on the expectation of good news before the end of last year. Have been tempted to off-load some to invest elsewhere but decided to add at this silly price and hope for news by the end of Q1 !",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461735+00:00"
      },
      {
        "event_id": "SOCIAL-Today1202-dvharris-31043482",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969593",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Premium paid!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461753+00:00"
      },
      {
        "event_id": "SOCIAL-Today1201-dvharris-63432153",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I don't think too many would argue that a \u00a317M mcap seriously undervalues the potential of this company to deliver much needed treatments in areas currently pretty ill served. We have a quality BoD focused on results and maximising shareholder value. Good enough for me!\ud83d\udc4c",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461770+00:00"
      },
      {
        "event_id": "SOCIAL-Today1159-DaffyPic--5860497",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970426",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!!   11:59:01\t0.263\t8,000,000\t21.06k",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461788+00:00"
      },
      {
        "event_id": "SOCIAL-Today1155-Makingmi-27750112",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970838",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Sometimes it\u2019s not worth trying to be too clever and get the top or bottom of every price move right. Price can move quickly, so if it\u2019s a good price and you are happy with where it\u2019s going, buy it. If it goes down a bit it comes back. Less stressful too. It\u2019s called investing then, rather than gambling.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461805+00:00"
      },
      {
        "event_id": "SOCIAL-Today1138-dvharris-50000831",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971259",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "When folks are confident the seller is done we'll see plenty of buyers snapping up sub 0.3p shares.",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461823+00:00"
      },
      {
        "event_id": "SOCIAL-Today1135-MrsRobin-17793941",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971665",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Over 25m buys today and no significant sells other than big delayed sell so looking promising.",
          "sentiment": 0.0,
          "engagement": "186",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461841+00:00"
      },
      {
        "event_id": "SOCIAL-Today1106-DaffyPic--3643765",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972083",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"The pesky seller has a lot to answer for...\" Yes, but surely they do not have many left??   If any!!",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461858+00:00"
      },
      {
        "event_id": "SOCIAL-Today1041-Makingmi--2027372",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972495",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Yes, probably safe to get some more now dvh.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461876+00:00"
      },
      {
        "event_id": "SOCIAL-Today1031-DrMicho-71096040",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972902",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes, hopefully that sell is the end and we can move on...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461894+00:00"
      },
      {
        "event_id": "SOCIAL-Today1030-dvharris-54682193",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973325",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "After the news we had earlier this week and further newsflow on other fronts expected this quarter we really should be trading above 0.3p imo. The pesky seller has a lot to answer for...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461912+00:00"
      },
      {
        "event_id": "SOCIAL-Today1029-Makingmi-67091664",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973731",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Seems the effect of the excellent news release got lost in that selling session. Bit of catching up with events to come now.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461929+00:00"
      },
      {
        "event_id": "SOCIAL-Today1024-Makingmi-88171507",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974146",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Bought in earlier so hope you are right.  No problem either way at this price though.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461947+00:00"
      },
      {
        "event_id": "SOCIAL-Today1018-dvharris-88558259",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974564",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think we've just seen the reason the SP went down yesterday and folks couldn't get sell quotes. It's an odd figure so maybe the last of the selling? Looks like a few of us are buying in the hope that is the case.......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461964+00:00"
      },
      {
        "event_id": "SOCIAL-Today0946-DaffyPic--2675971",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974975",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "In the short term.  That's 0.44.    But I am still waiting for a penny.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-01-30T23:25:17.461981+00:00"
      },
      {
        "event_id": "SOCIAL-Today0851-dvharris-70305255",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484140",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just imagine if they have finished and you could have bought sub 0.25p! So tempted but will hold fire for the moment....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-01-30T23:25:17.461999+00:00"
      },
      {
        "event_id": "SOCIAL-Today0846-DrMicho-75052556",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484578",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I am not to sure its finished yet..if it is this will move up soon enough.",
          "sentiment": 0.5,
          "engagement": "8,159",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-01-30T23:25:17.462017+00:00"
      },
      {
        "event_id": "SOCIAL-Today0839-dvharris--2551653",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I can sell 5M shares (pre NT) with barclays at 0.2421p. Is our seller interested? Buying at this level is an absolute gift, but worried our seller might push the price lower. Conundrum!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-01-30T23:25:17.462035+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262348-TrickyEF-17892870",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485452",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "From a poster on telegram. Had a q and a with Gemini about the executive order and how it may impact Solvonis. You are right to be highly optimistic.  It is rare to see a micro caps pipeline match a major executive order's priorities so precisely. Especially with a board chair who has $15 billion track record in us life sciences. Will it be flat tomorrow??",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-01-30T23:25:17.462053+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262344-TrickyEF-35772575",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485875",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Seems pretty legit \ud83d\ude09\ud83d\ude09 https://www.whitehouse.gov/presidential-actions/2026/01/addressing-addiction-through-the-great-american-recovery-initiative/",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "from some ****e called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=05EF86B5-7368-48E4-884F-EF5C39F8DEF2"
        },
        "ingested_at": "2026-01-30T23:25:17.462071+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261710-LlamaFar--2662778",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486299",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "0.18p? Its on the chart from June last year...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462090+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261630-dvharris--2686833",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486716",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, absolutely no incentive to buy until it drops to sub 0 2p imo. 0.2421p to sell just before the close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462132+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261622-DrMicho-43921402",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487131",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looking like the seller will have to take whats on offer as no one is buying. Same price tomorrow seller \ud83d\ude01 get on with it...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462152+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261522-DrMicho--5962038",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487538",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Me too, Im here for the foreseeable so when it is finished selling I will buy its shares on the cheap...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462170+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261500-dvharris-57544332",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487949",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The SP of my only other small cap investment seems to be on the runway ready for take off. Potentially even more money to invest here in the short/medium term....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462189+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261457-dvharris-19012353",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488375",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "No rush for me as long term hold but would add significantly more if the MMs drop the SP to sub 0.2p......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462207+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261447-LlamaFar--4963004",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488788",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope, mms dropped the price. I added at 0.18p on the way up, wasnt expecting the opportunity on the way back down. Have to ask how many does this seller have?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462225+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261436-RhHh-65933450",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Seller hopefully done. Time for the MMs to take it up.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-01-30T23:25:17.462244+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261331-LlamaFar-87065377",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489614",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Google is interesting. Says that the MM's can offer to take them out lock stock and barrel, maybe they sell down until they ruin the market for the stock and then the MM takes the rest at a lower price and everything goes back to normal? \"Immediate Liquidity Provision: If a seller cannot find another buyer, the market maker steps in to buy the security (hitting the bid), allowing the seller to exit the position instantly.\"",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462262+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261315-dvharris-92198154",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490027",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Can only sell 500k shares so our 5M seller will either have to wait or accept a (much) lower price. I think we will see an absence of buyers until the position becomes clearer....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462280+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261252-LlamaFar-84041771",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490451",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - same as that. We've been told in the last few RNS and Co interviews what newsflow to expect, if you are selling at this point its through desperation? The MM's job is to make an orderly market where we can sell as well as buy, if dropping the price does that then what are they waiting for?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462298+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261245-dvharris-68052257",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'd rather they drop the SP to sub 0.2p than buy anymore until the seller has finished. Otherwise just funding their sales/profits. Expecting the SP to drop later.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462317+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261242-RhHh--9974749",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491287",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pay day tomorrow but no point in topping up until the seller is done. Must admit I thought they would have finished by now.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462335+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261239-LlamaFar--4251308",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491750",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They've still shut it all off - must have lots more 5m blocks to shift into us mug punters?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462353+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261203-LlamaFar--7724728",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492241",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They were struggling to work that last 5m sell, had to close off all other sells in order to squeeze it through, previously over the last few sessions they had reduced the sells you could do to 5m shares, that's not making an orderly market so they will either have to drop the price hard, or stop performing their function as a market maker. Pretty pi55 poor  performance from the MM after the sterling RNS of yesterday, the seller is obviously desperate, cut his prices and get him/her gone.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462377+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261131-dvharris--2354269",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492748",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, I was going to add more sub 0.3p but only when the seller has finished dumping their holding...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462395+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261124-DrMicho--1666919",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493174",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I totally agree.. hopefully seller gets low prices to match his desperation \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462413+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261121-LlamaFar-24097420",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493586",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "No point in buying more if each big sell reduces the price, easier to wait till the bottom and add more on the way back up?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462431+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261120-DrMicho-52836092",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493998",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our seller was waiting for some buying before unloading\u2026 \ud83d\ude02\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462449+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261110-LlamaFar--4173973",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.494420",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "6AM in New York, Toronto, Washington...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462467+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261034-dvharris--8000885",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.436927",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462484+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260909-LlamaFar--6825714",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437392",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-01-30T23:25:17.462502+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260837-dvharris--4978645",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437820",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462520+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260819-LlamaFar--3064952",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438249",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462538+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260815-LlamaFar-44924991",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438688",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462556+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260010-TrickyEF--3397474",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439148",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-01-30T23:25:17.462575+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260005-TrickyEF-71034802",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439582",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-01-30T23:25:17.462593+00:00"
      },
      {
        "event_id": "SOCIAL-Today1034-dvharris--8000885",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.348543",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462611+00:00"
      },
      {
        "event_id": "SOCIAL-Today0909-LlamaFar--6825714",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349238",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-01-30T23:25:17.462630+00:00"
      },
      {
        "event_id": "SOCIAL-Today0837-dvharris--4978645",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349995",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462648+00:00"
      },
      {
        "event_id": "SOCIAL-Today0819-LlamaFar--3064952",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.350809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462665+00:00"
      },
      {
        "event_id": "SOCIAL-Today0815-LlamaFar-44924991",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.351641",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-01-30T23:25:17.462683+00:00"
      },
      {
        "event_id": "SOCIAL-Today0010-TrickyEF--3397474",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.352511",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-01-30T23:25:17.462701+00:00"
      },
      {
        "event_id": "SOCIAL-Today0005-TrickyEF-71034802",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.353336",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-01-30T23:25:17.462719+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262015-TrickyEF-45560068",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354159",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "For use at home on a daily basis. This was an attractive investment 12 months ago now it's looking fooking beautiful. Fingers crossed it don't turn into a munter.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-01-30T23:25:17.462737+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262006-TrickyEF--4674918",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354968",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "The OTF delivery system could turn out to be a goldmine. What's next?? Solvonis said SVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles, and noted the compound has also been selected for evaluation in the US National Institute on Drug Abuse Addiction Treatment Discovery Program for stimulant use disorders. Solvonis Therapeutics plc (LON: SVNS), (\"Solvonis\" or the \"Company\") an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that Awakn Life Sciences Corp. (\"Awakn\"), the company Solvonis plans to acquire, has reached a significant regulatory milestone. Awakn announced a positive outcome from a Pre-Investigational New Drug (\"Pre-IND\") meeting with the U.S. Food and Drug Administration (\"FDA\") regarding AWKN-002, a proprietary oral thin film (\"OTF\") formulation of esketamine, designed for sublingual and buccal administration in combination with structured alcohol education. This drug candidate is being developed for the treatment of moderate to severe alcohol use disorder (\"AUD\") with a focus on U.S market",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-01-30T23:25:17.462755+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261933-MadEngli-26618120",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.355775",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "LHogbog, just keep holding, this is going to blow the bl00dy doors off one day.  When this gets picked up, JVd, bought out, it'll be by a big player and you'll be so happy you were in @ .3p. ATB ME",
          "sentiment": 0.0,
          "engagement": "721",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-01-30T23:25:17.462774+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261907-Hogbog--2185292",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.356560",
        "source": "LSE_CHAT",
        "data": {
          "author": "Hogbog",
          "content": "In various forms it is forever on social media, but what I\u2019m keen to know if when my two large holdings both in the 3s will actually make a profit.",
          "sentiment": 0.0,
          "engagement": "892",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-01-30T23:25:17.462792+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261903-VikR-85646070",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.357390",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Https://www.linkedin.com/posts/jonathanmichaelholmes_this-novel-antidepressant-targets-more-than-activity- Just noted on linkedIN a motivated investor speaking highly of the pipeline. The story here just keeps more compelling with each new discovery. SSRIs are prescribed in the million &  millions and the anxiety and depression market is multi billion. Everything SVNS targets are huge addressable markets. Once the newsflow starts here it won\u2019t stop. I understand the frustration of shareholders who are getting bored with a stagnant share price but this team is not in it for a small slice of the pie, they want to hit it big. There has to be, absolutely has to be strong interest from mainstream pharma willing to put the funds to progress the projects further. I just wait for the day the blessed RNS lands. 7422302011582484482-UjTC?utm_medium=ios_app&rcm=ACoAAErGYQIB6gTMGcSk4EsXpWwMe6tdaF1kU5E&utm_source=social_share_send&utm_campaign=copy_link",
          "sentiment": 0.5,
          "engagement": "981",
          "price_at_post": "0.265",
          "thread_title": "Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-01-30T23:25:17.462810+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261827-TrickyEF--6267374",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.358233",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I for one hope to be still holding these come  2028/2029 and have a massive \ud83d\ude01\ud83d\ude01\ud83d\ude01 on my face. 8months old and with  just \u00a32.25 million of funding the AI of Solvonis has already popped out svn15 which is in the running for $15 million of NIH funding based on early data in relation too meth and coke addiction. This NIH support was provided before they even new about the potential for depression. No wonder the AI fund raised was covered by just 3 individuals. For \u00a32.25 million down they possibly realised  \u00a310.8 million in NIH funding. Given today's news the odds would have shortened on securing that funding. FANTASTIC new science being delivered here.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-01-30T23:25:17.462829+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261810-TrickyEF--3056858",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359029",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "At around the 3min 45 second mark. Early days but WOW.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-01-30T23:25:17.462847+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261649-DrMicho-91797353",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359813",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Hopefully the smell of the seller will vanish soon enough. Waiting for buys to squeeze that little extra so must be desperate for the money. That desperation will   help move it on\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462865+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261546-LlamaFar-91491934",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.360501",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope ... cant sell, can buy",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462883+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261520-ComesMar-47217639",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.361160",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think it just appeared ,  10m",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462901+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261515-LlamaFar--1636447",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362046",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Sellers still hanging about, waiting for a large odd amount trade to show... that's the way I've seen these end before.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462919+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261504-dvharris-19673846",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362765",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Wouldn't it be nice if the latest 10M trade was the last of our sellers holding!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462937+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261400-DrMicho--2724162",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363274",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes me too DV...it would be nice to see some grants/funding to prevent any further need for funding/placings.. but the biggy is going to be a partnership or licensing deal. This would go bonkers, absolute crazy when it happens. Taking into consideration we have a fair amount of irons in the fire it surely cant be that far away.",
          "sentiment": 0.5,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462956+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261357-LlamaFar-70699941",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363733",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The further the pipelines move down the track, the bigger the numbers, i'm not rushed for answers at the moment. 015a Meth & Coke and 015b Depression are both new news, the pipelines are being widened and getting longer as they are progressed. Sit tight and add each time someone else is forced into selling, the lower the better imo.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462973+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261343-dvharris--3428494",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364170",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'm waiting for the outcome of the discussions with the big pharmas that have been ongoing for a while now....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.462992+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261303-dafad--1456072",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364584",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Soon I think-usually a proactive interview would be out by now-lack of anything leads me to think nore news soon",
          "sentiment": 0.0,
          "engagement": "2,397",
          "price_at_post": "0.265",
          "thread_title": "More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-01-30T23:25:17.463009+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261215-LlamaFar-40662814",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365003",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - sit tight and wait for the bargains. If they have to sell cheaply the price will be dropping?",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-30T23:25:17.463027+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261205-ComesMar-39000561",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365476",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "According to Gemini, these are probably Canadian investors or institutions, with the clear mandate to quit. There is nothing to do other than wait that they are done with selling.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-30T23:25:17.463045+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261156-dvharris-71568018",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691006",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think you are right Llama, but the seller does seem to want to dispose of an awful lot of shares....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-30T23:25:17.463063+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261140-cinderco--4430318",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691680",
        "source": "LSE_CHAT",
        "data": {
          "author": "cindercone",
          "content": "Yep, some individual is selling into every rise. How much longer is anyone's guess as not a lot of liquidity here.",
          "sentiment": 0.0,
          "engagement": "2,102",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-30T23:25:17.463081+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261120-LlamaFar-12643173",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692318",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "There's obviously a large seller about - they must be in a forced sale position as you wouldn't be selling otherwise on this mornings news. Once the seller dries up, my opinion is it rockets.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-01-30T23:25:17.463108+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261119-dvharris-81340293",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692922",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, didn't think I'd be on the verge of meeting desmond again!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-30T23:25:17.463127+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261118-LlamaFar--7892977",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.693581",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "3.50mins - \"All depressives\" All depressives\" refers to the broad spectrum of clinical, chronic, and situational mental health conditions characterized by persistent low mood, loss of interest, and decreased energy. Psychiatrists often view depression as a range of experiences rather than one single disease, spanning from mild, temporary, to severe. Here is a breakdown of the various types of depression based on recognized diagnostic criteria (DSM-5): Primary Types of Depressive Disorders Major Depressive Disorder (MDD) / Clinical Depression: The most common form, involving severe symptoms\u2014such as intense sadness, hopelessness, or loss of interest\u2014that last for at least two weeks and interfere with daily life. Persistent Depressive Disorder (PDD) / Dysthymia: A chronic, low-grade, or moderate depression that lasts for two years or more. Bipolar Disorder (Manic Depression): While not exclusively a depressive disorder, this involves alternating episodes of depression and high-energy mania or hypomania. Premenstrual Dysphoric Disorder (PMDD): A severe form of PMS causing extreme irritability, anxiety, or depression in the week before a period. Disruptive Mood Dysregulation Disorder (DMDD): A childhood condition characterized by extreme irritability and intense anger outbursts.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-30T23:25:17.463145+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261115-DrMicho--1402191",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694200",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Absolutely amazed that we are worse off after a positive update.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-30T23:25:17.463163+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261113-LlamaFar-52347955",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694808",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.youtube.com/watch?v=ZLhyKGvWypg At 1.50m GAME ON!!!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-30T23:25:17.463182+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261059-Bill999-65886731",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.695431",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bill999",
          "content": "Good video out on Proactive today with David Nutt.",
          "sentiment": 0.0,
          "engagement": "3",
          "price_at_post": "0.265",
          "thread_title": "Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-01-30T23:25:17.463201+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261055-dvharris-25022500",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696024",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very funny!\ud83d\ude01",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.26",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463219+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261029-bonesgt--5848460",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696635",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Going to stick my neck out ,think we will finish up today. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463237+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261027-dvharris--5152066",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697256",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "And we're red!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463255+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261022-bonesgt-38792632",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697855",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Was that an 8m buy disguised as a sell . Is that our buyer mopping up. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463273+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260908-ComesMar-82912320",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.698463",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "There could be tons of reasons why selling despite good news and expected catalysts. This is a gift for the ones believing in the story and with available cash.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463292+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260858-DrMicho--6894469",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699053",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our 5M buyer early on has took a 1500 quid hit. The thing that is going to move this properly is a licensing deal/large funding/partnership news. All of this could happen imminently, US listing, results take time.. still hopeful of something dropping that will shift this selling trend.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463310+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260856-TheDealB-45210544",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699614",
        "source": "LSE_CHAT",
        "data": {
          "author": "TheDealBreaker",
          "content": "The bigger question is not who is selling but why?  Why sell on good news and the potential of more good news? They are clearly not moving shares into an ISA as there are no corresponding buys. Thanks",
          "sentiment": 0.0,
          "engagement": "304",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463328+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260847-RhHh--1902586",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700037",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I thought the seller was finished ages ago! Who is it?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463347+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260842-bonesgt-62008413",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700480",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "This is nuts ,what will it take. Who is the seller? Can't have many left surely.",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463365+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260838-dvharris-39766076",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700904",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pow,  5M number 3! Not another red day after yet another positive update surely?",
          "sentiment": 0.0,
          "engagement": "21,054",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463383+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260836-RhHh-81750246",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.701462",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I hate that damn seller! Be a red finish at this rate ffs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463401+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260816-dvharris--7890775",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702149",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like the 5M seller is up early. Oh well......",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463419+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260815-RhHh--9105687",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702662",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Tq",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463437+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260811-LlamaFar--3537107",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703082",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Get a broker and buy on the pre market - hence the premium.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463456+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260805-EpicViru--2843147",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703515",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "You can place an order to be executed",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463474+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260804-RhHh-48871362",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703931",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "How can you buy before the open?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463492+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260802-dvharris--2050001",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.704377",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "With the number of darts we're throwing at the board one is going to hit the bullseye!\ud83c\udfaf",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.29",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463510+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260755-DaffyPic-32942353",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558067",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice and early. 07:54:38\t0.295\t5,000,000\t14.75k",
          "sentiment": 0.0,
          "engagement": "3,575",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463529+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260740-Scoutt-16230460",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558633",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "Diversification always good in binary developments, shaping up to be a wonder treatment, if it goes half as well as I\u2019m expecting we will be a penny share by mid year.  Substance mis-use, PTSD, Depression, if we can use it for Anxiety we can shout Bingo.",
          "sentiment": 0.0,
          "engagement": "975",
          "price_at_post": "0.27",
          "thread_title": "Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-01-30T23:25:17.463547+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260724-Stretcht-38114382",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559180",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Good news, let\u2019s see how that is received.",
          "sentiment": 0.0,
          "engagement": "207",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-01-30T23:25:17.463565+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260711-Andys288-43565861",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559701",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019m feeling a bit blue today, if only there was a new treatment for depression\u2026.. #hellofreddy",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-01-30T23:25:17.463583+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260706-EpicViru-45074576",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560283",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Here we go hold onto your seats. An hour before the floodgates open.",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-01-30T23:25:17.463601+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261602-bonesgt--6270088",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560797",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Flat or up a point today, be nice all in all we're still on track. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463620+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261147-TrickyEF-11814747",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561345",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice bones. May join ya and the Dr with a purchase this week.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463638+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261141-bonesgt-60657475",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561848",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Never  mind Tricky I've just bought another 1 mil and again another 170k . Nothings changed on coarse for licencing,  among other great things we are working on. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463656+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261139-RhHh--7607024",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562370",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Looks like the sells are being mopped up. Might even be a flat close. Not long to wait for news.",
          "sentiment": 0.5,
          "engagement": "324",
          "price_at_post": "0.255",
          "thread_title": "Buyers coming in",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18FDEE2C-AFBF-4A99-A347-D1CDEDF15437"
        },
        "ingested_at": "2026-01-30T23:25:17.463674+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261137-covgaz-78089652",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562870",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "If it hits 23 will I be correct?",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463695+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261134-TrickyEF--7808542",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.563524",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "If something is the same as it was there is no change. It looks the same to me as it did on the 20th. Not pretty not ugly the same. Same same.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463714+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261129-TrickyEF--6991472",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564177",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Covgaz don't think you realise that when you said it was going to 0.23p the trades where at 0.264p on the 20th. Guess what today's latest trade is for the same price. So it's identical price to the 20th when you posted. How is it getting messy if there is no change. \ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udee3\ud83e\udee3\ud83e\udee3",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463732+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261124-covgaz-81922990",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564764",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "It's getting very ugly here , I did say will this be testing 23 again. Looks like it will.",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463750+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261120-DrMicho-42112700",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565378",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I have bought another 3M over the past few days to add to my growing collection. I\u2019m not complaining just curious why some would sell so close to news. Anyway GL to all\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463768+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261113-Andys288--4892442",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565967",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019ve not sold anything and have bought a few more over the last few weeks,  I\u2019ve not seen or heard anything to dissuade me that this is a great share to hold, and as a long term holder I am still in profit.  Just waiting for the news flow to start and this should go bonkers",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463786+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261108-DrMicho--4538771",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.566597",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering it\u2019s been reported that we are expecting a news rich period (originally dec) it\u2019s looking pretty grim at the moment. I am surprised at the constant selling tbh, is someone aware of something.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463804+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20262005-LlamaFar-17737568",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567196",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nice lumpy rollover, then a bed n isa.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463823+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261601-dvharris-21128084",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567625",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like someone is taking steps to protect future profits from HMRC!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463841+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261226-LlamaFar--5294737",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568050",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 26 / 90. Looks like traders entered on Friday as the MM's ran it up 10% and were stopped out this morning after no RNS turned up to save their positions....",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463859+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261131-ComesMar--7021971",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568488",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "It is clear that until news lands, the sp will be at the mercy of traders. In the long term perspective this is just noise, provided that the science behaves the way they claim.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463878+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260956-turnthec--5239992",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569024",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Couldn\u2019t resist another top up at 0.2768 as only a matter of time will make this look like steal",
          "sentiment": 0.0,
          "engagement": "314",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463896+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260927-wookieem--2092699",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569681",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "As volitile as an alcoholic this share",
          "sentiment": 0.0,
          "engagement": "4,352",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463914+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260925-RhHh-88794551",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570224",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "As expected after the ut on Friday. Poxy MMs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "**** drop",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DDC62C70-85CB-418D-B6A7-4EC41E27F08D"
        },
        "ingested_at": "2026-01-30T23:25:17.463933+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262144-LlamaFar--4355399",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570667",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Only slightly .. 001 and 002 - Aud - market leading results 014 - Ptsd - no other treatment 015 - Meth & coke - no other treatment.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463950+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262003-dvharris-76343361",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.571083",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Are you suggesting we're undervalued?  \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-01-30T23:25:17.463969+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261725-MadEngli--2115524",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.233592",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Next week Rodney...\ud83d\ude01 ATB",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.28",
          "thread_title": "This time...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=784600CF-6EA6-48B9-8E3B-25B205222B70"
        },
        "ingested_at": "2026-01-30T23:25:17.463987+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261122-Stretcht-60731326",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234032",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Time to test those recent highs and have some positive news hitting the wires.",
          "sentiment": 0.0,
          "engagement": "195",
          "price_at_post": "0.28",
          "thread_title": "RE: 24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-01-30T23:25:17.464004+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261107-EpicViru--2854368",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234477",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Let's keep this countdown ticking. GLA \ud83d\udc0e Time to run the race",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.28",
          "thread_title": "24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-01-30T23:25:17.464022+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261047-dvharris--4224846",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234903",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Nice to see some upward movement ahead of expected newsflow this quarter......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.28",
          "thread_title": "RE: FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-01-30T23:25:17.464040+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261031-Andys288--5087428",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Strong support today, and I wouldn\u2019t want to be out over the weekend with all the expected news,",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-01-30T23:25:17.464058+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261836-MadEngli-85895022",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235739",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-01-30T23:25:17.464077+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261521-Andys288-26921026",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236157",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-30T23:25:17.464096+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261219-LlamaFar-23188676",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236578",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-30T23:25:17.464123+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261122-dvharris-60930534",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236990",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-30T23:25:17.464141+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260924-EpicViru--4221828",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237415",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-30T23:25:17.464160+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260826-dvharris-14292344",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237828",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-30T23:25:17.464178+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260732-EpicViru--1178003",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238254",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-01-30T23:25:17.464196+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF--1157640",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238671",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-30T23:25:17.464214+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb--2388643",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239142",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-30T23:25:17.464232+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris--8747676",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239562",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-30T23:25:17.464250+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar--4164913",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239967",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-30T23:25:17.464269+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh-50409104",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240392",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-30T23:25:17.464287+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar--7654105",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-01-30T23:25:17.464305+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz-74869988",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241235",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,499",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-30T23:25:17.464323+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar-67370750",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241643",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-30T23:25:17.464342+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb-83538540",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242059",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-30T23:25:17.464360+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar--8897940",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242517",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-30T23:25:17.464379+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--9051120",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242929",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-30T23:25:17.464397+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF--4413822",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243353",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-01-30T23:25:17.464415+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar-74290954",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243772",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-01-30T23:25:17.464433+00:00"
      },
      {
        "event_id": "SOCIAL-Today1609-dvharris--2116631",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.588646",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, full ask for anything at Barclays....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-06T23:28:25.071230+00:00"
      },
      {
        "event_id": "SOCIAL-Today1550-bonesgt-65234628",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589082",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Here's hoping ,times a ticking, need your tickets, trains hopefully building steam for the journey ahead. Gla",
          "sentiment": 0.5,
          "engagement": "1,570",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-06T23:28:25.071267+00:00"
      },
      {
        "event_id": "SOCIAL-Today1506-Andys288-74231207",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589521",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "FOMO Friday\u2026..",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-06T23:28:25.071306+00:00"
      },
      {
        "event_id": "SOCIAL-Today1503-TrickyEF-28297206",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589937",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Someone has not curved their enthusiasm.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-06T23:28:25.071344+00:00"
      },
      {
        "event_id": "SOCIAL-Today1459-DaffyPic--5437951",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590360",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!! 14:56:22\t0.25\t8,000,000\t20.00k",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-06T23:28:25.071381+00:00"
      },
      {
        "event_id": "SOCIAL-Today1457-DrMicho--4593462",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590770",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yep, looks like we have movement upwards...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.24",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-06T23:28:25.071405+00:00"
      },
      {
        "event_id": "SOCIAL-Today1424-RhHh--2636550",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pretty certain that we've hit the bottom. Only going up from here.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.24",
          "thread_title": "Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-06T23:28:25.071424+00:00"
      },
      {
        "event_id": "SOCIAL-Today1110-dvharris-40870312",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591616",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just added another 2M+ which is showing red! Far too cheap.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-06T23:28:25.071442+00:00"
      },
      {
        "event_id": "SOCIAL-Today1015-turnthec-27491505",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592020",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Can\u2019t believe one can buy below 25 so another top up of 1 million this morning",
          "sentiment": 0.0,
          "engagement": "323",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-06T23:28:25.071460+00:00"
      },
      {
        "event_id": "SOCIAL-Today0750-thetripl-35705185",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592470",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "The recent drift to 0.25p is a gift. We are seeing a classic \"forced washout\" (likely silver-crash margin calls) meeting a rock-solid floor. Why I\u2019m holding for the re-rate: Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%\u2014they are CNS pros building for a major exit. The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from \"AI discovery\" to \"clinical reality.\" Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the \"Prozac-sized\" depression market have fundamentally changed the valuation floor. Buyout Potential: At an \u00a318m market cap, we are a \"snack\" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels. The seller is running dry and the news is incoming. For those with averages in the 30s\u2014patience pays here. The science is better than it\u2019s ever been.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.24",
          "thread_title": "The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-06T23:28:25.071479+00:00"
      },
      {
        "event_id": "SOCIAL-Today0023-LlamaFar--5906037",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592896",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "At the moment you either hold cash or imo you hold decent opportunity Pharmas for the multibag opportunity. Has to have low cash burn, has to have multiple products in a pipeline so it doesn't blow up on one delay or failure, has to have an exerienced, cohesive BOD that are fit for purpose.. 1.In early 2026, U.S. markets experienced significant volatility, leading to increased margin requirements and, in some cases, margin calls, particularly within the metals sector. A sharp, late-January 2026, sell-off in commodities, where silver fell nearly 30%, followed a record-breaking, speculative rally. This correction forced liquidations on leveraged positions as exchanges tightened rules, this resulted in investors selling anything liquid to cover their blown up positions, I reckon thats where our sellers came from. 2. Holding pharmaceutical stocks during a market correction is generally considered a defensive strategy, as the sector provides essential products that remain in demand regardless of economic conditions. 3.Patent Cliff Approaching. 4.Pipeline of large unmet needs.Repurposed and novel molecule pipeline.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "Holding pharma stocks in a market correction?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BF229829-D5CE-43E3-9AE7-7062F3875B81"
        },
        "ingested_at": "2026-02-06T23:28:25.071497+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261939-LlamaFar--2337017",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593359",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Wood from trees. If warrants, would have been rns as cash inflow to business no rns no warrants flipped. If you've looked up who owns those 0.10p lending warrants you will understand why/ how they are holding, quite a?few of the pi's are still holding from 0.10p as well ;) Legacy graft polymer - they went long ago - link to lending warrants. Good question to ask any small cap, when are you placing next? The CEO replied to that direct question \"we are not looking to raise funds at the moment, we have a cash runway until q1 2027, we are in talks with more than 1 party to out license our svn001 asset\". If you read the news, ur obvs on Twitter to know of Harald, the wider u.s. market has had a lot of leverage calls recently. I doubt if you need to look further than that for your seller. Add to that ceo saying at Mar A Lago there was an ultra high net worth investor on nearly every table, i.e. we have a lot of u.s. investors, wouldnt be a surprise if one or two had got caught and trimmed their portfolios? The positive is that the s.p. hasn't cratered, has widened its pipeline of assets, reconfirmed 001 still in negotiations etc etc. Hope you time yr buy ins correctly ;)",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071515+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261935-woodfrom--5685132",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593775",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "If they have sufficient cash to last until 2027, then the main overhang is likely the cheap warrants being sold. It\u2019s unclear whether these warrants were ever repriced. The CEO, at least, appears to have a credible track record.",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071534+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261924-woodfrom-65885883",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594191",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "What's causing the price weakness?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071552+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261917-woodfrom--1631821",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594590",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Has your brain been replaced with an AI robot?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071570+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261912-ComesMar--7649657",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595016",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "The \"WFTT\" Profile: A Sophisticated Opportunist \u200bThe \"AI-Style\" Researcher (Upland Resources - Jan 2026): Just two weeks ago, WFTT was posting on the Upland (UPL) board using highly detailed, institutional-sounding language (very similar to the \"Jigger\" report) to defend a director's options. They were explaining complex 5p options and arguing for a massive re-rating. \u200bThe Takeaway: They are capable of doing deep, positive research when it suits them. This proves their current \"Strong Sell\" on SVNS is a deliberate choice, not a lack of understanding. \u200bThe \"Rumour Monger\" (Reabold Resources - Jan 2026): On the RBD board, they were active in spreading rumours about \"well-known pump and dumpers\" like Harald. They have a history of using fear-based narratives to influence small-cap sentiment. \u200bThe \"Contradiction\": While they attack SVNS for \"cash burn,\" they were recently celebrating the \"NAV value\" of Hot Rocks (HRIP.PL) despite similar market conditions.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071588+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261852-woodfrom--5253086",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595447",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Whenever you see a seller finished ramp you know you're in for a treat. Legacy graft Polymer overhang? or is it the 0.1p warrant overhang....",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071607+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261825-Andys288-62283504",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595860",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Perhaps you should listen to the recent pod cast again where \u201c A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027\u201d Placing from a troll or cash runway from the MD I wonder who I believe\u2026.",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071625+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261819-woodfrom-88490643",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596288",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "To me looks like a placing will be incoming imminently here. \u00a31.7m cash burn/6months and they had \u00a31.7m June last year so would have been down to 0 at year end... however raised \u00a31.2m in October which gives them 3 - 4 months taking it to March when they'll be on fumes again Looks like the ramp crew is all over this now to get the price up pre rug pull.",
          "sentiment": -0.5,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071644+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261715-VikR--7640138",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596692",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "And on that note also took \u00a35k today",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071662+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261714-VikR-58644678",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597114",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Welcome definitely oversold and undervalued. SVN 001 is getting out licensed this year, good as confirmed in the last interview. SVN 002 is a massive play but incremental stages to be reached with bridging study confirmation and then FDA application swiftly after for phase 2B. SVN015 hopefully gets selected for the grant. SVN-SDN-14 series gets added in for good measure. While the SP is quiet and stagnant that\u2019s the best time to accumulate, when it shoot\u2019s up on deal announcement it will trigger a HUMONGOUS re rate for the ENTIRE PORTFOLIO, 100 Million MCAP minimum",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071680+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261639-RhHh-23643795",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597527",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Nice one, NaxosDon. Good decision I reckon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071698+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261340-Andys288--5280725",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597934",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Balls going deeper, added another 5k. Now let\u2019s see this SP get back on track",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071716+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261338-MadEngli-22175276",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598349",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "I didn't know anyone in the UK knew Curb. Genius stuff. ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071735+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261320-ComesMar--3669407",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598761",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I find this quote of Richard as king John quite appreciated: \u200b\"Wait, I have an idea. Maybe if you tell me the bad news in a good way, it wouldn't sound so bad.\"",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071753+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261312-TrickyEF-40049101",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.694318",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Loved Richard Lewis and his work on curb",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071771+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261258-LlamaFar--4320126",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695150",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.dailymail.co.uk/tvshowbiz/article-15529379/jamie-lee-curtis-27-sobriety-journey-richard-lewis.html",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071790+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261231-TrickyEF--2308051",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695967",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I no longer checking in as often. Day to day movements is just pure nonsense. However fook the seller \ud83e\udd2a\ud83e\udd2a\ud83e\udd2a",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071808+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261222-MadEngli-25301276",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.696999",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Dvh...it will be back and then some.  Trust the science and the need for it. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071826+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261152-dvharris--2360726",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.697813",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very true ME, although looking at the Solvonis value in my share account when the SP was 0.4p was much more enjoyable! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071844+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261139-MadEngli-37724455",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.698618",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "It matters not that people are selling, the science hasn't changed, the potential hasn't changed, the need for this science hasn't changed. When this moves it will move quickly and massively. Happy to sit on my holding. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071862+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261136-dvharris--2202155",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.699419",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, looks like peeps selling (boredom?)....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071880+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261128-DrMicho--8637393",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700202",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Added again over the last few days. I wasn\u2019t expecting it to be this low so a decent buys for the future.",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071898+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261123-DaffyPic--7646791",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700986",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "When this gets to 0.75 - to 1.00 , my depression is going to lift.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071916+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260933-LlamaFar--6421304",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.701866",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The last couple of sessions looks like PI's selling after the event. The larger, more structured seller i.e 5m blocks isn't here - to me that says GO time... Professor Nutt has said a couple of things recently in interviews that were very  interesting, we all know that we are waiting for 001, aside from that, Nutt said. 1.On 015b Depression - well depending on how much we raise we could look at all of the depressives. A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027. Conclusion: Nutt must have been looking ahead to the U.S. listing. for his small molecules that the AI engine is pumping out. 2.On lead molecule - we will have that done in a month or so. Personally I've been adding on this dip - each to their own.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071935+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260904-dvharris--4459968",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.702633",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Poor start to the day and sells now sub published Bid of 0.25p. We need some positive news to stop the decline in SP and get us trading back above 0.3p.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071953+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261505-RhHh--2666205",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703277",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "No big sells for a few days leads me to believe that the big seller is done. If no more appear this week I think it will be safe to start topping up again.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-06T23:28:25.071971+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261345-dvharris-45704736",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703876",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like we might be heading lower again. NT to sell anything at barclays atm....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-06T23:28:25.071989+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261037-DrMicho-38861686",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.704471",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "In need of something to create a bit of volume, our seller drowned the last piece of news...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-06T23:28:25.072007+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260916-LlamaFar--2417299",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705068",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Prof David Nutt on the Mums podcast on Monday said a month or so for lead drug ... worth listening to podcast.link below a few posts ago. 001 news due. 002 news due Seems 2026 will be busy.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-06T23:28:25.072030+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260828-dvharris--4780395",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Interesting ME. Now, assuming the Seller has finished (6M available to sell now pre NT) we just need the CEO to light the touch paper with licence/funding news and watch this re rate....\ud83d\ude80\ud83d\ude80",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-06T23:28:25.072048+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261539-MadEngli--2514675",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.706455",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Based on recent industry activity, the most likely acquirer among top-tier pharmaceutical companies for Solvonis Therapeutics is AbbVie, as they have already shown active interest in acquiring similar addiction treatment pipelines. Top Potential Acquirers AbbVie: In 2025, reports indicated AbbVie was preparing a $1bn offer for Gilgamesh Pharmaceuticals, a U.S. peer in the same space, highlighting a strong strategic desire to enter this market. Other Potential Top-10 Contenders: Given the high unmet need in CNS (Central Nervous System) disorders, other top-10 firms with strong histories of psychiatric or neurological acquisitions\u2014such as Pfizer, Novartis, or Johnson & Johnson\u2014are considered likely acquirers for de-risked late-stage assets.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-06T23:28:25.072066+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261538-MadEngli-74835668",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707080",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Why Solvonis is an Attractive Target Solvonis has positioned itself as a major player in addiction treatment, particularly following its acquisition of Awakn Life Sciences in May 2025. Lead Asset (SVN-001): A Phase 3, first-of-its-kind combination therapy (IV ketamine + manualized CBT) for severe Alcohol Use Disorder (AUD), with results expected in late 2027/early 2028. US Market Asset (SVN-002): A sublingual/buccal esketamine formulation for moderate-to-severe AUD, which may follow a \"regulatory shortcut\" to bypass early trials, reducing cost and time-to-market. Discovery Engine: A pipeline targeting stimulant addiction (methamphetamine/cocaine) and a PTSD program (SVN-SDN-14).",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-06T23:28:25.072085+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261536-MadEngli--3496070",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707703",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Timing and Strategic Drivers Late-Stage Focus: Solvonis explicitly positioned itself as a \"partner of choice\" for large pharma, with discussions already underway for licensing SVN-001. High Value Target: With positive Phase 2b data, the assets are considered de-risked, and similar deals in this space have commanded up to $1.2 billion in total value.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-06T23:28:25.072124+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261524-TrickyEF-75687398",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708341",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Solvonis currently is the stand out play of the market for investors. The mouth watering situation on offer here is insane. The company currently worth \u00a317million. They have enough money to carry on with every aspect of the business for 12 months and within this  12 months window a licensing deal and \u00a312 million in funding for  svn15  may well be attained to see it all the way through phase 1. If any of this news drops then it's flying over 2p for starters. Positive Bridging data would also be a catalyst to get us over 1p.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "Cash runway covered til Q1 2027",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F5298FB3-E0C6-4F50-8445-616D8BC77247"
        },
        "ingested_at": "2026-02-06T23:28:25.072144+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261326-LlamaFar-22758932",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708995",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "E.D. Look at the value of USA early stage Pharmas dealing in same fields as this. There are a lot at the same level of progress as Solvonis, only Atai is ahead of the curve, and worth substantially more. A.T. laid it out in the Mums interview ( see link below ) that SVNS is worth money when the following inflection points happen. 001 - Phase 3 - Current stage 002 Phase 2b - About to enter 014 Phase 1 - Lead candidate then about to enter. 015a Phase 1 - Short to medium term 015b Phase 1 - short to medium term. Atai for a comparison is worth circa $1.2BN, SVNS don't need funding for 12 months, if 001 is outlicensed, will not need funding at all so stops at 6.8bn shares. that would be 17 cents a share or 12.43p per share. No wonder these American Ultra High Net Worth individuals are already invested and via Pamlico Shoals happy to keep funding.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-06T23:28:25.072162+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261316-erniedam--7261456",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.709601",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "LlamaFarmer, Thanks for your reply. Yeah, realise med term is a subjective time period. Guess I'm getting a bit impatient. Cheers for all your in depth research, it's much appreciated.",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-06T23:28:25.072181+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261205-RhHh-48365265",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710193",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "It would be good to have an updated research note from Singer to reflect the new developments. Hopefully that will happen soon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072199+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261129-LlamaFar-29943014",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710845",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "BIGGER Cost to the U.K. than Alcohol... Smoking and nicotine use impose a total annual cost of over \u00a350 billion on the UK society and economy, according to ASH Scotland estimates. This massive burden, largely from tobacco, includes around \u00a327.6 billion in lost productivity, \u00a31.82 billion for NHS healthcare, and \u00a313.9 billion in social care, far exceeding tax revenue. Key Annual Costs of Nicotine/Smoking in the UK: Total Societal Cost: Estimated at over \u00a350 billion, or \u00a349.2 billion in England alone. Lost Productivity: The largest factor, totaling \u00a327.6 billion to \u00a332 billion annually through smoking-related sickness, unemployment, and premature death. Health and Social Care: Roughly \u00a31.82 billion for the NHS and \u00a313.9 billion to \u00a315 billion in social care costs. Smoking-Related Fires: Approximately \u00a3328 million\u2013\u00a3332 million per year. Personal Costs: A 20-a-day smoking habit can cost an individual over \u00a34,200 to \u00a35,500 annually. Stop Smoking Aids: The net cost to the NHS for prescription quitting aids was \u00a313.8 million in 2024/25. Rising Trends: Costs have increased by 25% in recent years, with smoking in England costing at least \u00a321.8 billion in direct, measurable impacts. While cigarette sales are declining, the nicotine pouch market in the UK is growing rapidly, valued at over \u00a3170 million.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-06T23:28:25.072217+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261127-LlamaFar--5243317",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.711481",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Alcohol-related harm costs the UK society and economy between \u00a327 billion and \u00a352 billion annually. In England alone, the cost is estimated at \u00a327.4 billion, which includes nearly \u00a35 billion for the NHS, over \u00a314 billion for crime, and over \u00a35 billion in lost productivity. This impact exceeds the roughly \u00a312.5\u2013\u00a314 billion generated in annual alcohol tax revenue. Key components of the annual costs include: Healthcare: Approximately \u00a33.5 billion to \u00a34.91 billion for the NHS. Crime & Disorder: Roughly \u00a314.6 billion, including police, legal, and fire services. Lost Productivity: \u00a34.6 billion to \u00a35.06 billion due to absenteeism, premature death, or unemployment. Social Services: An estimated \u00a32.89 billion. With over 1.25 million annual alcohol-related hospital admissions, the total societal burden equates to roughly \u00a3485 per person per year.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Cheers",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B230C66D-50ED-4829-81AB-3229BACF0749"
        },
        "ingested_at": "2026-02-06T23:28:25.072235+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261126-dvharris--8775394",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.036870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I suspect that this time next year we'll be talking about an SP way higher than today. Remember last years Research Note valuation of 1.6p and we've made progress on a number of fronts since then.......",
          "sentiment": 0.0,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072254+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261117-LlamaFar--8209944",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037371",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky, I like the honesty, for me it makes it investable - park some money up and wait! A.T. I thought we would have out licensed 001 by Q4 2025, but we have to accept our size and wait our turn, imo referring to the Pharma events that ran from Nov 2025 - Jan 2026 that have delayed news ( and cashflow ). A.T. I went to Mar A Lago at the invitation of one of our largest share holders and met all of the Ultra High Net Worth investors, there was one of these existing Solvonis investors at each table. A.T. 002 will give us the most financial benefit, in the USA there are two parts of the world, there's the USA and there's the R.O.W. the rest of the world, that's why we will be running our 002 trial in America, its inflection point is in Phase 2b. P.N. I did my Uni thesis on Cocaine in 1979, I think these new small molecules will do something for that. K.H. (Interviewer) I don't mind telling you, I'm an investor here myself with a decent sized position! Loads of great info, listened to it twice, got more out of it the second time.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072272+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261059-RhHh--6607537",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037785",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Gonna be a great year here.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072290+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261058-TrickyEF--8048407",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038215",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Llama that interview by Nutt and AT yesterday was superb. Best yet",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072308+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20260858-LlamaFar-41705225",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038656",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ED. 10 months left in 2026, is that short or medium term? I think the focus is  getting 002 into a usa trial and funding it. He clearly said phase 2b is its inflection point. Also said he has been to America and spoken to all of their existing ultra high net worth investors via the Michael Layman Pamlico Shoals event at Mar A Lago. He must have worked out a way to get 002 into phase 2b trials, funded from current cashflows and out license of 001 that could be done from the London Exchange listing while the Nasdaq listing goes through. Another thing to note from that interview, he was tighter with certain parts of info that might affect negotiations, so maybe theres some of that as well with the Nasdaq? Look at 015a and 015b neither of these were signalled, they just landed.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072327+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262310-erniedam-23445319",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039078",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "Hi LlamaFarmer, Good video, thanks for sharing. One segment I picked up on, AT mentioned that he has aspirations to list on the NASDAQ in the med to long term. I thought he previously said this year?",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072345+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262258-LlamaFar--3008205",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039537",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Mdma - synthesised form of, for ptsd type treatments being worked on. 001 still in talks with more than 1 party - A.T. wouldn't be drawn on the number \ud83d\ude02. 002 - AT said will have most value - inflection point phase 2b, will be run in USA. 015 - Prof Nutts favourite - he's been working on cocaine addiction since 1979, thinks this new molecule will do it. Basically,what we already knew plus the new stuff. A.T. Went to Mar a Lago - UHNW investors evening, there was an existing Solvonis investor on each table as Anthony networked around the room. Money from 001 will kick start this, but 002 will take it to the Bank. These novel treatments of 014, 15a and 15b will then kick it on a gear, their inflection points AT phase 1. All that adds up to a $1bn Co. Imo",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072363+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262250-LlamaFar--3601508",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039947",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://youtu.be/AO2VdmBHBMY?si=5NzRDDTscSQEglpC",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-06T23:28:25.072381+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261523-ComesMar-10700303",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040417",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "Solvonis - has received a Notice of Allowance from the USPTO for compounds within its SVN-SDN-14 PTSD discovery programme, strengthening the intellectual property ahead of lead candidate selection expected in Q1 2026. The patent covers novel serotonin, dopamine and noradrenaline modulators designed to support pro-social engagement and enhance psychological therapy effectiveness in PTSD patients. The compounds address historical development challenges by incorporating predictable metabolic deactivation to improve pharmacokinetic control, dosing flexibility and safety margins while maintaining therapeutic activity. The USPTO examiner confirmed the novelty of the approach, finding no existing patents or publications disclosed the claimed compounds. The company has also expanded its SVN-015 programme into depression following positive preclinical data showing antidepressant-like activity comparable to fluoxetine (Prozac) after 14-day dosing in validated rodent models. SVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor designed to address symptoms poorly controlled by SSRIs, including anhedonia and reduced motivation, targeting a market of over 20 million adults with Major Depressive Disorder in the US alone. The compound is being developed as a once-daily oral therapy for at-home use aligned with standard antidepressant treatment cycles, and has separately been selected for evaluation by the US National Institute on Drug Abuse for stimulant use disorders, providing independent validation of its pharmacological profile. This remains an exceptional pharma play.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.26",
          "thread_title": "Charles Archer small cap review",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=62CD6955-201F-415B-BAD4-B42ECE570F38"
        },
        "ingested_at": "2026-02-06T23:28:25.072400+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261426-Cambsblu-27749685",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040833",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "I do hope you are right. Just taken another 5m so now sitting at an average of 0.3p rather than 0.35 this time last week. I expected the Whitehouse announcement last week to prompt some action from one or more of the big US companies so fingers crossed for news very soon!",
          "sentiment": 0.0,
          "engagement": "23",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-06T23:28:25.072418+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261409-dvharris-33646286",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041279",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "It wasn't so long ago we were on the cusp of trading above 0.4p. A placing and a (distressed?) seller later and here we are with a mcap of just \u00a317M! As Yazoo would say....the only way is up! \ud83d\udd7a \ud83d\udc83",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-06T23:28:25.072436+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261355-MadEngli--7987304",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041693",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "We don't get traders off-loading the second we head back into the 3s. ATB",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.255",
          "thread_title": "Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-06T23:28:25.072454+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261349-DaffyPic-80969836",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042116",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Thanks!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.26",
          "thread_title": "RE: Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-06T23:28:25.072472+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261305-DaffyPic-73122856",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042527",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Let's have some  showing today please!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-06T23:28:25.072490+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261228-Makingmi-13683047",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Given the timing, pricing, and fact price not affected, imo, would say those 2 x 10000000 trades were a sale and repurchase.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-06T23:28:25.072508+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261130-DaffyPic--8630806",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043373",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "10,599,803   Sold Value\t\u00a326.78k 10,140,159    Bought Value\t\u00a326.18k Approx.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-06T23:28:25.072526+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261129-DaffyPic-76935041",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043792",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"so the seller should have finished on Friday.\" I think you're right and I certainly hope you're right.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-06T23:28:25.072544+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261018-LlamaFar-70114473",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044243",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "C.M. Looks like it doesn't it. Recent sells look more retail. As DVH and Triplestar have said it's undervalued for what they have here. Worth repasting what DVH points out... A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!).",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-06T23:28:25.072563+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260955-ComesMar--4857420",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044655",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I am also noticing that up to now there are no SINT trades. My taks is that mm are not trying anymore to walk the sp, so the seller should have finished on Friday. News about 002 and 014 (and 001?) are in line for Q1.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-06T23:28:25.072581+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260952-dvharris-40617893",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045070",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!). The BoD is slowly putting the pieces of the jigsaw together and the picture isbecoming clearer.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-06T23:28:25.072598+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260935-thetripl--2206702",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045525",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "When you look at this pipeline alongside a \u00a318m\u2013\u00a320m market cap, the disconnect is obvious: Most Phase 3 biotechs trade at \u00a3100m\u2013\u00a3300m. Solvonis is being valued like a discovery-stage company, even though they have a Phase 3 trial that is largely taxpayer-funded. My Take: The market is currently ignoring the SVN-001 Phase 3 because \"Phase 3 takes time,\" and it's ignoring the SVN-015/SDN-14 because it's \"early stage.\" Once the Q1 Lead Candidate Selection (from that AI discovery engine) is announced, it acts as the bridge that proves the whole pipeline is moving forward. This is a \"sum-of-the-parts\" play. Even if you value SVN-001 at just \u00a350m and the rest of the pipeline at \u00a320m, the stock should be trading at 3x-4x its current price.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.255",
          "thread_title": "The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-06T23:28:25.072616+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260835-dvharris--1410156",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045938",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Full ask to buy even 10 quids worth...",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-06T23:28:25.072633+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260823-ParetoPr-12550379",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046361",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "SEDAR filings: https://thecse.com/listings/awakn-life-sciences-corp/sedar-filings/",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-06T23:28:25.072651+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260821-ParetoPr--8597564",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046768",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "For anyone who doesn\u2019t know, the SEDAR filings are the CAE equivalent of an RNS",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-06T23:28:25.072669+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260819-ParetoPr--2010179",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.047188",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "All CSE listings for Awakn Life Sciences: https://thecse.com/listings/awakn-life-sciences-corp/cse-filings/?page=2",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-06T23:28:25.072686+00:00"
      },
      {
        "event_id": "SOCIAL-Today1626-dvharris--6068347",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.964825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, still sell many millions of shares and now full ask for anything!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072705+00:00"
      },
      {
        "event_id": "SOCIAL-Today1620-Makingmi--6009101",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965393",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well was monitoring what I could sell a reasonable amount at and it stayed same but after that sell has now increased.  Not worth overthinking it. It\u2019s a good price to keep holding.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072723+00:00"
      },
      {
        "event_id": "SOCIAL-Today1514-dvharris--5099895",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965819",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The ask is dropping which usually signifies a worked sell. Interesting though that you can sell many millions of shares atm. We'll see after close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072742+00:00"
      },
      {
        "event_id": "SOCIAL-Today1512-DrMicho-85373761",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966247",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I was thinking the same thing to be honest... with the amount of buying i expected this to have moved up.",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072760+00:00"
      },
      {
        "event_id": "SOCIAL-Today1458-DaffyPic-58058038",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966667",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "I'm surprised it hasn't ticked up yet. Perhaps there is a big sell order being worked ??",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072778+00:00"
      },
      {
        "event_id": "SOCIAL-Today1333-Cambsblu--5155271",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967076",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Must admit I was tempted to sell several times over the past couple of months, but have been convinced it is worth holding on and adding.",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072797+00:00"
      },
      {
        "event_id": "SOCIAL-Today1328-Makingmi-72620358",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967503",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Possibly a few depressed people on here, with the price at this low level. Fortunately just a small dose of patience will do the trick. Lol.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072815+00:00"
      },
      {
        "event_id": "SOCIAL-Today1327-Andys288-90416070",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967912",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Welcome back cambsblue. I thought you had sold up months ago",
          "sentiment": 0.0,
          "engagement": "517",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072834+00:00"
      },
      {
        "event_id": "SOCIAL-Today1311-DaffyPic--8567559",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968340",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "There are a lot of depressed people on planet Earth, so  this should do very well.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072852+00:00"
      },
      {
        "event_id": "SOCIAL-Today1217-dvharris-44210596",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968754",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A very decent holding!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072870+00:00"
      },
      {
        "event_id": "SOCIAL-Today1215-Cambsblu-55408939",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969178",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Yes, couldn't resist at this level. Already have 48m bought last Autumn on the expectation of good news before the end of last year. Have been tempted to off-load some to invest elsewhere but decided to add at this silly price and hope for news by the end of Q1 !",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072888+00:00"
      },
      {
        "event_id": "SOCIAL-Today1202-dvharris--5610142",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969593",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Premium paid!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072906+00:00"
      },
      {
        "event_id": "SOCIAL-Today1201-dvharris-40883361",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I don't think too many would argue that a \u00a317M mcap seriously undervalues the potential of this company to deliver much needed treatments in areas currently pretty ill served. We have a quality BoD focused on results and maximising shareholder value. Good enough for me!\ud83d\udc4c",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072924+00:00"
      },
      {
        "event_id": "SOCIAL-Today1159-DaffyPic-21675363",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970426",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!!   11:59:01\t0.263\t8,000,000\t21.06k",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072942+00:00"
      },
      {
        "event_id": "SOCIAL-Today1155-Makingmi--6995355",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970838",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Sometimes it\u2019s not worth trying to be too clever and get the top or bottom of every price move right. Price can move quickly, so if it\u2019s a good price and you are happy with where it\u2019s going, buy it. If it goes down a bit it comes back. Less stressful too. It\u2019s called investing then, rather than gambling.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072960+00:00"
      },
      {
        "event_id": "SOCIAL-Today1138-dvharris--6521129",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971259",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "When folks are confident the seller is done we'll see plenty of buyers snapping up sub 0.3p shares.",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072979+00:00"
      },
      {
        "event_id": "SOCIAL-Today1135-MrsRobin-65543778",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971665",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Over 25m buys today and no significant sells other than big delayed sell so looking promising.",
          "sentiment": 0.0,
          "engagement": "186",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.072998+00:00"
      },
      {
        "event_id": "SOCIAL-Today1106-DaffyPic--9164715",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972083",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"The pesky seller has a lot to answer for...\" Yes, but surely they do not have many left??   If any!!",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073016+00:00"
      },
      {
        "event_id": "SOCIAL-Today1041-Makingmi-81632777",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972495",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Yes, probably safe to get some more now dvh.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073035+00:00"
      },
      {
        "event_id": "SOCIAL-Today1031-DrMicho--5968447",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972902",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes, hopefully that sell is the end and we can move on...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073053+00:00"
      },
      {
        "event_id": "SOCIAL-Today1030-dvharris-60988159",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973325",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "After the news we had earlier this week and further newsflow on other fronts expected this quarter we really should be trading above 0.3p imo. The pesky seller has a lot to answer for...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073070+00:00"
      },
      {
        "event_id": "SOCIAL-Today1029-Makingmi--7578330",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973731",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Seems the effect of the excellent news release got lost in that selling session. Bit of catching up with events to come now.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073089+00:00"
      },
      {
        "event_id": "SOCIAL-Today1024-Makingmi-28743517",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974146",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Bought in earlier so hope you are right.  No problem either way at this price though.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073123+00:00"
      },
      {
        "event_id": "SOCIAL-Today1018-dvharris-55786636",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974564",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think we've just seen the reason the SP went down yesterday and folks couldn't get sell quotes. It's an odd figure so maybe the last of the selling? Looks like a few of us are buying in the hope that is the case.......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073142+00:00"
      },
      {
        "event_id": "SOCIAL-Today0946-DaffyPic-77817550",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974975",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "In the short term.  That's 0.44.    But I am still waiting for a penny.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-06T23:28:25.073161+00:00"
      },
      {
        "event_id": "SOCIAL-Today0851-dvharris-71297265",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484140",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just imagine if they have finished and you could have bought sub 0.25p! So tempted but will hold fire for the moment....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-06T23:28:25.073178+00:00"
      },
      {
        "event_id": "SOCIAL-Today0846-DrMicho--6745362",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484578",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I am not to sure its finished yet..if it is this will move up soon enough.",
          "sentiment": 0.5,
          "engagement": "8,159",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-06T23:28:25.073196+00:00"
      },
      {
        "event_id": "SOCIAL-Today0839-dvharris-75190844",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I can sell 5M shares (pre NT) with barclays at 0.2421p. Is our seller interested? Buying at this level is an absolute gift, but worried our seller might push the price lower. Conundrum!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-06T23:28:25.073214+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262348-TrickyEF--7942179",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485452",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "From a poster on telegram. Had a q and a with Gemini about the executive order and how it may impact Solvonis. You are right to be highly optimistic.  It is rare to see a micro caps pipeline match a major executive order's priorities so precisely. Especially with a board chair who has $15 billion track record in us life sciences. Will it be flat tomorrow??",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-06T23:28:25.073233+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262344-TrickyEF--6369910",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485875",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Seems pretty legit \ud83d\ude09\ud83d\ude09 https://www.whitehouse.gov/presidential-actions/2026/01/addressing-addiction-through-the-great-american-recovery-initiative/",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "from some ****e called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=05EF86B5-7368-48E4-884F-EF5C39F8DEF2"
        },
        "ingested_at": "2026-02-06T23:28:25.073252+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261710-LlamaFar--6921471",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486299",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "0.18p? Its on the chart from June last year...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073271+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261630-dvharris--3091568",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486716",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, absolutely no incentive to buy until it drops to sub 0 2p imo. 0.2421p to sell just before the close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073289+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261622-DrMicho--8839947",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487131",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looking like the seller will have to take whats on offer as no one is buying. Same price tomorrow seller \ud83d\ude01 get on with it...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073307+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261522-DrMicho-45029629",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487538",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Me too, Im here for the foreseeable so when it is finished selling I will buy its shares on the cheap...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073326+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261500-dvharris-74482994",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487949",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The SP of my only other small cap investment seems to be on the runway ready for take off. Potentially even more money to invest here in the short/medium term....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073344+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261457-dvharris--4897805",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488375",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "No rush for me as long term hold but would add significantly more if the MMs drop the SP to sub 0.2p......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073363+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261447-LlamaFar-43926800",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488788",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope, mms dropped the price. I added at 0.18p on the way up, wasnt expecting the opportunity on the way back down. Have to ask how many does this seller have?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073381+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261436-RhHh-74364452",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Seller hopefully done. Time for the MMs to take it up.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-06T23:28:25.073399+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261331-LlamaFar--5820897",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489614",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Google is interesting. Says that the MM's can offer to take them out lock stock and barrel, maybe they sell down until they ruin the market for the stock and then the MM takes the rest at a lower price and everything goes back to normal? \"Immediate Liquidity Provision: If a seller cannot find another buyer, the market maker steps in to buy the security (hitting the bid), allowing the seller to exit the position instantly.\"",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073418+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261315-dvharris-88629493",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490027",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Can only sell 500k shares so our 5M seller will either have to wait or accept a (much) lower price. I think we will see an absence of buyers until the position becomes clearer....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073436+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261252-LlamaFar-43364671",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490451",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - same as that. We've been told in the last few RNS and Co interviews what newsflow to expect, if you are selling at this point its through desperation? The MM's job is to make an orderly market where we can sell as well as buy, if dropping the price does that then what are they waiting for?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073454+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261245-dvharris--8134971",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'd rather they drop the SP to sub 0.2p than buy anymore until the seller has finished. Otherwise just funding their sales/profits. Expecting the SP to drop later.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073472+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261242-RhHh--8155604",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491287",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pay day tomorrow but no point in topping up until the seller is done. Must admit I thought they would have finished by now.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073490+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261239-LlamaFar--6700164",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491750",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They've still shut it all off - must have lots more 5m blocks to shift into us mug punters?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073509+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261203-LlamaFar-84585862",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492241",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They were struggling to work that last 5m sell, had to close off all other sells in order to squeeze it through, previously over the last few sessions they had reduced the sells you could do to 5m shares, that's not making an orderly market so they will either have to drop the price hard, or stop performing their function as a market maker. Pretty pi55 poor  performance from the MM after the sterling RNS of yesterday, the seller is obviously desperate, cut his prices and get him/her gone.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073527+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261131-dvharris-54290949",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492748",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, I was going to add more sub 0.3p but only when the seller has finished dumping their holding...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073546+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261124-DrMicho--1033027",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493174",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I totally agree.. hopefully seller gets low prices to match his desperation \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073564+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261121-LlamaFar-60901515",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493586",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "No point in buying more if each big sell reduces the price, easier to wait till the bottom and add more on the way back up?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073583+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261120-DrMicho-37881857",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493998",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our seller was waiting for some buying before unloading\u2026 \ud83d\ude02\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073601+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261110-LlamaFar--8361737",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.494420",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "6AM in New York, Toronto, Washington...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073620+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261034-dvharris-42111935",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.436927",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073638+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260909-LlamaFar-63316062",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437392",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-06T23:28:25.073656+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260837-dvharris-54564514",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437820",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073677+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260819-LlamaFar-62981885",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438249",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073696+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260815-LlamaFar-82556802",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438688",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073714+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260010-TrickyEF--5487409",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439148",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-06T23:28:25.073733+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260005-TrickyEF-11997326",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439582",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-06T23:28:25.073751+00:00"
      },
      {
        "event_id": "SOCIAL-Today1034-dvharris-42111935",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.348543",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073769+00:00"
      },
      {
        "event_id": "SOCIAL-Today0909-LlamaFar-63316062",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349238",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-06T23:28:25.073787+00:00"
      },
      {
        "event_id": "SOCIAL-Today0837-dvharris-54564514",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349995",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073805+00:00"
      },
      {
        "event_id": "SOCIAL-Today0819-LlamaFar-62981885",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.350809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073823+00:00"
      },
      {
        "event_id": "SOCIAL-Today0815-LlamaFar-82556802",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.351641",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-06T23:28:25.073842+00:00"
      },
      {
        "event_id": "SOCIAL-Today0010-TrickyEF--5487409",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.352511",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-06T23:28:25.073860+00:00"
      },
      {
        "event_id": "SOCIAL-Today0005-TrickyEF-11997326",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.353336",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-06T23:28:25.073878+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262015-TrickyEF-32820268",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354159",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "For use at home on a daily basis. This was an attractive investment 12 months ago now it's looking fooking beautiful. Fingers crossed it don't turn into a munter.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-06T23:28:25.073897+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262006-TrickyEF--5973845",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354968",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "The OTF delivery system could turn out to be a goldmine. What's next?? Solvonis said SVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles, and noted the compound has also been selected for evaluation in the US National Institute on Drug Abuse Addiction Treatment Discovery Program for stimulant use disorders. Solvonis Therapeutics plc (LON: SVNS), (\"Solvonis\" or the \"Company\") an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that Awakn Life Sciences Corp. (\"Awakn\"), the company Solvonis plans to acquire, has reached a significant regulatory milestone. Awakn announced a positive outcome from a Pre-Investigational New Drug (\"Pre-IND\") meeting with the U.S. Food and Drug Administration (\"FDA\") regarding AWKN-002, a proprietary oral thin film (\"OTF\") formulation of esketamine, designed for sublingual and buccal administration in combination with structured alcohol education. This drug candidate is being developed for the treatment of moderate to severe alcohol use disorder (\"AUD\") with a focus on U.S market",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-06T23:28:25.073915+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261933-MadEngli--1483867",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.355775",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "LHogbog, just keep holding, this is going to blow the bl00dy doors off one day.  When this gets picked up, JVd, bought out, it'll be by a big player and you'll be so happy you were in @ .3p. ATB ME",
          "sentiment": 0.0,
          "engagement": "721",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-06T23:28:25.073933+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261907-Hogbog--1394819",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.356560",
        "source": "LSE_CHAT",
        "data": {
          "author": "Hogbog",
          "content": "In various forms it is forever on social media, but what I\u2019m keen to know if when my two large holdings both in the 3s will actually make a profit.",
          "sentiment": 0.0,
          "engagement": "892",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-06T23:28:25.073952+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261903-VikR-54746628",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.357390",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Https://www.linkedin.com/posts/jonathanmichaelholmes_this-novel-antidepressant-targets-more-than-activity- Just noted on linkedIN a motivated investor speaking highly of the pipeline. The story here just keeps more compelling with each new discovery. SSRIs are prescribed in the million &  millions and the anxiety and depression market is multi billion. Everything SVNS targets are huge addressable markets. Once the newsflow starts here it won\u2019t stop. I understand the frustration of shareholders who are getting bored with a stagnant share price but this team is not in it for a small slice of the pie, they want to hit it big. There has to be, absolutely has to be strong interest from mainstream pharma willing to put the funds to progress the projects further. I just wait for the day the blessed RNS lands. 7422302011582484482-UjTC?utm_medium=ios_app&rcm=ACoAAErGYQIB6gTMGcSk4EsXpWwMe6tdaF1kU5E&utm_source=social_share_send&utm_campaign=copy_link",
          "sentiment": 0.5,
          "engagement": "981",
          "price_at_post": "0.265",
          "thread_title": "Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-06T23:28:25.073970+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261827-TrickyEF--4729866",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.358233",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I for one hope to be still holding these come  2028/2029 and have a massive \ud83d\ude01\ud83d\ude01\ud83d\ude01 on my face. 8months old and with  just \u00a32.25 million of funding the AI of Solvonis has already popped out svn15 which is in the running for $15 million of NIH funding based on early data in relation too meth and coke addiction. This NIH support was provided before they even new about the potential for depression. No wonder the AI fund raised was covered by just 3 individuals. For \u00a32.25 million down they possibly realised  \u00a310.8 million in NIH funding. Given today's news the odds would have shortened on securing that funding. FANTASTIC new science being delivered here.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-06T23:28:25.073988+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261810-TrickyEF-14497594",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359029",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "At around the 3min 45 second mark. Early days but WOW.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-06T23:28:25.074007+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261649-DrMicho--7729072",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359813",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Hopefully the smell of the seller will vanish soon enough. Waiting for buys to squeeze that little extra so must be desperate for the money. That desperation will   help move it on\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074025+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261546-LlamaFar-24496226",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.360501",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope ... cant sell, can buy",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074043+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261520-ComesMar--2213205",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.361160",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think it just appeared ,  10m",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074061+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261515-LlamaFar-55071579",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362046",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Sellers still hanging about, waiting for a large odd amount trade to show... that's the way I've seen these end before.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074079+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261504-dvharris-87626511",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362765",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Wouldn't it be nice if the latest 10M trade was the last of our sellers holding!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074107+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261400-DrMicho--5473553",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363274",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes me too DV...it would be nice to see some grants/funding to prevent any further need for funding/placings.. but the biggy is going to be a partnership or licensing deal. This would go bonkers, absolute crazy when it happens. Taking into consideration we have a fair amount of irons in the fire it surely cant be that far away.",
          "sentiment": 0.5,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074140+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261357-LlamaFar-33089939",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363733",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The further the pipelines move down the track, the bigger the numbers, i'm not rushed for answers at the moment. 015a Meth & Coke and 015b Depression are both new news, the pipelines are being widened and getting longer as they are progressed. Sit tight and add each time someone else is forced into selling, the lower the better imo.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074160+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261343-dvharris--1065824",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364170",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'm waiting for the outcome of the discussions with the big pharmas that have been ongoing for a while now....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074178+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261303-dafad--5631279",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364584",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Soon I think-usually a proactive interview would be out by now-lack of anything leads me to think nore news soon",
          "sentiment": 0.0,
          "engagement": "2,397",
          "price_at_post": "0.265",
          "thread_title": "More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-06T23:28:25.074196+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261215-LlamaFar--4664152",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365003",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - sit tight and wait for the bargains. If they have to sell cheaply the price will be dropping?",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-06T23:28:25.074215+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261205-ComesMar--4881442",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365476",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "According to Gemini, these are probably Canadian investors or institutions, with the clear mandate to quit. There is nothing to do other than wait that they are done with selling.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-06T23:28:25.074233+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261156-dvharris-33815357",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691006",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think you are right Llama, but the seller does seem to want to dispose of an awful lot of shares....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-06T23:28:25.074252+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261140-cinderco--3615397",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691680",
        "source": "LSE_CHAT",
        "data": {
          "author": "cindercone",
          "content": "Yep, some individual is selling into every rise. How much longer is anyone's guess as not a lot of liquidity here.",
          "sentiment": 0.0,
          "engagement": "2,102",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-06T23:28:25.074271+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261120-LlamaFar-17052077",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692318",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "There's obviously a large seller about - they must be in a forced sale position as you wouldn't be selling otherwise on this mornings news. Once the seller dries up, my opinion is it rockets.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-06T23:28:25.074288+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261119-dvharris-12082615",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692922",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, didn't think I'd be on the verge of meeting desmond again!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-06T23:28:25.074307+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261118-LlamaFar--5711114",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.693581",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "3.50mins - \"All depressives\" All depressives\" refers to the broad spectrum of clinical, chronic, and situational mental health conditions characterized by persistent low mood, loss of interest, and decreased energy. Psychiatrists often view depression as a range of experiences rather than one single disease, spanning from mild, temporary, to severe. Here is a breakdown of the various types of depression based on recognized diagnostic criteria (DSM-5): Primary Types of Depressive Disorders Major Depressive Disorder (MDD) / Clinical Depression: The most common form, involving severe symptoms\u2014such as intense sadness, hopelessness, or loss of interest\u2014that last for at least two weeks and interfere with daily life. Persistent Depressive Disorder (PDD) / Dysthymia: A chronic, low-grade, or moderate depression that lasts for two years or more. Bipolar Disorder (Manic Depression): While not exclusively a depressive disorder, this involves alternating episodes of depression and high-energy mania or hypomania. Premenstrual Dysphoric Disorder (PMDD): A severe form of PMS causing extreme irritability, anxiety, or depression in the week before a period. Disruptive Mood Dysregulation Disorder (DMDD): A childhood condition characterized by extreme irritability and intense anger outbursts.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-06T23:28:25.074325+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261115-DrMicho--3884721",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694200",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Absolutely amazed that we are worse off after a positive update.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-06T23:28:25.074343+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261113-LlamaFar-48808614",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694808",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.youtube.com/watch?v=ZLhyKGvWypg At 1.50m GAME ON!!!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-06T23:28:25.074362+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261059-Bill999-62355395",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.695431",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bill999",
          "content": "Good video out on Proactive today with David Nutt.",
          "sentiment": 0.0,
          "engagement": "3",
          "price_at_post": "0.265",
          "thread_title": "Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-06T23:28:25.074380+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261055-dvharris-82490583",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696024",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very funny!\ud83d\ude01",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.26",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074399+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261029-bonesgt--7599768",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696635",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Going to stick my neck out ,think we will finish up today. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074417+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261027-dvharris--4401103",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697256",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "And we're red!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074435+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261022-bonesgt--4676306",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697855",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Was that an 8m buy disguised as a sell . Is that our buyer mopping up. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074453+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260908-ComesMar-23711434",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.698463",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "There could be tons of reasons why selling despite good news and expected catalysts. This is a gift for the ones believing in the story and with available cash.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074471+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260858-DrMicho--6838257",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699053",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our 5M buyer early on has took a 1500 quid hit. The thing that is going to move this properly is a licensing deal/large funding/partnership news. All of this could happen imminently, US listing, results take time.. still hopeful of something dropping that will shift this selling trend.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074489+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260856-TheDealB--1717185",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699614",
        "source": "LSE_CHAT",
        "data": {
          "author": "TheDealBreaker",
          "content": "The bigger question is not who is selling but why?  Why sell on good news and the potential of more good news? They are clearly not moving shares into an ISA as there are no corresponding buys. Thanks",
          "sentiment": 0.0,
          "engagement": "304",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074507+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260847-RhHh-32309325",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700037",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I thought the seller was finished ages ago! Who is it?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074526+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260842-bonesgt-19231838",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700480",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "This is nuts ,what will it take. Who is the seller? Can't have many left surely.",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074544+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260838-dvharris-49313241",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700904",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pow,  5M number 3! Not another red day after yet another positive update surely?",
          "sentiment": 0.0,
          "engagement": "21,054",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074562+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260836-RhHh-77842901",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.701462",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I hate that damn seller! Be a red finish at this rate ffs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074580+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260816-dvharris--7929621",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702149",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like the 5M seller is up early. Oh well......",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074598+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260815-RhHh-41229611",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702662",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Tq",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074615+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260811-LlamaFar-86089545",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703082",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Get a broker and buy on the pre market - hence the premium.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074633+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260805-EpicViru-62548394",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703515",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "You can place an order to be executed",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074651+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260804-RhHh-58770848",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703931",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "How can you buy before the open?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074669+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260802-dvharris--1999580",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.704377",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "With the number of darts we're throwing at the board one is going to hit the bullseye!\ud83c\udfaf",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.29",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074687+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260755-DaffyPic--8890335",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558067",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice and early. 07:54:38\t0.295\t5,000,000\t14.75k",
          "sentiment": 0.0,
          "engagement": "3,575",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074705+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260740-Scoutt--3497329",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558633",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "Diversification always good in binary developments, shaping up to be a wonder treatment, if it goes half as well as I\u2019m expecting we will be a penny share by mid year.  Substance mis-use, PTSD, Depression, if we can use it for Anxiety we can shout Bingo.",
          "sentiment": 0.0,
          "engagement": "975",
          "price_at_post": "0.27",
          "thread_title": "Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-06T23:28:25.074723+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260724-Stretcht-74108119",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559180",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Good news, let\u2019s see how that is received.",
          "sentiment": 0.0,
          "engagement": "207",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-06T23:28:25.074741+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260711-Andys288--8136190",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559701",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019m feeling a bit blue today, if only there was a new treatment for depression\u2026.. #hellofreddy",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-06T23:28:25.074759+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260706-EpicViru--1999459",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560283",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Here we go hold onto your seats. An hour before the floodgates open.",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-06T23:28:25.074778+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261602-bonesgt-90180909",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560797",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Flat or up a point today, be nice all in all we're still on track. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074795+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261147-TrickyEF--5823888",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561345",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice bones. May join ya and the Dr with a purchase this week.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074813+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261141-bonesgt-12728309",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561848",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Never  mind Tricky I've just bought another 1 mil and again another 170k . Nothings changed on coarse for licencing,  among other great things we are working on. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074831+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261139-RhHh-59954751",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562370",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Looks like the sells are being mopped up. Might even be a flat close. Not long to wait for news.",
          "sentiment": 0.5,
          "engagement": "324",
          "price_at_post": "0.255",
          "thread_title": "Buyers coming in",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18FDEE2C-AFBF-4A99-A347-D1CDEDF15437"
        },
        "ingested_at": "2026-02-06T23:28:25.074849+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261137-covgaz--8157353",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562870",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "If it hits 23 will I be correct?",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074867+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261134-TrickyEF--5060949",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.563524",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "If something is the same as it was there is no change. It looks the same to me as it did on the 20th. Not pretty not ugly the same. Same same.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074885+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261129-TrickyEF-76114480",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564177",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Covgaz don't think you realise that when you said it was going to 0.23p the trades where at 0.264p on the 20th. Guess what today's latest trade is for the same price. So it's identical price to the 20th when you posted. How is it getting messy if there is no change. \ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udee3\ud83e\udee3\ud83e\udee3",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074903+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261124-covgaz--8663096",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564764",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "It's getting very ugly here , I did say will this be testing 23 again. Looks like it will.",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074921+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261120-DrMicho-15890628",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565378",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I have bought another 3M over the past few days to add to my growing collection. I\u2019m not complaining just curious why some would sell so close to news. Anyway GL to all\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074939+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261113-Andys288-28529494",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565967",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019ve not sold anything and have bought a few more over the last few weeks,  I\u2019ve not seen or heard anything to dissuade me that this is a great share to hold, and as a long term holder I am still in profit.  Just waiting for the news flow to start and this should go bonkers",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074957+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261108-DrMicho--2169052",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.566597",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering it\u2019s been reported that we are expecting a news rich period (originally dec) it\u2019s looking pretty grim at the moment. I am surprised at the constant selling tbh, is someone aware of something.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074976+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20262005-LlamaFar-76970749",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567196",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nice lumpy rollover, then a bed n isa.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.074994+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261601-dvharris--8273387",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567625",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like someone is taking steps to protect future profits from HMRC!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.075012+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261226-LlamaFar--6585404",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568050",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 26 / 90. Looks like traders entered on Friday as the MM's ran it up 10% and were stopped out this morning after no RNS turned up to save their positions....",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.075031+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261131-ComesMar-51445583",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568488",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "It is clear that until news lands, the sp will be at the mercy of traders. In the long term perspective this is just noise, provided that the science behaves the way they claim.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.075195+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260956-turnthec-13321282",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569024",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Couldn\u2019t resist another top up at 0.2768 as only a matter of time will make this look like steal",
          "sentiment": 0.0,
          "engagement": "314",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.075214+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260927-wookieem--8347732",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569681",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "As volitile as an alcoholic this share",
          "sentiment": 0.0,
          "engagement": "4,352",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.075233+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260925-RhHh-14102736",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570224",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "As expected after the ut on Friday. Poxy MMs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "**** drop",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DDC62C70-85CB-418D-B6A7-4EC41E27F08D"
        },
        "ingested_at": "2026-02-06T23:28:25.075250+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262144-LlamaFar-44337644",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570667",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Only slightly .. 001 and 002 - Aud - market leading results 014 - Ptsd - no other treatment 015 - Meth & coke - no other treatment.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.075269+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262003-dvharris--7785368",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.571083",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Are you suggesting we're undervalued?  \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-06T23:28:25.075287+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261725-MadEngli--2129163",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.233592",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Next week Rodney...\ud83d\ude01 ATB",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.28",
          "thread_title": "This time...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=784600CF-6EA6-48B9-8E3B-25B205222B70"
        },
        "ingested_at": "2026-02-06T23:28:25.075305+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261122-Stretcht-31631047",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234032",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Time to test those recent highs and have some positive news hitting the wires.",
          "sentiment": 0.0,
          "engagement": "195",
          "price_at_post": "0.28",
          "thread_title": "RE: 24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-06T23:28:25.075323+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261107-EpicViru--7842978",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234477",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Let's keep this countdown ticking. GLA \ud83d\udc0e Time to run the race",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.28",
          "thread_title": "24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-06T23:28:25.075341+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261047-dvharris-60583035",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234903",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Nice to see some upward movement ahead of expected newsflow this quarter......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.28",
          "thread_title": "RE: FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-06T23:28:25.075359+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261031-Andys288-24181756",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Strong support today, and I wouldn\u2019t want to be out over the weekend with all the expected news,",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-06T23:28:25.075377+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261836-MadEngli-64327488",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235739",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-02-06T23:28:25.075395+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261521-Andys288--1106340",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236157",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-06T23:28:25.075413+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261219-LlamaFar-17082453",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236578",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-06T23:28:25.075432+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261122-dvharris-91483226",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236990",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-06T23:28:25.075450+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260924-EpicViru-44482540",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237415",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-06T23:28:25.075468+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260826-dvharris-24121796",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237828",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-06T23:28:25.075486+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260732-EpicViru--5318677",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238254",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-06T23:28:25.075503+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF-59385226",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238671",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-06T23:28:25.075521+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb--5706815",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239142",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-06T23:28:25.075539+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris-41152398",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239562",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-06T23:28:25.075557+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar-64880966",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239967",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-06T23:28:25.075575+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh-50093235",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240392",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-06T23:28:25.075593+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar--7122953",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-06T23:28:25.075611+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz--3744476",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241235",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,499",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-06T23:28:25.075629+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar--5242510",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241643",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-06T23:28:25.075648+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb-62869555",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242059",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-06T23:28:25.075669+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar-49577672",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242517",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-06T23:28:25.075687+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--3427396",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242929",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-06T23:28:25.075705+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF-83304775",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243353",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-06T23:28:25.075724+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar--7542764",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243772",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-02-06T23:28:25.075741+00:00"
      },
      {
        "event_id": "SOCIAL-Today1618-TrickyEF--9636475",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.123321",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi llama. A lil blue would concur with your post re seller being out.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285722+00:00"
      },
      {
        "event_id": "SOCIAL-Today1546-LlamaFar-90277329",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.123764",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky - the MM's were trying to pick up 12m last week on the cheap.. that's what you've seen being resold imo. Sellers gone, what's left are PI's with Xmas and January sales credit card bills to pay selling a few, from what i've read, everyone else has been adding what they can.",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285763+00:00"
      },
      {
        "event_id": "SOCIAL-Today1540-dvharris-24322094",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.124215",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Approaching the middle of Q1 and we were told this quarter was going to be news rich. Action packed second half it is then......",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285797+00:00"
      },
      {
        "event_id": "SOCIAL-Today1501-TrickyEF-41192557",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.124645",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I to have a feeling in my bones. Let's have some good bridging data news. Rather the licensing deal comes after positive bridging data. Would Improves Solvonis hand big time.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285829+00:00"
      },
      {
        "event_id": "SOCIAL-Today1457-bonesgt--7095249",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125055",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "He's done be positive Tricky ,its gana fly a feeling.",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285861+00:00"
      },
      {
        "event_id": "SOCIAL-Today1453-TrickyEF--2484831",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125487",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Il say has the seller c u not finished or waiting till tomorrow to drop some. 12mil bought today sod all sold.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285895+00:00"
      },
      {
        "event_id": "SOCIAL-Today1252-RhHh--5305374",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125896",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I'm not frightened! Only a matter of waiting and we should be rewarded. Encouraging to think the seller is done.",
          "sentiment": 0.0,
          "engagement": "332",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285927+00:00"
      },
      {
        "event_id": "SOCIAL-Today1248-bonesgt--9089594",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.126312",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "I think everyone frightened to say anything.  Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285958+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20260941-LlamaFar--2154826",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.126768",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Missing targets is never a good look, but to recap the reasons given. 1. 001 not licensed yet as big pharma move more slowly, conference season, have to accept our 2. 002 - Wuxi App Tec chosen due to lower cost and their FDA accreditation, to provide the bridging data. China have strict import controls on Ketamin from Germany, where LTS Lohann mfr the oral thin film, has slowed the results. On one side of the argument there is capital protection, on the other is speed of response, with that great gift of hindsight, would they have been better to raise again and use a more expensive 'Western' provider and be entering phase 2b and maybe list in the USA quicker rather than wait a month or two? Was there a learning curve there? On balance, I was ok with the explanations given, nothing has failed a trial, they haven't placed and diluted me. In the meantime, they've added 15a depression and 15b meth & coke with non dillutive USA Govt funding to the pipeline on 15b, from that same saved cashflow from using Wuxi on 002, which I wasn't expecting from them. So while encountering difficulties and time delays in one area of the business ( AUD ) they've smashed it in two others of depression and drug addiction whilst also progression the PTSD arm Like an ambidextrous boxer, they met resistance and flowed seamlessly, into southpaw and haven't stopped moving forwards. Add 15a and 15b into a Nasdaq listing with 001 out licensed, 002 and 014 and I can see a market cap to get excited over. Is it still at the point of jam tomorrow? As of today, Yes 100%, but the jam looks stickier and the lumps of fruit in it look bigger!",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.245",
          "thread_title": "SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-09T23:48:17.285991+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261609-dvharris--1585635",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127188",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, full ask for anything at Barclays....",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286029+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261550-bonesgt--6460161",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127587",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Here's hoping ,times a ticking, need your tickets, trains hopefully building steam for the journey ahead. Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286054+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261506-Andys288--4687732",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127987",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "FOMO Friday\u2026..",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286074+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261503-TrickyEF--5604138",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.128407",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Someone has not curved their enthusiasm.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286092+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261459-DaffyPic--6187828",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.128818",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!! 14:56:22\t0.25\t8,000,000\t20.00k",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286127+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261457-DrMicho-73011628",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.129232",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yep, looks like we have movement upwards...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.24",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286146+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261424-RhHh--2943212",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.129634",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pretty certain that we've hit the bottom. Only going up from here.",
          "sentiment": 0.5,
          "engagement": "332",
          "price_at_post": "0.24",
          "thread_title": "Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286165+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261110-dvharris--1350231",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130040",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just added another 2M+ which is showing red! Far too cheap.....",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-09T23:48:17.286184+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261015-turnthec--4597729",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130463",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Can\u2019t believe one can buy below 25 so another top up of 1 million this morning",
          "sentiment": 0.0,
          "engagement": "325",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-09T23:48:17.286203+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20260750-thetripl-74747555",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130894",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "The recent drift to 0.25p is a gift. We are seeing a classic \"forced washout\" (likely silver-crash margin calls) meeting a rock-solid floor. Why I\u2019m holding for the re-rate: Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%\u2014they are CNS pros building for a major exit. The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from \"AI discovery\" to \"clinical reality.\" Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the \"Prozac-sized\" depression market have fundamentally changed the valuation floor. Buyout Potential: At an \u00a318m market cap, we are a \"snack\" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels. The seller is running dry and the news is incoming. For those with averages in the 30s\u2014patience pays here. The science is better than it\u2019s ever been.",
          "sentiment": 0.0,
          "engagement": "915",
          "price_at_post": "0.24",
          "thread_title": "The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-09T23:48:17.286221+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20260023-LlamaFar--7673484",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.131336",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "At the moment you either hold cash or imo you hold decent opportunity Pharmas for the multibag opportunity. Has to have low cash burn, has to have multiple products in a pipeline so it doesn't blow up on one delay or failure, has to have an exerienced, cohesive BOD that are fit for purpose.. 1.In early 2026, U.S. markets experienced significant volatility, leading to increased margin requirements and, in some cases, margin calls, particularly within the metals sector. A sharp, late-January 2026, sell-off in commodities, where silver fell nearly 30%, followed a record-breaking, speculative rally. This correction forced liquidations on leveraged positions as exchanges tightened rules, this resulted in investors selling anything liquid to cover their blown up positions, I reckon thats where our sellers came from. 2. Holding pharmaceutical stocks during a market correction is generally considered a defensive strategy, as the sector provides essential products that remain in demand regardless of economic conditions. 3.Patent Cliff Approaching. 4.Pipeline of large unmet needs.Repurposed and novel molecule pipeline.",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.245",
          "thread_title": "Holding pharma stocks in a market correction?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BF229829-D5CE-43E3-9AE7-7062F3875B81"
        },
        "ingested_at": "2026-02-09T23:48:17.286239+00:00"
      },
      {
        "event_id": "SOCIAL-Today1609-dvharris--1585635",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.588646",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, full ask for anything at Barclays....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286258+00:00"
      },
      {
        "event_id": "SOCIAL-Today1550-bonesgt--6460161",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589082",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Here's hoping ,times a ticking, need your tickets, trains hopefully building steam for the journey ahead. Gla",
          "sentiment": 0.5,
          "engagement": "1,570",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286277+00:00"
      },
      {
        "event_id": "SOCIAL-Today1506-Andys288--4687732",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589521",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "FOMO Friday\u2026..",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286295+00:00"
      },
      {
        "event_id": "SOCIAL-Today1503-TrickyEF--5604138",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589937",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Someone has not curved their enthusiasm.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286313+00:00"
      },
      {
        "event_id": "SOCIAL-Today1459-DaffyPic--6187828",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590360",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!! 14:56:22\t0.25\t8,000,000\t20.00k",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286332+00:00"
      },
      {
        "event_id": "SOCIAL-Today1457-DrMicho-73011628",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590770",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yep, looks like we have movement upwards...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.24",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286350+00:00"
      },
      {
        "event_id": "SOCIAL-Today1424-RhHh--2943212",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pretty certain that we've hit the bottom. Only going up from here.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.24",
          "thread_title": "Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-09T23:48:17.286368+00:00"
      },
      {
        "event_id": "SOCIAL-Today1110-dvharris--1350231",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591616",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just added another 2M+ which is showing red! Far too cheap.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-09T23:48:17.286386+00:00"
      },
      {
        "event_id": "SOCIAL-Today1015-turnthec--4597729",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592020",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Can\u2019t believe one can buy below 25 so another top up of 1 million this morning",
          "sentiment": 0.0,
          "engagement": "323",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-09T23:48:17.286404+00:00"
      },
      {
        "event_id": "SOCIAL-Today0750-thetripl-74747555",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592470",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "The recent drift to 0.25p is a gift. We are seeing a classic \"forced washout\" (likely silver-crash margin calls) meeting a rock-solid floor. Why I\u2019m holding for the re-rate: Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%\u2014they are CNS pros building for a major exit. The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from \"AI discovery\" to \"clinical reality.\" Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the \"Prozac-sized\" depression market have fundamentally changed the valuation floor. Buyout Potential: At an \u00a318m market cap, we are a \"snack\" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels. The seller is running dry and the news is incoming. For those with averages in the 30s\u2014patience pays here. The science is better than it\u2019s ever been.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.24",
          "thread_title": "The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-09T23:48:17.286422+00:00"
      },
      {
        "event_id": "SOCIAL-Today0023-LlamaFar--7673484",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592896",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "At the moment you either hold cash or imo you hold decent opportunity Pharmas for the multibag opportunity. Has to have low cash burn, has to have multiple products in a pipeline so it doesn't blow up on one delay or failure, has to have an exerienced, cohesive BOD that are fit for purpose.. 1.In early 2026, U.S. markets experienced significant volatility, leading to increased margin requirements and, in some cases, margin calls, particularly within the metals sector. A sharp, late-January 2026, sell-off in commodities, where silver fell nearly 30%, followed a record-breaking, speculative rally. This correction forced liquidations on leveraged positions as exchanges tightened rules, this resulted in investors selling anything liquid to cover their blown up positions, I reckon thats where our sellers came from. 2. Holding pharmaceutical stocks during a market correction is generally considered a defensive strategy, as the sector provides essential products that remain in demand regardless of economic conditions. 3.Patent Cliff Approaching. 4.Pipeline of large unmet needs.Repurposed and novel molecule pipeline.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "Holding pharma stocks in a market correction?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BF229829-D5CE-43E3-9AE7-7062F3875B81"
        },
        "ingested_at": "2026-02-09T23:48:17.286440+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261939-LlamaFar--1729554",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593359",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Wood from trees. If warrants, would have been rns as cash inflow to business no rns no warrants flipped. If you've looked up who owns those 0.10p lending warrants you will understand why/ how they are holding, quite a?few of the pi's are still holding from 0.10p as well ;) Legacy graft polymer - they went long ago - link to lending warrants. Good question to ask any small cap, when are you placing next? The CEO replied to that direct question \"we are not looking to raise funds at the moment, we have a cash runway until q1 2027, we are in talks with more than 1 party to out license our svn001 asset\". If you read the news, ur obvs on Twitter to know of Harald, the wider u.s. market has had a lot of leverage calls recently. I doubt if you need to look further than that for your seller. Add to that ceo saying at Mar A Lago there was an ultra high net worth investor on nearly every table, i.e. we have a lot of u.s. investors, wouldnt be a surprise if one or two had got caught and trimmed their portfolios? The positive is that the s.p. hasn't cratered, has widened its pipeline of assets, reconfirmed 001 still in negotiations etc etc. Hope you time yr buy ins correctly ;)",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286459+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261935-woodfrom--8770142",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593775",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "If they have sufficient cash to last until 2027, then the main overhang is likely the cheap warrants being sold. It\u2019s unclear whether these warrants were ever repriced. The CEO, at least, appears to have a credible track record.",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286478+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261924-woodfrom--4250851",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594191",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "What's causing the price weakness?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286495+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261917-woodfrom--5516554",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594590",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Has your brain been replaced with an AI robot?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286513+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261912-ComesMar--5709564",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595016",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "The \"WFTT\" Profile: A Sophisticated Opportunist \u200bThe \"AI-Style\" Researcher (Upland Resources - Jan 2026): Just two weeks ago, WFTT was posting on the Upland (UPL) board using highly detailed, institutional-sounding language (very similar to the \"Jigger\" report) to defend a director's options. They were explaining complex 5p options and arguing for a massive re-rating. \u200bThe Takeaway: They are capable of doing deep, positive research when it suits them. This proves their current \"Strong Sell\" on SVNS is a deliberate choice, not a lack of understanding. \u200bThe \"Rumour Monger\" (Reabold Resources - Jan 2026): On the RBD board, they were active in spreading rumours about \"well-known pump and dumpers\" like Harald. They have a history of using fear-based narratives to influence small-cap sentiment. \u200bThe \"Contradiction\": While they attack SVNS for \"cash burn,\" they were recently celebrating the \"NAV value\" of Hot Rocks (HRIP.PL) despite similar market conditions.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286531+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261852-woodfrom-76248859",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595447",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Whenever you see a seller finished ramp you know you're in for a treat. Legacy graft Polymer overhang? or is it the 0.1p warrant overhang....",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286549+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261825-Andys288-66621427",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595860",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Perhaps you should listen to the recent pod cast again where \u201c A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027\u201d Placing from a troll or cash runway from the MD I wonder who I believe\u2026.",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286567+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261819-woodfrom-16188487",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596288",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "To me looks like a placing will be incoming imminently here. \u00a31.7m cash burn/6months and they had \u00a31.7m June last year so would have been down to 0 at year end... however raised \u00a31.2m in October which gives them 3 - 4 months taking it to March when they'll be on fumes again Looks like the ramp crew is all over this now to get the price up pre rug pull.",
          "sentiment": -0.5,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286585+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261715-VikR-79403361",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596692",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "And on that note also took \u00a35k today",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286603+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261714-VikR-17988987",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597114",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Welcome definitely oversold and undervalued. SVN 001 is getting out licensed this year, good as confirmed in the last interview. SVN 002 is a massive play but incremental stages to be reached with bridging study confirmation and then FDA application swiftly after for phase 2B. SVN015 hopefully gets selected for the grant. SVN-SDN-14 series gets added in for good measure. While the SP is quiet and stagnant that\u2019s the best time to accumulate, when it shoot\u2019s up on deal announcement it will trigger a HUMONGOUS re rate for the ENTIRE PORTFOLIO, 100 Million MCAP minimum",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286621+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261639-RhHh-58788627",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597527",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Nice one, NaxosDon. Good decision I reckon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286639+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261340-Andys288--7261138",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597934",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Balls going deeper, added another 5k. Now let\u2019s see this SP get back on track",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286658+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261338-MadEngli-45348468",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598349",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "I didn't know anyone in the UK knew Curb. Genius stuff. ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286676+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261320-ComesMar--2435235",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598761",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I find this quote of Richard as king John quite appreciated: \u200b\"Wait, I have an idea. Maybe if you tell me the bad news in a good way, it wouldn't sound so bad.\"",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286695+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261312-TrickyEF--2501820",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.694318",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Loved Richard Lewis and his work on curb",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286713+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261258-LlamaFar-62836860",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695150",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.dailymail.co.uk/tvshowbiz/article-15529379/jamie-lee-curtis-27-sobriety-journey-richard-lewis.html",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286731+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261231-TrickyEF-88693625",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695967",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I no longer checking in as often. Day to day movements is just pure nonsense. However fook the seller \ud83e\udd2a\ud83e\udd2a\ud83e\udd2a",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286750+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261222-MadEngli--5057098",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.696999",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Dvh...it will be back and then some.  Trust the science and the need for it. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286768+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261152-dvharris-70428702",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.697813",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very true ME, although looking at the Solvonis value in my share account when the SP was 0.4p was much more enjoyable! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286786+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261139-MadEngli-89552294",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.698618",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "It matters not that people are selling, the science hasn't changed, the potential hasn't changed, the need for this science hasn't changed. When this moves it will move quickly and massively. Happy to sit on my holding. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286805+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261136-dvharris--3014904",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.699419",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, looks like peeps selling (boredom?)....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286823+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261128-DrMicho--2625862",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700202",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Added again over the last few days. I wasn\u2019t expecting it to be this low so a decent buys for the future.",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286841+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261123-DaffyPic--4996160",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700986",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "When this gets to 0.75 - to 1.00 , my depression is going to lift.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286859+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260933-LlamaFar--3928189",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.701866",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The last couple of sessions looks like PI's selling after the event. The larger, more structured seller i.e 5m blocks isn't here - to me that says GO time... Professor Nutt has said a couple of things recently in interviews that were very  interesting, we all know that we are waiting for 001, aside from that, Nutt said. 1.On 015b Depression - well depending on how much we raise we could look at all of the depressives. A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027. Conclusion: Nutt must have been looking ahead to the U.S. listing. for his small molecules that the AI engine is pumping out. 2.On lead molecule - we will have that done in a month or so. Personally I've been adding on this dip - each to their own.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286878+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260904-dvharris-20529882",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.702633",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Poor start to the day and sells now sub published Bid of 0.25p. We need some positive news to stop the decline in SP and get us trading back above 0.3p.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286896+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261505-RhHh-88879779",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703277",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "No big sells for a few days leads me to believe that the big seller is done. If no more appear this week I think it will be safe to start topping up again.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-09T23:48:17.286914+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261345-dvharris--7856855",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703876",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like we might be heading lower again. NT to sell anything at barclays atm....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-09T23:48:17.286932+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261037-DrMicho-38601659",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.704471",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "In need of something to create a bit of volume, our seller drowned the last piece of news...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-09T23:48:17.286950+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260916-LlamaFar-12741078",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705068",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Prof David Nutt on the Mums podcast on Monday said a month or so for lead drug ... worth listening to podcast.link below a few posts ago. 001 news due. 002 news due Seems 2026 will be busy.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-09T23:48:17.286968+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260828-dvharris-42973712",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Interesting ME. Now, assuming the Seller has finished (6M available to sell now pre NT) we just need the CEO to light the touch paper with licence/funding news and watch this re rate....\ud83d\ude80\ud83d\ude80",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-09T23:48:17.286986+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261539-MadEngli--8305984",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.706455",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Based on recent industry activity, the most likely acquirer among top-tier pharmaceutical companies for Solvonis Therapeutics is AbbVie, as they have already shown active interest in acquiring similar addiction treatment pipelines. Top Potential Acquirers AbbVie: In 2025, reports indicated AbbVie was preparing a $1bn offer for Gilgamesh Pharmaceuticals, a U.S. peer in the same space, highlighting a strong strategic desire to enter this market. Other Potential Top-10 Contenders: Given the high unmet need in CNS (Central Nervous System) disorders, other top-10 firms with strong histories of psychiatric or neurological acquisitions\u2014such as Pfizer, Novartis, or Johnson & Johnson\u2014are considered likely acquirers for de-risked late-stage assets.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-09T23:48:17.287004+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261538-MadEngli-38893805",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707080",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Why Solvonis is an Attractive Target Solvonis has positioned itself as a major player in addiction treatment, particularly following its acquisition of Awakn Life Sciences in May 2025. Lead Asset (SVN-001): A Phase 3, first-of-its-kind combination therapy (IV ketamine + manualized CBT) for severe Alcohol Use Disorder (AUD), with results expected in late 2027/early 2028. US Market Asset (SVN-002): A sublingual/buccal esketamine formulation for moderate-to-severe AUD, which may follow a \"regulatory shortcut\" to bypass early trials, reducing cost and time-to-market. Discovery Engine: A pipeline targeting stimulant addiction (methamphetamine/cocaine) and a PTSD program (SVN-SDN-14).",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-09T23:48:17.287022+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261536-MadEngli-73260477",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707703",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Timing and Strategic Drivers Late-Stage Focus: Solvonis explicitly positioned itself as a \"partner of choice\" for large pharma, with discussions already underway for licensing SVN-001. High Value Target: With positive Phase 2b data, the assets are considered de-risked, and similar deals in this space have commanded up to $1.2 billion in total value.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-09T23:48:17.287041+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261524-TrickyEF-64857547",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708341",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Solvonis currently is the stand out play of the market for investors. The mouth watering situation on offer here is insane. The company currently worth \u00a317million. They have enough money to carry on with every aspect of the business for 12 months and within this  12 months window a licensing deal and \u00a312 million in funding for  svn15  may well be attained to see it all the way through phase 1. If any of this news drops then it's flying over 2p for starters. Positive Bridging data would also be a catalyst to get us over 1p.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "Cash runway covered til Q1 2027",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F5298FB3-E0C6-4F50-8445-616D8BC77247"
        },
        "ingested_at": "2026-02-09T23:48:17.287059+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261326-LlamaFar--5809724",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708995",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "E.D. Look at the value of USA early stage Pharmas dealing in same fields as this. There are a lot at the same level of progress as Solvonis, only Atai is ahead of the curve, and worth substantially more. A.T. laid it out in the Mums interview ( see link below ) that SVNS is worth money when the following inflection points happen. 001 - Phase 3 - Current stage 002 Phase 2b - About to enter 014 Phase 1 - Lead candidate then about to enter. 015a Phase 1 - Short to medium term 015b Phase 1 - short to medium term. Atai for a comparison is worth circa $1.2BN, SVNS don't need funding for 12 months, if 001 is outlicensed, will not need funding at all so stops at 6.8bn shares. that would be 17 cents a share or 12.43p per share. No wonder these American Ultra High Net Worth individuals are already invested and via Pamlico Shoals happy to keep funding.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-09T23:48:17.287077+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261316-erniedam--5416862",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.709601",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "LlamaFarmer, Thanks for your reply. Yeah, realise med term is a subjective time period. Guess I'm getting a bit impatient. Cheers for all your in depth research, it's much appreciated.",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-09T23:48:17.287096+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261205-RhHh-34127127",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710193",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "It would be good to have an updated research note from Singer to reflect the new developments. Hopefully that will happen soon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287131+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261129-LlamaFar--8660347",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710845",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "BIGGER Cost to the U.K. than Alcohol... Smoking and nicotine use impose a total annual cost of over \u00a350 billion on the UK society and economy, according to ASH Scotland estimates. This massive burden, largely from tobacco, includes around \u00a327.6 billion in lost productivity, \u00a31.82 billion for NHS healthcare, and \u00a313.9 billion in social care, far exceeding tax revenue. Key Annual Costs of Nicotine/Smoking in the UK: Total Societal Cost: Estimated at over \u00a350 billion, or \u00a349.2 billion in England alone. Lost Productivity: The largest factor, totaling \u00a327.6 billion to \u00a332 billion annually through smoking-related sickness, unemployment, and premature death. Health and Social Care: Roughly \u00a31.82 billion for the NHS and \u00a313.9 billion to \u00a315 billion in social care costs. Smoking-Related Fires: Approximately \u00a3328 million\u2013\u00a3332 million per year. Personal Costs: A 20-a-day smoking habit can cost an individual over \u00a34,200 to \u00a35,500 annually. Stop Smoking Aids: The net cost to the NHS for prescription quitting aids was \u00a313.8 million in 2024/25. Rising Trends: Costs have increased by 25% in recent years, with smoking in England costing at least \u00a321.8 billion in direct, measurable impacts. While cigarette sales are declining, the nicotine pouch market in the UK is growing rapidly, valued at over \u00a3170 million.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-09T23:48:17.287150+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261127-LlamaFar--4927336",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.711481",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Alcohol-related harm costs the UK society and economy between \u00a327 billion and \u00a352 billion annually. In England alone, the cost is estimated at \u00a327.4 billion, which includes nearly \u00a35 billion for the NHS, over \u00a314 billion for crime, and over \u00a35 billion in lost productivity. This impact exceeds the roughly \u00a312.5\u2013\u00a314 billion generated in annual alcohol tax revenue. Key components of the annual costs include: Healthcare: Approximately \u00a33.5 billion to \u00a34.91 billion for the NHS. Crime & Disorder: Roughly \u00a314.6 billion, including police, legal, and fire services. Lost Productivity: \u00a34.6 billion to \u00a35.06 billion due to absenteeism, premature death, or unemployment. Social Services: An estimated \u00a32.89 billion. With over 1.25 million annual alcohol-related hospital admissions, the total societal burden equates to roughly \u00a3485 per person per year.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Cheers",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B230C66D-50ED-4829-81AB-3229BACF0749"
        },
        "ingested_at": "2026-02-09T23:48:17.287169+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261126-dvharris--2069357",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.036870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I suspect that this time next year we'll be talking about an SP way higher than today. Remember last years Research Note valuation of 1.6p and we've made progress on a number of fronts since then.......",
          "sentiment": 0.0,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287187+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261117-LlamaFar--1010503",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037371",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky, I like the honesty, for me it makes it investable - park some money up and wait! A.T. I thought we would have out licensed 001 by Q4 2025, but we have to accept our size and wait our turn, imo referring to the Pharma events that ran from Nov 2025 - Jan 2026 that have delayed news ( and cashflow ). A.T. I went to Mar A Lago at the invitation of one of our largest share holders and met all of the Ultra High Net Worth investors, there was one of these existing Solvonis investors at each table. A.T. 002 will give us the most financial benefit, in the USA there are two parts of the world, there's the USA and there's the R.O.W. the rest of the world, that's why we will be running our 002 trial in America, its inflection point is in Phase 2b. P.N. I did my Uni thesis on Cocaine in 1979, I think these new small molecules will do something for that. K.H. (Interviewer) I don't mind telling you, I'm an investor here myself with a decent sized position! Loads of great info, listened to it twice, got more out of it the second time.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287205+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261059-RhHh-60120816",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037785",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Gonna be a great year here.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287223+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261058-TrickyEF-73090947",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038215",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Llama that interview by Nutt and AT yesterday was superb. Best yet",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287242+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20260858-LlamaFar-96796262",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038656",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ED. 10 months left in 2026, is that short or medium term? I think the focus is  getting 002 into a usa trial and funding it. He clearly said phase 2b is its inflection point. Also said he has been to America and spoken to all of their existing ultra high net worth investors via the Michael Layman Pamlico Shoals event at Mar A Lago. He must have worked out a way to get 002 into phase 2b trials, funded from current cashflows and out license of 001 that could be done from the London Exchange listing while the Nasdaq listing goes through. Another thing to note from that interview, he was tighter with certain parts of info that might affect negotiations, so maybe theres some of that as well with the Nasdaq? Look at 015a and 015b neither of these were signalled, they just landed.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287260+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262310-erniedam--1521544",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039078",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "Hi LlamaFarmer, Good video, thanks for sharing. One segment I picked up on, AT mentioned that he has aspirations to list on the NASDAQ in the med to long term. I thought he previously said this year?",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287278+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262258-LlamaFar--6914466",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039537",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Mdma - synthesised form of, for ptsd type treatments being worked on. 001 still in talks with more than 1 party - A.T. wouldn't be drawn on the number \ud83d\ude02. 002 - AT said will have most value - inflection point phase 2b, will be run in USA. 015 - Prof Nutts favourite - he's been working on cocaine addiction since 1979, thinks this new molecule will do it. Basically,what we already knew plus the new stuff. A.T. Went to Mar a Lago - UHNW investors evening, there was an existing Solvonis investor on each table as Anthony networked around the room. Money from 001 will kick start this, but 002 will take it to the Bank. These novel treatments of 014, 15a and 15b will then kick it on a gear, their inflection points AT phase 1. All that adds up to a $1bn Co. Imo",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287296+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262250-LlamaFar--3425763",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039947",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://youtu.be/AO2VdmBHBMY?si=5NzRDDTscSQEglpC",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-09T23:48:17.287315+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261523-ComesMar--2311250",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040417",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "Solvonis - has received a Notice of Allowance from the USPTO for compounds within its SVN-SDN-14 PTSD discovery programme, strengthening the intellectual property ahead of lead candidate selection expected in Q1 2026. The patent covers novel serotonin, dopamine and noradrenaline modulators designed to support pro-social engagement and enhance psychological therapy effectiveness in PTSD patients. The compounds address historical development challenges by incorporating predictable metabolic deactivation to improve pharmacokinetic control, dosing flexibility and safety margins while maintaining therapeutic activity. The USPTO examiner confirmed the novelty of the approach, finding no existing patents or publications disclosed the claimed compounds. The company has also expanded its SVN-015 programme into depression following positive preclinical data showing antidepressant-like activity comparable to fluoxetine (Prozac) after 14-day dosing in validated rodent models. SVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor designed to address symptoms poorly controlled by SSRIs, including anhedonia and reduced motivation, targeting a market of over 20 million adults with Major Depressive Disorder in the US alone. The compound is being developed as a once-daily oral therapy for at-home use aligned with standard antidepressant treatment cycles, and has separately been selected for evaluation by the US National Institute on Drug Abuse for stimulant use disorders, providing independent validation of its pharmacological profile. This remains an exceptional pharma play.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.26",
          "thread_title": "Charles Archer small cap review",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=62CD6955-201F-415B-BAD4-B42ECE570F38"
        },
        "ingested_at": "2026-02-09T23:48:17.287334+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261426-Cambsblu-22664086",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040833",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "I do hope you are right. Just taken another 5m so now sitting at an average of 0.3p rather than 0.35 this time last week. I expected the Whitehouse announcement last week to prompt some action from one or more of the big US companies so fingers crossed for news very soon!",
          "sentiment": 0.0,
          "engagement": "23",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-09T23:48:17.287352+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261409-dvharris--2787165",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041279",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "It wasn't so long ago we were on the cusp of trading above 0.4p. A placing and a (distressed?) seller later and here we are with a mcap of just \u00a317M! As Yazoo would say....the only way is up! \ud83d\udd7a \ud83d\udc83",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-09T23:48:17.287370+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261355-MadEngli-82883606",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041693",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "We don't get traders off-loading the second we head back into the 3s. ATB",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.255",
          "thread_title": "Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-09T23:48:17.287389+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261349-DaffyPic-49097765",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042116",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Thanks!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.26",
          "thread_title": "RE: Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-09T23:48:17.287407+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261305-DaffyPic--6837849",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042527",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Let's have some  showing today please!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-09T23:48:17.287426+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261228-Makingmi--2780196",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Given the timing, pricing, and fact price not affected, imo, would say those 2 x 10000000 trades were a sale and repurchase.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-09T23:48:17.287444+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261130-DaffyPic--9090510",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043373",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "10,599,803   Sold Value\t\u00a326.78k 10,140,159    Bought Value\t\u00a326.18k Approx.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-09T23:48:17.287462+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261129-DaffyPic-50858422",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043792",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"so the seller should have finished on Friday.\" I think you're right and I certainly hope you're right.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-09T23:48:17.287480+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261018-LlamaFar--4952522",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044243",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "C.M. Looks like it doesn't it. Recent sells look more retail. As DVH and Triplestar have said it's undervalued for what they have here. Worth repasting what DVH points out... A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!).",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-09T23:48:17.287499+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260955-ComesMar--8544078",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044655",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I am also noticing that up to now there are no SINT trades. My taks is that mm are not trying anymore to walk the sp, so the seller should have finished on Friday. News about 002 and 014 (and 001?) are in line for Q1.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-09T23:48:17.287517+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260952-dvharris--4435430",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045070",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!). The BoD is slowly putting the pieces of the jigsaw together and the picture isbecoming clearer.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-09T23:48:17.287535+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260935-thetripl--9093723",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045525",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "When you look at this pipeline alongside a \u00a318m\u2013\u00a320m market cap, the disconnect is obvious: Most Phase 3 biotechs trade at \u00a3100m\u2013\u00a3300m. Solvonis is being valued like a discovery-stage company, even though they have a Phase 3 trial that is largely taxpayer-funded. My Take: The market is currently ignoring the SVN-001 Phase 3 because \"Phase 3 takes time,\" and it's ignoring the SVN-015/SDN-14 because it's \"early stage.\" Once the Q1 Lead Candidate Selection (from that AI discovery engine) is announced, it acts as the bridge that proves the whole pipeline is moving forward. This is a \"sum-of-the-parts\" play. Even if you value SVN-001 at just \u00a350m and the rest of the pipeline at \u00a320m, the stock should be trading at 3x-4x its current price.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.255",
          "thread_title": "The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-09T23:48:17.287554+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260835-dvharris--3737895",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045938",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Full ask to buy even 10 quids worth...",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-09T23:48:17.287571+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260823-ParetoPr--7875861",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046361",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "SEDAR filings: https://thecse.com/listings/awakn-life-sciences-corp/sedar-filings/",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-09T23:48:17.287590+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260821-ParetoPr-37257427",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046768",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "For anyone who doesn\u2019t know, the SEDAR filings are the CAE equivalent of an RNS",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-09T23:48:17.287608+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260819-ParetoPr--3593049",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.047188",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "All CSE listings for Awakn Life Sciences: https://thecse.com/listings/awakn-life-sciences-corp/cse-filings/?page=2",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-09T23:48:17.287626+00:00"
      },
      {
        "event_id": "SOCIAL-Today1626-dvharris--3431934",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.964825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, still sell many millions of shares and now full ask for anything!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287644+00:00"
      },
      {
        "event_id": "SOCIAL-Today1620-Makingmi--7302572",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965393",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well was monitoring what I could sell a reasonable amount at and it stayed same but after that sell has now increased.  Not worth overthinking it. It\u2019s a good price to keep holding.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287662+00:00"
      },
      {
        "event_id": "SOCIAL-Today1514-dvharris-13278434",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965819",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The ask is dropping which usually signifies a worked sell. Interesting though that you can sell many millions of shares atm. We'll see after close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287680+00:00"
      },
      {
        "event_id": "SOCIAL-Today1512-DrMicho--4090196",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966247",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I was thinking the same thing to be honest... with the amount of buying i expected this to have moved up.",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287698+00:00"
      },
      {
        "event_id": "SOCIAL-Today1458-DaffyPic--2696634",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966667",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "I'm surprised it hasn't ticked up yet. Perhaps there is a big sell order being worked ??",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287716+00:00"
      },
      {
        "event_id": "SOCIAL-Today1333-Cambsblu--8457716",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967076",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Must admit I was tempted to sell several times over the past couple of months, but have been convinced it is worth holding on and adding.",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287734+00:00"
      },
      {
        "event_id": "SOCIAL-Today1328-Makingmi--2436189",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967503",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Possibly a few depressed people on here, with the price at this low level. Fortunately just a small dose of patience will do the trick. Lol.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287752+00:00"
      },
      {
        "event_id": "SOCIAL-Today1327-Andys288--6261642",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967912",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Welcome back cambsblue. I thought you had sold up months ago",
          "sentiment": 0.0,
          "engagement": "517",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287770+00:00"
      },
      {
        "event_id": "SOCIAL-Today1311-DaffyPic--2611299",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968340",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "There are a lot of depressed people on planet Earth, so  this should do very well.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287789+00:00"
      },
      {
        "event_id": "SOCIAL-Today1217-dvharris-13712951",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968754",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A very decent holding!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287806+00:00"
      },
      {
        "event_id": "SOCIAL-Today1215-Cambsblu--3557368",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969178",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Yes, couldn't resist at this level. Already have 48m bought last Autumn on the expectation of good news before the end of last year. Have been tempted to off-load some to invest elsewhere but decided to add at this silly price and hope for news by the end of Q1 !",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287825+00:00"
      },
      {
        "event_id": "SOCIAL-Today1202-dvharris-63828058",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969593",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Premium paid!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287842+00:00"
      },
      {
        "event_id": "SOCIAL-Today1201-dvharris--7974661",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I don't think too many would argue that a \u00a317M mcap seriously undervalues the potential of this company to deliver much needed treatments in areas currently pretty ill served. We have a quality BoD focused on results and maximising shareholder value. Good enough for me!\ud83d\udc4c",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287869+00:00"
      },
      {
        "event_id": "SOCIAL-Today1159-DaffyPic--6370348",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970426",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!!   11:59:01\t0.263\t8,000,000\t21.06k",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287887+00:00"
      },
      {
        "event_id": "SOCIAL-Today1155-Makingmi-79692380",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970838",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Sometimes it\u2019s not worth trying to be too clever and get the top or bottom of every price move right. Price can move quickly, so if it\u2019s a good price and you are happy with where it\u2019s going, buy it. If it goes down a bit it comes back. Less stressful too. It\u2019s called investing then, rather than gambling.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287905+00:00"
      },
      {
        "event_id": "SOCIAL-Today1138-dvharris-57449943",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971259",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "When folks are confident the seller is done we'll see plenty of buyers snapping up sub 0.3p shares.",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287923+00:00"
      },
      {
        "event_id": "SOCIAL-Today1135-MrsRobin-28035680",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971665",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Over 25m buys today and no significant sells other than big delayed sell so looking promising.",
          "sentiment": 0.0,
          "engagement": "186",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287941+00:00"
      },
      {
        "event_id": "SOCIAL-Today1106-DaffyPic-18207985",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972083",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"The pesky seller has a lot to answer for...\" Yes, but surely they do not have many left??   If any!!",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287959+00:00"
      },
      {
        "event_id": "SOCIAL-Today1041-Makingmi--6205022",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972495",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Yes, probably safe to get some more now dvh.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287977+00:00"
      },
      {
        "event_id": "SOCIAL-Today1031-DrMicho--3980920",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972902",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes, hopefully that sell is the end and we can move on...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.287995+00:00"
      },
      {
        "event_id": "SOCIAL-Today1030-dvharris--2781803",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973325",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "After the news we had earlier this week and further newsflow on other fronts expected this quarter we really should be trading above 0.3p imo. The pesky seller has a lot to answer for...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.288013+00:00"
      },
      {
        "event_id": "SOCIAL-Today1029-Makingmi--7935687",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973731",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Seems the effect of the excellent news release got lost in that selling session. Bit of catching up with events to come now.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.288031+00:00"
      },
      {
        "event_id": "SOCIAL-Today1024-Makingmi-11970822",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974146",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Bought in earlier so hope you are right.  No problem either way at this price though.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.288050+00:00"
      },
      {
        "event_id": "SOCIAL-Today1018-dvharris-27516699",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974564",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think we've just seen the reason the SP went down yesterday and folks couldn't get sell quotes. It's an odd figure so maybe the last of the selling? Looks like a few of us are buying in the hope that is the case.......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.288068+00:00"
      },
      {
        "event_id": "SOCIAL-Today0946-DaffyPic--7500423",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974975",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "In the short term.  That's 0.44.    But I am still waiting for a penny.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-09T23:48:17.288086+00:00"
      },
      {
        "event_id": "SOCIAL-Today0851-dvharris--8272142",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484140",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just imagine if they have finished and you could have bought sub 0.25p! So tempted but will hold fire for the moment....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-09T23:48:17.288120+00:00"
      },
      {
        "event_id": "SOCIAL-Today0846-DrMicho-44497030",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484578",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I am not to sure its finished yet..if it is this will move up soon enough.",
          "sentiment": 0.5,
          "engagement": "8,159",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-09T23:48:17.288145+00:00"
      },
      {
        "event_id": "SOCIAL-Today0839-dvharris-83816302",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I can sell 5M shares (pre NT) with barclays at 0.2421p. Is our seller interested? Buying at this level is an absolute gift, but worried our seller might push the price lower. Conundrum!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-09T23:48:17.288164+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262348-TrickyEF-90134625",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485452",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "From a poster on telegram. Had a q and a with Gemini about the executive order and how it may impact Solvonis. You are right to be highly optimistic.  It is rare to see a micro caps pipeline match a major executive order's priorities so precisely. Especially with a board chair who has $15 billion track record in us life sciences. Will it be flat tomorrow??",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-09T23:48:17.288183+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262344-TrickyEF-67637507",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485875",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Seems pretty legit \ud83d\ude09\ud83d\ude09 https://www.whitehouse.gov/presidential-actions/2026/01/addressing-addiction-through-the-great-american-recovery-initiative/",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "from some ****e called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=05EF86B5-7368-48E4-884F-EF5C39F8DEF2"
        },
        "ingested_at": "2026-02-09T23:48:17.288201+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261710-LlamaFar--3943371",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486299",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "0.18p? Its on the chart from June last year...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288220+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261630-dvharris-60707762",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486716",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, absolutely no incentive to buy until it drops to sub 0 2p imo. 0.2421p to sell just before the close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288238+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261622-DrMicho-14544040",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487131",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looking like the seller will have to take whats on offer as no one is buying. Same price tomorrow seller \ud83d\ude01 get on with it...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288257+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261522-DrMicho--8170405",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487538",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Me too, Im here for the foreseeable so when it is finished selling I will buy its shares on the cheap...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288275+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261500-dvharris-21039884",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487949",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The SP of my only other small cap investment seems to be on the runway ready for take off. Potentially even more money to invest here in the short/medium term....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288293+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261457-dvharris--6712702",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488375",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "No rush for me as long term hold but would add significantly more if the MMs drop the SP to sub 0.2p......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288311+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261447-LlamaFar--9202817",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488788",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope, mms dropped the price. I added at 0.18p on the way up, wasnt expecting the opportunity on the way back down. Have to ask how many does this seller have?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288329+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261436-RhHh--8589583",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Seller hopefully done. Time for the MMs to take it up.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-09T23:48:17.288348+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261331-LlamaFar--4576863",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489614",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Google is interesting. Says that the MM's can offer to take them out lock stock and barrel, maybe they sell down until they ruin the market for the stock and then the MM takes the rest at a lower price and everything goes back to normal? \"Immediate Liquidity Provision: If a seller cannot find another buyer, the market maker steps in to buy the security (hitting the bid), allowing the seller to exit the position instantly.\"",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288366+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261315-dvharris--3839927",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490027",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Can only sell 500k shares so our 5M seller will either have to wait or accept a (much) lower price. I think we will see an absence of buyers until the position becomes clearer....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288384+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261252-LlamaFar--7128533",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490451",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - same as that. We've been told in the last few RNS and Co interviews what newsflow to expect, if you are selling at this point its through desperation? The MM's job is to make an orderly market where we can sell as well as buy, if dropping the price does that then what are they waiting for?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288402+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261245-dvharris--6194564",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'd rather they drop the SP to sub 0.2p than buy anymore until the seller has finished. Otherwise just funding their sales/profits. Expecting the SP to drop later.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288420+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261242-RhHh--5879091",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491287",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pay day tomorrow but no point in topping up until the seller is done. Must admit I thought they would have finished by now.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288438+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261239-LlamaFar--2681940",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491750",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They've still shut it all off - must have lots more 5m blocks to shift into us mug punters?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288456+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261203-LlamaFar--4144295",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492241",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They were struggling to work that last 5m sell, had to close off all other sells in order to squeeze it through, previously over the last few sessions they had reduced the sells you could do to 5m shares, that's not making an orderly market so they will either have to drop the price hard, or stop performing their function as a market maker. Pretty pi55 poor  performance from the MM after the sterling RNS of yesterday, the seller is obviously desperate, cut his prices and get him/her gone.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288474+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261131-dvharris--5171934",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492748",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, I was going to add more sub 0.3p but only when the seller has finished dumping their holding...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288492+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261124-DrMicho--3609922",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493174",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I totally agree.. hopefully seller gets low prices to match his desperation \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288510+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261121-LlamaFar-66672038",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493586",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "No point in buying more if each big sell reduces the price, easier to wait till the bottom and add more on the way back up?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288529+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261120-DrMicho-78983713",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493998",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our seller was waiting for some buying before unloading\u2026 \ud83d\ude02\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288547+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261110-LlamaFar-10796894",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.494420",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "6AM in New York, Toronto, Washington...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288565+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261034-dvharris--4824788",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.436927",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288583+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260909-LlamaFar--8180585",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437392",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-09T23:48:17.288601+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260837-dvharris-70535190",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437820",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288619+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260819-LlamaFar--1636670",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438249",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288638+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260815-LlamaFar-33769294",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438688",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288656+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260010-TrickyEF-44473667",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439148",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-09T23:48:17.288674+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260005-TrickyEF-91094525",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439582",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-09T23:48:17.288692+00:00"
      },
      {
        "event_id": "SOCIAL-Today1034-dvharris--4824788",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.348543",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288710+00:00"
      },
      {
        "event_id": "SOCIAL-Today0909-LlamaFar--8180585",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349238",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-09T23:48:17.288728+00:00"
      },
      {
        "event_id": "SOCIAL-Today0837-dvharris-70535190",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349995",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288746+00:00"
      },
      {
        "event_id": "SOCIAL-Today0819-LlamaFar--1636670",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.350809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288763+00:00"
      },
      {
        "event_id": "SOCIAL-Today0815-LlamaFar-33769294",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.351641",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-09T23:48:17.288781+00:00"
      },
      {
        "event_id": "SOCIAL-Today0010-TrickyEF-44473667",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.352511",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-09T23:48:17.288799+00:00"
      },
      {
        "event_id": "SOCIAL-Today0005-TrickyEF-91094525",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.353336",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-09T23:48:17.288817+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262015-TrickyEF--7731519",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354159",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "For use at home on a daily basis. This was an attractive investment 12 months ago now it's looking fooking beautiful. Fingers crossed it don't turn into a munter.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-09T23:48:17.288835+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262006-TrickyEF--9701391",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354968",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "The OTF delivery system could turn out to be a goldmine. What's next?? Solvonis said SVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles, and noted the compound has also been selected for evaluation in the US National Institute on Drug Abuse Addiction Treatment Discovery Program for stimulant use disorders. Solvonis Therapeutics plc (LON: SVNS), (\"Solvonis\" or the \"Company\") an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that Awakn Life Sciences Corp. (\"Awakn\"), the company Solvonis plans to acquire, has reached a significant regulatory milestone. Awakn announced a positive outcome from a Pre-Investigational New Drug (\"Pre-IND\") meeting with the U.S. Food and Drug Administration (\"FDA\") regarding AWKN-002, a proprietary oral thin film (\"OTF\") formulation of esketamine, designed for sublingual and buccal administration in combination with structured alcohol education. This drug candidate is being developed for the treatment of moderate to severe alcohol use disorder (\"AUD\") with a focus on U.S market",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-09T23:48:17.288853+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261933-MadEngli--3686472",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.355775",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "LHogbog, just keep holding, this is going to blow the bl00dy doors off one day.  When this gets picked up, JVd, bought out, it'll be by a big player and you'll be so happy you were in @ .3p. ATB ME",
          "sentiment": 0.0,
          "engagement": "721",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-09T23:48:17.288872+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261907-Hogbog--6001360",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.356560",
        "source": "LSE_CHAT",
        "data": {
          "author": "Hogbog",
          "content": "In various forms it is forever on social media, but what I\u2019m keen to know if when my two large holdings both in the 3s will actually make a profit.",
          "sentiment": 0.0,
          "engagement": "892",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-09T23:48:17.288891+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261903-VikR-37553024",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.357390",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Https://www.linkedin.com/posts/jonathanmichaelholmes_this-novel-antidepressant-targets-more-than-activity- Just noted on linkedIN a motivated investor speaking highly of the pipeline. The story here just keeps more compelling with each new discovery. SSRIs are prescribed in the million &  millions and the anxiety and depression market is multi billion. Everything SVNS targets are huge addressable markets. Once the newsflow starts here it won\u2019t stop. I understand the frustration of shareholders who are getting bored with a stagnant share price but this team is not in it for a small slice of the pie, they want to hit it big. There has to be, absolutely has to be strong interest from mainstream pharma willing to put the funds to progress the projects further. I just wait for the day the blessed RNS lands. 7422302011582484482-UjTC?utm_medium=ios_app&rcm=ACoAAErGYQIB6gTMGcSk4EsXpWwMe6tdaF1kU5E&utm_source=social_share_send&utm_campaign=copy_link",
          "sentiment": 0.5,
          "engagement": "981",
          "price_at_post": "0.265",
          "thread_title": "Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-09T23:48:17.288910+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261827-TrickyEF-33207920",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.358233",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I for one hope to be still holding these come  2028/2029 and have a massive \ud83d\ude01\ud83d\ude01\ud83d\ude01 on my face. 8months old and with  just \u00a32.25 million of funding the AI of Solvonis has already popped out svn15 which is in the running for $15 million of NIH funding based on early data in relation too meth and coke addiction. This NIH support was provided before they even new about the potential for depression. No wonder the AI fund raised was covered by just 3 individuals. For \u00a32.25 million down they possibly realised  \u00a310.8 million in NIH funding. Given today's news the odds would have shortened on securing that funding. FANTASTIC new science being delivered here.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-09T23:48:17.288928+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261810-TrickyEF-46027071",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359029",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "At around the 3min 45 second mark. Early days but WOW.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-09T23:48:17.288946+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261649-DrMicho-43796769",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359813",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Hopefully the smell of the seller will vanish soon enough. Waiting for buys to squeeze that little extra so must be desperate for the money. That desperation will   help move it on\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.288963+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261546-LlamaFar--4178466",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.360501",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope ... cant sell, can buy",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.288982+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261520-ComesMar-93338068",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.361160",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think it just appeared ,  10m",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.289000+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261515-LlamaFar--6676492",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362046",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Sellers still hanging about, waiting for a large odd amount trade to show... that's the way I've seen these end before.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.289017+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261504-dvharris--5738168",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362765",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Wouldn't it be nice if the latest 10M trade was the last of our sellers holding!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.289035+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261400-DrMicho-85338510",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363274",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes me too DV...it would be nice to see some grants/funding to prevent any further need for funding/placings.. but the biggy is going to be a partnership or licensing deal. This would go bonkers, absolute crazy when it happens. Taking into consideration we have a fair amount of irons in the fire it surely cant be that far away.",
          "sentiment": 0.5,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.289053+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261357-LlamaFar-43233425",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363733",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The further the pipelines move down the track, the bigger the numbers, i'm not rushed for answers at the moment. 015a Meth & Coke and 015b Depression are both new news, the pipelines are being widened and getting longer as they are progressed. Sit tight and add each time someone else is forced into selling, the lower the better imo.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.289071+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261343-dvharris--2684195",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364170",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'm waiting for the outcome of the discussions with the big pharmas that have been ongoing for a while now....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.289089+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261303-dafad-69141406",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364584",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Soon I think-usually a proactive interview would be out by now-lack of anything leads me to think nore news soon",
          "sentiment": 0.0,
          "engagement": "2,397",
          "price_at_post": "0.265",
          "thread_title": "More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-09T23:48:17.289115+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261215-LlamaFar--3015129",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365003",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - sit tight and wait for the bargains. If they have to sell cheaply the price will be dropping?",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-09T23:48:17.289134+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261205-ComesMar--8275836",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365476",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "According to Gemini, these are probably Canadian investors or institutions, with the clear mandate to quit. There is nothing to do other than wait that they are done with selling.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-09T23:48:17.289152+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261156-dvharris-61984982",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691006",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think you are right Llama, but the seller does seem to want to dispose of an awful lot of shares....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-09T23:48:17.289170+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261140-cinderco-91199936",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691680",
        "source": "LSE_CHAT",
        "data": {
          "author": "cindercone",
          "content": "Yep, some individual is selling into every rise. How much longer is anyone's guess as not a lot of liquidity here.",
          "sentiment": 0.0,
          "engagement": "2,102",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-09T23:48:17.289188+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261120-LlamaFar-86650058",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692318",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "There's obviously a large seller about - they must be in a forced sale position as you wouldn't be selling otherwise on this mornings news. Once the seller dries up, my opinion is it rockets.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-09T23:48:17.289206+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261119-dvharris--6407334",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692922",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, didn't think I'd be on the verge of meeting desmond again!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-09T23:48:17.289223+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261118-LlamaFar--5697248",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.693581",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "3.50mins - \"All depressives\" All depressives\" refers to the broad spectrum of clinical, chronic, and situational mental health conditions characterized by persistent low mood, loss of interest, and decreased energy. Psychiatrists often view depression as a range of experiences rather than one single disease, spanning from mild, temporary, to severe. Here is a breakdown of the various types of depression based on recognized diagnostic criteria (DSM-5): Primary Types of Depressive Disorders Major Depressive Disorder (MDD) / Clinical Depression: The most common form, involving severe symptoms\u2014such as intense sadness, hopelessness, or loss of interest\u2014that last for at least two weeks and interfere with daily life. Persistent Depressive Disorder (PDD) / Dysthymia: A chronic, low-grade, or moderate depression that lasts for two years or more. Bipolar Disorder (Manic Depression): While not exclusively a depressive disorder, this involves alternating episodes of depression and high-energy mania or hypomania. Premenstrual Dysphoric Disorder (PMDD): A severe form of PMS causing extreme irritability, anxiety, or depression in the week before a period. Disruptive Mood Dysregulation Disorder (DMDD): A childhood condition characterized by extreme irritability and intense anger outbursts.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-09T23:48:17.289241+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261115-DrMicho--2376123",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694200",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Absolutely amazed that we are worse off after a positive update.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-09T23:48:17.289260+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261113-LlamaFar--5794695",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694808",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.youtube.com/watch?v=ZLhyKGvWypg At 1.50m GAME ON!!!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-09T23:48:17.289420+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261059-Bill999--2639113",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.695431",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bill999",
          "content": "Good video out on Proactive today with David Nutt.",
          "sentiment": 0.0,
          "engagement": "3",
          "price_at_post": "0.265",
          "thread_title": "Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-09T23:48:17.289439+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261055-dvharris--1455844",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696024",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very funny!\ud83d\ude01",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.26",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289457+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261029-bonesgt-73337879",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696635",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Going to stick my neck out ,think we will finish up today. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289475+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261027-dvharris-41480903",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697256",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "And we're red!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289493+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261022-bonesgt-42699327",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697855",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Was that an 8m buy disguised as a sell . Is that our buyer mopping up. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289511+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260908-ComesMar--7510018",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.698463",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "There could be tons of reasons why selling despite good news and expected catalysts. This is a gift for the ones believing in the story and with available cash.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289528+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260858-DrMicho-89967879",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699053",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our 5M buyer early on has took a 1500 quid hit. The thing that is going to move this properly is a licensing deal/large funding/partnership news. All of this could happen imminently, US listing, results take time.. still hopeful of something dropping that will shift this selling trend.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289546+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260856-TheDealB-56207255",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699614",
        "source": "LSE_CHAT",
        "data": {
          "author": "TheDealBreaker",
          "content": "The bigger question is not who is selling but why?  Why sell on good news and the potential of more good news? They are clearly not moving shares into an ISA as there are no corresponding buys. Thanks",
          "sentiment": 0.0,
          "engagement": "304",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289564+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260847-RhHh-59720032",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700037",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I thought the seller was finished ages ago! Who is it?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289582+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260842-bonesgt-32877592",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700480",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "This is nuts ,what will it take. Who is the seller? Can't have many left surely.",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289600+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260838-dvharris-45254189",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700904",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pow,  5M number 3! Not another red day after yet another positive update surely?",
          "sentiment": 0.0,
          "engagement": "21,054",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289618+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260836-RhHh--8169342",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.701462",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I hate that damn seller! Be a red finish at this rate ffs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289636+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260816-dvharris--1334135",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702149",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like the 5M seller is up early. Oh well......",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289654+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260815-RhHh-88391639",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702662",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Tq",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289671+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260811-LlamaFar-64653462",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703082",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Get a broker and buy on the pre market - hence the premium.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289689+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260805-EpicViru--3230527",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703515",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "You can place an order to be executed",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289708+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260804-RhHh-38870566",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703931",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "How can you buy before the open?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289725+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260802-dvharris-41671977",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.704377",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "With the number of darts we're throwing at the board one is going to hit the bullseye!\ud83c\udfaf",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.29",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289743+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260755-DaffyPic--7674880",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558067",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice and early. 07:54:38\t0.295\t5,000,000\t14.75k",
          "sentiment": 0.0,
          "engagement": "3,575",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289761+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260740-Scoutt--1303009",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558633",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "Diversification always good in binary developments, shaping up to be a wonder treatment, if it goes half as well as I\u2019m expecting we will be a penny share by mid year.  Substance mis-use, PTSD, Depression, if we can use it for Anxiety we can shout Bingo.",
          "sentiment": 0.0,
          "engagement": "975",
          "price_at_post": "0.27",
          "thread_title": "Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-09T23:48:17.289779+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260724-Stretcht-72274094",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559180",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Good news, let\u2019s see how that is received.",
          "sentiment": 0.0,
          "engagement": "207",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-09T23:48:17.289797+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260711-Andys288--4401020",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559701",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019m feeling a bit blue today, if only there was a new treatment for depression\u2026.. #hellofreddy",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-09T23:48:17.289815+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260706-EpicViru--3818684",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560283",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Here we go hold onto your seats. An hour before the floodgates open.",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-09T23:48:17.289833+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261602-bonesgt--5051465",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560797",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Flat or up a point today, be nice all in all we're still on track. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289851+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261147-TrickyEF-90411451",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561345",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice bones. May join ya and the Dr with a purchase this week.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289869+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261141-bonesgt-49059592",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561848",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Never  mind Tricky I've just bought another 1 mil and again another 170k . Nothings changed on coarse for licencing,  among other great things we are working on. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289887+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261139-RhHh-61739777",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562370",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Looks like the sells are being mopped up. Might even be a flat close. Not long to wait for news.",
          "sentiment": 0.5,
          "engagement": "324",
          "price_at_post": "0.255",
          "thread_title": "Buyers coming in",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18FDEE2C-AFBF-4A99-A347-D1CDEDF15437"
        },
        "ingested_at": "2026-02-09T23:48:17.289905+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261137-covgaz-16936887",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562870",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "If it hits 23 will I be correct?",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289923+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261134-TrickyEF--6343713",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.563524",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "If something is the same as it was there is no change. It looks the same to me as it did on the 20th. Not pretty not ugly the same. Same same.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289941+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261129-TrickyEF-32254381",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564177",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Covgaz don't think you realise that when you said it was going to 0.23p the trades where at 0.264p on the 20th. Guess what today's latest trade is for the same price. So it's identical price to the 20th when you posted. How is it getting messy if there is no change. \ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udee3\ud83e\udee3\ud83e\udee3",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289959+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261124-covgaz--4458527",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564764",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "It's getting very ugly here , I did say will this be testing 23 again. Looks like it will.",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289977+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261120-DrMicho--3585296",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565378",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I have bought another 3M over the past few days to add to my growing collection. I\u2019m not complaining just curious why some would sell so close to news. Anyway GL to all\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.289995+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261113-Andys288--1377737",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565967",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019ve not sold anything and have bought a few more over the last few weeks,  I\u2019ve not seen or heard anything to dissuade me that this is a great share to hold, and as a long term holder I am still in profit.  Just waiting for the news flow to start and this should go bonkers",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290013+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261108-DrMicho--8049885",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.566597",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering it\u2019s been reported that we are expecting a news rich period (originally dec) it\u2019s looking pretty grim at the moment. I am surprised at the constant selling tbh, is someone aware of something.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290030+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20262005-LlamaFar-24910930",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567196",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nice lumpy rollover, then a bed n isa.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290048+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261601-dvharris-71425881",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567625",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like someone is taking steps to protect future profits from HMRC!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290066+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261226-LlamaFar--3890584",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568050",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 26 / 90. Looks like traders entered on Friday as the MM's ran it up 10% and were stopped out this morning after no RNS turned up to save their positions....",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290084+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261131-ComesMar-25742648",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568488",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "It is clear that until news lands, the sp will be at the mercy of traders. In the long term perspective this is just noise, provided that the science behaves the way they claim.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290110+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260956-turnthec--8673462",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569024",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Couldn\u2019t resist another top up at 0.2768 as only a matter of time will make this look like steal",
          "sentiment": 0.0,
          "engagement": "314",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290128+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260927-wookieem--7641269",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569681",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "As volitile as an alcoholic this share",
          "sentiment": 0.0,
          "engagement": "4,352",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290146+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260925-RhHh--6208855",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570224",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "As expected after the ut on Friday. Poxy MMs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "**** drop",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DDC62C70-85CB-418D-B6A7-4EC41E27F08D"
        },
        "ingested_at": "2026-02-09T23:48:17.290164+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262144-LlamaFar-65880833",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570667",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Only slightly .. 001 and 002 - Aud - market leading results 014 - Ptsd - no other treatment 015 - Meth & coke - no other treatment.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290183+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262003-dvharris--5777343",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.571083",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Are you suggesting we're undervalued?  \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-09T23:48:17.290200+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261725-MadEngli--2606629",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.233592",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Next week Rodney...\ud83d\ude01 ATB",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.28",
          "thread_title": "This time...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=784600CF-6EA6-48B9-8E3B-25B205222B70"
        },
        "ingested_at": "2026-02-09T23:48:17.290218+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261122-Stretcht-13234371",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234032",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Time to test those recent highs and have some positive news hitting the wires.",
          "sentiment": 0.0,
          "engagement": "195",
          "price_at_post": "0.28",
          "thread_title": "RE: 24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-09T23:48:17.290236+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261107-EpicViru-45970818",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234477",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Let's keep this countdown ticking. GLA \ud83d\udc0e Time to run the race",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.28",
          "thread_title": "24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-09T23:48:17.290254+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261047-dvharris-51977791",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234903",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Nice to see some upward movement ahead of expected newsflow this quarter......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.28",
          "thread_title": "RE: FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-09T23:48:17.290272+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261031-Andys288--3290304",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Strong support today, and I wouldn\u2019t want to be out over the weekend with all the expected news,",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-09T23:48:17.290290+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261836-MadEngli-55099541",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235739",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-02-09T23:48:17.290308+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261521-Andys288--6353046",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236157",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-09T23:48:17.290325+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261219-LlamaFar-22743633",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236578",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-09T23:48:17.290343+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261122-dvharris--6866482",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236990",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-09T23:48:17.290365+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260924-EpicViru-11419892",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237415",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-09T23:48:17.290383+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260826-dvharris--3983951",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237828",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-09T23:48:17.290401+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260732-EpicViru-30993896",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238254",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-09T23:48:17.290420+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF--1820100",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238671",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-09T23:48:17.290438+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb--5457475",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239142",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-09T23:48:17.290457+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris-38293056",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239562",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-09T23:48:17.290475+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar-35206192",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239967",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-09T23:48:17.290494+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh--2865973",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240392",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-09T23:48:17.290512+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar-40732615",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-09T23:48:17.290531+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz-12643486",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241235",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,499",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-09T23:48:17.290549+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar--5768916",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241643",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-09T23:48:17.290568+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb-30148689",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242059",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-09T23:48:17.290586+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar-28330353",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242517",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-09T23:48:17.290605+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--2932957",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242929",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-09T23:48:17.290623+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF--2280374",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243353",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-09T23:48:17.290642+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar--9049621",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243772",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-02-09T23:48:17.290660+00:00"
      },
      {
        "event_id": "SOCIAL-Today1740-MadEngli-28816933",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.701433",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Now what we need is...NEWS ATB ME",
          "sentiment": 0.0,
          "engagement": "737",
          "price_at_post": "0.27",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417170+00:00"
      },
      {
        "event_id": "SOCIAL-Today1126-dvharris-43618513",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.702154",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think LTHs have been increasing their holding. Now need more new converts to join the party \ud83e\udd73",
          "sentiment": 0.5,
          "engagement": "21,120",
          "price_at_post": "0.27",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417196+00:00"
      },
      {
        "event_id": "SOCIAL-Today1005-turnthec-88891397",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.702850",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Dvh Two minds thinking alike as I\u2019ve just had another top up !!",
          "sentiment": 0.0,
          "engagement": "327",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417216+00:00"
      },
      {
        "event_id": "SOCIAL-Today0941-dvharris--3404369",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.703563",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, our Seller has certainly created an opportunity for PIs to load up sub 0.3p before the BoD delivers the next updates.....",
          "sentiment": 0.0,
          "engagement": "21,120",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417249+00:00"
      },
      {
        "event_id": "SOCIAL-Today0936-TrickyEF-63247964",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.704271",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice start to the day",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417271+00:00"
      },
      {
        "event_id": "SOCIAL-Today0831-dvharris-69928832",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.704960",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like a buyer wants all the shares at 0.26p and below this morning....",
          "sentiment": 0.5,
          "engagement": "21,120",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417289+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261618-TrickyEF--1782510",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.705416",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi llama. A lil blue would concur with your post re seller being out.",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417308+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261546-LlamaFar-78553829",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.705836",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky - the MM's were trying to pick up 12m last week on the cheap.. that's what you've seen being resold imo. Sellers gone, what's left are PI's with Xmas and January sales credit card bills to pay selling a few, from what i've read, everyone else has been adding what they can.",
          "sentiment": 0.0,
          "engagement": "898",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417326+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261540-dvharris--2216046",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.706292",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Approaching the middle of Q1 and we were told this quarter was going to be news rich. Action packed second half it is then......",
          "sentiment": 0.5,
          "engagement": "21,120",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417345+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261501-TrickyEF-83105279",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.706719",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I to have a feeling in my bones. Let's have some good bridging data news. Rather the licensing deal comes after positive bridging data. Would Improves Solvonis hand big time.",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417363+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261457-bonesgt-71280106",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.707146",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "He's done be positive Tricky ,its gana fly a feeling.",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417381+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261453-TrickyEF--5276019",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.707563",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Il say has the seller c u not finished or waiting till tomorrow to drop some. 12mil bought today sod all sold.",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417400+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261252-RhHh-44019751",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.707967",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I'm not frightened! Only a matter of waiting and we should be rewarded. Encouraging to think the seller is done.",
          "sentiment": 0.0,
          "engagement": "332",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417417+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261248-bonesgt--1312048",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.708384",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "I think everyone frightened to say anything.  Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417435+00:00"
      },
      {
        "event_id": "SOCIAL-Today1618-TrickyEF--1782510",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.123321",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi llama. A lil blue would concur with your post re seller being out.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417455+00:00"
      },
      {
        "event_id": "SOCIAL-Today1546-LlamaFar-78553829",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.123764",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky - the MM's were trying to pick up 12m last week on the cheap.. that's what you've seen being resold imo. Sellers gone, what's left are PI's with Xmas and January sales credit card bills to pay selling a few, from what i've read, everyone else has been adding what they can.",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417473+00:00"
      },
      {
        "event_id": "SOCIAL-Today1540-dvharris--2216046",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.124215",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Approaching the middle of Q1 and we were told this quarter was going to be news rich. Action packed second half it is then......",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417491+00:00"
      },
      {
        "event_id": "SOCIAL-Today1501-TrickyEF-83105279",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.124645",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I to have a feeling in my bones. Let's have some good bridging data news. Rather the licensing deal comes after positive bridging data. Would Improves Solvonis hand big time.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417509+00:00"
      },
      {
        "event_id": "SOCIAL-Today1457-bonesgt-71280106",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125055",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "He's done be positive Tricky ,its gana fly a feeling.",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417527+00:00"
      },
      {
        "event_id": "SOCIAL-Today1453-TrickyEF--5276019",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125487",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Il say has the seller c u not finished or waiting till tomorrow to drop some. 12mil bought today sod all sold.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417545+00:00"
      },
      {
        "event_id": "SOCIAL-Today1252-RhHh-44019751",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125896",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I'm not frightened! Only a matter of waiting and we should be rewarded. Encouraging to think the seller is done.",
          "sentiment": 0.0,
          "engagement": "332",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417564+00:00"
      },
      {
        "event_id": "SOCIAL-Today1248-bonesgt--1312048",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.126312",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "I think everyone frightened to say anything.  Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417582+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20260941-LlamaFar--1666547",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.126768",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Missing targets is never a good look, but to recap the reasons given. 1. 001 not licensed yet as big pharma move more slowly, conference season, have to accept our 2. 002 - Wuxi App Tec chosen due to lower cost and their FDA accreditation, to provide the bridging data. China have strict import controls on Ketamin from Germany, where LTS Lohann mfr the oral thin film, has slowed the results. On one side of the argument there is capital protection, on the other is speed of response, with that great gift of hindsight, would they have been better to raise again and use a more expensive 'Western' provider and be entering phase 2b and maybe list in the USA quicker rather than wait a month or two? Was there a learning curve there? On balance, I was ok with the explanations given, nothing has failed a trial, they haven't placed and diluted me. In the meantime, they've added 15a depression and 15b meth & coke with non dillutive USA Govt funding to the pipeline on 15b, from that same saved cashflow from using Wuxi on 002, which I wasn't expecting from them. So while encountering difficulties and time delays in one area of the business ( AUD ) they've smashed it in two others of depression and drug addiction whilst also progression the PTSD arm Like an ambidextrous boxer, they met resistance and flowed seamlessly, into southpaw and haven't stopped moving forwards. Add 15a and 15b into a Nasdaq listing with 001 out licensed, 002 and 014 and I can see a market cap to get excited over. Is it still at the point of jam tomorrow? As of today, Yes 100%, but the jam looks stickier and the lumps of fruit in it look bigger!",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.245",
          "thread_title": "SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-10T23:12:42.417600+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261609-dvharris-52082389",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127188",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, full ask for anything at Barclays....",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417618+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261550-bonesgt--2276106",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127587",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Here's hoping ,times a ticking, need your tickets, trains hopefully building steam for the journey ahead. Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417636+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261506-Andys288-53716568",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127987",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "FOMO Friday\u2026..",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417655+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261503-TrickyEF--7491228",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.128407",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Someone has not curved their enthusiasm.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417673+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261459-DaffyPic--1618026",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.128818",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!! 14:56:22\t0.25\t8,000,000\t20.00k",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417691+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261457-DrMicho--1793710",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.129232",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yep, looks like we have movement upwards...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.24",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417709+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261424-RhHh--7036133",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.129634",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pretty certain that we've hit the bottom. Only going up from here.",
          "sentiment": 0.5,
          "engagement": "332",
          "price_at_post": "0.24",
          "thread_title": "Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417727+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261110-dvharris--9120459",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130040",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just added another 2M+ which is showing red! Far too cheap.....",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-10T23:12:42.417745+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261015-turnthec--8491575",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130463",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Can\u2019t believe one can buy below 25 so another top up of 1 million this morning",
          "sentiment": 0.0,
          "engagement": "325",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-10T23:12:42.417763+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20260750-thetripl--5782102",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130894",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "The recent drift to 0.25p is a gift. We are seeing a classic \"forced washout\" (likely silver-crash margin calls) meeting a rock-solid floor. Why I\u2019m holding for the re-rate: Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%\u2014they are CNS pros building for a major exit. The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from \"AI discovery\" to \"clinical reality.\" Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the \"Prozac-sized\" depression market have fundamentally changed the valuation floor. Buyout Potential: At an \u00a318m market cap, we are a \"snack\" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels. The seller is running dry and the news is incoming. For those with averages in the 30s\u2014patience pays here. The science is better than it\u2019s ever been.",
          "sentiment": 0.0,
          "engagement": "915",
          "price_at_post": "0.24",
          "thread_title": "The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-10T23:12:42.417782+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20260023-LlamaFar--4650103",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.131336",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "At the moment you either hold cash or imo you hold decent opportunity Pharmas for the multibag opportunity. Has to have low cash burn, has to have multiple products in a pipeline so it doesn't blow up on one delay or failure, has to have an exerienced, cohesive BOD that are fit for purpose.. 1.In early 2026, U.S. markets experienced significant volatility, leading to increased margin requirements and, in some cases, margin calls, particularly within the metals sector. A sharp, late-January 2026, sell-off in commodities, where silver fell nearly 30%, followed a record-breaking, speculative rally. This correction forced liquidations on leveraged positions as exchanges tightened rules, this resulted in investors selling anything liquid to cover their blown up positions, I reckon thats where our sellers came from. 2. Holding pharmaceutical stocks during a market correction is generally considered a defensive strategy, as the sector provides essential products that remain in demand regardless of economic conditions. 3.Patent Cliff Approaching. 4.Pipeline of large unmet needs.Repurposed and novel molecule pipeline.",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.245",
          "thread_title": "Holding pharma stocks in a market correction?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BF229829-D5CE-43E3-9AE7-7062F3875B81"
        },
        "ingested_at": "2026-02-10T23:12:42.417799+00:00"
      },
      {
        "event_id": "SOCIAL-Today1609-dvharris-52082389",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.588646",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, full ask for anything at Barclays....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417817+00:00"
      },
      {
        "event_id": "SOCIAL-Today1550-bonesgt--2276106",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589082",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Here's hoping ,times a ticking, need your tickets, trains hopefully building steam for the journey ahead. Gla",
          "sentiment": 0.5,
          "engagement": "1,570",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417835+00:00"
      },
      {
        "event_id": "SOCIAL-Today1506-Andys288-53716568",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589521",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "FOMO Friday\u2026..",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417853+00:00"
      },
      {
        "event_id": "SOCIAL-Today1503-TrickyEF--7491228",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589937",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Someone has not curved their enthusiasm.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417871+00:00"
      },
      {
        "event_id": "SOCIAL-Today1459-DaffyPic--1618026",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590360",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!! 14:56:22\t0.25\t8,000,000\t20.00k",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417888+00:00"
      },
      {
        "event_id": "SOCIAL-Today1457-DrMicho--1793710",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590770",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yep, looks like we have movement upwards...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.24",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417906+00:00"
      },
      {
        "event_id": "SOCIAL-Today1424-RhHh--7036133",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pretty certain that we've hit the bottom. Only going up from here.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.24",
          "thread_title": "Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-10T23:12:42.417924+00:00"
      },
      {
        "event_id": "SOCIAL-Today1110-dvharris--9120459",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591616",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just added another 2M+ which is showing red! Far too cheap.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-10T23:12:42.417942+00:00"
      },
      {
        "event_id": "SOCIAL-Today1015-turnthec--8491575",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592020",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Can\u2019t believe one can buy below 25 so another top up of 1 million this morning",
          "sentiment": 0.0,
          "engagement": "323",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-10T23:12:42.417961+00:00"
      },
      {
        "event_id": "SOCIAL-Today0750-thetripl--5782102",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592470",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "The recent drift to 0.25p is a gift. We are seeing a classic \"forced washout\" (likely silver-crash margin calls) meeting a rock-solid floor. Why I\u2019m holding for the re-rate: Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%\u2014they are CNS pros building for a major exit. The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from \"AI discovery\" to \"clinical reality.\" Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the \"Prozac-sized\" depression market have fundamentally changed the valuation floor. Buyout Potential: At an \u00a318m market cap, we are a \"snack\" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels. The seller is running dry and the news is incoming. For those with averages in the 30s\u2014patience pays here. The science is better than it\u2019s ever been.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.24",
          "thread_title": "The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-10T23:12:42.417979+00:00"
      },
      {
        "event_id": "SOCIAL-Today0023-LlamaFar--4650103",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592896",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "At the moment you either hold cash or imo you hold decent opportunity Pharmas for the multibag opportunity. Has to have low cash burn, has to have multiple products in a pipeline so it doesn't blow up on one delay or failure, has to have an exerienced, cohesive BOD that are fit for purpose.. 1.In early 2026, U.S. markets experienced significant volatility, leading to increased margin requirements and, in some cases, margin calls, particularly within the metals sector. A sharp, late-January 2026, sell-off in commodities, where silver fell nearly 30%, followed a record-breaking, speculative rally. This correction forced liquidations on leveraged positions as exchanges tightened rules, this resulted in investors selling anything liquid to cover their blown up positions, I reckon thats where our sellers came from. 2. Holding pharmaceutical stocks during a market correction is generally considered a defensive strategy, as the sector provides essential products that remain in demand regardless of economic conditions. 3.Patent Cliff Approaching. 4.Pipeline of large unmet needs.Repurposed and novel molecule pipeline.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "Holding pharma stocks in a market correction?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BF229829-D5CE-43E3-9AE7-7062F3875B81"
        },
        "ingested_at": "2026-02-10T23:12:42.417998+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261939-LlamaFar--9114614",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593359",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Wood from trees. If warrants, would have been rns as cash inflow to business no rns no warrants flipped. If you've looked up who owns those 0.10p lending warrants you will understand why/ how they are holding, quite a?few of the pi's are still holding from 0.10p as well ;) Legacy graft polymer - they went long ago - link to lending warrants. Good question to ask any small cap, when are you placing next? The CEO replied to that direct question \"we are not looking to raise funds at the moment, we have a cash runway until q1 2027, we are in talks with more than 1 party to out license our svn001 asset\". If you read the news, ur obvs on Twitter to know of Harald, the wider u.s. market has had a lot of leverage calls recently. I doubt if you need to look further than that for your seller. Add to that ceo saying at Mar A Lago there was an ultra high net worth investor on nearly every table, i.e. we have a lot of u.s. investors, wouldnt be a surprise if one or two had got caught and trimmed their portfolios? The positive is that the s.p. hasn't cratered, has widened its pipeline of assets, reconfirmed 001 still in negotiations etc etc. Hope you time yr buy ins correctly ;)",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418017+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261935-woodfrom-44963467",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593775",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "If they have sufficient cash to last until 2027, then the main overhang is likely the cheap warrants being sold. It\u2019s unclear whether these warrants were ever repriced. The CEO, at least, appears to have a credible track record.",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418035+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261924-woodfrom-18025176",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594191",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "What's causing the price weakness?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418054+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261917-woodfrom--4644447",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594590",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Has your brain been replaced with an AI robot?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418073+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261912-ComesMar-14620149",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595016",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "The \"WFTT\" Profile: A Sophisticated Opportunist \u200bThe \"AI-Style\" Researcher (Upland Resources - Jan 2026): Just two weeks ago, WFTT was posting on the Upland (UPL) board using highly detailed, institutional-sounding language (very similar to the \"Jigger\" report) to defend a director's options. They were explaining complex 5p options and arguing for a massive re-rating. \u200bThe Takeaway: They are capable of doing deep, positive research when it suits them. This proves their current \"Strong Sell\" on SVNS is a deliberate choice, not a lack of understanding. \u200bThe \"Rumour Monger\" (Reabold Resources - Jan 2026): On the RBD board, they were active in spreading rumours about \"well-known pump and dumpers\" like Harald. They have a history of using fear-based narratives to influence small-cap sentiment. \u200bThe \"Contradiction\": While they attack SVNS for \"cash burn,\" they were recently celebrating the \"NAV value\" of Hot Rocks (HRIP.PL) despite similar market conditions.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418091+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261852-woodfrom-50324292",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595447",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Whenever you see a seller finished ramp you know you're in for a treat. Legacy graft Polymer overhang? or is it the 0.1p warrant overhang....",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418132+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261825-Andys288--4054962",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595860",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Perhaps you should listen to the recent pod cast again where \u201c A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027\u201d Placing from a troll or cash runway from the MD I wonder who I believe\u2026.",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418151+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261819-woodfrom-77793859",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596288",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "To me looks like a placing will be incoming imminently here. \u00a31.7m cash burn/6months and they had \u00a31.7m June last year so would have been down to 0 at year end... however raised \u00a31.2m in October which gives them 3 - 4 months taking it to March when they'll be on fumes again Looks like the ramp crew is all over this now to get the price up pre rug pull.",
          "sentiment": -0.5,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418170+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261715-VikR-71122737",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596692",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "And on that note also took \u00a35k today",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418189+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261714-VikR-91753420",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597114",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Welcome definitely oversold and undervalued. SVN 001 is getting out licensed this year, good as confirmed in the last interview. SVN 002 is a massive play but incremental stages to be reached with bridging study confirmation and then FDA application swiftly after for phase 2B. SVN015 hopefully gets selected for the grant. SVN-SDN-14 series gets added in for good measure. While the SP is quiet and stagnant that\u2019s the best time to accumulate, when it shoot\u2019s up on deal announcement it will trigger a HUMONGOUS re rate for the ENTIRE PORTFOLIO, 100 Million MCAP minimum",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418207+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261639-RhHh--3019685",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597527",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Nice one, NaxosDon. Good decision I reckon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418226+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261340-Andys288-60221048",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597934",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Balls going deeper, added another 5k. Now let\u2019s see this SP get back on track",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418245+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261338-MadEngli--1726785",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598349",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "I didn't know anyone in the UK knew Curb. Genius stuff. ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418263+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261320-ComesMar--5480986",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598761",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I find this quote of Richard as king John quite appreciated: \u200b\"Wait, I have an idea. Maybe if you tell me the bad news in a good way, it wouldn't sound so bad.\"",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418282+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261312-TrickyEF--5972641",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.694318",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Loved Richard Lewis and his work on curb",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418300+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261258-LlamaFar-13324305",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695150",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.dailymail.co.uk/tvshowbiz/article-15529379/jamie-lee-curtis-27-sobriety-journey-richard-lewis.html",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418318+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261231-TrickyEF-23388501",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695967",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I no longer checking in as often. Day to day movements is just pure nonsense. However fook the seller \ud83e\udd2a\ud83e\udd2a\ud83e\udd2a",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418337+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261222-MadEngli-11017583",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.696999",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Dvh...it will be back and then some.  Trust the science and the need for it. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418356+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261152-dvharris-78610122",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.697813",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very true ME, although looking at the Solvonis value in my share account when the SP was 0.4p was much more enjoyable! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418374+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261139-MadEngli-72846463",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.698618",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "It matters not that people are selling, the science hasn't changed, the potential hasn't changed, the need for this science hasn't changed. When this moves it will move quickly and massively. Happy to sit on my holding. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418393+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261136-dvharris-38934359",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.699419",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, looks like peeps selling (boredom?)....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418411+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261128-DrMicho-48762611",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700202",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Added again over the last few days. I wasn\u2019t expecting it to be this low so a decent buys for the future.",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418430+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261123-DaffyPic--5277097",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700986",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "When this gets to 0.75 - to 1.00 , my depression is going to lift.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418449+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260933-LlamaFar--1003384",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.701866",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The last couple of sessions looks like PI's selling after the event. The larger, more structured seller i.e 5m blocks isn't here - to me that says GO time... Professor Nutt has said a couple of things recently in interviews that were very  interesting, we all know that we are waiting for 001, aside from that, Nutt said. 1.On 015b Depression - well depending on how much we raise we could look at all of the depressives. A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027. Conclusion: Nutt must have been looking ahead to the U.S. listing. for his small molecules that the AI engine is pumping out. 2.On lead molecule - we will have that done in a month or so. Personally I've been adding on this dip - each to their own.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418467+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260904-dvharris--8044179",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.702633",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Poor start to the day and sells now sub published Bid of 0.25p. We need some positive news to stop the decline in SP and get us trading back above 0.3p.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418485+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261505-RhHh--2852415",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703277",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "No big sells for a few days leads me to believe that the big seller is done. If no more appear this week I think it will be safe to start topping up again.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-10T23:12:42.418504+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261345-dvharris-36886283",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703876",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like we might be heading lower again. NT to sell anything at barclays atm....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-10T23:12:42.418522+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261037-DrMicho--6528359",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.704471",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "In need of something to create a bit of volume, our seller drowned the last piece of news...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-10T23:12:42.418540+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260916-LlamaFar-36962146",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705068",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Prof David Nutt on the Mums podcast on Monday said a month or so for lead drug ... worth listening to podcast.link below a few posts ago. 001 news due. 002 news due Seems 2026 will be busy.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-10T23:12:42.418558+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260828-dvharris--8290521",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Interesting ME. Now, assuming the Seller has finished (6M available to sell now pre NT) we just need the CEO to light the touch paper with licence/funding news and watch this re rate....\ud83d\ude80\ud83d\ude80",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-10T23:12:42.418576+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261539-MadEngli--8264716",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.706455",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Based on recent industry activity, the most likely acquirer among top-tier pharmaceutical companies for Solvonis Therapeutics is AbbVie, as they have already shown active interest in acquiring similar addiction treatment pipelines. Top Potential Acquirers AbbVie: In 2025, reports indicated AbbVie was preparing a $1bn offer for Gilgamesh Pharmaceuticals, a U.S. peer in the same space, highlighting a strong strategic desire to enter this market. Other Potential Top-10 Contenders: Given the high unmet need in CNS (Central Nervous System) disorders, other top-10 firms with strong histories of psychiatric or neurological acquisitions\u2014such as Pfizer, Novartis, or Johnson & Johnson\u2014are considered likely acquirers for de-risked late-stage assets.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-10T23:12:42.418595+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261538-MadEngli-91071930",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707080",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Why Solvonis is an Attractive Target Solvonis has positioned itself as a major player in addiction treatment, particularly following its acquisition of Awakn Life Sciences in May 2025. Lead Asset (SVN-001): A Phase 3, first-of-its-kind combination therapy (IV ketamine + manualized CBT) for severe Alcohol Use Disorder (AUD), with results expected in late 2027/early 2028. US Market Asset (SVN-002): A sublingual/buccal esketamine formulation for moderate-to-severe AUD, which may follow a \"regulatory shortcut\" to bypass early trials, reducing cost and time-to-market. Discovery Engine: A pipeline targeting stimulant addiction (methamphetamine/cocaine) and a PTSD program (SVN-SDN-14).",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-10T23:12:42.418613+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261536-MadEngli--2135366",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707703",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Timing and Strategic Drivers Late-Stage Focus: Solvonis explicitly positioned itself as a \"partner of choice\" for large pharma, with discussions already underway for licensing SVN-001. High Value Target: With positive Phase 2b data, the assets are considered de-risked, and similar deals in this space have commanded up to $1.2 billion in total value.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-10T23:12:42.418631+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261524-TrickyEF-79989205",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708341",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Solvonis currently is the stand out play of the market for investors. The mouth watering situation on offer here is insane. The company currently worth \u00a317million. They have enough money to carry on with every aspect of the business for 12 months and within this  12 months window a licensing deal and \u00a312 million in funding for  svn15  may well be attained to see it all the way through phase 1. If any of this news drops then it's flying over 2p for starters. Positive Bridging data would also be a catalyst to get us over 1p.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "Cash runway covered til Q1 2027",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F5298FB3-E0C6-4F50-8445-616D8BC77247"
        },
        "ingested_at": "2026-02-10T23:12:42.418650+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261326-LlamaFar--5547407",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708995",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "E.D. Look at the value of USA early stage Pharmas dealing in same fields as this. There are a lot at the same level of progress as Solvonis, only Atai is ahead of the curve, and worth substantially more. A.T. laid it out in the Mums interview ( see link below ) that SVNS is worth money when the following inflection points happen. 001 - Phase 3 - Current stage 002 Phase 2b - About to enter 014 Phase 1 - Lead candidate then about to enter. 015a Phase 1 - Short to medium term 015b Phase 1 - short to medium term. Atai for a comparison is worth circa $1.2BN, SVNS don't need funding for 12 months, if 001 is outlicensed, will not need funding at all so stops at 6.8bn shares. that would be 17 cents a share or 12.43p per share. No wonder these American Ultra High Net Worth individuals are already invested and via Pamlico Shoals happy to keep funding.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-10T23:12:42.418668+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261316-erniedam-13025542",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.709601",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "LlamaFarmer, Thanks for your reply. Yeah, realise med term is a subjective time period. Guess I'm getting a bit impatient. Cheers for all your in depth research, it's much appreciated.",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-10T23:12:42.418686+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261205-RhHh--8393877",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710193",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "It would be good to have an updated research note from Singer to reflect the new developments. Hopefully that will happen soon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418705+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261129-LlamaFar-48753696",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710845",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "BIGGER Cost to the U.K. than Alcohol... Smoking and nicotine use impose a total annual cost of over \u00a350 billion on the UK society and economy, according to ASH Scotland estimates. This massive burden, largely from tobacco, includes around \u00a327.6 billion in lost productivity, \u00a31.82 billion for NHS healthcare, and \u00a313.9 billion in social care, far exceeding tax revenue. Key Annual Costs of Nicotine/Smoking in the UK: Total Societal Cost: Estimated at over \u00a350 billion, or \u00a349.2 billion in England alone. Lost Productivity: The largest factor, totaling \u00a327.6 billion to \u00a332 billion annually through smoking-related sickness, unemployment, and premature death. Health and Social Care: Roughly \u00a31.82 billion for the NHS and \u00a313.9 billion to \u00a315 billion in social care costs. Smoking-Related Fires: Approximately \u00a3328 million\u2013\u00a3332 million per year. Personal Costs: A 20-a-day smoking habit can cost an individual over \u00a34,200 to \u00a35,500 annually. Stop Smoking Aids: The net cost to the NHS for prescription quitting aids was \u00a313.8 million in 2024/25. Rising Trends: Costs have increased by 25% in recent years, with smoking in England costing at least \u00a321.8 billion in direct, measurable impacts. While cigarette sales are declining, the nicotine pouch market in the UK is growing rapidly, valued at over \u00a3170 million.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-10T23:12:42.418723+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261127-LlamaFar--2481410",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.711481",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Alcohol-related harm costs the UK society and economy between \u00a327 billion and \u00a352 billion annually. In England alone, the cost is estimated at \u00a327.4 billion, which includes nearly \u00a35 billion for the NHS, over \u00a314 billion for crime, and over \u00a35 billion in lost productivity. This impact exceeds the roughly \u00a312.5\u2013\u00a314 billion generated in annual alcohol tax revenue. Key components of the annual costs include: Healthcare: Approximately \u00a33.5 billion to \u00a34.91 billion for the NHS. Crime & Disorder: Roughly \u00a314.6 billion, including police, legal, and fire services. Lost Productivity: \u00a34.6 billion to \u00a35.06 billion due to absenteeism, premature death, or unemployment. Social Services: An estimated \u00a32.89 billion. With over 1.25 million annual alcohol-related hospital admissions, the total societal burden equates to roughly \u00a3485 per person per year.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Cheers",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B230C66D-50ED-4829-81AB-3229BACF0749"
        },
        "ingested_at": "2026-02-10T23:12:42.418741+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261126-dvharris-32054244",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.036870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I suspect that this time next year we'll be talking about an SP way higher than today. Remember last years Research Note valuation of 1.6p and we've made progress on a number of fronts since then.......",
          "sentiment": 0.0,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418760+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261117-LlamaFar-91049946",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037371",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky, I like the honesty, for me it makes it investable - park some money up and wait! A.T. I thought we would have out licensed 001 by Q4 2025, but we have to accept our size and wait our turn, imo referring to the Pharma events that ran from Nov 2025 - Jan 2026 that have delayed news ( and cashflow ). A.T. I went to Mar A Lago at the invitation of one of our largest share holders and met all of the Ultra High Net Worth investors, there was one of these existing Solvonis investors at each table. A.T. 002 will give us the most financial benefit, in the USA there are two parts of the world, there's the USA and there's the R.O.W. the rest of the world, that's why we will be running our 002 trial in America, its inflection point is in Phase 2b. P.N. I did my Uni thesis on Cocaine in 1979, I think these new small molecules will do something for that. K.H. (Interviewer) I don't mind telling you, I'm an investor here myself with a decent sized position! Loads of great info, listened to it twice, got more out of it the second time.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418779+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261059-RhHh-81761997",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037785",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Gonna be a great year here.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418797+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261058-TrickyEF--3974527",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038215",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Llama that interview by Nutt and AT yesterday was superb. Best yet",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418815+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20260858-LlamaFar-71461889",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038656",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ED. 10 months left in 2026, is that short or medium term? I think the focus is  getting 002 into a usa trial and funding it. He clearly said phase 2b is its inflection point. Also said he has been to America and spoken to all of their existing ultra high net worth investors via the Michael Layman Pamlico Shoals event at Mar A Lago. He must have worked out a way to get 002 into phase 2b trials, funded from current cashflows and out license of 001 that could be done from the London Exchange listing while the Nasdaq listing goes through. Another thing to note from that interview, he was tighter with certain parts of info that might affect negotiations, so maybe theres some of that as well with the Nasdaq? Look at 015a and 015b neither of these were signalled, they just landed.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418833+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262310-erniedam-29529332",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039078",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "Hi LlamaFarmer, Good video, thanks for sharing. One segment I picked up on, AT mentioned that he has aspirations to list on the NASDAQ in the med to long term. I thought he previously said this year?",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418851+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262258-LlamaFar--2956341",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039537",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Mdma - synthesised form of, for ptsd type treatments being worked on. 001 still in talks with more than 1 party - A.T. wouldn't be drawn on the number \ud83d\ude02. 002 - AT said will have most value - inflection point phase 2b, will be run in USA. 015 - Prof Nutts favourite - he's been working on cocaine addiction since 1979, thinks this new molecule will do it. Basically,what we already knew plus the new stuff. A.T. Went to Mar a Lago - UHNW investors evening, there was an existing Solvonis investor on each table as Anthony networked around the room. Money from 001 will kick start this, but 002 will take it to the Bank. These novel treatments of 014, 15a and 15b will then kick it on a gear, their inflection points AT phase 1. All that adds up to a $1bn Co. Imo",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418869+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262250-LlamaFar--7694934",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039947",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://youtu.be/AO2VdmBHBMY?si=5NzRDDTscSQEglpC",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-10T23:12:42.418888+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261523-ComesMar-31004653",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040417",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "Solvonis - has received a Notice of Allowance from the USPTO for compounds within its SVN-SDN-14 PTSD discovery programme, strengthening the intellectual property ahead of lead candidate selection expected in Q1 2026. The patent covers novel serotonin, dopamine and noradrenaline modulators designed to support pro-social engagement and enhance psychological therapy effectiveness in PTSD patients. The compounds address historical development challenges by incorporating predictable metabolic deactivation to improve pharmacokinetic control, dosing flexibility and safety margins while maintaining therapeutic activity. The USPTO examiner confirmed the novelty of the approach, finding no existing patents or publications disclosed the claimed compounds. The company has also expanded its SVN-015 programme into depression following positive preclinical data showing antidepressant-like activity comparable to fluoxetine (Prozac) after 14-day dosing in validated rodent models. SVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor designed to address symptoms poorly controlled by SSRIs, including anhedonia and reduced motivation, targeting a market of over 20 million adults with Major Depressive Disorder in the US alone. The compound is being developed as a once-daily oral therapy for at-home use aligned with standard antidepressant treatment cycles, and has separately been selected for evaluation by the US National Institute on Drug Abuse for stimulant use disorders, providing independent validation of its pharmacological profile. This remains an exceptional pharma play.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.26",
          "thread_title": "Charles Archer small cap review",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=62CD6955-201F-415B-BAD4-B42ECE570F38"
        },
        "ingested_at": "2026-02-10T23:12:42.418906+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261426-Cambsblu--8009075",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040833",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "I do hope you are right. Just taken another 5m so now sitting at an average of 0.3p rather than 0.35 this time last week. I expected the Whitehouse announcement last week to prompt some action from one or more of the big US companies so fingers crossed for news very soon!",
          "sentiment": 0.0,
          "engagement": "23",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-10T23:12:42.418924+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261409-dvharris--3559342",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041279",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "It wasn't so long ago we were on the cusp of trading above 0.4p. A placing and a (distressed?) seller later and here we are with a mcap of just \u00a317M! As Yazoo would say....the only way is up! \ud83d\udd7a \ud83d\udc83",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-10T23:12:42.418942+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261355-MadEngli--3223330",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041693",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "We don't get traders off-loading the second we head back into the 3s. ATB",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.255",
          "thread_title": "Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-10T23:12:42.418961+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261349-DaffyPic-68411007",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042116",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Thanks!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.26",
          "thread_title": "RE: Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-10T23:12:42.418979+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261305-DaffyPic--2092474",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042527",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Let's have some  showing today please!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-10T23:12:42.418997+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261228-Makingmi--3383941",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Given the timing, pricing, and fact price not affected, imo, would say those 2 x 10000000 trades were a sale and repurchase.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-10T23:12:42.419015+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261130-DaffyPic--2524373",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043373",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "10,599,803   Sold Value\t\u00a326.78k 10,140,159    Bought Value\t\u00a326.18k Approx.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-10T23:12:42.419034+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261129-DaffyPic-92974712",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043792",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"so the seller should have finished on Friday.\" I think you're right and I certainly hope you're right.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-10T23:12:42.419052+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261018-LlamaFar--4548479",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044243",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "C.M. Looks like it doesn't it. Recent sells look more retail. As DVH and Triplestar have said it's undervalued for what they have here. Worth repasting what DVH points out... A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!).",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-10T23:12:42.419070+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260955-ComesMar-72909547",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044655",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I am also noticing that up to now there are no SINT trades. My taks is that mm are not trying anymore to walk the sp, so the seller should have finished on Friday. News about 002 and 014 (and 001?) are in line for Q1.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-10T23:12:42.419088+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260952-dvharris-18177153",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045070",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!). The BoD is slowly putting the pieces of the jigsaw together and the picture isbecoming clearer.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-10T23:12:42.419126+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260935-thetripl-83996963",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045525",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "When you look at this pipeline alongside a \u00a318m\u2013\u00a320m market cap, the disconnect is obvious: Most Phase 3 biotechs trade at \u00a3100m\u2013\u00a3300m. Solvonis is being valued like a discovery-stage company, even though they have a Phase 3 trial that is largely taxpayer-funded. My Take: The market is currently ignoring the SVN-001 Phase 3 because \"Phase 3 takes time,\" and it's ignoring the SVN-015/SDN-14 because it's \"early stage.\" Once the Q1 Lead Candidate Selection (from that AI discovery engine) is announced, it acts as the bridge that proves the whole pipeline is moving forward. This is a \"sum-of-the-parts\" play. Even if you value SVN-001 at just \u00a350m and the rest of the pipeline at \u00a320m, the stock should be trading at 3x-4x its current price.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.255",
          "thread_title": "The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-10T23:12:42.419145+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260835-dvharris--5529960",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045938",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Full ask to buy even 10 quids worth...",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-10T23:12:42.419163+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260823-ParetoPr-75423877",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046361",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "SEDAR filings: https://thecse.com/listings/awakn-life-sciences-corp/sedar-filings/",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-10T23:12:42.419183+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260821-ParetoPr--2018921",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046768",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "For anyone who doesn\u2019t know, the SEDAR filings are the CAE equivalent of an RNS",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-10T23:12:42.419201+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260819-ParetoPr-53769906",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.047188",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "All CSE listings for Awakn Life Sciences: https://thecse.com/listings/awakn-life-sciences-corp/cse-filings/?page=2",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-10T23:12:42.419220+00:00"
      },
      {
        "event_id": "SOCIAL-Today1626-dvharris--9011583",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.964825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, still sell many millions of shares and now full ask for anything!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419238+00:00"
      },
      {
        "event_id": "SOCIAL-Today1620-Makingmi-90638021",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965393",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well was monitoring what I could sell a reasonable amount at and it stayed same but after that sell has now increased.  Not worth overthinking it. It\u2019s a good price to keep holding.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419256+00:00"
      },
      {
        "event_id": "SOCIAL-Today1514-dvharris--4872010",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965819",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The ask is dropping which usually signifies a worked sell. Interesting though that you can sell many millions of shares atm. We'll see after close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419275+00:00"
      },
      {
        "event_id": "SOCIAL-Today1512-DrMicho--1261579",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966247",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I was thinking the same thing to be honest... with the amount of buying i expected this to have moved up.",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419293+00:00"
      },
      {
        "event_id": "SOCIAL-Today1458-DaffyPic--5899775",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966667",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "I'm surprised it hasn't ticked up yet. Perhaps there is a big sell order being worked ??",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419312+00:00"
      },
      {
        "event_id": "SOCIAL-Today1333-Cambsblu--5356942",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967076",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Must admit I was tempted to sell several times over the past couple of months, but have been convinced it is worth holding on and adding.",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419330+00:00"
      },
      {
        "event_id": "SOCIAL-Today1328-Makingmi--4979955",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967503",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Possibly a few depressed people on here, with the price at this low level. Fortunately just a small dose of patience will do the trick. Lol.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419505+00:00"
      },
      {
        "event_id": "SOCIAL-Today1327-Andys288--3419732",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967912",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Welcome back cambsblue. I thought you had sold up months ago",
          "sentiment": 0.0,
          "engagement": "517",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419524+00:00"
      },
      {
        "event_id": "SOCIAL-Today1311-DaffyPic-46492706",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968340",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "There are a lot of depressed people on planet Earth, so  this should do very well.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419542+00:00"
      },
      {
        "event_id": "SOCIAL-Today1217-dvharris--4953237",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968754",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A very decent holding!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419561+00:00"
      },
      {
        "event_id": "SOCIAL-Today1215-Cambsblu--6311490",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969178",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Yes, couldn't resist at this level. Already have 48m bought last Autumn on the expectation of good news before the end of last year. Have been tempted to off-load some to invest elsewhere but decided to add at this silly price and hope for news by the end of Q1 !",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419578+00:00"
      },
      {
        "event_id": "SOCIAL-Today1202-dvharris-26867399",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969593",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Premium paid!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419596+00:00"
      },
      {
        "event_id": "SOCIAL-Today1201-dvharris--2792579",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I don't think too many would argue that a \u00a317M mcap seriously undervalues the potential of this company to deliver much needed treatments in areas currently pretty ill served. We have a quality BoD focused on results and maximising shareholder value. Good enough for me!\ud83d\udc4c",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419614+00:00"
      },
      {
        "event_id": "SOCIAL-Today1159-DaffyPic--6830329",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970426",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!!   11:59:01\t0.263\t8,000,000\t21.06k",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419632+00:00"
      },
      {
        "event_id": "SOCIAL-Today1155-Makingmi-42547372",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970838",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Sometimes it\u2019s not worth trying to be too clever and get the top or bottom of every price move right. Price can move quickly, so if it\u2019s a good price and you are happy with where it\u2019s going, buy it. If it goes down a bit it comes back. Less stressful too. It\u2019s called investing then, rather than gambling.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419650+00:00"
      },
      {
        "event_id": "SOCIAL-Today1138-dvharris--1144569",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971259",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "When folks are confident the seller is done we'll see plenty of buyers snapping up sub 0.3p shares.",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419668+00:00"
      },
      {
        "event_id": "SOCIAL-Today1135-MrsRobin-36181108",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971665",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Over 25m buys today and no significant sells other than big delayed sell so looking promising.",
          "sentiment": 0.0,
          "engagement": "186",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419685+00:00"
      },
      {
        "event_id": "SOCIAL-Today1106-DaffyPic-10584165",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972083",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"The pesky seller has a lot to answer for...\" Yes, but surely they do not have many left??   If any!!",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419703+00:00"
      },
      {
        "event_id": "SOCIAL-Today1041-Makingmi--1311204",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972495",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Yes, probably safe to get some more now dvh.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419729+00:00"
      },
      {
        "event_id": "SOCIAL-Today1031-DrMicho-38547895",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972902",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes, hopefully that sell is the end and we can move on...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419748+00:00"
      },
      {
        "event_id": "SOCIAL-Today1030-dvharris--3171528",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973325",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "After the news we had earlier this week and further newsflow on other fronts expected this quarter we really should be trading above 0.3p imo. The pesky seller has a lot to answer for...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419766+00:00"
      },
      {
        "event_id": "SOCIAL-Today1029-Makingmi-71745151",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973731",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Seems the effect of the excellent news release got lost in that selling session. Bit of catching up with events to come now.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419784+00:00"
      },
      {
        "event_id": "SOCIAL-Today1024-Makingmi-63221421",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974146",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Bought in earlier so hope you are right.  No problem either way at this price though.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419802+00:00"
      },
      {
        "event_id": "SOCIAL-Today1018-dvharris-52207826",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974564",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think we've just seen the reason the SP went down yesterday and folks couldn't get sell quotes. It's an odd figure so maybe the last of the selling? Looks like a few of us are buying in the hope that is the case.......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419819+00:00"
      },
      {
        "event_id": "SOCIAL-Today0946-DaffyPic--8138663",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974975",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "In the short term.  That's 0.44.    But I am still waiting for a penny.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-10T23:12:42.419837+00:00"
      },
      {
        "event_id": "SOCIAL-Today0851-dvharris-17747182",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484140",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just imagine if they have finished and you could have bought sub 0.25p! So tempted but will hold fire for the moment....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-10T23:12:42.419855+00:00"
      },
      {
        "event_id": "SOCIAL-Today0846-DrMicho--7143543",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484578",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I am not to sure its finished yet..if it is this will move up soon enough.",
          "sentiment": 0.5,
          "engagement": "8,159",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-10T23:12:42.419872+00:00"
      },
      {
        "event_id": "SOCIAL-Today0839-dvharris--1381385",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I can sell 5M shares (pre NT) with barclays at 0.2421p. Is our seller interested? Buying at this level is an absolute gift, but worried our seller might push the price lower. Conundrum!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-10T23:12:42.419890+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262348-TrickyEF--5057791",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485452",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "From a poster on telegram. Had a q and a with Gemini about the executive order and how it may impact Solvonis. You are right to be highly optimistic.  It is rare to see a micro caps pipeline match a major executive order's priorities so precisely. Especially with a board chair who has $15 billion track record in us life sciences. Will it be flat tomorrow??",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-10T23:12:42.419909+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262344-TrickyEF--1437993",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485875",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Seems pretty legit \ud83d\ude09\ud83d\ude09 https://www.whitehouse.gov/presidential-actions/2026/01/addressing-addiction-through-the-great-american-recovery-initiative/",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "from some ****e called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=05EF86B5-7368-48E4-884F-EF5C39F8DEF2"
        },
        "ingested_at": "2026-02-10T23:12:42.419927+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261710-LlamaFar-67547759",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486299",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "0.18p? Its on the chart from June last year...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.419945+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261630-dvharris--3862886",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486716",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, absolutely no incentive to buy until it drops to sub 0 2p imo. 0.2421p to sell just before the close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.419962+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261622-DrMicho--8265426",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487131",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looking like the seller will have to take whats on offer as no one is buying. Same price tomorrow seller \ud83d\ude01 get on with it...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.419981+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261522-DrMicho-50761880",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487538",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Me too, Im here for the foreseeable so when it is finished selling I will buy its shares on the cheap...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.419999+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261500-dvharris-20763732",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487949",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The SP of my only other small cap investment seems to be on the runway ready for take off. Potentially even more money to invest here in the short/medium term....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.420016+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261457-dvharris-42944145",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488375",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "No rush for me as long term hold but would add significantly more if the MMs drop the SP to sub 0.2p......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.420034+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261447-LlamaFar--3831658",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488788",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope, mms dropped the price. I added at 0.18p on the way up, wasnt expecting the opportunity on the way back down. Have to ask how many does this seller have?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.420052+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261436-RhHh--8002891",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Seller hopefully done. Time for the MMs to take it up.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-10T23:12:42.420070+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261331-LlamaFar--8876835",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489614",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Google is interesting. Says that the MM's can offer to take them out lock stock and barrel, maybe they sell down until they ruin the market for the stock and then the MM takes the rest at a lower price and everything goes back to normal? \"Immediate Liquidity Provision: If a seller cannot find another buyer, the market maker steps in to buy the security (hitting the bid), allowing the seller to exit the position instantly.\"",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420088+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261315-dvharris-53224532",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490027",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Can only sell 500k shares so our 5M seller will either have to wait or accept a (much) lower price. I think we will see an absence of buyers until the position becomes clearer....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420126+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261252-LlamaFar--4343850",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490451",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - same as that. We've been told in the last few RNS and Co interviews what newsflow to expect, if you are selling at this point its through desperation? The MM's job is to make an orderly market where we can sell as well as buy, if dropping the price does that then what are they waiting for?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420147+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261245-dvharris-46510472",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'd rather they drop the SP to sub 0.2p than buy anymore until the seller has finished. Otherwise just funding their sales/profits. Expecting the SP to drop later.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420165+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261242-RhHh-51240521",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491287",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pay day tomorrow but no point in topping up until the seller is done. Must admit I thought they would have finished by now.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420184+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261239-LlamaFar-67331745",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491750",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They've still shut it all off - must have lots more 5m blocks to shift into us mug punters?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420202+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261203-LlamaFar--1531888",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492241",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They were struggling to work that last 5m sell, had to close off all other sells in order to squeeze it through, previously over the last few sessions they had reduced the sells you could do to 5m shares, that's not making an orderly market so they will either have to drop the price hard, or stop performing their function as a market maker. Pretty pi55 poor  performance from the MM after the sterling RNS of yesterday, the seller is obviously desperate, cut his prices and get him/her gone.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420220+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261131-dvharris-55240811",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492748",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, I was going to add more sub 0.3p but only when the seller has finished dumping their holding...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420238+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261124-DrMicho--7146127",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493174",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I totally agree.. hopefully seller gets low prices to match his desperation \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420257+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261121-LlamaFar-41148355",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493586",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "No point in buying more if each big sell reduces the price, easier to wait till the bottom and add more on the way back up?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420275+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261120-DrMicho-76233640",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493998",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our seller was waiting for some buying before unloading\u2026 \ud83d\ude02\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420293+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261110-LlamaFar-22657706",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.494420",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "6AM in New York, Toronto, Washington...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420311+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261034-dvharris-21921204",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.436927",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420329+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260909-LlamaFar--1601920",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437392",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-10T23:12:42.420347+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260837-dvharris--6672654",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437820",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420364+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260819-LlamaFar-69680542",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438249",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420382+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260815-LlamaFar--2412864",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438688",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420400+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260010-TrickyEF-71706680",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439148",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-10T23:12:42.420418+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260005-TrickyEF--9381828",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439582",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-10T23:12:42.420437+00:00"
      },
      {
        "event_id": "SOCIAL-Today1034-dvharris-21921204",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.348543",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420455+00:00"
      },
      {
        "event_id": "SOCIAL-Today0909-LlamaFar--1601920",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349238",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-10T23:12:42.420473+00:00"
      },
      {
        "event_id": "SOCIAL-Today0837-dvharris--6672654",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349995",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420491+00:00"
      },
      {
        "event_id": "SOCIAL-Today0819-LlamaFar-69680542",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.350809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420509+00:00"
      },
      {
        "event_id": "SOCIAL-Today0815-LlamaFar--2412864",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.351641",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-10T23:12:42.420527+00:00"
      },
      {
        "event_id": "SOCIAL-Today0010-TrickyEF-71706680",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.352511",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-10T23:12:42.420544+00:00"
      },
      {
        "event_id": "SOCIAL-Today0005-TrickyEF--9381828",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.353336",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-10T23:12:42.420563+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262015-TrickyEF-61680257",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354159",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "For use at home on a daily basis. This was an attractive investment 12 months ago now it's looking fooking beautiful. Fingers crossed it don't turn into a munter.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-10T23:12:42.420582+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262006-TrickyEF-28396633",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354968",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "The OTF delivery system could turn out to be a goldmine. What's next?? Solvonis said SVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles, and noted the compound has also been selected for evaluation in the US National Institute on Drug Abuse Addiction Treatment Discovery Program for stimulant use disorders. Solvonis Therapeutics plc (LON: SVNS), (\"Solvonis\" or the \"Company\") an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that Awakn Life Sciences Corp. (\"Awakn\"), the company Solvonis plans to acquire, has reached a significant regulatory milestone. Awakn announced a positive outcome from a Pre-Investigational New Drug (\"Pre-IND\") meeting with the U.S. Food and Drug Administration (\"FDA\") regarding AWKN-002, a proprietary oral thin film (\"OTF\") formulation of esketamine, designed for sublingual and buccal administration in combination with structured alcohol education. This drug candidate is being developed for the treatment of moderate to severe alcohol use disorder (\"AUD\") with a focus on U.S market",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-10T23:12:42.420600+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261933-MadEngli-85707447",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.355775",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "LHogbog, just keep holding, this is going to blow the bl00dy doors off one day.  When this gets picked up, JVd, bought out, it'll be by a big player and you'll be so happy you were in @ .3p. ATB ME",
          "sentiment": 0.0,
          "engagement": "721",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-10T23:12:42.420618+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261907-Hogbog-21214641",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.356560",
        "source": "LSE_CHAT",
        "data": {
          "author": "Hogbog",
          "content": "In various forms it is forever on social media, but what I\u2019m keen to know if when my two large holdings both in the 3s will actually make a profit.",
          "sentiment": 0.0,
          "engagement": "892",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-10T23:12:42.420636+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261903-VikR--6385975",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.357390",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Https://www.linkedin.com/posts/jonathanmichaelholmes_this-novel-antidepressant-targets-more-than-activity- Just noted on linkedIN a motivated investor speaking highly of the pipeline. The story here just keeps more compelling with each new discovery. SSRIs are prescribed in the million &  millions and the anxiety and depression market is multi billion. Everything SVNS targets are huge addressable markets. Once the newsflow starts here it won\u2019t stop. I understand the frustration of shareholders who are getting bored with a stagnant share price but this team is not in it for a small slice of the pie, they want to hit it big. There has to be, absolutely has to be strong interest from mainstream pharma willing to put the funds to progress the projects further. I just wait for the day the blessed RNS lands. 7422302011582484482-UjTC?utm_medium=ios_app&rcm=ACoAAErGYQIB6gTMGcSk4EsXpWwMe6tdaF1kU5E&utm_source=social_share_send&utm_campaign=copy_link",
          "sentiment": 0.5,
          "engagement": "981",
          "price_at_post": "0.265",
          "thread_title": "Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-10T23:12:42.420654+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261827-TrickyEF-71870771",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.358233",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I for one hope to be still holding these come  2028/2029 and have a massive \ud83d\ude01\ud83d\ude01\ud83d\ude01 on my face. 8months old and with  just \u00a32.25 million of funding the AI of Solvonis has already popped out svn15 which is in the running for $15 million of NIH funding based on early data in relation too meth and coke addiction. This NIH support was provided before they even new about the potential for depression. No wonder the AI fund raised was covered by just 3 individuals. For \u00a32.25 million down they possibly realised  \u00a310.8 million in NIH funding. Given today's news the odds would have shortened on securing that funding. FANTASTIC new science being delivered here.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-10T23:12:42.420672+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261810-TrickyEF--1954098",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359029",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "At around the 3min 45 second mark. Early days but WOW.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-10T23:12:42.420690+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261649-DrMicho--3332980",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359813",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Hopefully the smell of the seller will vanish soon enough. Waiting for buys to squeeze that little extra so must be desperate for the money. That desperation will   help move it on\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420708+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261546-LlamaFar-13418899",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.360501",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope ... cant sell, can buy",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420726+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261520-ComesMar-66074711",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.361160",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think it just appeared ,  10m",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420744+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261515-LlamaFar--2814406",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362046",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Sellers still hanging about, waiting for a large odd amount trade to show... that's the way I've seen these end before.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420763+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261504-dvharris-73607978",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362765",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Wouldn't it be nice if the latest 10M trade was the last of our sellers holding!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420781+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261400-DrMicho--4485758",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363274",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes me too DV...it would be nice to see some grants/funding to prevent any further need for funding/placings.. but the biggy is going to be a partnership or licensing deal. This would go bonkers, absolute crazy when it happens. Taking into consideration we have a fair amount of irons in the fire it surely cant be that far away.",
          "sentiment": 0.5,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420799+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261357-LlamaFar-14272120",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363733",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The further the pipelines move down the track, the bigger the numbers, i'm not rushed for answers at the moment. 015a Meth & Coke and 015b Depression are both new news, the pipelines are being widened and getting longer as they are progressed. Sit tight and add each time someone else is forced into selling, the lower the better imo.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420817+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261343-dvharris-77802503",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364170",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'm waiting for the outcome of the discussions with the big pharmas that have been ongoing for a while now....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420836+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261303-dafad--7795361",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364584",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Soon I think-usually a proactive interview would be out by now-lack of anything leads me to think nore news soon",
          "sentiment": 0.0,
          "engagement": "2,397",
          "price_at_post": "0.265",
          "thread_title": "More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-10T23:12:42.420854+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261215-LlamaFar--9030320",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365003",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - sit tight and wait for the bargains. If they have to sell cheaply the price will be dropping?",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-10T23:12:42.420873+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261205-ComesMar--2666680",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365476",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "According to Gemini, these are probably Canadian investors or institutions, with the clear mandate to quit. There is nothing to do other than wait that they are done with selling.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-10T23:12:42.420891+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261156-dvharris-55900693",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691006",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think you are right Llama, but the seller does seem to want to dispose of an awful lot of shares....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-10T23:12:42.420908+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261140-cinderco--1424614",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691680",
        "source": "LSE_CHAT",
        "data": {
          "author": "cindercone",
          "content": "Yep, some individual is selling into every rise. How much longer is anyone's guess as not a lot of liquidity here.",
          "sentiment": 0.0,
          "engagement": "2,102",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-10T23:12:42.420926+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261120-LlamaFar--4620664",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692318",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "There's obviously a large seller about - they must be in a forced sale position as you wouldn't be selling otherwise on this mornings news. Once the seller dries up, my opinion is it rockets.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-10T23:12:42.420944+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261119-dvharris-18828821",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692922",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, didn't think I'd be on the verge of meeting desmond again!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-10T23:12:42.420962+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261118-LlamaFar--7043473",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.693581",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "3.50mins - \"All depressives\" All depressives\" refers to the broad spectrum of clinical, chronic, and situational mental health conditions characterized by persistent low mood, loss of interest, and decreased energy. Psychiatrists often view depression as a range of experiences rather than one single disease, spanning from mild, temporary, to severe. Here is a breakdown of the various types of depression based on recognized diagnostic criteria (DSM-5): Primary Types of Depressive Disorders Major Depressive Disorder (MDD) / Clinical Depression: The most common form, involving severe symptoms\u2014such as intense sadness, hopelessness, or loss of interest\u2014that last for at least two weeks and interfere with daily life. Persistent Depressive Disorder (PDD) / Dysthymia: A chronic, low-grade, or moderate depression that lasts for two years or more. Bipolar Disorder (Manic Depression): While not exclusively a depressive disorder, this involves alternating episodes of depression and high-energy mania or hypomania. Premenstrual Dysphoric Disorder (PMDD): A severe form of PMS causing extreme irritability, anxiety, or depression in the week before a period. Disruptive Mood Dysregulation Disorder (DMDD): A childhood condition characterized by extreme irritability and intense anger outbursts.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-10T23:12:42.420980+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261115-DrMicho--1140403",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694200",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Absolutely amazed that we are worse off after a positive update.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-10T23:12:42.420998+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261113-LlamaFar-34783576",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694808",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.youtube.com/watch?v=ZLhyKGvWypg At 1.50m GAME ON!!!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-10T23:12:42.421016+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261059-Bill999--8460510",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.695431",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bill999",
          "content": "Good video out on Proactive today with David Nutt.",
          "sentiment": 0.0,
          "engagement": "3",
          "price_at_post": "0.265",
          "thread_title": "Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-10T23:12:42.421035+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261055-dvharris--5544479",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696024",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very funny!\ud83d\ude01",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.26",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421052+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261029-bonesgt-38829656",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696635",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Going to stick my neck out ,think we will finish up today. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421070+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261027-dvharris--3609430",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697256",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "And we're red!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421088+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261022-bonesgt--6902858",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697855",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Was that an 8m buy disguised as a sell . Is that our buyer mopping up. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421137+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260908-ComesMar-45098404",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.698463",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "There could be tons of reasons why selling despite good news and expected catalysts. This is a gift for the ones believing in the story and with available cash.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421156+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260858-DrMicho-66428963",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699053",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our 5M buyer early on has took a 1500 quid hit. The thing that is going to move this properly is a licensing deal/large funding/partnership news. All of this could happen imminently, US listing, results take time.. still hopeful of something dropping that will shift this selling trend.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421175+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260856-TheDealB-82374664",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699614",
        "source": "LSE_CHAT",
        "data": {
          "author": "TheDealBreaker",
          "content": "The bigger question is not who is selling but why?  Why sell on good news and the potential of more good news? They are clearly not moving shares into an ISA as there are no corresponding buys. Thanks",
          "sentiment": 0.0,
          "engagement": "304",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421194+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260847-RhHh--7990170",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700037",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I thought the seller was finished ages ago! Who is it?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421212+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260842-bonesgt--6430547",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700480",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "This is nuts ,what will it take. Who is the seller? Can't have many left surely.",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421230+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260838-dvharris--5963039",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700904",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pow,  5M number 3! Not another red day after yet another positive update surely?",
          "sentiment": 0.0,
          "engagement": "21,054",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421248+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260836-RhHh-59456369",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.701462",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I hate that damn seller! Be a red finish at this rate ffs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421266+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260816-dvharris-57163450",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702149",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like the 5M seller is up early. Oh well......",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421284+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260815-RhHh-15151973",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702662",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Tq",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421302+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260811-LlamaFar--5950749",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703082",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Get a broker and buy on the pre market - hence the premium.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421319+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260805-EpicViru-59889518",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703515",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "You can place an order to be executed",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421337+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260804-RhHh-38817646",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703931",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "How can you buy before the open?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421355+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260802-dvharris--2878849",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.704377",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "With the number of darts we're throwing at the board one is going to hit the bullseye!\ud83c\udfaf",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.29",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421373+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260755-DaffyPic-48861601",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558067",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice and early. 07:54:38\t0.295\t5,000,000\t14.75k",
          "sentiment": 0.0,
          "engagement": "3,575",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421391+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260740-Scoutt--1118585",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558633",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "Diversification always good in binary developments, shaping up to be a wonder treatment, if it goes half as well as I\u2019m expecting we will be a penny share by mid year.  Substance mis-use, PTSD, Depression, if we can use it for Anxiety we can shout Bingo.",
          "sentiment": 0.0,
          "engagement": "975",
          "price_at_post": "0.27",
          "thread_title": "Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-10T23:12:42.421409+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260724-Stretcht--8399396",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559180",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Good news, let\u2019s see how that is received.",
          "sentiment": 0.0,
          "engagement": "207",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-10T23:12:42.421427+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260711-Andys288--1873151",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559701",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019m feeling a bit blue today, if only there was a new treatment for depression\u2026.. #hellofreddy",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-10T23:12:42.421445+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260706-EpicViru--4274869",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560283",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Here we go hold onto your seats. An hour before the floodgates open.",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-10T23:12:42.421464+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261602-bonesgt-24083476",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560797",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Flat or up a point today, be nice all in all we're still on track. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421481+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261147-TrickyEF--4778281",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561345",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice bones. May join ya and the Dr with a purchase this week.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421499+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261141-bonesgt--7547031",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561848",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Never  mind Tricky I've just bought another 1 mil and again another 170k . Nothings changed on coarse for licencing,  among other great things we are working on. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421517+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261139-RhHh--6160178",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562370",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Looks like the sells are being mopped up. Might even be a flat close. Not long to wait for news.",
          "sentiment": 0.5,
          "engagement": "324",
          "price_at_post": "0.255",
          "thread_title": "Buyers coming in",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18FDEE2C-AFBF-4A99-A347-D1CDEDF15437"
        },
        "ingested_at": "2026-02-10T23:12:42.421535+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261137-covgaz--5495689",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562870",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "If it hits 23 will I be correct?",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421553+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261134-TrickyEF--8313283",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.563524",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "If something is the same as it was there is no change. It looks the same to me as it did on the 20th. Not pretty not ugly the same. Same same.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421571+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261129-TrickyEF--4175817",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564177",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Covgaz don't think you realise that when you said it was going to 0.23p the trades where at 0.264p on the 20th. Guess what today's latest trade is for the same price. So it's identical price to the 20th when you posted. How is it getting messy if there is no change. \ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udee3\ud83e\udee3\ud83e\udee3",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421588+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261124-covgaz--5403245",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564764",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "It's getting very ugly here , I did say will this be testing 23 again. Looks like it will.",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421606+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261120-DrMicho-55211248",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565378",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I have bought another 3M over the past few days to add to my growing collection. I\u2019m not complaining just curious why some would sell so close to news. Anyway GL to all\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421624+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261113-Andys288--3081203",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565967",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019ve not sold anything and have bought a few more over the last few weeks,  I\u2019ve not seen or heard anything to dissuade me that this is a great share to hold, and as a long term holder I am still in profit.  Just waiting for the news flow to start and this should go bonkers",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421642+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261108-DrMicho-75940607",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.566597",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering it\u2019s been reported that we are expecting a news rich period (originally dec) it\u2019s looking pretty grim at the moment. I am surprised at the constant selling tbh, is someone aware of something.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421661+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20262005-LlamaFar--6169996",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567196",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nice lumpy rollover, then a bed n isa.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421679+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261601-dvharris--8326436",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567625",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like someone is taking steps to protect future profits from HMRC!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421697+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261226-LlamaFar-79934734",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568050",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 26 / 90. Looks like traders entered on Friday as the MM's ran it up 10% and were stopped out this morning after no RNS turned up to save their positions....",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421715+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261131-ComesMar--9089708",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568488",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "It is clear that until news lands, the sp will be at the mercy of traders. In the long term perspective this is just noise, provided that the science behaves the way they claim.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421733+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260956-turnthec-88932005",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569024",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Couldn\u2019t resist another top up at 0.2768 as only a matter of time will make this look like steal",
          "sentiment": 0.0,
          "engagement": "314",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421751+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260927-wookieem--6561842",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569681",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "As volitile as an alcoholic this share",
          "sentiment": 0.0,
          "engagement": "4,352",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421768+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260925-RhHh--3426935",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570224",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "As expected after the ut on Friday. Poxy MMs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "**** drop",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DDC62C70-85CB-418D-B6A7-4EC41E27F08D"
        },
        "ingested_at": "2026-02-10T23:12:42.421786+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262144-LlamaFar--3089269",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570667",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Only slightly .. 001 and 002 - Aud - market leading results 014 - Ptsd - no other treatment 015 - Meth & coke - no other treatment.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421804+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262003-dvharris-17852115",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.571083",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Are you suggesting we're undervalued?  \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-10T23:12:42.421823+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261725-MadEngli--6066541",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.233592",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Next week Rodney...\ud83d\ude01 ATB",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.28",
          "thread_title": "This time...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=784600CF-6EA6-48B9-8E3B-25B205222B70"
        },
        "ingested_at": "2026-02-10T23:12:42.421841+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261122-Stretcht-75385814",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234032",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Time to test those recent highs and have some positive news hitting the wires.",
          "sentiment": 0.0,
          "engagement": "195",
          "price_at_post": "0.28",
          "thread_title": "RE: 24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-10T23:12:42.421859+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261107-EpicViru-90076542",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234477",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Let's keep this countdown ticking. GLA \ud83d\udc0e Time to run the race",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.28",
          "thread_title": "24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-10T23:12:42.421877+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261047-dvharris-80068692",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234903",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Nice to see some upward movement ahead of expected newsflow this quarter......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.28",
          "thread_title": "RE: FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-10T23:12:42.421895+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261031-Andys288--2779588",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Strong support today, and I wouldn\u2019t want to be out over the weekend with all the expected news,",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-10T23:12:42.421913+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261836-MadEngli-55479481",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235739",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-02-10T23:12:42.421931+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261521-Andys288--3032317",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236157",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-10T23:12:42.421949+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261219-LlamaFar--6560423",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236578",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-10T23:12:42.421967+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261122-dvharris-13248290",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236990",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-10T23:12:42.421985+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260924-EpicViru--2858141",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237415",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-10T23:12:42.422004+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260826-dvharris-37494662",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237828",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-10T23:12:42.422022+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260732-EpicViru-12303069",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238254",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-10T23:12:42.422040+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF-81581793",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238671",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-10T23:12:42.422058+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb-50327643",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239142",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-10T23:12:42.422076+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris--8535750",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239562",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-10T23:12:42.422094+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar-42373190",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239967",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-10T23:12:42.422120+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh--3732591",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240392",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-10T23:12:42.422138+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar--5356730",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-10T23:12:42.422157+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz--6046870",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241235",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,499",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-10T23:12:42.422175+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar-72003374",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241643",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-10T23:12:42.422193+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb--4040134",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242059",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-10T23:12:42.422211+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar-36829946",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242517",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-10T23:12:42.422230+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho-19486117",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242929",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-10T23:12:42.422248+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF-45657052",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243353",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-10T23:12:42.422266+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar--4661518",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243772",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-02-10T23:12:42.422285+00:00"
      },
      {
        "event_id": "SOCIAL-Today1234-TrickyEF--7589608",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.723950",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Yep Monday was a day off for the sellers. Seems to be just as many big sells showing again",
          "sentiment": 0.0,
          "engagement": "16,077",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DA7ED745-36C6-48FF-915F-7A4318863F80"
        },
        "ingested_at": "2026-02-11T17:11:28.885935+00:00"
      },
      {
        "event_id": "SOCIAL-Today1131-LlamaFar--2958990",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.724406",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://investingnews.com/search/?q=solvonis Jan 2026 article on U.S. Patent. Jan 2026 article 015 Paul Carter appointed. Just because you don't bother to research your investment doesn't mean that your investment isn't reaching out into new markets with its new products... the BOD are working here, what they aren't doing is posting Reach RNS to get you pumped up for a placing... they don't need to, what they are doing is progressing multiple assets to the point of news, we will be advised when the market is. Until then look at the growth in the pipeline.",
          "sentiment": 0.0,
          "engagement": "903",
          "price_at_post": "0.26",
          "thread_title": "North American Edition of INN",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5AE2EBC8-9011-4457-8137-549B91ECC12C"
        },
        "ingested_at": "2026-02-11T17:11:28.885974+00:00"
      },
      {
        "event_id": "SOCIAL-Today1046-LlamaFar--8000272",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.724835",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 42 of 90, maybe you missed these two ? So far in 2026 ... https://www.lse.co.uk/rns/SVNS/us-patent-allowance-for-ptsd-discovery-programme-avzhfgwc0dqc4bc.html https://www.lse.co.uk/rns/SVNS/expansion-of-svn-015-into-depression-tyyilt2cisyp4w4.html Plus the S.P. has swallowed a large sell off , held at resistance and now bounced off of it .... Apart from that of course ...",
          "sentiment": 0.0,
          "engagement": "903",
          "price_at_post": "0.27",
          "thread_title": "RE: Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DA7ED745-36C6-48FF-915F-7A4318863F80"
        },
        "ingested_at": "2026-02-11T17:11:28.886004+00:00"
      },
      {
        "event_id": "SOCIAL-Today1039-dvharris-17039321",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.725251",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, still plenty of sells as the SP moved up. Really could do with a decent update from the BoD to get some upward momentum to the share price. This was (is!) the Quarter when the BoD delivers news on a number of fronts....",
          "sentiment": 0.0,
          "engagement": "21,130",
          "price_at_post": "0.26",
          "thread_title": "RE: Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DA7ED745-36C6-48FF-915F-7A4318863F80"
        },
        "ingested_at": "2026-02-11T17:11:28.886022+00:00"
      },
      {
        "event_id": "SOCIAL-Today1035-LlamaFar-83408487",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.725667",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "NOTE: They were trying to treat Alzheimers and Parkinsons and got weight loss New Directions in the Pharmacological Treatment of Food Addiction, Overeating, and Obesity Tesofensine Another medication, Tesofensine, is a combined norepinephrine-serotonin-dopamine reuptake inhibitor currently under way for Phase 3 trials. This drug was initially developed for treatment for Parkinson\u2019s disease and Alzheimer\u2019s dementia but was found to have limited effectiveness for these diseases; however, it had the reported side effect of weight loss. Phase 2 data demonstrated an average of 6.5%, 11.2%, and 12.6% among patients treated with 0.25 mg, 0.5 mg, and 1.0 mg of tesofensine, respectively, for 24 months. Patients treated with placebo lost an average of 2% of their body weight (Neurosearch, 2009). Common side effects include dry mouth, headache, nausea, insomnia, diarrhea, and constipation. Blood pressure and heart rate were increased by 1\u20133 mmHg and up to 8 bpm, respectively. This is a promising new drug that produces a weight loss twice that of currently approved anti-obesity drugs.",
          "sentiment": 0.0,
          "engagement": "903",
          "price_at_post": "0.27",
          "thread_title": "RE: Sert, Dat, Net 014, 015a, 015b etc ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E40C7423-5397-41D4-9F13-844A964109E4"
        },
        "ingested_at": "2026-02-11T17:11:28.886040+00:00"
      },
      {
        "event_id": "SOCIAL-Today1034-LlamaFar--4709943",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.726082",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "NOTE : The side effects on this one ... Tesofensine Tesofensine is an inhibitor of neuronal reuptake of dopamine, noradrenaline, and serotonin. There has been considerable interest in this investigational drug for weight reduction as an adjunct to energy restriction. Placebo-controlled studies In a phase II clinical trial of tesofensine in Denmark there was a significant reduction in body weight compared with placebo [118C]. The common adverse events were dry mouth, nausea, constipation, diarrhea, and insomnia. After 24 weeks, tesofensine 0.25 and 0.5 mg/day had no significant effect on systolic and diastolic blood pressures compared with placebo, but heart rate increased by 7.4/minute. However, there is a reduction in blood pressure of 3\u20135 mmHg systolic and 2\u20133 mmHg diastolic with weight losses of 4\u20135 kg, and increases of 1 mmHg in systolic pressure and 2\u20133 mmHg in diastolic pressure among participants taking tesofensine 0.5 mg compared with controls seem to suggest that tesofensine can increase blood pressure [119r]. Drug development in the field of weight reduction has regularly faced pharmacovigilance hurdles, because anorexigenic drugs affect various neurotransmitter systems and can lead to serious adverse effects. It has been suggested that the bar should be set high when new drugs are introduced for obesity, in order to avoid repetition of drug scandals related to antiobesity drugs [120r].",
          "sentiment": 0.0,
          "engagement": "903",
          "price_at_post": "0.27",
          "thread_title": "RE: Sert, Dat, Net 014, 015a, 015b etc ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E40C7423-5397-41D4-9F13-844A964109E4"
        },
        "ingested_at": "2026-02-11T17:11:28.886058+00:00"
      },
      {
        "event_id": "SOCIAL-Today1032-TrickyEF--9255094",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.726498",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Monday was a day off",
          "sentiment": 0.0,
          "engagement": "16,077",
          "price_at_post": "0.27",
          "thread_title": "RE: Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DA7ED745-36C6-48FF-915F-7A4318863F80"
        },
        "ingested_at": "2026-02-11T17:11:28.886076+00:00"
      },
      {
        "event_id": "SOCIAL-Today1032-TrickyEF-62176746",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.726902",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Monday for as a day off \ud83e\udee3\ud83e\udd23",
          "sentiment": 0.0,
          "engagement": "16,077",
          "price_at_post": "0.27",
          "thread_title": "Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DA7ED745-36C6-48FF-915F-7A4318863F80"
        },
        "ingested_at": "2026-02-11T17:11:28.886094+00:00"
      },
      {
        "event_id": "SOCIAL-Today1026-LlamaFar--6554913",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.727338",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Based on recent research, GLP-1 receptor agonists (GLP-1s) such as semaglutide and exenatide modulate central neural pathways, particularly those involving dopamine (DAT), serotonin (SERT), and norepinephrine (NET), to control food intake, reward-seeking behavior, and metabolism. They do not act as direct reuptake inhibitors, but rather influence the activity of these systems indirectly. Key Interactions of GLP-1s with Monoamine Systems: Dopamine Transporter (DAT) Modulation: GLP-1 receptor agonists are known to modulate brain reward circuitry by influencing dopamine signaling in the ventral tegmental area (VTA) and nucleus accumbens. While some studies showed that GLP-1 can increase DA uptake and DAT surface expression in specific regions (like the lateral septum), other studies show that GLP-1R agonists like semaglutide suppress VTA dopamine neuron responsiveness during palatable food consumption, thus reducing the motivation to eat. Serotonergic and Noradrenergic Pathways: GLP-1 receptors are found on serotonin-producing (5-HT) neurons, and GLP-1 has been shown to modulate serotonergic pathways that regulate appetite. GLP-1 also indirectly enhances satiety through increased sympathetic activity (norepinephrine system). Reward and Addiction: GLP-1 agonists reduce reward-seeking behavior (for both food and substances like alcohol/cocaine) by attenuating the dopaminergic activity associated with addiction and craving. Comparison to Triple-Reuptake Inhibitors: Unlike drugs such as tesofensine\u2014which directly act as triple monoamine reuptake inhibitors (targeting SERT, DAT, and NET to increase synaptic levels of serotonin, dopamine, and norepinephrine)\u2014GLP-1s work via receptor-mediated signaling to modulate neural activity rather than direct transporter inhibition.",
          "sentiment": 0.0,
          "engagement": "903",
          "price_at_post": "0.27",
          "thread_title": "Sert, Dat, Net 014, 015a, 015b etc ...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E40C7423-5397-41D4-9F13-844A964109E4"
        },
        "ingested_at": "2026-02-11T17:11:28.886138+00:00"
      },
      {
        "event_id": "SOCIAL-10Feb20261740-MadEngli-58318555",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.727747",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Now what we need is...NEWS ATB ME",
          "sentiment": 0.0,
          "engagement": "739",
          "price_at_post": "0.27",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886158+00:00"
      },
      {
        "event_id": "SOCIAL-10Feb20261126-dvharris--4126927",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.728160",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think LTHs have been increasing their holding. Now need more new converts to join the party \ud83e\udd73",
          "sentiment": 0.5,
          "engagement": "21,130",
          "price_at_post": "0.27",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886176+00:00"
      },
      {
        "event_id": "SOCIAL-10Feb20261005-turnthec-70757000",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.728560",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Dvh Two minds thinking alike as I\u2019ve just had another top up !!",
          "sentiment": 0.0,
          "engagement": "327",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886195+00:00"
      },
      {
        "event_id": "SOCIAL-10Feb20260941-dvharris--1998540",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.728957",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, our Seller has certainly created an opportunity for PIs to load up sub 0.3p before the BoD delivers the next updates.....",
          "sentiment": 0.0,
          "engagement": "21,130",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886212+00:00"
      },
      {
        "event_id": "SOCIAL-10Feb20260936-TrickyEF-86391802",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.729366",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice start to the day",
          "sentiment": 0.0,
          "engagement": "16,077",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886230+00:00"
      },
      {
        "event_id": "SOCIAL-10Feb20260831-dvharris-17285809",
        "event_type": "social_post",
        "date": "2026-02-11T17:11:20.729762",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like a buyer wants all the shares at 0.26p and below this morning....",
          "sentiment": 0.5,
          "engagement": "21,130",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886248+00:00"
      },
      {
        "event_id": "SOCIAL-Today1740-MadEngli-58318555",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.701433",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Now what we need is...NEWS ATB ME",
          "sentiment": 0.0,
          "engagement": "737",
          "price_at_post": "0.27",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886267+00:00"
      },
      {
        "event_id": "SOCIAL-Today1126-dvharris--4126927",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.702154",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think LTHs have been increasing their holding. Now need more new converts to join the party \ud83e\udd73",
          "sentiment": 0.5,
          "engagement": "21,120",
          "price_at_post": "0.27",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886284+00:00"
      },
      {
        "event_id": "SOCIAL-Today1005-turnthec-70757000",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.702850",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Dvh Two minds thinking alike as I\u2019ve just had another top up !!",
          "sentiment": 0.0,
          "engagement": "327",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886302+00:00"
      },
      {
        "event_id": "SOCIAL-Today0941-dvharris--1998540",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.703563",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, our Seller has certainly created an opportunity for PIs to load up sub 0.3p before the BoD delivers the next updates.....",
          "sentiment": 0.0,
          "engagement": "21,120",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886320+00:00"
      },
      {
        "event_id": "SOCIAL-Today0936-TrickyEF-86391802",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.704271",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice start to the day",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.265",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886338+00:00"
      },
      {
        "event_id": "SOCIAL-Today0831-dvharris-17285809",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.704960",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like a buyer wants all the shares at 0.26p and below this morning....",
          "sentiment": 0.5,
          "engagement": "21,120",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886355+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261618-TrickyEF-87911585",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.705416",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi llama. A lil blue would concur with your post re seller being out.",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886381+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261546-LlamaFar-78113908",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.705836",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky - the MM's were trying to pick up 12m last week on the cheap.. that's what you've seen being resold imo. Sellers gone, what's left are PI's with Xmas and January sales credit card bills to pay selling a few, from what i've read, everyone else has been adding what they can.",
          "sentiment": 0.0,
          "engagement": "898",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886400+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261540-dvharris-64077439",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.706292",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Approaching the middle of Q1 and we were told this quarter was going to be news rich. Action packed second half it is then......",
          "sentiment": 0.5,
          "engagement": "21,120",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886417+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261501-TrickyEF--4327272",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.706719",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I to have a feeling in my bones. Let's have some good bridging data news. Rather the licensing deal comes after positive bridging data. Would Improves Solvonis hand big time.",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886436+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261457-bonesgt--2191487",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.707146",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "He's done be positive Tricky ,its gana fly a feeling.",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886454+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261453-TrickyEF-89585259",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.707563",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Il say has the seller c u not finished or waiting till tomorrow to drop some. 12mil bought today sod all sold.",
          "sentiment": 0.0,
          "engagement": "16,074",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886472+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261252-RhHh-52841194",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.707967",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I'm not frightened! Only a matter of waiting and we should be rewarded. Encouraging to think the seller is done.",
          "sentiment": 0.0,
          "engagement": "332",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886490+00:00"
      },
      {
        "event_id": "SOCIAL-9Feb20261248-bonesgt-86858869",
        "event_type": "social_post",
        "date": "2026-02-10T23:12:34.708384",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "I think everyone frightened to say anything.  Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886508+00:00"
      },
      {
        "event_id": "SOCIAL-Today1618-TrickyEF-87911585",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.123321",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Hi llama. A lil blue would concur with your post re seller being out.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.255",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886526+00:00"
      },
      {
        "event_id": "SOCIAL-Today1546-LlamaFar-78113908",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.123764",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky - the MM's were trying to pick up 12m last week on the cheap.. that's what you've seen being resold imo. Sellers gone, what's left are PI's with Xmas and January sales credit card bills to pay selling a few, from what i've read, everyone else has been adding what they can.",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886544+00:00"
      },
      {
        "event_id": "SOCIAL-Today1540-dvharris-64077439",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.124215",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Approaching the middle of Q1 and we were told this quarter was going to be news rich. Action packed second half it is then......",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886562+00:00"
      },
      {
        "event_id": "SOCIAL-Today1501-TrickyEF--4327272",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.124645",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I to have a feeling in my bones. Let's have some good bridging data news. Rather the licensing deal comes after positive bridging data. Would Improves Solvonis hand big time.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886580+00:00"
      },
      {
        "event_id": "SOCIAL-Today1457-bonesgt--2191487",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125055",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "He's done be positive Tricky ,its gana fly a feeling.",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886597+00:00"
      },
      {
        "event_id": "SOCIAL-Today1453-TrickyEF-89585259",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125487",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Il say has the seller c u not finished or waiting till tomorrow to drop some. 12mil bought today sod all sold.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886615+00:00"
      },
      {
        "event_id": "SOCIAL-Today1252-RhHh-52841194",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.125896",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I'm not frightened! Only a matter of waiting and we should be rewarded. Encouraging to think the seller is done.",
          "sentiment": 0.0,
          "engagement": "332",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886633+00:00"
      },
      {
        "event_id": "SOCIAL-Today1248-bonesgt-86858869",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.126312",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "I think everyone frightened to say anything.  Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.25",
          "thread_title": "RE: SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886651+00:00"
      },
      {
        "event_id": "SOCIAL-8Feb20260941-LlamaFar--6410989",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.126768",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Missing targets is never a good look, but to recap the reasons given. 1. 001 not licensed yet as big pharma move more slowly, conference season, have to accept our 2. 002 - Wuxi App Tec chosen due to lower cost and their FDA accreditation, to provide the bridging data. China have strict import controls on Ketamin from Germany, where LTS Lohann mfr the oral thin film, has slowed the results. On one side of the argument there is capital protection, on the other is speed of response, with that great gift of hindsight, would they have been better to raise again and use a more expensive 'Western' provider and be entering phase 2b and maybe list in the USA quicker rather than wait a month or two? Was there a learning curve there? On balance, I was ok with the explanations given, nothing has failed a trial, they haven't placed and diluted me. In the meantime, they've added 15a depression and 15b meth & coke with non dillutive USA Govt funding to the pipeline on 15b, from that same saved cashflow from using Wuxi on 002, which I wasn't expecting from them. So while encountering difficulties and time delays in one area of the business ( AUD ) they've smashed it in two others of depression and drug addiction whilst also progression the PTSD arm Like an ambidextrous boxer, they met resistance and flowed seamlessly, into southpaw and haven't stopped moving forwards. Add 15a and 15b into a Nasdaq listing with 001 out licensed, 002 and 014 and I can see a market cap to get excited over. Is it still at the point of jam tomorrow? As of today, Yes 100%, but the jam looks stickier and the lumps of fruit in it look bigger!",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.245",
          "thread_title": "SVNS  39/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DFD90192-AACB-42BB-82DA-7571AADCB919"
        },
        "ingested_at": "2026-02-11T17:11:28.886669+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261609-dvharris--3824452",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127188",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, full ask for anything at Barclays....",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886687+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261550-bonesgt--8881450",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127587",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Here's hoping ,times a ticking, need your tickets, trains hopefully building steam for the journey ahead. Gla",
          "sentiment": 0.5,
          "engagement": "1,572",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886705+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261506-Andys288-61738986",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.127987",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "FOMO Friday\u2026..",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886723+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261503-TrickyEF--6075180",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.128407",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Someone has not curved their enthusiasm.",
          "sentiment": 0.0,
          "engagement": "16,071",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886741+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261459-DaffyPic-34071640",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.128818",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!! 14:56:22\t0.25\t8,000,000\t20.00k",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886760+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261457-DrMicho--4403300",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.129232",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yep, looks like we have movement upwards...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.24",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886778+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261424-RhHh-30388747",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.129634",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pretty certain that we've hit the bottom. Only going up from here.",
          "sentiment": 0.5,
          "engagement": "332",
          "price_at_post": "0.24",
          "thread_title": "Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886797+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261110-dvharris--2757149",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130040",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just added another 2M+ which is showing red! Far too cheap.....",
          "sentiment": 0.5,
          "engagement": "21,116",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-11T17:11:28.886816+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20261015-turnthec-38249483",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130463",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Can\u2019t believe one can buy below 25 so another top up of 1 million this morning",
          "sentiment": 0.0,
          "engagement": "325",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-11T17:11:28.886835+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20260750-thetripl--8987495",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.130894",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "The recent drift to 0.25p is a gift. We are seeing a classic \"forced washout\" (likely silver-crash margin calls) meeting a rock-solid floor. Why I\u2019m holding for the re-rate: Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%\u2014they are CNS pros building for a major exit. The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from \"AI discovery\" to \"clinical reality.\" Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the \"Prozac-sized\" depression market have fundamentally changed the valuation floor. Buyout Potential: At an \u00a318m market cap, we are a \"snack\" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels. The seller is running dry and the news is incoming. For those with averages in the 30s\u2014patience pays here. The science is better than it\u2019s ever been.",
          "sentiment": 0.0,
          "engagement": "915",
          "price_at_post": "0.24",
          "thread_title": "The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-11T17:11:28.886853+00:00"
      },
      {
        "event_id": "SOCIAL-6Feb20260023-LlamaFar-10016160",
        "event_type": "social_post",
        "date": "2026-02-09T23:48:08.131336",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "At the moment you either hold cash or imo you hold decent opportunity Pharmas for the multibag opportunity. Has to have low cash burn, has to have multiple products in a pipeline so it doesn't blow up on one delay or failure, has to have an exerienced, cohesive BOD that are fit for purpose.. 1.In early 2026, U.S. markets experienced significant volatility, leading to increased margin requirements and, in some cases, margin calls, particularly within the metals sector. A sharp, late-January 2026, sell-off in commodities, where silver fell nearly 30%, followed a record-breaking, speculative rally. This correction forced liquidations on leveraged positions as exchanges tightened rules, this resulted in investors selling anything liquid to cover their blown up positions, I reckon thats where our sellers came from. 2. Holding pharmaceutical stocks during a market correction is generally considered a defensive strategy, as the sector provides essential products that remain in demand regardless of economic conditions. 3.Patent Cliff Approaching. 4.Pipeline of large unmet needs.Repurposed and novel molecule pipeline.",
          "sentiment": 0.0,
          "engagement": "896",
          "price_at_post": "0.245",
          "thread_title": "Holding pharma stocks in a market correction?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BF229829-D5CE-43E3-9AE7-7062F3875B81"
        },
        "ingested_at": "2026-02-11T17:11:28.886872+00:00"
      },
      {
        "event_id": "SOCIAL-Today1609-dvharris--3824452",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.588646",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Well, full ask for anything at Barclays....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886891+00:00"
      },
      {
        "event_id": "SOCIAL-Today1550-bonesgt--8881450",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589082",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Here's hoping ,times a ticking, need your tickets, trains hopefully building steam for the journey ahead. Gla",
          "sentiment": 0.5,
          "engagement": "1,570",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886909+00:00"
      },
      {
        "event_id": "SOCIAL-Today1506-Andys288-61738986",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589521",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "FOMO Friday\u2026..",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886927+00:00"
      },
      {
        "event_id": "SOCIAL-Today1503-TrickyEF--6075180",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.589937",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Someone has not curved their enthusiasm.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886946+00:00"
      },
      {
        "event_id": "SOCIAL-Today1459-DaffyPic-34071640",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590360",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!! 14:56:22\t0.25\t8,000,000\t20.00k",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886964+00:00"
      },
      {
        "event_id": "SOCIAL-Today1457-DrMicho--4403300",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.590770",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yep, looks like we have movement upwards...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.24",
          "thread_title": "RE: Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.886982+00:00"
      },
      {
        "event_id": "SOCIAL-Today1424-RhHh-30388747",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pretty certain that we've hit the bottom. Only going up from here.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.24",
          "thread_title": "Bottom hit this morning",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BB39C431-BD12-49B9-B5E2-3C6E6102A82B"
        },
        "ingested_at": "2026-02-11T17:11:28.887000+00:00"
      },
      {
        "event_id": "SOCIAL-Today1110-dvharris--2757149",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.591616",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just added another 2M+ which is showing red! Far too cheap.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-11T17:11:28.887018+00:00"
      },
      {
        "event_id": "SOCIAL-Today1015-turnthec-38249483",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592020",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Can\u2019t believe one can buy below 25 so another top up of 1 million this morning",
          "sentiment": 0.0,
          "engagement": "323",
          "price_at_post": "0.24",
          "thread_title": "RE: The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-11T17:11:28.887036+00:00"
      },
      {
        "event_id": "SOCIAL-Today0750-thetripl--8987495",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592470",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "The recent drift to 0.25p is a gift. We are seeing a classic \"forced washout\" (likely silver-crash margin calls) meeting a rock-solid floor. Why I\u2019m holding for the re-rate: Director Skin in the Game: The board is anchored with massive holdings. Nelson, Tennyson, and Purcell aren't holding through this for 10%\u2014they are CNS pros building for a major exit. The Q1 Catalyst Cluster: By March 31, we expect the PTSD Lead Candidate Selection and NIDA safety data. This takes us from \"AI discovery\" to \"clinical reality.\" Expansion & Patents: The Jan 7th US Patent and the SVN-015 expansion into the \"Prozac-sized\" depression market have fundamentally changed the valuation floor. Buyout Potential: At an \u00a318m market cap, we are a \"snack\" for Big Pharma. Any licensing deal or buyout will target the 1.40p+ analyst marks, not these depressed levels. The seller is running dry and the news is incoming. For those with averages in the 30s\u2014patience pays here. The science is better than it\u2019s ever been.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.24",
          "thread_title": "The Silver-Crash Exit vs. The Q1 Launchpad",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=6C6CFC26-D001-4BAE-82F5-A87566D1A5D3"
        },
        "ingested_at": "2026-02-11T17:11:28.887054+00:00"
      },
      {
        "event_id": "SOCIAL-Today0023-LlamaFar-10016160",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.592896",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "At the moment you either hold cash or imo you hold decent opportunity Pharmas for the multibag opportunity. Has to have low cash burn, has to have multiple products in a pipeline so it doesn't blow up on one delay or failure, has to have an exerienced, cohesive BOD that are fit for purpose.. 1.In early 2026, U.S. markets experienced significant volatility, leading to increased margin requirements and, in some cases, margin calls, particularly within the metals sector. A sharp, late-January 2026, sell-off in commodities, where silver fell nearly 30%, followed a record-breaking, speculative rally. This correction forced liquidations on leveraged positions as exchanges tightened rules, this resulted in investors selling anything liquid to cover their blown up positions, I reckon thats where our sellers came from. 2. Holding pharmaceutical stocks during a market correction is generally considered a defensive strategy, as the sector provides essential products that remain in demand regardless of economic conditions. 3.Patent Cliff Approaching. 4.Pipeline of large unmet needs.Repurposed and novel molecule pipeline.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "Holding pharma stocks in a market correction?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=BF229829-D5CE-43E3-9AE7-7062F3875B81"
        },
        "ingested_at": "2026-02-11T17:11:28.887072+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261939-LlamaFar-14058117",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593359",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Wood from trees. If warrants, would have been rns as cash inflow to business no rns no warrants flipped. If you've looked up who owns those 0.10p lending warrants you will understand why/ how they are holding, quite a?few of the pi's are still holding from 0.10p as well ;) Legacy graft polymer - they went long ago - link to lending warrants. Good question to ask any small cap, when are you placing next? The CEO replied to that direct question \"we are not looking to raise funds at the moment, we have a cash runway until q1 2027, we are in talks with more than 1 party to out license our svn001 asset\". If you read the news, ur obvs on Twitter to know of Harald, the wider u.s. market has had a lot of leverage calls recently. I doubt if you need to look further than that for your seller. Add to that ceo saying at Mar A Lago there was an ultra high net worth investor on nearly every table, i.e. we have a lot of u.s. investors, wouldnt be a surprise if one or two had got caught and trimmed their portfolios? The positive is that the s.p. hasn't cratered, has widened its pipeline of assets, reconfirmed 001 still in negotiations etc etc. Hope you time yr buy ins correctly ;)",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887091+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261935-woodfrom-76172778",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.593775",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "If they have sufficient cash to last until 2027, then the main overhang is likely the cheap warrants being sold. It\u2019s unclear whether these warrants were ever repriced. The CEO, at least, appears to have a credible track record.",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887122+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261924-woodfrom--5366502",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594191",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "What's causing the price weakness?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887140+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261917-woodfrom--8510409",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.594590",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Has your brain been replaced with an AI robot?",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887159+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261912-ComesMar--8243348",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595016",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "The \"WFTT\" Profile: A Sophisticated Opportunist \u200bThe \"AI-Style\" Researcher (Upland Resources - Jan 2026): Just two weeks ago, WFTT was posting on the Upland (UPL) board using highly detailed, institutional-sounding language (very similar to the \"Jigger\" report) to defend a director's options. They were explaining complex 5p options and arguing for a massive re-rating. \u200bThe Takeaway: They are capable of doing deep, positive research when it suits them. This proves their current \"Strong Sell\" on SVNS is a deliberate choice, not a lack of understanding. \u200bThe \"Rumour Monger\" (Reabold Resources - Jan 2026): On the RBD board, they were active in spreading rumours about \"well-known pump and dumpers\" like Harald. They have a history of using fear-based narratives to influence small-cap sentiment. \u200bThe \"Contradiction\": While they attack SVNS for \"cash burn,\" they were recently celebrating the \"NAV value\" of Hot Rocks (HRIP.PL) despite similar market conditions.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887178+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261852-woodfrom-50028639",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595447",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "Whenever you see a seller finished ramp you know you're in for a treat. Legacy graft Polymer overhang? or is it the 0.1p warrant overhang....",
          "sentiment": 0.0,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887197+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261825-Andys288-23200042",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.595860",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Perhaps you should listen to the recent pod cast again where \u201c A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027\u201d Placing from a troll or cash runway from the MD I wonder who I believe\u2026.",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887215+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261819-woodfrom-60512022",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596288",
        "source": "LSE_CHAT",
        "data": {
          "author": "woodfromthetrees",
          "content": "To me looks like a placing will be incoming imminently here. \u00a31.7m cash burn/6months and they had \u00a31.7m June last year so would have been down to 0 at year end... however raised \u00a31.2m in October which gives them 3 - 4 months taking it to March when they'll be on fumes again Looks like the ramp crew is all over this now to get the price up pre rug pull.",
          "sentiment": -0.5,
          "engagement": "574",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887234+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261715-VikR-14488861",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.596692",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "And on that note also took \u00a35k today",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887253+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261714-VikR--1308666",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597114",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Welcome definitely oversold and undervalued. SVN 001 is getting out licensed this year, good as confirmed in the last interview. SVN 002 is a massive play but incremental stages to be reached with bridging study confirmation and then FDA application swiftly after for phase 2B. SVN015 hopefully gets selected for the grant. SVN-SDN-14 series gets added in for good measure. While the SP is quiet and stagnant that\u2019s the best time to accumulate, when it shoot\u2019s up on deal announcement it will trigger a HUMONGOUS re rate for the ENTIRE PORTFOLIO, 100 Million MCAP minimum",
          "sentiment": 0.5,
          "engagement": "1,019",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887271+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261639-RhHh--2803457",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597527",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Nice one, NaxosDon. Good decision I reckon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887290+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261340-Andys288-77916078",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.597934",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Balls going deeper, added another 5k. Now let\u2019s see this SP get back on track",
          "sentiment": 0.0,
          "engagement": "521",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887309+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261338-MadEngli-54485811",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598349",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "I didn't know anyone in the UK knew Curb. Genius stuff. ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887329+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261320-ComesMar-26656338",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:16.598761",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I find this quote of Richard as king John quite appreciated: \u200b\"Wait, I have an idea. Maybe if you tell me the bad news in a good way, it wouldn't sound so bad.\"",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887347+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261312-TrickyEF-34508248",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.694318",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Loved Richard Lewis and his work on curb",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887366+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261258-LlamaFar-86850849",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695150",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.dailymail.co.uk/tvshowbiz/article-15529379/jamie-lee-curtis-27-sobriety-journey-richard-lewis.html",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887385+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261231-TrickyEF-19055628",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.695967",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I no longer checking in as often. Day to day movements is just pure nonsense. However fook the seller \ud83e\udd2a\ud83e\udd2a\ud83e\udd2a",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887403+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261222-MadEngli-11397771",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.696999",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Dvh...it will be back and then some.  Trust the science and the need for it. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887421+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261152-dvharris-70586392",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.697813",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very true ME, although looking at the Solvonis value in my share account when the SP was 0.4p was much more enjoyable! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887440+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261139-MadEngli--2129272",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.698618",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "It matters not that people are selling, the science hasn't changed, the potential hasn't changed, the need for this science hasn't changed. When this moves it will move quickly and massively. Happy to sit on my holding. ATB ME",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887458+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261136-dvharris--8286422",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.699419",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, looks like peeps selling (boredom?)....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887476+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261128-DrMicho--5800849",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700202",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Added again over the last few days. I wasn\u2019t expecting it to be this low so a decent buys for the future.",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887494+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20261123-DaffyPic-47955337",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.700986",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "When this gets to 0.75 - to 1.00 , my depression is going to lift.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.245",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887513+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260933-LlamaFar-45643542",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.701866",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The last couple of sessions looks like PI's selling after the event. The larger, more structured seller i.e 5m blocks isn't here - to me that says GO time... Professor Nutt has said a couple of things recently in interviews that were very  interesting, we all know that we are waiting for 001, aside from that, Nutt said. 1.On 015b Depression - well depending on how much we raise we could look at all of the depressives. A.T. then says we have no plans to raise at the moment, we have a cash runway until Q1 2027. Conclusion: Nutt must have been looking ahead to the U.S. listing. for his small molecules that the AI engine is pumping out. 2.On lead molecule - we will have that done in a month or so. Personally I've been adding on this dip - each to their own.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887531+00:00"
      },
      {
        "event_id": "SOCIAL-5Feb20260904-dvharris-59079026",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.702633",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Poor start to the day and sells now sub published Bid of 0.25p. We need some positive news to stop the decline in SP and get us trading back above 0.3p.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887549+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261505-RhHh-15738614",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703277",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "No big sells for a few days leads me to believe that the big seller is done. If no more appear this week I think it will be safe to start topping up again.",
          "sentiment": 0.5,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "Seller finished?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=9498C293-B6B4-49B3-9E11-6AAD81A07836"
        },
        "ingested_at": "2026-02-11T17:11:28.887567+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261345-dvharris--8159607",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.703876",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like we might be heading lower again. NT to sell anything at barclays atm....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-11T17:11:28.887590+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20261037-DrMicho-82766149",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.704471",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "In need of something to create a bit of volume, our seller drowned the last piece of news...",
          "sentiment": 0.5,
          "engagement": "8,162",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-11T17:11:28.887625+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260916-LlamaFar-53957803",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705068",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Prof David Nutt on the Mums podcast on Monday said a month or so for lead drug ... worth listening to podcast.link below a few posts ago. 001 news due. 002 news due Seems 2026 will be busy.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-11T17:11:28.887660+00:00"
      },
      {
        "event_id": "SOCIAL-4Feb20260828-dvharris-46588468",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.705825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Interesting ME. Now, assuming the Seller has finished (6M available to sell now pre NT) we just need the CEO to light the touch paper with licence/funding news and watch this re rate....\ud83d\ude80\ud83d\ude80",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-11T17:11:28.887697+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261539-MadEngli-71619518",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.706455",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Based on recent industry activity, the most likely acquirer among top-tier pharmaceutical companies for Solvonis Therapeutics is AbbVie, as they have already shown active interest in acquiring similar addiction treatment pipelines. Top Potential Acquirers AbbVie: In 2025, reports indicated AbbVie was preparing a $1bn offer for Gilgamesh Pharmaceuticals, a U.S. peer in the same space, highlighting a strong strategic desire to enter this market. Other Potential Top-10 Contenders: Given the high unmet need in CNS (Central Nervous System) disorders, other top-10 firms with strong histories of psychiatric or neurological acquisitions\u2014such as Pfizer, Novartis, or Johnson & Johnson\u2014are considered likely acquirers for de-risked late-stage assets.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-11T17:11:28.887723+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261538-MadEngli--4870378",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707080",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Why Solvonis is an Attractive Target Solvonis has positioned itself as a major player in addiction treatment, particularly following its acquisition of Awakn Life Sciences in May 2025. Lead Asset (SVN-001): A Phase 3, first-of-its-kind combination therapy (IV ketamine + manualized CBT) for severe Alcohol Use Disorder (AUD), with results expected in late 2027/early 2028. US Market Asset (SVN-002): A sublingual/buccal esketamine formulation for moderate-to-severe AUD, which may follow a \"regulatory shortcut\" to bypass early trials, reducing cost and time-to-market. Discovery Engine: A pipeline targeting stimulant addiction (methamphetamine/cocaine) and a PTSD program (SVN-SDN-14).",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "RE: Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-11T17:11:28.887742+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261536-MadEngli--5816239",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.707703",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Timing and Strategic Drivers Late-Stage Focus: Solvonis explicitly positioned itself as a \"partner of choice\" for large pharma, with discussions already underway for licensing SVN-001. High Value Target: With positive Phase 2b data, the assets are considered de-risked, and similar deals in this space have commanded up to $1.2 billion in total value.",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.26",
          "thread_title": "Answers from AI...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=8AA9058C-802A-4ECD-BFA4-30FF1BB2E77C"
        },
        "ingested_at": "2026-02-11T17:11:28.887761+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261524-TrickyEF--3751034",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708341",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Solvonis currently is the stand out play of the market for investors. The mouth watering situation on offer here is insane. The company currently worth \u00a317million. They have enough money to carry on with every aspect of the business for 12 months and within this  12 months window a licensing deal and \u00a312 million in funding for  svn15  may well be attained to see it all the way through phase 1. If any of this news drops then it's flying over 2p for starters. Positive Bridging data would also be a catalyst to get us over 1p.",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "Cash runway covered til Q1 2027",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=F5298FB3-E0C6-4F50-8445-616D8BC77247"
        },
        "ingested_at": "2026-02-11T17:11:28.887780+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261326-LlamaFar--4917336",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.708995",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "E.D. Look at the value of USA early stage Pharmas dealing in same fields as this. There are a lot at the same level of progress as Solvonis, only Atai is ahead of the curve, and worth substantially more. A.T. laid it out in the Mums interview ( see link below ) that SVNS is worth money when the following inflection points happen. 001 - Phase 3 - Current stage 002 Phase 2b - About to enter 014 Phase 1 - Lead candidate then about to enter. 015a Phase 1 - Short to medium term 015b Phase 1 - short to medium term. Atai for a comparison is worth circa $1.2BN, SVNS don't need funding for 12 months, if 001 is outlicensed, will not need funding at all so stops at 6.8bn shares. that would be 17 cents a share or 12.43p per share. No wonder these American Ultra High Net Worth individuals are already invested and via Pamlico Shoals happy to keep funding.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-11T17:11:28.887798+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261316-erniedam--1825042",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.709601",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "LlamaFarmer, Thanks for your reply. Yeah, realise med term is a subjective time period. Guess I'm getting a bit impatient. Cheers for all your in depth research, it's much appreciated.",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-11T17:11:28.887818+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261205-RhHh--4514508",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710193",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "It would be good to have an updated research note from Singer to reflect the new developments. Hopefully that will happen soon.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.887836+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261129-LlamaFar-12831158",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.710845",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "BIGGER Cost to the U.K. than Alcohol... Smoking and nicotine use impose a total annual cost of over \u00a350 billion on the UK society and economy, according to ASH Scotland estimates. This massive burden, largely from tobacco, includes around \u00a327.6 billion in lost productivity, \u00a31.82 billion for NHS healthcare, and \u00a313.9 billion in social care, far exceeding tax revenue. Key Annual Costs of Nicotine/Smoking in the UK: Total Societal Cost: Estimated at over \u00a350 billion, or \u00a349.2 billion in England alone. Lost Productivity: The largest factor, totaling \u00a327.6 billion to \u00a332 billion annually through smoking-related sickness, unemployment, and premature death. Health and Social Care: Roughly \u00a31.82 billion for the NHS and \u00a313.9 billion to \u00a315 billion in social care costs. Smoking-Related Fires: Approximately \u00a3328 million\u2013\u00a3332 million per year. Personal Costs: A 20-a-day smoking habit can cost an individual over \u00a34,200 to \u00a35,500 annually. Stop Smoking Aids: The net cost to the NHS for prescription quitting aids was \u00a313.8 million in 2024/25. Rising Trends: Costs have increased by 25% in recent years, with smoking in England costing at least \u00a321.8 billion in direct, measurable impacts. While cigarette sales are declining, the nicotine pouch market in the UK is growing rapidly, valued at over \u00a3170 million.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Prof Nutt Hinted at other addictions?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=2D9BDC11-F4CC-45E2-9D6B-32562C1F22AA"
        },
        "ingested_at": "2026-02-11T17:11:28.887866+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261127-LlamaFar--8719064",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:20.711481",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Alcohol-related harm costs the UK society and economy between \u00a327 billion and \u00a352 billion annually. In England alone, the cost is estimated at \u00a327.4 billion, which includes nearly \u00a35 billion for the NHS, over \u00a314 billion for crime, and over \u00a35 billion in lost productivity. This impact exceeds the roughly \u00a312.5\u2013\u00a314 billion generated in annual alcohol tax revenue. Key components of the annual costs include: Healthcare: Approximately \u00a33.5 billion to \u00a34.91 billion for the NHS. Crime & Disorder: Roughly \u00a314.6 billion, including police, legal, and fire services. Lost Productivity: \u00a34.6 billion to \u00a35.06 billion due to absenteeism, premature death, or unemployment. Social Services: An estimated \u00a32.89 billion. With over 1.25 million annual alcohol-related hospital admissions, the total societal burden equates to roughly \u00a3485 per person per year.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "Cheers",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=B230C66D-50ED-4829-81AB-3229BACF0749"
        },
        "ingested_at": "2026-02-11T17:11:28.887886+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261126-dvharris-45931948",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.036870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I suspect that this time next year we'll be talking about an SP way higher than today. Remember last years Research Note valuation of 1.6p and we've made progress on a number of fronts since then.......",
          "sentiment": 0.0,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.887904+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261117-LlamaFar-11012867",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037371",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Tricky, I like the honesty, for me it makes it investable - park some money up and wait! A.T. I thought we would have out licensed 001 by Q4 2025, but we have to accept our size and wait our turn, imo referring to the Pharma events that ran from Nov 2025 - Jan 2026 that have delayed news ( and cashflow ). A.T. I went to Mar A Lago at the invitation of one of our largest share holders and met all of the Ultra High Net Worth investors, there was one of these existing Solvonis investors at each table. A.T. 002 will give us the most financial benefit, in the USA there are two parts of the world, there's the USA and there's the R.O.W. the rest of the world, that's why we will be running our 002 trial in America, its inflection point is in Phase 2b. P.N. I did my Uni thesis on Cocaine in 1979, I think these new small molecules will do something for that. K.H. (Interviewer) I don't mind telling you, I'm an investor here myself with a decent sized position! Loads of great info, listened to it twice, got more out of it the second time.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.887923+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261059-RhHh-10768976",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.037785",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Gonna be a great year here.",
          "sentiment": 0.0,
          "engagement": "331",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.887942+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20261058-TrickyEF-26508930",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038215",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Llama that interview by Nutt and AT yesterday was superb. Best yet",
          "sentiment": 0.0,
          "engagement": "16,062",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.887961+00:00"
      },
      {
        "event_id": "SOCIAL-3Feb20260858-LlamaFar-82039554",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.038656",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "ED. 10 months left in 2026, is that short or medium term? I think the focus is  getting 002 into a usa trial and funding it. He clearly said phase 2b is its inflection point. Also said he has been to America and spoken to all of their existing ultra high net worth investors via the Michael Layman Pamlico Shoals event at Mar A Lago. He must have worked out a way to get 002 into phase 2b trials, funded from current cashflows and out license of 001 that could be done from the London Exchange listing while the Nasdaq listing goes through. Another thing to note from that interview, he was tighter with certain parts of info that might affect negotiations, so maybe theres some of that as well with the Nasdaq? Look at 015a and 015b neither of these were signalled, they just landed.",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.887980+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262310-erniedam-92940355",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039078",
        "source": "LSE_CHAT",
        "data": {
          "author": "erniedamini",
          "content": "Hi LlamaFarmer, Good video, thanks for sharing. One segment I picked up on, AT mentioned that he has aspirations to list on the NASDAQ in the med to long term. I thought he previously said this year?",
          "sentiment": 0.0,
          "engagement": "264",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.887998+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262258-LlamaFar--3547116",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039537",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Mdma - synthesised form of, for ptsd type treatments being worked on. 001 still in talks with more than 1 party - A.T. wouldn't be drawn on the number \ud83d\ude02. 002 - AT said will have most value - inflection point phase 2b, will be run in USA. 015 - Prof Nutts favourite - he's been working on cocaine addiction since 1979, thinks this new molecule will do it. Basically,what we already knew plus the new stuff. A.T. Went to Mar a Lago - UHNW investors evening, there was an existing Solvonis investor on each table as Anthony networked around the room. Money from 001 will kick start this, but 002 will take it to the Bank. These novel treatments of 014, 15a and 15b will then kick it on a gear, their inflection points AT phase 1. All that adds up to a $1bn Co. Imo",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "RE: If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.888017+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20262250-LlamaFar-50914596",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.039947",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://youtu.be/AO2VdmBHBMY?si=5NzRDDTscSQEglpC",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.26",
          "thread_title": "If you are invested this is a much watch/listen",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=D9373C9B-17B6-475E-A66D-C1D41B372C64"
        },
        "ingested_at": "2026-02-11T17:11:28.888035+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261523-ComesMar--1185506",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040417",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "Solvonis - has received a Notice of Allowance from the USPTO for compounds within its SVN-SDN-14 PTSD discovery programme, strengthening the intellectual property ahead of lead candidate selection expected in Q1 2026. The patent covers novel serotonin, dopamine and noradrenaline modulators designed to support pro-social engagement and enhance psychological therapy effectiveness in PTSD patients. The compounds address historical development challenges by incorporating predictable metabolic deactivation to improve pharmacokinetic control, dosing flexibility and safety margins while maintaining therapeutic activity. The USPTO examiner confirmed the novelty of the approach, finding no existing patents or publications disclosed the claimed compounds. The company has also expanded its SVN-015 programme into depression following positive preclinical data showing antidepressant-like activity comparable to fluoxetine (Prozac) after 14-day dosing in validated rodent models. SVN-015 is a novel Serotonin-Dopamine Reuptake Inhibitor designed to address symptoms poorly controlled by SSRIs, including anhedonia and reduced motivation, targeting a market of over 20 million adults with Major Depressive Disorder in the US alone. The compound is being developed as a once-daily oral therapy for at-home use aligned with standard antidepressant treatment cycles, and has separately been selected for evaluation by the US National Institute on Drug Abuse for stimulant use disorders, providing independent validation of its pharmacological profile. This remains an exceptional pharma play.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.26",
          "thread_title": "Charles Archer small cap review",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=62CD6955-201F-415B-BAD4-B42ECE570F38"
        },
        "ingested_at": "2026-02-11T17:11:28.888054+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261426-Cambsblu--8607706",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.040833",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "I do hope you are right. Just taken another 5m so now sitting at an average of 0.3p rather than 0.35 this time last week. I expected the Whitehouse announcement last week to prompt some action from one or more of the big US companies so fingers crossed for news very soon!",
          "sentiment": 0.0,
          "engagement": "23",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-11T17:11:28.888072+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261409-dvharris-64775605",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041279",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "It wasn't so long ago we were on the cusp of trading above 0.4p. A placing and a (distressed?) seller later and here we are with a mcap of just \u00a317M! As Yazoo would say....the only way is up! \ud83d\udd7a \ud83d\udc83",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.26",
          "thread_title": "RE: Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-11T17:11:28.888091+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261355-MadEngli-17309786",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.041693",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "We don't get traders off-loading the second we head back into the 3s. ATB",
          "sentiment": 0.0,
          "engagement": "734",
          "price_at_post": "0.255",
          "thread_title": "Here's hoping",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=546F714F-1F07-4165-9571-37D5BEF4D4E8"
        },
        "ingested_at": "2026-02-11T17:11:28.888122+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261349-DaffyPic-16646228",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042116",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Thanks!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.26",
          "thread_title": "RE: Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-11T17:11:28.888141+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261305-DaffyPic-10074335",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042527",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Let's have some  showing today please!!",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "Twenty Seven",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=90FD39CC-6D3D-4B0A-B089-D23D446F3C4A"
        },
        "ingested_at": "2026-02-11T17:11:28.888159+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261228-Makingmi-68793479",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.042938",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Given the timing, pricing, and fact price not affected, imo, would say those 2 x 10000000 trades were a sale and repurchase.",
          "sentiment": 0.0,
          "engagement": "95",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-11T17:11:28.888178+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261130-DaffyPic-24124042",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043373",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "10,599,803   Sold Value\t\u00a326.78k 10,140,159    Bought Value\t\u00a326.18k Approx.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-11T17:11:28.888196+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261129-DaffyPic--8535621",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.043792",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"so the seller should have finished on Friday.\" I think you're right and I certainly hope you're right.",
          "sentiment": 0.0,
          "engagement": "3,604",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-11T17:11:28.888215+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20261018-LlamaFar-28262166",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044243",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "C.M. Looks like it doesn't it. Recent sells look more retail. As DVH and Triplestar have said it's undervalued for what they have here. Worth repasting what DVH points out... A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!).",
          "sentiment": 0.0,
          "engagement": "891",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-11T17:11:28.888234+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260955-ComesMar--2437100",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.044655",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I am also noticing that up to now there are no SINT trades. My taks is that mm are not trying anymore to walk the sp, so the seller should have finished on Friday. News about 002 and 014 (and 001?) are in line for Q1.",
          "sentiment": 0.0,
          "engagement": "72",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-11T17:11:28.888253+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260952-dvharris--3264961",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045070",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A spark will suddenly ignite the SP here imo (remember IMM SP drifted and then 10 bagged in 4 weeks!). The BoD is slowly putting the pieces of the jigsaw together and the picture isbecoming clearer.....",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-11T17:11:28.888271+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260935-thetripl--7136215",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045525",
        "source": "LSE_CHAT",
        "data": {
          "author": "thetriplestar",
          "content": "When you look at this pipeline alongside a \u00a318m\u2013\u00a320m market cap, the disconnect is obvious: Most Phase 3 biotechs trade at \u00a3100m\u2013\u00a3300m. Solvonis is being valued like a discovery-stage company, even though they have a Phase 3 trial that is largely taxpayer-funded. My Take: The market is currently ignoring the SVN-001 Phase 3 because \"Phase 3 takes time,\" and it's ignoring the SVN-015/SDN-14 because it's \"early stage.\" Once the Q1 Lead Candidate Selection (from that AI discovery engine) is announced, it acts as the bridge that proves the whole pipeline is moving forward. This is a \"sum-of-the-parts\" play. Even if you value SVN-001 at just \u00a350m and the rest of the pipeline at \u00a320m, the stock should be trading at 3x-4x its current price.",
          "sentiment": 0.0,
          "engagement": "914",
          "price_at_post": "0.255",
          "thread_title": "The Pipeline",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=AF12076F-EA04-4D3E-8E2B-889F9846F1C9"
        },
        "ingested_at": "2026-02-11T17:11:28.888290+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260835-dvharris--9100422",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.045938",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Full ask to buy even 10 quids worth...",
          "sentiment": 0.5,
          "engagement": "21,106",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-11T17:11:28.888308+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260823-ParetoPr-37532675",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046361",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "SEDAR filings: https://thecse.com/listings/awakn-life-sciences-corp/sedar-filings/",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-11T17:11:28.888327+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260821-ParetoPr--4882686",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.046768",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "For anyone who doesn\u2019t know, the SEDAR filings are the CAE equivalent of an RNS",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "RE: For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-11T17:11:28.888346+00:00"
      },
      {
        "event_id": "SOCIAL-2Feb20260819-ParetoPr--5020433",
        "event_type": "social_post",
        "date": "2026-02-06T23:28:25.047188",
        "source": "LSE_CHAT",
        "data": {
          "author": "ParetoPrinciple",
          "content": "All CSE listings for Awakn Life Sciences: https://thecse.com/listings/awakn-life-sciences-corp/cse-filings/?page=2",
          "sentiment": 0.0,
          "engagement": "2,405",
          "price_at_post": "0.255",
          "thread_title": "For reference",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=6AFBB186-49FA-4740-B295-F8DE9FCEF910"
        },
        "ingested_at": "2026-02-11T17:11:28.888365+00:00"
      },
      {
        "event_id": "SOCIAL-Today1626-dvharris-21397312",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.964825",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, still sell many millions of shares and now full ask for anything!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888383+00:00"
      },
      {
        "event_id": "SOCIAL-Today1620-Makingmi-66139310",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965393",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Well was monitoring what I could sell a reasonable amount at and it stayed same but after that sell has now increased.  Not worth overthinking it. It\u2019s a good price to keep holding.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888401+00:00"
      },
      {
        "event_id": "SOCIAL-Today1514-dvharris--7662600",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.965819",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The ask is dropping which usually signifies a worked sell. Interesting though that you can sell many millions of shares atm. We'll see after close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888419+00:00"
      },
      {
        "event_id": "SOCIAL-Today1512-DrMicho--9105595",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966247",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I was thinking the same thing to be honest... with the amount of buying i expected this to have moved up.",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888438+00:00"
      },
      {
        "event_id": "SOCIAL-Today1458-DaffyPic-26203577",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.966667",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "I'm surprised it hasn't ticked up yet. Perhaps there is a big sell order being worked ??",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888456+00:00"
      },
      {
        "event_id": "SOCIAL-Today1333-Cambsblu-91646444",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967076",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Must admit I was tempted to sell several times over the past couple of months, but have been convinced it is worth holding on and adding.",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888474+00:00"
      },
      {
        "event_id": "SOCIAL-Today1328-Makingmi-76484270",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967503",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Possibly a few depressed people on here, with the price at this low level. Fortunately just a small dose of patience will do the trick. Lol.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888492+00:00"
      },
      {
        "event_id": "SOCIAL-Today1327-Andys288--3843024",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.967912",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Welcome back cambsblue. I thought you had sold up months ago",
          "sentiment": 0.0,
          "engagement": "517",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888510+00:00"
      },
      {
        "event_id": "SOCIAL-Today1311-DaffyPic-45433355",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968340",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "There are a lot of depressed people on planet Earth, so  this should do very well.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888528+00:00"
      },
      {
        "event_id": "SOCIAL-Today1217-dvharris--2413361",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.968754",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "A very decent holding!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888546+00:00"
      },
      {
        "event_id": "SOCIAL-Today1215-Cambsblu--5990600",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969178",
        "source": "LSE_CHAT",
        "data": {
          "author": "Cambsblue",
          "content": "Yes, couldn't resist at this level. Already have 48m bought last Autumn on the expectation of good news before the end of last year. Have been tempted to off-load some to invest elsewhere but decided to add at this silly price and hope for news by the end of Q1 !",
          "sentiment": 0.0,
          "engagement": "22",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888564+00:00"
      },
      {
        "event_id": "SOCIAL-Today1202-dvharris-50704762",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.969593",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Premium paid!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888582+00:00"
      },
      {
        "event_id": "SOCIAL-Today1201-dvharris-30982283",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I don't think too many would argue that a \u00a317M mcap seriously undervalues the potential of this company to deliver much needed treatments in areas currently pretty ill served. We have a quality BoD focused on results and maximising shareholder value. Good enough for me!\ud83d\udc4c",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888599+00:00"
      },
      {
        "event_id": "SOCIAL-Today1159-DaffyPic-68998687",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970426",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice!!   11:59:01\t0.263\t8,000,000\t21.06k",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888617+00:00"
      },
      {
        "event_id": "SOCIAL-Today1155-Makingmi--8929197",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.970838",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Sometimes it\u2019s not worth trying to be too clever and get the top or bottom of every price move right. Price can move quickly, so if it\u2019s a good price and you are happy with where it\u2019s going, buy it. If it goes down a bit it comes back. Less stressful too. It\u2019s called investing then, rather than gambling.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888635+00:00"
      },
      {
        "event_id": "SOCIAL-Today1138-dvharris--2434506",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971259",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "When folks are confident the seller is done we'll see plenty of buyers snapping up sub 0.3p shares.",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888653+00:00"
      },
      {
        "event_id": "SOCIAL-Today1135-MrsRobin--7101447",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.971665",
        "source": "LSE_CHAT",
        "data": {
          "author": "MrsRobinson",
          "content": "Over 25m buys today and no significant sells other than big delayed sell so looking promising.",
          "sentiment": 0.0,
          "engagement": "186",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888671+00:00"
      },
      {
        "event_id": "SOCIAL-Today1106-DaffyPic--6212596",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972083",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "\"The pesky seller has a lot to answer for...\" Yes, but surely they do not have many left??   If any!!",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888690+00:00"
      },
      {
        "event_id": "SOCIAL-Today1041-Makingmi--2106071",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972495",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Yes, probably safe to get some more now dvh.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888708+00:00"
      },
      {
        "event_id": "SOCIAL-Today1031-DrMicho--6650703",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.972902",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes, hopefully that sell is the end and we can move on...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888726+00:00"
      },
      {
        "event_id": "SOCIAL-Today1030-dvharris-34268858",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973325",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "After the news we had earlier this week and further newsflow on other fronts expected this quarter we really should be trading above 0.3p imo. The pesky seller has a lot to answer for...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888744+00:00"
      },
      {
        "event_id": "SOCIAL-Today1029-Makingmi-53997574",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.973731",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Seems the effect of the excellent news release got lost in that selling session. Bit of catching up with events to come now.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888762+00:00"
      },
      {
        "event_id": "SOCIAL-Today1024-Makingmi-31657697",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974146",
        "source": "LSE_CHAT",
        "data": {
          "author": "Makingmillions",
          "content": "Bought in earlier so hope you are right.  No problem either way at this price though.",
          "sentiment": 0.0,
          "engagement": "90",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888780+00:00"
      },
      {
        "event_id": "SOCIAL-Today1018-dvharris--7929127",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974564",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think we've just seen the reason the SP went down yesterday and folks couldn't get sell quotes. It's an odd figure so maybe the last of the selling? Looks like a few of us are buying in the hope that is the case.......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.255",
          "thread_title": "RE: Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888798+00:00"
      },
      {
        "event_id": "SOCIAL-Today0946-DaffyPic--5826317",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:09.974975",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "In the short term.  That's 0.44.    But I am still waiting for a penny.",
          "sentiment": 0.0,
          "engagement": "3,588",
          "price_at_post": "0.255",
          "thread_title": "Double Desmond",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EF9E8C19-3094-4498-A45F-2D79C7E1ED1E"
        },
        "ingested_at": "2026-02-11T17:11:28.888816+00:00"
      },
      {
        "event_id": "SOCIAL-Today0851-dvharris--6752860",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484140",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Just imagine if they have finished and you could have bought sub 0.25p! So tempted but will hold fire for the moment....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-11T17:11:28.888834+00:00"
      },
      {
        "event_id": "SOCIAL-Today0846-DrMicho--3261382",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.484578",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I am not to sure its finished yet..if it is this will move up soon enough.",
          "sentiment": 0.5,
          "engagement": "8,159",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-11T17:11:28.888852+00:00"
      },
      {
        "event_id": "SOCIAL-Today0839-dvharris-12674620",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485007",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I can sell 5M shares (pre NT) with barclays at 0.2421p. Is our seller interested? Buying at this level is an absolute gift, but worried our seller might push the price lower. Conundrum!",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-11T17:11:28.888870+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262348-TrickyEF-81320379",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485452",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "From a poster on telegram. Had a q and a with Gemini about the executive order and how it may impact Solvonis. You are right to be highly optimistic.  It is rare to see a micro caps pipeline match a major executive order's priorities so precisely. Especially with a board chair who has $15 billion track record in us life sciences. Will it be flat tomorrow??",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "From some site called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=A278FF6C-F4B1-48C7-BC16-FDE11632C70F"
        },
        "ingested_at": "2026-02-11T17:11:28.888888+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20262344-TrickyEF--5553762",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.485875",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Seems pretty legit \ud83d\ude09\ud83d\ude09 https://www.whitehouse.gov/presidential-actions/2026/01/addressing-addiction-through-the-great-american-recovery-initiative/",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.245",
          "thread_title": "from some ****e called the whitehouse",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=05EF86B5-7368-48E4-884F-EF5C39F8DEF2"
        },
        "ingested_at": "2026-02-11T17:11:28.888906+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261710-LlamaFar-92745170",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486299",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "0.18p? Its on the chart from June last year...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.888924+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261630-dvharris-50296491",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.486716",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, absolutely no incentive to buy until it drops to sub 0 2p imo. 0.2421p to sell just before the close.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.245",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.888942+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261622-DrMicho-46784392",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487131",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looking like the seller will have to take whats on offer as no one is buying. Same price tomorrow seller \ud83d\ude01 get on with it...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.255",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.888960+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261522-DrMicho--9058637",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487538",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Me too, Im here for the foreseeable so when it is finished selling I will buy its shares on the cheap...",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.888978+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261500-dvharris--4161587",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.487949",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The SP of my only other small cap investment seems to be on the runway ready for take off. Potentially even more money to invest here in the short/medium term....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.888997+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261457-dvharris--7538481",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488375",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "No rush for me as long term hold but would add significantly more if the MMs drop the SP to sub 0.2p......",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.889014+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261447-LlamaFar--7505638",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.488788",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope, mms dropped the price. I added at 0.18p on the way up, wasnt expecting the opportunity on the way back down. Have to ask how many does this seller have?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.889032+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261436-RhHh-18194955",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489200",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Seller hopefully done. Time for the MMs to take it up.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "Selling nearly over?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=60DC3F74-58B0-4310-BC40-89A699783933"
        },
        "ingested_at": "2026-02-11T17:11:28.889050+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261331-LlamaFar-79962112",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.489614",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Google is interesting. Says that the MM's can offer to take them out lock stock and barrel, maybe they sell down until they ruin the market for the stock and then the MM takes the rest at a lower price and everything goes back to normal? \"Immediate Liquidity Provision: If a seller cannot find another buyer, the market maker steps in to buy the security (hitting the bid), allowing the seller to exit the position instantly.\"",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889068+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261315-dvharris-29178447",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490027",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Can only sell 500k shares so our 5M seller will either have to wait or accept a (much) lower price. I think we will see an absence of buyers until the position becomes clearer....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889086+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261252-LlamaFar-41660778",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490451",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - same as that. We've been told in the last few RNS and Co interviews what newsflow to expect, if you are selling at this point its through desperation? The MM's job is to make an orderly market where we can sell as well as buy, if dropping the price does that then what are they waiting for?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889113+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261245-dvharris-62839364",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.490870",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'd rather they drop the SP to sub 0.2p than buy anymore until the seller has finished. Otherwise just funding their sales/profits. Expecting the SP to drop later.....",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889132+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261242-RhHh--6670158",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491287",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Pay day tomorrow but no point in topping up until the seller is done. Must admit I thought they would have finished by now.",
          "sentiment": 0.0,
          "engagement": "326",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889151+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261239-LlamaFar--1226784",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.491750",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They've still shut it all off - must have lots more 5m blocks to shift into us mug punters?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889169+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261203-LlamaFar-39708161",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492241",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "They were struggling to work that last 5m sell, had to close off all other sells in order to squeeze it through, previously over the last few sessions they had reduced the sells you could do to 5m shares, that's not making an orderly market so they will either have to drop the price hard, or stop performing their function as a market maker. Pretty pi55 poor  performance from the MM after the sterling RNS of yesterday, the seller is obviously desperate, cut his prices and get him/her gone.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889188+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261131-dvharris--3871860",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.492748",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, I was going to add more sub 0.3p but only when the seller has finished dumping their holding...",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889206+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261124-DrMicho--2570504",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493174",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I totally agree.. hopefully seller gets low prices to match his desperation \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889224+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261121-LlamaFar-75244150",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493586",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "No point in buying more if each big sell reduces the price, easier to wait till the bottom and add more on the way back up?",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889242+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261120-DrMicho-69534004",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.493998",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our seller was waiting for some buying before unloading\u2026 \ud83d\ude02\ud83d\ude02",
          "sentiment": 0.0,
          "engagement": "8,159",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889260+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261110-LlamaFar-73655083",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:13.494420",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "6AM in New York, Toronto, Washington...",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889278+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20261034-dvharris--8072940",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.436927",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889296+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260909-LlamaFar-16156795",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437392",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-11T17:11:28.889314+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260837-dvharris-17486951",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.437820",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,081",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889333+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260819-LlamaFar-80360826",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438249",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889351+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260815-LlamaFar-57500359",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.438688",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "876",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889369+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260010-TrickyEF-14738837",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439148",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-11T17:11:28.889387+00:00"
      },
      {
        "event_id": "SOCIAL-29Jan20260005-TrickyEF--2153870",
        "event_type": "social_post",
        "date": "2026-01-30T23:25:17.439582",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,049",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-11T17:11:28.889405+00:00"
      },
      {
        "event_id": "SOCIAL-Today1034-dvharris--8072940",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.348543",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Mr 5M just got up! \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889423+00:00"
      },
      {
        "event_id": "SOCIAL-Today0909-LlamaFar-16156795",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349238",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The amendments to the agreement mark three important developments for Solvonis: \u00b7 Expanded commitment - Professor Nutt's role increases to two days per week (40% FTE). \u00b7 Exclusive collaboration - his commercial CNS drug discovery and development expertise will be applied solely to Solvonis' programmes. \u00b7 Strengthened governance - as Interim Chair of the SAC, Professor Nutt will convene leading international experts to provide independent oversight and recommendations directly to the Board.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecules Come From The CNS Library",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5677FD43-E414-4F2B-A606-16259F75FAF9"
        },
        "ingested_at": "2026-02-11T17:11:28.889593+00:00"
      },
      {
        "event_id": "SOCIAL-Today0837-dvharris-17486951",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.349995",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD will continue to progress the multiple irons in the fire, the seller will run out of shares to sell and the SP will be free to reflect fair value (which isn't sub \u00a320M mcap imo!)",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889612+00:00"
      },
      {
        "event_id": "SOCIAL-Today0819-LlamaFar-80360826",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.350809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Once the large seller (s ?) is out, the S.P. can react positively, the market will then look and understand what they actually have here! The science people already know it, the investors know it, the rest of the market will catch on!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889630+00:00"
      },
      {
        "event_id": "SOCIAL-Today0815-LlamaFar-57500359",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.351641",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "New Science IP owned Patents Owned Replace existing and repurposed medicines Patent cliff approaching Solvonis own it all, Professor Nutt contracted to them, this work can be spread to other industry professionals, via his Scientific Committee that is also within Solvonis.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "Small Molecule Treatments",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=876A4041-61C4-40C2-8AC5-ED93B6AF9586"
        },
        "ingested_at": "2026-02-11T17:11:28.889648+00:00"
      },
      {
        "event_id": "SOCIAL-Today0010-TrickyEF-14738837",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.352511",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "A oral thin film you can administer in privacy, pure stigma KILLER. Is there gold in these darns hills \ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0\ud83d\udcb0 Japan reports lower clinical depression rates than many Western nations, though actual prevalence is likely higher due to cultural stigma and low treatment-seeking behavior. Treatment and Barriers Low Consultation Rates: Only 6% of people in Japan have used psychological counseling, compared to over 50% in the US and Europe. Underdiagnosis: Many people with clinical symptoms do not seek help; one study found while only 5% were officially diagnosed, 35% met the criteria for depression on screening scales. Economic Impact: The total societal cost of depression in Japan is estimated to exceed $13.5 billion USD annually.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-11T17:11:28.889666+00:00"
      },
      {
        "event_id": "SOCIAL-Today0005-TrickyEF--2153870",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.353336",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Japan. Think first time this has been mentioned as a potential market place. Paul carter appointment few months back seems very forward thinking. Chair of Kyowa Kirin International plc, the European subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), a Japan-based global specialty pharmaceutical company",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Jone word in today's rns",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=44633F07-3576-4633-A312-ABFA022ED130"
        },
        "ingested_at": "2026-02-11T17:11:28.889684+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262015-TrickyEF--3146548",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354159",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "For use at home on a daily basis. This was an attractive investment 12 months ago now it's looking fooking beautiful. Fingers crossed it don't turn into a munter.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-11T17:11:28.889702+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20262006-TrickyEF-57921566",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.354968",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "The OTF delivery system could turn out to be a goldmine. What's next?? Solvonis said SVN-015 is expected to be developed as a once-daily oral therapy suitable for at-home use, aligned with standard antidepressant treatment cycles, and noted the compound has also been selected for evaluation in the US National Institute on Drug Abuse Addiction Treatment Discovery Program for stimulant use disorders. Solvonis Therapeutics plc (LON: SVNS), (\"Solvonis\" or the \"Company\") an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that Awakn Life Sciences Corp. (\"Awakn\"), the company Solvonis plans to acquire, has reached a significant regulatory milestone. Awakn announced a positive outcome from a Pre-Investigational New Drug (\"Pre-IND\") meeting with the U.S. Food and Drug Administration (\"FDA\") regarding AWKN-002, a proprietary oral thin film (\"OTF\") formulation of esketamine, designed for sublingual and buccal administration in combination with structured alcohol education. This drug candidate is being developed for the treatment of moderate to severe alcohol use disorder (\"AUD\") with a focus on U.S market",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Oral thin films Synergy",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=73B33BF2-CF94-4379-9F1A-DCD0D5B03DB8"
        },
        "ingested_at": "2026-02-11T17:11:28.889720+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261933-MadEngli-79680486",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.355775",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "LHogbog, just keep holding, this is going to blow the bl00dy doors off one day.  When this gets picked up, JVd, bought out, it'll be by a big player and you'll be so happy you were in @ .3p. ATB ME",
          "sentiment": 0.0,
          "engagement": "721",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-11T17:11:28.889738+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261907-Hogbog-89921795",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.356560",
        "source": "LSE_CHAT",
        "data": {
          "author": "Hogbog",
          "content": "In various forms it is forever on social media, but what I\u2019m keen to know if when my two large holdings both in the 3s will actually make a profit.",
          "sentiment": 0.0,
          "engagement": "892",
          "price_at_post": "0.265",
          "thread_title": "RE: Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-11T17:11:28.889756+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261903-VikR-21780593",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.357390",
        "source": "LSE_CHAT",
        "data": {
          "author": "VikR",
          "content": "Https://www.linkedin.com/posts/jonathanmichaelholmes_this-novel-antidepressant-targets-more-than-activity- Just noted on linkedIN a motivated investor speaking highly of the pipeline. The story here just keeps more compelling with each new discovery. SSRIs are prescribed in the million &  millions and the anxiety and depression market is multi billion. Everything SVNS targets are huge addressable markets. Once the newsflow starts here it won\u2019t stop. I understand the frustration of shareholders who are getting bored with a stagnant share price but this team is not in it for a small slice of the pie, they want to hit it big. There has to be, absolutely has to be strong interest from mainstream pharma willing to put the funds to progress the projects further. I just wait for the day the blessed RNS lands. 7422302011582484482-UjTC?utm_medium=ios_app&rcm=ACoAAErGYQIB6gTMGcSk4EsXpWwMe6tdaF1kU5E&utm_source=social_share_send&utm_campaign=copy_link",
          "sentiment": 0.5,
          "engagement": "981",
          "price_at_post": "0.265",
          "thread_title": "Attracting social media attention",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=10990B12-A1DC-48E2-985D-17DC0555A7C7"
        },
        "ingested_at": "2026-02-11T17:11:28.889774+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261827-TrickyEF--3877827",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.358233",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "I for one hope to be still holding these come  2028/2029 and have a massive \ud83d\ude01\ud83d\ude01\ud83d\ude01 on my face. 8months old and with  just \u00a32.25 million of funding the AI of Solvonis has already popped out svn15 which is in the running for $15 million of NIH funding based on early data in relation too meth and coke addiction. This NIH support was provided before they even new about the potential for depression. No wonder the AI fund raised was covered by just 3 individuals. For \u00a32.25 million down they possibly realised  \u00a310.8 million in NIH funding. Given today's news the odds would have shortened on securing that funding. FANTASTIC new science being delivered here.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "RE: Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-11T17:11:28.889792+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261810-TrickyEF-50012081",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359029",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "At around the 3min 45 second mark. Early days but WOW.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.265",
          "thread_title": "Proff Nutt  interview",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=3171DEAE-4B30-40AD-ACBE-498FFDACBC4C"
        },
        "ingested_at": "2026-02-11T17:11:28.889810+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261649-DrMicho--4769498",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.359813",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Hopefully the smell of the seller will vanish soon enough. Waiting for buys to squeeze that little extra so must be desperate for the money. That desperation will   help move it on\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889828+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261546-LlamaFar-16033314",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.360501",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nope ... cant sell, can buy",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889846+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261520-ComesMar--2741684",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.361160",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think it just appeared ,  10m",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889864+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261515-LlamaFar-73129664",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362046",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Sellers still hanging about, waiting for a large odd amount trade to show... that's the way I've seen these end before.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889882+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261504-dvharris-52764006",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.362765",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Wouldn't it be nice if the latest 10M trade was the last of our sellers holding!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889900+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261400-DrMicho-25333959",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363274",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Yes me too DV...it would be nice to see some grants/funding to prevent any further need for funding/placings.. but the biggy is going to be a partnership or licensing deal. This would go bonkers, absolute crazy when it happens. Taking into consideration we have a fair amount of irons in the fire it surely cant be that far away.",
          "sentiment": 0.5,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889918+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261357-LlamaFar--7788767",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.363733",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "The further the pipelines move down the track, the bigger the numbers, i'm not rushed for answers at the moment. 015a Meth & Coke and 015b Depression are both new news, the pipelines are being widened and getting longer as they are progressed. Sit tight and add each time someone else is forced into selling, the lower the better imo.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889941+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261343-dvharris-50727887",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364170",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I'm waiting for the outcome of the discussions with the big pharmas that have been ongoing for a while now....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889959+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261303-dafad-81087340",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.364584",
        "source": "LSE_CHAT",
        "data": {
          "author": "dafad",
          "content": "Soon I think-usually a proactive interview would be out by now-lack of anything leads me to think nore news soon",
          "sentiment": 0.0,
          "engagement": "2,397",
          "price_at_post": "0.265",
          "thread_title": "More news...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=EAA076E1-B206-4EBC-B628-4F26952E44E2"
        },
        "ingested_at": "2026-02-11T17:11:28.889977+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261215-LlamaFar--5095913",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365003",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - sit tight and wait for the bargains. If they have to sell cheaply the price will be dropping?",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-11T17:11:28.889995+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261205-ComesMar--4273157",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:20.365476",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "According to Gemini, these are probably Canadian investors or institutions, with the clear mandate to quit. There is nothing to do other than wait that they are done with selling.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-11T17:11:28.890013+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261156-dvharris-83405224",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691006",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "I think you are right Llama, but the seller does seem to want to dispose of an awful lot of shares....",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-11T17:11:28.890031+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261140-cinderco--3196287",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.691680",
        "source": "LSE_CHAT",
        "data": {
          "author": "cindercone",
          "content": "Yep, some individual is selling into every rise. How much longer is anyone's guess as not a lot of liquidity here.",
          "sentiment": 0.0,
          "engagement": "2,102",
          "price_at_post": "0.255",
          "thread_title": "RE: Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-11T17:11:28.890049+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261120-LlamaFar-62210490",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692318",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "There's obviously a large seller about - they must be in a forced sale position as you wouldn't be selling otherwise on this mornings news. Once the seller dries up, my opinion is it rockets.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "Large Seller",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DB6CDD77-AF21-4E6F-9684-704E6F8C5C50"
        },
        "ingested_at": "2026-02-11T17:11:28.890068+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261119-dvharris-40734833",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.692922",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Yep, didn't think I'd be on the verge of meeting desmond again!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.255",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-11T17:11:28.890085+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261118-LlamaFar--8359621",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.693581",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "3.50mins - \"All depressives\" All depressives\" refers to the broad spectrum of clinical, chronic, and situational mental health conditions characterized by persistent low mood, loss of interest, and decreased energy. Psychiatrists often view depression as a range of experiences rather than one single disease, spanning from mild, temporary, to severe. Here is a breakdown of the various types of depression based on recognized diagnostic criteria (DSM-5): Primary Types of Depressive Disorders Major Depressive Disorder (MDD) / Clinical Depression: The most common form, involving severe symptoms\u2014such as intense sadness, hopelessness, or loss of interest\u2014that last for at least two weeks and interfere with daily life. Persistent Depressive Disorder (PDD) / Dysthymia: A chronic, low-grade, or moderate depression that lasts for two years or more. Bipolar Disorder (Manic Depression): While not exclusively a depressive disorder, this involves alternating episodes of depression and high-energy mania or hypomania. Premenstrual Dysphoric Disorder (PMDD): A severe form of PMS causing extreme irritability, anxiety, or depression in the week before a period. Disruptive Mood Dysregulation Disorder (DMDD): A childhood condition characterized by extreme irritability and intense anger outbursts.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-11T17:11:28.890116+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261115-DrMicho--7697522",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694200",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Absolutely amazed that we are worse off after a positive update.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-11T17:11:28.890135+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261113-LlamaFar--7800509",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.694808",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Https://www.youtube.com/watch?v=ZLhyKGvWypg At 1.50m GAME ON!!!",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.26",
          "thread_title": "RE: Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-11T17:11:28.890153+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261059-Bill999--8189771",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.695431",
        "source": "LSE_CHAT",
        "data": {
          "author": "Bill999",
          "content": "Good video out on Proactive today with David Nutt.",
          "sentiment": 0.0,
          "engagement": "3",
          "price_at_post": "0.265",
          "thread_title": "Video",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=1F31B1EC-E1CB-4745-A3A4-09377CB2B431"
        },
        "ingested_at": "2026-02-11T17:11:28.890171+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261055-dvharris--6594901",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696024",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Very funny!\ud83d\ude01",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.26",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890189+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261029-bonesgt-71573523",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.696635",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Going to stick my neck out ,think we will finish up today. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890207+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261027-dvharris--1510028",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697256",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "And we're red!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.265",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890225+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20261022-bonesgt--1709853",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.697855",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Was that an 8m buy disguised as a sell . Is that our buyer mopping up. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890242+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260908-ComesMar--9922025",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.698463",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "There could be tons of reasons why selling despite good news and expected catalysts. This is a gift for the ones believing in the story and with available cash.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890260+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260858-DrMicho--3474063",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699053",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Looks like our 5M buyer early on has took a 1500 quid hit. The thing that is going to move this properly is a licensing deal/large funding/partnership news. All of this could happen imminently, US listing, results take time.. still hopeful of something dropping that will shift this selling trend.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890277+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260856-TheDealB-75452288",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.699614",
        "source": "LSE_CHAT",
        "data": {
          "author": "TheDealBreaker",
          "content": "The bigger question is not who is selling but why?  Why sell on good news and the potential of more good news? They are clearly not moving shares into an ISA as there are no corresponding buys. Thanks",
          "sentiment": 0.0,
          "engagement": "304",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890296+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260847-RhHh--7959973",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700037",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I thought the seller was finished ages ago! Who is it?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890313+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260842-bonesgt-55399960",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700480",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "This is nuts ,what will it take. Who is the seller? Can't have many left surely.",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890331+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260838-dvharris-40081476",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.700904",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Pow,  5M number 3! Not another red day after yet another positive update surely?",
          "sentiment": 0.0,
          "engagement": "21,054",
          "price_at_post": "0.275",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890349+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260836-RhHh-13751573",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.701462",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "I hate that damn seller! Be a red finish at this rate ffs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890366+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260816-dvharris--4534202",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702149",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like the 5M seller is up early. Oh well......",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.285",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890384+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260815-RhHh--2154115",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.702662",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Tq",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890402+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260811-LlamaFar--6372685",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703082",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Get a broker and buy on the pre market - hence the premium.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890421+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260805-EpicViru--3329891",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703515",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "You can place an order to be executed",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890439+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260804-RhHh--5640909",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.703931",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "How can you buy before the open?",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890457+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260802-dvharris--2735843",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:25.704377",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "With the number of darts we're throwing at the board one is going to hit the bullseye!\ud83c\udfaf",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.29",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890475+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260755-DaffyPic--5634320",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558067",
        "source": "LSE_CHAT",
        "data": {
          "author": "DaffyPicker",
          "content": "Nice and early. 07:54:38\t0.295\t5,000,000\t14.75k",
          "sentiment": 0.0,
          "engagement": "3,575",
          "price_at_post": "0.27",
          "thread_title": "RE: Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890493+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260740-Scoutt-35034534",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.558633",
        "source": "LSE_CHAT",
        "data": {
          "author": "Scoutt",
          "content": "Diversification always good in binary developments, shaping up to be a wonder treatment, if it goes half as well as I\u2019m expecting we will be a penny share by mid year.  Substance mis-use, PTSD, Depression, if we can use it for Anxiety we can shout Bingo.",
          "sentiment": 0.0,
          "engagement": "975",
          "price_at_post": "0.27",
          "thread_title": "Diversification",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=C2918D8D-0F02-47DD-9F4E-B709B44078CC"
        },
        "ingested_at": "2026-02-11T17:11:28.890510+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260724-Stretcht-64860698",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559180",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Good news, let\u2019s see how that is received.",
          "sentiment": 0.0,
          "engagement": "207",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-11T17:11:28.890529+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260711-Andys288-63970885",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.559701",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019m feeling a bit blue today, if only there was a new treatment for depression\u2026.. #hellofreddy",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.27",
          "thread_title": "RE: 28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-11T17:11:28.890546+00:00"
      },
      {
        "event_id": "SOCIAL-28Jan20260706-EpicViru--2545970",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560283",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Here we go hold onto your seats. An hour before the floodgates open.",
          "sentiment": 0.0,
          "engagement": "38",
          "price_at_post": "0.27",
          "thread_title": "28/90 News",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=CCF1AC23-A632-44C9-9214-2ADE47B0A02D"
        },
        "ingested_at": "2026-02-11T17:11:28.890565+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261602-bonesgt-21293965",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.560797",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Flat or up a point today, be nice all in all we're still on track. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890583+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261147-TrickyEF--1937717",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561345",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Nice bones. May join ya and the Dr with a purchase this week.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890600+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261141-bonesgt-66431901",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.561848",
        "source": "LSE_CHAT",
        "data": {
          "author": "bonesgt",
          "content": "Never  mind Tricky I've just bought another 1 mil and again another 170k . Nothings changed on coarse for licencing,  among other great things we are working on. Gla",
          "sentiment": 0.5,
          "engagement": "1,569",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890618+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261139-RhHh--7953421",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562370",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "Looks like the sells are being mopped up. Might even be a flat close. Not long to wait for news.",
          "sentiment": 0.5,
          "engagement": "324",
          "price_at_post": "0.255",
          "thread_title": "Buyers coming in",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=18FDEE2C-AFBF-4A99-A347-D1CDEDF15437"
        },
        "ingested_at": "2026-02-11T17:11:28.890636+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261137-covgaz--7291440",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.562870",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "If it hits 23 will I be correct?",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890653+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261134-TrickyEF--7535782",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.563524",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "If something is the same as it was there is no change. It looks the same to me as it did on the 20th. Not pretty not ugly the same. Same same.",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890671+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261129-TrickyEF-29691462",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564177",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Covgaz don't think you realise that when you said it was going to 0.23p the trades where at 0.264p on the 20th. Guess what today's latest trade is for the same price. So it's identical price to the 20th when you posted. How is it getting messy if there is no change. \ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udd14\ud83e\udee3\ud83e\udee3\ud83e\udee3",
          "sentiment": 0.0,
          "engagement": "16,047",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890689+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261124-covgaz--6764893",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.564764",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "It's getting very ugly here , I did say will this be testing 23 again. Looks like it will.",
          "sentiment": 0.0,
          "engagement": "3,506",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890707+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261120-DrMicho--4188836",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565378",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "I have bought another 3M over the past few days to add to my growing collection. I\u2019m not complaining just curious why some would sell so close to news. Anyway GL to all\u2026",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.255",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890724+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261113-Andys288-38112517",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.565967",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "I\u2019ve not sold anything and have bought a few more over the last few weeks,  I\u2019ve not seen or heard anything to dissuade me that this is a great share to hold, and as a long term holder I am still in profit.  Just waiting for the news flow to start and this should go bonkers",
          "sentiment": 0.0,
          "engagement": "516",
          "price_at_post": "0.26",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890742+00:00"
      },
      {
        "event_id": "SOCIAL-27Jan20261108-DrMicho-29333417",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.566597",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering it\u2019s been reported that we are expecting a news rich period (originally dec) it\u2019s looking pretty grim at the moment. I am surprised at the constant selling tbh, is someone aware of something.",
          "sentiment": 0.0,
          "engagement": "8,152",
          "price_at_post": "0.265",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890760+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20262005-LlamaFar--5174217",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567196",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Nice lumpy rollover, then a bed n isa.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890778+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261601-dvharris-24200507",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.567625",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Looks like someone is taking steps to protect future profits from HMRC!",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890796+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261226-LlamaFar--6802906",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568050",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Day 26 / 90. Looks like traders entered on Friday as the MM's ran it up 10% and were stopped out this morning after no RNS turned up to save their positions....",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890814+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20261131-ComesMar-62844918",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.568488",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "It is clear that until news lands, the sp will be at the mercy of traders. In the long term perspective this is just noise, provided that the science behaves the way they claim.",
          "sentiment": 0.0,
          "engagement": "68",
          "price_at_post": "0.27",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890832+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260956-turnthec-22535574",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569024",
        "source": "LSE_CHAT",
        "data": {
          "author": "turnthecorner",
          "content": "Couldn\u2019t resist another top up at 0.2768 as only a matter of time will make this look like steal",
          "sentiment": 0.0,
          "engagement": "314",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890850+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260927-wookieem-69757674",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.569681",
        "source": "LSE_CHAT",
        "data": {
          "author": "wookieemonster",
          "content": "As volitile as an alcoholic this share",
          "sentiment": 0.0,
          "engagement": "4,352",
          "price_at_post": "0.275",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890868+00:00"
      },
      {
        "event_id": "SOCIAL-26Jan20260925-RhHh-55064570",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570224",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "As expected after the ut on Friday. Poxy MMs.",
          "sentiment": 0.0,
          "engagement": "324",
          "price_at_post": "0.275",
          "thread_title": "**** drop",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=DDC62C70-85CB-418D-B6A7-4EC41E27F08D"
        },
        "ingested_at": "2026-02-11T17:11:28.890886+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262144-LlamaFar-16143265",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.570667",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Only slightly .. 001 and 002 - Aud - market leading results 014 - Ptsd - no other treatment 015 - Meth & coke - no other treatment.",
          "sentiment": 0.0,
          "engagement": "868",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890904+00:00"
      },
      {
        "event_id": "SOCIAL-25Jan20262003-dvharris-68273754",
        "event_type": "social_post",
        "date": "2026-01-29T10:41:29.571083",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Are you suggesting we're undervalued?  \ud83e\udd23",
          "sentiment": 0.5,
          "engagement": "21,054",
          "price_at_post": "0.28",
          "thread_title": "RE: GDP",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&share=SVNS&thread=754FAE72-C2E8-491B-9AE7-6ED238B6448A"
        },
        "ingested_at": "2026-02-11T17:11:28.890922+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261725-MadEngli-66891860",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.233592",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Next week Rodney...\ud83d\ude01 ATB",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.28",
          "thread_title": "This time...",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=784600CF-6EA6-48B9-8E3B-25B205222B70"
        },
        "ingested_at": "2026-02-11T17:11:28.890939+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261122-Stretcht--3098624",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234032",
        "source": "LSE_CHAT",
        "data": {
          "author": "Stretchtarget",
          "content": "Time to test those recent highs and have some positive news hitting the wires.",
          "sentiment": 0.0,
          "engagement": "195",
          "price_at_post": "0.28",
          "thread_title": "RE: 24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-11T17:11:28.890958+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261107-EpicViru--7500039",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234477",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Let's keep this countdown ticking. GLA \ud83d\udc0e Time to run the race",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.28",
          "thread_title": "24/90 Countdown",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=E34D1E5A-0A41-4B77-B181-9068B2C44E35"
        },
        "ingested_at": "2026-02-11T17:11:28.890976+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261047-dvharris-70613080",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.234903",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Nice to see some upward movement ahead of expected newsflow this quarter......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.28",
          "thread_title": "RE: FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-11T17:11:28.890994+00:00"
      },
      {
        "event_id": "SOCIAL-23Jan20261031-Andys288-48441603",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235327",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Strong support today, and I wouldn\u2019t want to be out over the weekend with all the expected news,",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "FOMO Friday?",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=2673E788-F193-4D8C-85F6-7DDB79844627"
        },
        "ingested_at": "2026-02-11T17:11:28.891011+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261836-MadEngli--1522242",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.235739",
        "source": "LSE_CHAT",
        "data": {
          "author": "MadEnglish",
          "content": "Https://thatstocksguy.substack.com/p/solvonis-therapeutics",
          "sentiment": 0.0,
          "engagement": "719",
          "price_at_post": "0.27",
          "thread_title": "Charles Archer notes on Solvonis Therapeutics",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=4275A401-E4C9-4252-BFFC-45397A4B8DC5"
        },
        "ingested_at": "2026-02-11T17:11:28.891030+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261521-Andys288--3208488",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236157",
        "source": "LSE_CHAT",
        "data": {
          "author": "Andys288",
          "content": "Shame it\u2019s only 68 more, one more would be funnier",
          "sentiment": 0.0,
          "engagement": "514",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-11T17:11:28.891048+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261219-LlamaFar-46597115",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236578",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "DVH - Spot on. It's akin to someone saying Hi how are you, 5 minutes later, Hi how are you, 5 minutes after that .... Hi are you still ok? 31/03/2026 is 90/90 ,there'll be a lot of, Hi how are you's till then :)",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-11T17:11:28.891065+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20261122-dvharris--2912440",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.236990",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "The BoD told us that Q1 was going to be news rich, so we patiently await their updates......",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-11T17:11:28.891083+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260924-EpicViru-20419800",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237415",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Its all intentional, we dont want a rushed licenced deal for peanuts were going for the big stuff. The board know what we have, just play the long game make everyone work for it. The longer its delayed the better IMO we arent selling ourselves short over here - fully funded for the year",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-11T17:11:28.891110+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260826-dvharris--1956582",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.237828",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Volume very thin atm. Hopefully next update will blow the doors off.....",
          "sentiment": 0.5,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-11T17:11:28.891129+00:00"
      },
      {
        "event_id": "SOCIAL-22Jan20260732-EpicViru-20358589",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238254",
        "source": "LSE_CHAT",
        "data": {
          "author": "EpicViruz",
          "content": "Can feel the pressure building, day by day. Like a popcorn kettle, patience is a virtue. Gla",
          "sentiment": 0.0,
          "engagement": "36",
          "price_at_post": "0.27",
          "thread_title": "News Imminent 22/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=15CDBC14-53BF-4D08-96D2-B017BF3C12D4"
        },
        "ingested_at": "2026-02-11T17:11:28.891147+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261117-TrickyEF--6616020",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.238671",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "Along with licensing news/funding the bridging data news if positive may be one hell of a catalyst to get the share motoring. Lord give me patience and I want it right now \ud83d\ude01",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-11T17:11:28.891165+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261102-BuckFuzb--4736672",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239142",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Conversation with Gemini SVNS trading pattern today Today\u2019s trading for Solvonis Therapeutics (SVNS) is characterized by high-volume \"deck clearing\" and a major ownership transfer during the early SETSqx auctions. Following a period of compression, the pattern today suggests we are witnessing the final stages of a strategic supply overhang (a \"wall\" of shares from a large seller) being absorbed by the market. 1. Level 2 & The \"Wall\" Dynamics The Level 2 order book today shows a heavy concentration of volume at the 0.26p - 0.27p support floor. Spotting the Wall: Throughout the morning, large blocks (including a 3.15 million share print at 08:01:01) have hit the tape. This is a classic sign of a \"Principal Trade\" or a managed \"Leak-Out\" where a dominant institutional seller is fulfilling a quota. Signs of a Break: We are seeing \"Volume Exhaustion.\" While the price has drifted slightly, the trade frequency is decreasing despite high unit volume. This indicates the seller is running out of \"ammo,\" and the liquidity vacuum behind the wall is starting to form. 2. SETSqx Auction Advantage The 08:00 opening auction was the most significant event today, uncrossing the 3.1M block at 0.2699p. The Strategy: Traders using the Auction Advantage look for these uncrossings to gauge the \"true\" demand. The fact that such a large block was absorbed without the price collapsing below 0.26p suggests that buyers (likely institutional) are waiting at this floor. Next Milestone: The 11:00 intraday auction will be critical. If the uncrossing price holds above 0.27p, it confirms the \"Transfer of Ownership\" is complete and the overhead supply is exhausted.",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-11T17:11:28.891183+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261101-dvharris--1552180",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239562",
        "source": "LSE_CHAT",
        "data": {
          "author": "dvharrison",
          "content": "Only news on licence/funding will move the dial here atm. Just a steady drift down with the help of our seller....",
          "sentiment": 0.0,
          "engagement": "21,007",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-11T17:11:28.891201+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261056-LlamaFar-55080272",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.239967",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Trying their best aren't they!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-11T17:11:28.891219+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20261021-RhHh-53627727",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240392",
        "source": "LSE_CHAT",
        "data": {
          "author": "RhHh",
          "content": "The seller is pretty relentless.",
          "sentiment": 0.0,
          "engagement": "318",
          "price_at_post": "0.27",
          "thread_title": "RE: Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-11T17:11:28.891236+00:00"
      },
      {
        "event_id": "SOCIAL-21Jan20260832-LlamaFar--4743530",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.240809",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Swapped sides,and on the upside now. https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.27",
          "thread_title": "Sint Trades",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=5D09592D-5CC5-465C-90DD-7C0D95739039"
        },
        "ingested_at": "2026-02-11T17:11:28.891255+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20262319-covgaz--6454064",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241235",
        "source": "LSE_CHAT",
        "data": {
          "author": "covgaz",
          "content": "AI bulls T , get a grip. The trend is down , nobody knows where it will stop , I suggest 23. We'll see soon enough.",
          "sentiment": 0.0,
          "engagement": "3,499",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-11T17:11:28.891272+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261812-ComesMar--2763327",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.241643",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I use Gemini. I think it does a great job, specifically if you feed it with data, to stress test any information or statements you find. One thing to be wary: you can tune the answer to be supportive, balanced or challenging.  I tried all three, and I found that the challenging mode falls into generic warning signals, so I prefer the balanced mode. I find  useful to rephrase the same question more times in different ways, to double check the consistency.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-11T17:11:28.891290+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261754-BuckFuzb--7633029",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242059",
        "source": "LSE_CHAT",
        "data": {
          "author": "BuckFuzby",
          "content": "Hello @ComesMarcellino thank you for your input. Just out of interest, which AI are you using to answer your questions?",
          "sentiment": 0.0,
          "engagement": "6",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-11T17:11:28.891308+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261654-ComesMar--1708692",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242517",
        "source": "LSE_CHAT",
        "data": {
          "author": "ComesMarcellino",
          "content": "I think today the battle was definitely won by the seller. I asked AI a few more things. This time I summarise with my own words: Q: Was the seller an insider knowing poor RNs is coming? A: No, that would drive panic selling and not a slow walk down of the SP Q: Could this selling have been predicted? A: The SINT trades in the previous days might have signaled an SP exploration to find out at what level new buyers could be found. Reading that correctly could have suggested to wait for today as a better entry if the target was to load more. Q: can the SP drop further? A: If the seller has more to sell, yes. I am leaning towards that the seller has finished. Q: Can this affect the SP future performance? A: That depends on the quality of the next RNs. All scenarios are the same as before. Q: will geopolitics matter? A: If the science will prove good, the deal will be made.",
          "sentiment": 0.0,
          "engagement": "64",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-11T17:11:28.891326+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261627-DrMicho--3327586",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.242929",
        "source": "LSE_CHAT",
        "data": {
          "author": "DrMicho",
          "content": "Considering we are waiting for an influx of news it seems that people know something we dont.... if its another begging bowl I wont be happy..",
          "sentiment": 0.0,
          "engagement": "8,146",
          "price_at_post": "0.265",
          "thread_title": "RE: Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-11T17:11:28.891344+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261608-TrickyEF-11967742",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243353",
        "source": "LSE_CHAT",
        "data": {
          "author": "TrickyEFC",
          "content": "What will it bring",
          "sentiment": 0.0,
          "engagement": "16,035",
          "price_at_post": "0.265",
          "thread_title": "Tomorrow",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=0022D90F-E1E5-4ED5-808A-6EA0084FA79D"
        },
        "ingested_at": "2026-02-11T17:11:28.891362+00:00"
      },
      {
        "event_id": "SOCIAL-20Jan20261555-LlamaFar--9084035",
        "event_type": "social_post",
        "date": "2026-01-24T02:08:53.243772",
        "source": "LSE_CHAT",
        "data": {
          "author": "LlamaFarmer",
          "content": "Agree broadly for the markets, disagree for Pharmas, especially those addressing large unmet needs that affect the EU 4, USA, Japan & China. Same as last time round with Covid, you didn't have to be out of the market - you had to place the capital correctly. Good news will increase it's value, if Trump sees a treatment for Meth, coke and alcohol on the horizon he will let it in, no matter what other ideas he is having that day, something that helps \" the American people\" will fit his mantra and get bought  up. If only we had an existing investor who was a member at Mar a Lago and could promote the company!",
          "sentiment": 0.0,
          "engagement": "853",
          "price_at_post": "0.265",
          "thread_title": "RE: Day 20/90",
          "thread_url": "https://www.lse.co.uk/ShareChat.html?ShareTicker=SVNS&thread=CE424D84-983C-4F1B-8F7D-71ACE0B583C6"
        },
        "ingested_at": "2026-02-11T17:11:28.891379+00:00"
      }
    ],
    "catalyst_dates": {
      "proxy_date": "2025-10-07"
    }
  },
  "ai_insights": {
    "key_insights": [],
    "hidden_patterns": [],
    "contrarian_signals": [],
    "risk_warnings": [],
    "opportunity_flags": [],
    "narrative_summary": "SVNS.L presents a standard crash recovery setup without unusual patterns detected. Monitor for catalyst developments and trend shifts.",
    "_is_real": false
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "INDUSTRIALS",
      "name": "Industrials",
      "icon": "\ud83c\udfed",
      "color": "#64748b",
      "crash_patterns": [
        "Order book decline or cancellations",
        "Margin compression (input costs)",
        "Cyclical demand weakness",
        "Project delays or overruns",
        "Working capital strain"
      ],
      "recovery_paths": [
        "Order book growth or new contracts",
        "Margin recovery (efficiency gains)",
        "Cyclical upturn (capex recovery)",
        "M&A consolidation",
        "Product innovation or new markets"
      ],
      "active_patterns": [],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Order book value (forward revenue)",
        "Book-to-bill ratio",
        "Operating margin trends",
        "Working capital efficiency",
        "Capex cycles (customer industries)"
      ]
    },
    "panic_analysis": {
      "panic_score": 50.5,
      "signal": "MODERATE_FEAR",
      "interpretation": "\ud83d\udfe1 Cautious sentiment - assess risk/reward",
      "breakdown": {
        "price_destruction": 28.5,
        "volume_death": 14,
        "social_silence": 6,
        "news_sentiment": 2
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 28/40 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 152% proven capacity"
      ],
      "verdict": "\u2696\ufe0f Mixed signals - Fear and facts balanced, wait for clarity"
    },
    "crashhunter_signals": [
      {
        "type": "BUILDING",
        "icon": "\ud83d\udcca",
        "text": "Building",
        "color": "#10b981"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 61",
        "color": "#3b82f6"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Expansion of SVN-015 into depression",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "US Patent allowance for PTSD discovery programme",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Research and Development Update - Q4 2025",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "SVN-015 accepted into US NIDA funded programme",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Total Voting Rights",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Funding announcement or operational update",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Volume expansion confirmation",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      }
    ],
    "decision_matrix": {
      "decision": "WATCH",
      "reason": "\u23f3 Monitor for timing regime change or panic escalation",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "50/100",
          "pass": false,
          "icon": "\ud83d\udfe2"
        },
        {
          "criterion": "Timing Regime",
          "value": "EARLY_BUILD",
          "pass": true,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "61/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "45/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "0 active",
          "pass": true,
          "icon": "\ud83c\udfed"
        }
      ],
      "pass_rate": "4/5"
    },
    "contrarian_panic": {
      "total_score": 32,
      "band": "\ud83d\udfe2 MILD COMPRESSION (Top 50% - WATCHLIST)",
      "components": {
        "compression": {
          "score": 3,
          "max": 40,
          "signals_30d": 1,
          "signals_60d": 1,
          "signals_90d": 1,
          "signals_per_week": 0.08,
          "total_signals": 31,
          "rsi_extreme_count": 0,
          "rsi_ultra_count": 0,
          "escalation_count": 0,
          "density_score": 3,
          "rsi_score": 0,
          "escalation_score": 0,
          "description": "0.1 signals/week | Early stage"
        },
        "intensification": {
          "score": 10,
          "max": 20,
          "recent_types": [
            "CRASH ZONE BOTTOM",
            "CRASH ZONE BOTTOM",
            "DEEP CRASH BOTTOM"
          ],
          "escalating": true,
          "sustained": false,
          "current_intensity": 2,
          "pattern": "ESCALATING - Getting worse"
        },
        "volume_death": {
          "score": 5,
          "max": 15,
          "relative_volume": 2.03,
          "description": "Elevated volume - Some activity"
        },
        "pop_potential": {
          "score": 14,
          "max": 15,
          "best_historical_rally": 648.2,
          "avg_rally": 128.7,
          "signal_count": 31,
          "description": "BIG POPPER - Historical 5x+ (648%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation detected"
        }
      },
      "ticker": "SVNS.L",
      "signal_date": "2025-03-10",
      "total_signals_history": 31
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +15 (AI_Technical_Score=12.0/20)",
      "Drawdown reversion potential: +18 (Drawdown_Pct=89.0%)",
      "Volume confirmation: +10 (Relative_Volume=2.0)",
      "Pattern reliability: +10 (Rally_Count=3.0)",
      "Upside history: +8 (best_rally_pct=152%)"
    ],
    "technical_score": {
      "points": 15,
      "ai_score": 12.0,
      "reason": "AI Technical Score 12.0/20 translates to 15/25 points"
    },
    "drawdown_score": {
      "points": 18,
      "drawdown_pct": 88.98,
      "reason": "Drawdown of 89.0% gives 18/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.03,
      "reason": "Relative volume 2.03x gives 10 points"
    },
    "pattern_score": {
      "points": 10,
      "rally_count": 3.0,
      "reason": "3.0 historical rallies gives 10/15 points"
    },
    "upside_score": {
      "points": 8,
      "best_rally_pct": 151.61,
      "reason": "Best rally of 152% gives 8/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Early stage positioning offers best R:R if catalysts appear",
        "tag": "MED",
        "evidence": [
          "timing_regime=EARLY_BUILD",
          "current_return_pct=76.8%"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2025-03-10"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Watch / Starter",
      "action": "Wait for base + catalyst confirmation; starter position only",
      "sizing": "0-1% until CONFIRMED",
      "risk": "Invalidation = breaks recent lows / dilution / suspension",
      "profit_taking": "Scale out 25% at +15%, 25% at +50%, runner above"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "EARLY_BUILD",
    "run_multiple": 0.51,
    "current_run_pct": 76.77,
    "avg_historical_run_pct": 151.61
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows EARLY_BUILD timing with 61/100 APEX score. Historical data shows 3 rallies averaging 152% upside. Current position: +76.8%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Early regime often offers best risk/reward"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Early accumulation phase. Watch for confirmation before committing size.",
    "confidence_explained": "Confidence 45/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": true
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  },
  "report_version": "5.0",
  "comprehensive_apex": {
    "score": 61,
    "rating": "MODERATE",
    "color": "#f59e0b",
    "calculation": "APEX Score: 61/100",
    "components": {
      "setup": {
        "score": 60,
        "weight": 0.25
      },
      "trust": {
        "score": 45,
        "weight": 0.2
      },
      "panic": {
        "score": 50.5,
        "weight": 0.3
      },
      "compression": {
        "score": 32,
        "weight": 0.25
      }
    },
    "timing": {
      "regime": "EARLY_BUILD",
      "multiplier": 1.0
    }
  }
}